Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.8859094229558164,1.8294851556868206,0.0,0.3729116184160184,0.33,2/10,1.56%,GULP1;ARHGAP12
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.7318651306496212,1.707249681047969,0.0,1.0,0.81,4/19,4.60%,PLA2G4A;IL1R1;NKD1;OCLN
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.8145191609377165,-1.7032568108830877,0.0,0.05464628106461047,0.05,26/73,8.96%,MAFF;SERPINE1;DDIT4;ANGPTL4;BHLHE40;ADM;LDHA;NDRG1;PCK1;PGK1;DTNA;KLF6;ATF3;SLC2A3;HSPA5;ERO1A;JUN;BNIP3L;FOS;AKAP12;SLC6A6;GAPDH;DUSP1;CDKN1B;SLC2A1;FOSL2
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.7334715859321567,1.663991920625715,0.0,1.0,0.96,4/22,6.67%,UBP1;RSAD2;EIF2AK2;FAM111A
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.8959779068460055,1.6590222202462759,0.0,1.0,0.97,4/11,6.67%,ATR;PRIMPOL;THOC1;FAM111A
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.7974460407692766,1.6422352204499238,0.0,1.0,0.99,2/11,1.58%,CREB5;UBE3D
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.8797389507554023,-1.6100267300971827,0.0,0.46995801715565,0.51,3/13,2.67%,MAP2;NRCAM;RTN4
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.817812281746167,1.609167672541949,0.037037037037037035,1.0,0.99,3/10,5.48%,HOMER1;RSAD2;IL15
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.8204979347577273,1.6044939581623403,0.0,1.0,0.99,6/13,13.50%,ATR;PRIMPOL;THOC1;FAM111A;MSH3;MCM9
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.8132585703611014,1.5947628110175154,0.06060606060606061,1.0,1.0,5/9,11.94%,PLA2G4A;MBOAT2;PLAAT3;PLA1A;OSBPL8
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.8943627466106643,1.5794526339769384,0.04,1.0,1.0,2/7,4.49%,ARID5B;TGFBR3
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.8653342821547978,1.5749069770910085,0.05405405405405406,1.0,1.0,3/7,5.61%,STX8;GBP1;ZDHHC2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.8192182470568843,1.5569174234825807,0.038461538461538464,1.0,1.0,1/7,5.19%,OTUD4
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.7618054139285989,1.5451470921401345,0.045454545454545456,1.0,1.0,3/13,3.19%,BMP6;IL6R;PRKD1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.9538908918336334,-1.541928180502711,0.014285714285714285,1.0,0.95,3/6,4.23%,RIMKLB;GLUD1;GLUL
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.9069043193380237,1.5383601350640521,0.034482758620689655,1.0,1.0,1/6,0.78%,ATG10
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.7340939220649876,1.5334303782568943,0.03333333333333333,1.0,1.0,1/9,0.16%,UBP1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.8130470512706116,-1.5328535093744586,0.025,1.0,0.97,1/22,0.08%,CEP57
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.7540885490585374,-1.5315367351557119,0.01098901098901099,1.0,0.97,29/70,16.23%,MAFF;SERPINE1;BHLHE40;BTG2;NR4A1;KLF6;ATF3;SLC2A3;JUN;FOS;HES1;JUNB;ATP2B1;NFE2L2;DUSP1;KLF2;IFNGR2;BCL6;REL;FOSL2;KLF4;SMAD3;ZFP36;DUSP5;NFKBIA;CCNL1;CDKN1A;BTG1;SOD2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.752563322791302,1.5298617901516465,0.0,1.0,1.0,2/10,1.56%,GULP1;ARHGAP12
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.9093164275720442,-1.5284911704035147,0.0125,1.0,0.97,2/11,3.50%,TBX3;HES1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.6840334837647771,1.5277792574272,0.0,1.0,1.0,4/20,11.45%,RSAD2;EIF2AK2;FAM111A;OAS3
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.9325487191179561,-1.5275999069841488,0.0,1.0,0.98,3/7,5.56%,PCK1;PGK1;GAPDH
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.7823820311696033,-1.5228770481592824,0.011111111111111112,1.0,0.98,1/33,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.8731396737142211,-1.5223372086326195,0.013157894736842105,1.0,0.98,1/13,0.60%,DDIT4
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.7394709274465565,-1.5204766608344913,0.0,0.9246150756132092,0.98,19/67,9.11%,PIK3R3;DDIT4;PSMC6;BHLHE40;BTG2;LDHA;PGK1;SLC2A3;HSPA5;ERO1A;PPA1;CD9;SLC6A6;GAPDH;CANX;GMPS;PLOD2;SLC2A1;PNP
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.7852821937558351,1.5167373819736802,0.04,1.0,1.0,1/6,4.15%,TTN
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.9509554926194251,-1.516302956266786,0.0,0.848838899203616,0.98,1/8,0.21%,TBX3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.9509554926194251,-1.516302956266786,0.0,0.848838899203616,0.98,1/8,0.21%,TBX3
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.8416380718506581,1.5128450814870869,0.043478260869565216,1.0,1.0,1/8,2.31%,UIMC1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.9865835658167939,-1.511456570465005,0.0,0.8827476171975538,0.98,1/5,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.7668552438665069,-1.5073960996889317,0.03488372093023256,0.8985409929338094,0.98,8/27,16.61%,CEP57;NR4A1;HYAL2;FGFR1;KIF16B;ZFP36;GRB2;RAB14
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.7154742021138533,-1.5061957467681801,0.0,0.8634112408208454,0.98,18/71,12.07%,TBX3;DDIT4;NRCAM;GRIK1;PBX3;SPOCK1;NES;ELP3;SEMA6B;GRIN2B;BTD;SMARCA1;SLC2A1;MBP;NPAS2;PRKN;SYNJ2;DCLK1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.9260405082155615,-1.505846495213561,0.0,0.8135465093493883,0.98,4/6,5.56%,PKM;LDHA;PGK1;GAPDH
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.9411997839129002,-1.5048133381208377,0.0,0.7817632679360744,0.98,3/6,5.56%,PCK1;PGK1;GAPDH
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.7323538867290955,-1.5034163326200498,0.0,0.7595833067980855,0.99,19/81,12.05%,PIK3R3;SERPINE1;LAMC1;BHLHE40;YTHDC1;MGLL;PPARG;SMAD7;MAP1B;ATP2B1;GRK5;DUSP1;CDKN1B;PRKCE;MAGI2;DLC1;GJA1;SYNJ2;WDR37
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.8807972654017989,-1.5027080142241689,0.013888888888888888,0.7339858382993996,1.0,2/15,2.88%,CCDC3;PPARG
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.8388921374014,-1.5026010283812032,0.0,0.7011117860589524,1.0,2/17,2.78%,DIXDC1;WNT2B
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.8859756147221683,1.496928209290503,0.02857142857142857,1.0,1.0,2/6,2.83%,GBP2;GBP4
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.8507929092495616,1.4963770460026593,0.16666666666666666,1.0,1.0,3/5,8.90%,ATR;ATM;ERCC6
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.8505958177036326,-1.4915659904597567,0.013157894736842105,0.8394709653068255,1.0,1/11,0.49%,MAP2
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.887808936513842,-1.4911258808643022,0.013888888888888888,0.8057842535163471,1.0,3/8,5.56%,PCK1;PGK1;GAPDH
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7218451721112307,-1.4870080802833527,0.0,0.8334745824984936,1.0,28/60,20.69%,RPS18;RPL23;RPS12;RPL34;RPS9;DMD;RPS27A;RRBP1;EEF1A1;GGT5;RPL37;RPS11;RPS15;RPS27;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;RPS28;RPL24;RPL7A;RPL31;RPLP1;RPL37A;RPS19
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.8012468691242106,-1.4839727292902185,0.028985507246376812,0.8406419570439245,1.0,1/18,0.16%,CCDC3
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.719636884869086,-1.4822697544200396,0.011764705882352941,0.8363066854127987,1.0,24/51,21.86%,RPS18;RPL23;RPS12;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS15;RPS27;RPL10;RPS6;RPL8;RPL15;RPS7;RPL13A;RPS28;RPL24;RPL7A;RPL31;RPLP1;RPL37A;RPS19;RPL21
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.7440889335765981,-1.4810955150393892,0.0,0.8306234721820792,1.0,6/42,7.55%,TBX3;LAMC1;PLS3;NES;PLOD2;SMARCA1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.8468231700594038,-1.4806197520769382,0.01282051282051282,0.8071458106876539,1.0,2/14,2.05%,PIK3R3;NR4A1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.9134008931294622,-1.480617977819908,0.0,0.7783191745916663,1.0,1/9,0.21%,TBX3
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.7506101609732311,-1.4803618867854318,0.0,0.7552492914033062,1.0,7/34,3.04%,DDIT4;ANGPTL4;PKM;LDHA;PGK1;HSPA5;ERO1A
prerank,MSigDB_Hallmark_2020__Coagulation,-0.7926638405709693,-1.478271237530642,0.023809523809523808,0.7661408605258389,1.0,9/30,10.83%,MAFF;SERPINE1;CD9;TIMP3;LAMP2;RAPGEF3;VWF;PECAM1;ANXA1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.7282763447273586,1.4778487357096441,0.11538461538461539,1.0,1.0,1/7,2.47%,NKD1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.9804419944214613,-1.4754120670439976,0.0,0.7816180975499446,1.0,1/5,0.16%,CCDC3
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.7634014336688372,-1.474898187283035,0.0,0.7677802489577771,1.0,4/49,2.88%,PIK3R3;PKM;PCK1;PPARG
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.9601311203411734,-1.4745668597834454,0.0,0.7474948870474293,1.0,1/6,0.60%,DDIT4
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.8563193469347049,1.4728599850091553,0.0967741935483871,1.0,1.0,5/6,11.94%,PLA2G4A;MBOAT2;PLAAT3;PLA1A;OSBPL8
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.7544290282330156,1.4690334613156402,0.12903225806451613,1.0,1.0,1/8,2.91%,YEATS2
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.8418767116593697,-1.4685802504786742,0.06451612903225806,0.8074791649076558,1.0,4/8,10.57%,RFC3;NPLOC4;RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.8280023042663496,-1.4653246695253903,0.0,0.8337461168143425,1.0,3/12,3.66%,BHLHE40;HES1;CX3CL1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.9356936816327378,-1.4652647138176988,0.01694915254237288,0.8124080451605423,1.0,2/5,2.67%,NRCAM;RTN4
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.9093920916482017,-1.4643554779379022,0.025974025974025976,0.8049249508165597,1.0,4/10,6.67%,ADAMTS9;HES1;SMAD7;FOXF1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.7460736679935974,-1.4639335122833752,0.012195121951219513,0.7886321193640101,1.0,4/29,2.88%,TBX3;LAMC1;PLS3;PPARG
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.9183471804486256,-1.4636129772394038,0.015384615384615385,0.7717736310355755,1.0,1/7,1.12%,BHLHE40
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.9196361822585004,-1.4600092741984263,0.0,0.8011144804071895,1.0,1/7,0.49%,MAP2
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7086222911455728,-1.4589830925147909,0.011363636363636364,0.795436598520964,1.0,29/67,20.69%,RPS18;PPA1;RPL23;RPS12;RPL34;RPS9;RPS27A;RRBP1;EEF1A1;RPL37;RPS11;RPS15;RPS27;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;PPA2;RPS28;RPL24;RPL7A;LARS1;RPL31;RPLP1;RPL37A;RPS19
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.8322828574111184,-1.4576930792041154,0.0,0.7980959239293348,1.0,6/15,7.17%,SERPINE1;VSIR;SPOCK1;PSMB9;GAPDH;TIMP3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.8171224903921441,-1.4553964870463472,0.04225352112676056,0.8113066472476123,1.0,2/14,5.61%,SERPINE1;LGALS3
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.8831228174614468,1.4540083836929811,0.030303030303030304,1.0,1.0,1/5,0.86%,PLA2G4A
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.8831228174614468,1.4540083836929811,0.030303030303030304,1.0,1.0,1/5,0.86%,PLA2G4A
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.8398796542214543,-1.4538034683427898,0.0136986301369863,0.8147263722360106,1.0,3/14,5.30%,ST18;SLC4A10;GRIA2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.868494004683029,1.4535248777419079,0.027777777777777776,1.0,1.0,2/5,1.01%,ATG10;UGCG
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7001394591814538,-1.4520886886331665,0.02247191011235955,0.8201799606897313,1.0,27/54,22.77%,RPS18;RPL23;RPS12;RPL34;RPS9;RPS27A;RPL37;TRAM1;RPS11;RPS15;RPS27;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;RPS28;RPL24;RPL7A;RPL31;RPLP1;RPL37A;RPS19;RPL21;SEC62
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.8275372312193852,1.4519997383140457,0.05263157894736842,1.0,1.0,2/6,3.79%,PACS2;ATP2A2
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.9417859161263036,-1.451654010847973,0.0,0.8075769971243957,1.0,4/5,5.56%,PKM;LDHA;PGK1;GAPDH
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.8351376464095106,-1.4507933352006122,0.01282051282051282,0.7992309277407073,1.0,3/17,5.43%,MAP2;KDM1A;GPC5
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6486072530699258,1.4497545916908867,0.1111111111111111,1.0,1.0,6/17,13.47%,EFNA5;CLASP1;BICD1;MARK2;ROCK1;PHLDB2
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7071156488009726,-1.4491196138043438,0.011494252873563218,0.8073988027296198,1.0,24/51,20.69%,RPS18;RPL23;RPS12;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS15;RPS27;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;RPS28;RPL24;RPL7A;RPL31;RPLP1;RPL37A;RPS19
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.7795690292862518,-1.4480695332518614,0.058823529411764705,0.80675754534978,1.0,10/21,16.54%,DDIT4;NRCAM;SPOCK1;MAP1B;ELP3;FGFR1;GPM6A;NAV1;ADGRL3;PAFAH1B1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.9387956387514778,-1.4480367878093834,0.01639344262295082,0.7910595646913012,1.0,1/6,1.12%,BHLHE40
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.920911786949656,-1.4472631012260762,0.03896103896103896,0.7851920541989521,1.0,1/7,0.29%,SERPINE1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.7010934304334059,-1.4459155192221766,0.02247191011235955,0.7866962693262962,1.0,28/55,22.77%,RPS18;RPL23;RPS12;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS15;RPS27;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;RPS28;RPL24;RPL7A;RPL31;RPLP1;RPL37A;SPCS3;RPS19;CHMP4B;RPL21;SEC62
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.8521033972540051,-1.4449258459869236,0.0379746835443038,0.7856691730421355,1.0,5/10,5.56%,PKM;LDHA;PCK1;PGK1;GAPDH
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.7089760529249465,-1.4442857702831255,0.04878048780487805,0.7792154892546308,1.0,12/42,10.85%,SERPINE1;UFL1;NFKBIZ;MGLL;PPARG;CX3CL1;BCL6;TMSB4X;KLF4;SNX6;ANXA1;HYAL2
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.6530600667627693,1.4405388024018906,0.08695652173913043,1.0,1.0,3/12,4.57%,IL6R;PRKD1;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.8980947673739397,-1.43894889896268,0.034482758620689655,0.8314183271793827,1.0,2/8,5.61%,SERPINE1;LGALS3
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.8229550960009128,-1.438492837095655,0.013333333333333334,0.8206700424167395,1.0,9/16,11.58%,MAFF;SERPINE1;BHLHE40;NFKBIZ;TINAGL1;LGALS3;FOSL2;KLF4;CD55
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.915471724668434,-1.4381922905994087,0.0,0.8108741144639918,1.0,2/7,2.91%,PPARG;PRKAG2
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.8997891032357318,-1.4376880039059918,0.047619047619047616,0.8008506707744639,1.0,2/8,2.91%,PPARG;PRKAG2
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.9049908704015878,-1.4362940649020028,0.02702702702702703,0.8035781940958652,1.0,2/6,1.90%,MTHFD1L;PCK1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.8691019984502563,-1.434683339263928,0.041666666666666664,0.7972981991393987,1.0,1/9,0.39%,LAMC1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.8691019984502563,-1.434683339263928,0.041666666666666664,0.7972981991393987,1.0,1/9,0.39%,LAMC1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.7577470440330992,-1.4314115198999269,0.011494252873563218,0.8205756075992314,1.0,6/28,9.45%,CCDC3;PCK1;PPARG;PRKAG2;LSS;SIN3B
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.889289417842845,1.430286789622457,0.08695652173913043,1.0,1.0,4/5,10.59%,ACAT1;HIBCH;HIBADH;AUH
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.889289417842845,1.430286789622457,0.08695652173913043,1.0,1.0,4/5,10.59%,ACAT1;HIBCH;HIBADH;AUH
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.9344431643884551,-1.4292382568190403,0.015625,0.8363483206745621,1.0,3/6,4.23%,RIMKLB;GLUD1;GLUL
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.8080546170739651,-1.427547895760626,0.046511627906976744,0.8444558120765586,1.0,6/15,11.79%,DDIT4;MAP3K5;FOS;GRIN2B;PRNP;EFNB2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.7944673702375008,-1.4264823815805576,0.05405405405405406,0.8442430068474128,1.0,3/18,5.53%,MAP3K5;BCAP31;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.9357735967673906,-1.424870803657982,0.03076923076923077,0.8506604419057696,1.0,2/6,2.67%,MAP2;RTN4
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.8133222878817162,-1.4242764047307432,0.02666666666666667,0.8475882877961671,1.0,1/17,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.8059107350664582,-1.4238294643477465,0.012048192771084338,0.8401062091903498,1.0,8/22,11.79%,DDIT4;MAP3K5;FOS;SLC6A6;GRIN2B;CDKN1B;PRNP;EFNB2
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.905253497004822,-1.4233797030905906,0.0136986301369863,0.8336329775160722,1.0,1/7,1.19%,MAP3K5
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.821759582144169,1.422368707034145,0.10810810810810811,1.0,1.0,4/6,12.38%,ATR;ATM;ERCC6;STK33
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.8771384214148302,-1.4219372519089364,0.031746031746031744,0.8379616870678983,1.0,1/11,0.21%,TBX3
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.9304115665843993,-1.4218142991847136,0.014492753623188406,0.8276987416462267,1.0,1/5,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.8150358063256817,1.4198319400391812,0.06896551724137931,1.0,1.0,1/6,0.31%,PGM5
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.7407868571613627,-1.4196902192476903,0.06756756756756757,0.845651199474847,1.0,6/16,14.93%,GLUL;RPS15;NPM1;RPS6;RPS7;RPS28
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.9217451380264554,-1.4171148136202238,0.030303030303030304,0.8664055575915091,1.0,2/6,5.53%,PSMB9;GRIN2B
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.7063740604820516,-1.4167594175044687,0.02564102564102564,0.8589804612750662,1.0,12/38,12.95%,TBX3;ANGPTL4;EPS8;TIMP3;COL18A1;LAMA5;TNS1;ITGB5;EPAS1;CD55;CST3;SHC2
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.9883527306638948,-1.415974414706508,0.0,0.8593309851680212,1.0,1/5,0.08%,CEP57
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.6656912067164205,-1.4155242585172514,0.041666666666666664,0.8532010146219314,1.0,20/76,18.54%,TBX3;NR4A1;JUN;RPL23;JUNB;GRK5;JUND;DUSP1;CDKN1B;RASSF1;MAGI2;CRLF3;SDCBP;SMAD3;RACK1;XIAP;CDKN1A;CYLD;CDK6;GADD45B
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.7759953691275798,-1.4148610652961848,0.037037037037037035,0.8512045390765429,1.0,4/17,10.18%,BHLHE40;HES1;CX3CL1;TGM2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.861528635007881,-1.4140351513837213,0.046875,0.849819729889391,1.0,3/8,3.04%,MAP3K5;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.8383969351929232,-1.4138252078347364,0.078125,0.8432128685792425,1.0,3/8,12.31%,POLA1;PURA;NOC3L
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.7198652817489211,-1.413057181625114,0.07228915662650602,0.8412794969896782,1.0,13/40,12.95%,CCDC3;DOK5;MAP2;ADM;NES;MAP1B;NFASC;ANK2;PTPRD;STOX2;GJA1;DCLK1;SHC2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.8497198749877003,-1.4130032685938592,0.047619047619047616,0.8317029048944665,1.0,1/11,0.29%,SERPINE1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.81137267846537,1.412313206385028,0.07142857142857142,1.0,1.0,1/7,0.05%,DSE
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.8804603133571797,-1.4118014439899653,0.04225352112676056,0.8364879511255984,1.0,1/8,0.29%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.9094418123509076,-1.4115945136916397,0.02857142857142857,0.827989916468122,1.0,3/6,8.62%,SMAD7;DMD;ANK2
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.7586543358173934,-1.4109347480996746,0.05263157894736842,0.8258093950406731,1.0,4/17,5.61%,PPP2R3A;PGK1;PPARG;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7993281502355952,1.407155217256795,0.15789473684210525,1.0,1.0,2/6,12.15%,RC3H1;PNPT1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.7876811831009253,1.4066712343230783,0.2,1.0,1.0,1/5,4.15%,TTN
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.8176604601161561,-1.406065355449739,0.08064516129032258,0.875111973942915,1.0,2/6,11.27%,SLC6A6;GJA1
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.6994213678320715,-1.4050910789786695,0.021505376344086023,0.8743404970337676,1.0,23/63,19.13%,MAFF;BHLHE40;NDRG1;NFKBIZ;KLF6;SLC2A3;AHNAK;EMP1;PNP;IFNGR1;PHTF2;TGM2;CD81;SERPINB6;PRNP;PLIN2;PLEC;PLPP1;GABARAPL1;ARL4A;MYO1E;GADD45B;IL18R1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.8974615957191987,-1.404284562624817,0.014925373134328358,0.8651499861274466,1.0,2/6,8.00%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.8974615957191987,-1.404284562624817,0.014925373134328358,0.8651499861274466,1.0,2/6,8.00%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.7931812494333121,-1.4038718970750574,0.047619047619047616,0.858376414925005,1.0,1/11,0.29%,SERPINE1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.7235837395826936,-1.403534857910335,0.022988505747126436,0.8528462931483541,1.0,10/47,16.04%,PIK3R3;CDKN1B;ARF1;SLC2A1;CFL1;VAV3;NCK1;TBK1;CDKN1A;GRB2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.8007560028005354,-1.4034383368371437,0.02702702702702703,0.8443150678773881,1.0,2/18,7.14%,TBX3;CDKN1B
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.5708410783289167,1.4034288134478246,0.05263157894736842,1.0,1.0,5/22,5.84%,BMP6;SMAD1;HIVEP1;TGFBR3;SMAD9
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.5708410783289167,1.4034288134478246,0.05263157894736842,1.0,1.0,5/22,5.84%,BMP6;SMAD1;HIVEP1;TGFBR3;SMAD9
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.9738109764008951,-1.401940308629967,0.0,0.8536699472397626,1.0,1/5,0.57%,B3GNT2
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.7845409318779784,-1.4011096512943306,0.024691358024691357,0.8550674000561415,1.0,6/22,7.84%,MTHFD1L;LDHA;PPARG;SCP2;BTD;GGT5
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.8941952412855423,-1.400342097078285,0.03125,0.8546910895871309,1.0,1/6,0.21%,TBX3
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6527301414079509,1.3992681366018347,0.13793103448275862,1.0,1.0,6/15,13.47%,EFNA5;CLASP1;BICD1;MARK2;ROCK1;PHLDB2
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.8333225970719205,-1.398471198259982,0.0410958904109589,0.8650218680522235,1.0,4/11,11.27%,PLS3;SULF2;TGM2;GJA1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.839757715206094,-1.3955111338691126,0.0,0.8905066885153814,1.0,5/11,11.63%,SERPINE1;SPOCK1;GAPDH;TIMP3;SERPINB6
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.7213610032301143,-1.395234395947752,0.0125,0.883692334824206,1.0,11/36,16.41%,LBR;RFC3;SPC25;PPM1D;RAD21;CDKN1B;IPO7;CBX5;CDKN1A;SMC6;SMC3
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.75171604830904,-1.3950238384150697,0.0375,0.8773516186434502,1.0,6/23,10.83%,MAP3K5;JUN;FOS;NFE2L2;TPM1;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.9592974781085009,-1.3946022489373193,0.016129032258064516,0.8727949456501221,1.0,1/6,0.65%,PSMC6
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.8544216538801654,1.3945251849065028,0.05128205128205128,1.0,1.0,2/5,3.69%,GBP1;EFNA5
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.8544216538801654,1.3945251849065028,0.05128205128205128,1.0,1.0,2/5,3.69%,GBP1;EFNA5
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.6738830867417646,-1.394050869890819,0.033707865168539325,0.8702966722349864,1.0,6/41,7.17%,LAMC1;PLS3;NES;DMD;KIAA1217;TIMP3
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.6392551977549312,1.3924651690819139,0.11538461538461539,1.0,1.0,6/17,15.71%,PSMD14;INO80;RAD51B;MCM9;SEM1;SPIDR
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.910559682971227,-1.3915968850124534,0.08064516129032258,0.8894899610912834,1.0,3/6,5.50%,MAP2;RTN4;SEMA6B
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.8775486385525201,-1.3911232219755,0.06756756756756757,0.8855912019588345,1.0,2/10,2.05%,PIK3R3;NR4A1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.6852864389907397,-1.389686148210867,0.0,0.8938646052199585,1.0,7/65,5.50%,PIK3R3;SUN2;NEDD9;VSIR;HSPA5;ELP3;SEMA6B
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.8497952306973868,-1.3894705725688983,0.013333333333333334,0.8877918892958255,1.0,3/9,3.66%,BHLHE40;HES1;CX3CL1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.7783110018386616,-1.3878542071382078,0.037037037037037035,0.9002584474815541,1.0,1/16,2.18%,YTHDC1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.8507310209572057,-1.3877500540113605,0.0958904109589041,0.8928996113575975,1.0,2/7,5.58%,CLIC2;DMD
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.8777486216646415,-1.387739617323499,0.056338028169014086,0.8846568977581146,1.0,3/6,10.98%,HES1;ERBB4;CRLF3
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.7305691580562877,-1.386324722599996,0.02247191011235955,0.8918475463378003,1.0,7/30,10.41%,SERPINE1;ADAMTS9;PGK1;PPARG;KLF2;KLF4;ADAMTS1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.6771405933296618,1.3860617094598835,0.08333333333333333,1.0,1.0,3/9,16.90%,PDGFC;PPP2R5A;PPP2R5E
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7733474664689687,1.3857820648958976,0.09375,1.0,1.0,4/6,18.64%,MBOAT2;TAPT1;SOX5;TRPS1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.7197100843594836,-1.3853228015767325,0.022727272727272728,0.8943941781583952,1.0,19/48,18.12%,DDIT4;BHLHE40;NRCAM;WNT2B;HES1;CX3CL1;SPOCK1;MAP1B;ELP3;SMARCA1;PTPRD;IL1RAPL1;FGFR1;GPM6A;NAV1;ADGRL3;PAFAH1B1;MYEF2;CDK6
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.7588483504403037,-1.3844630246321452,0.09090909090909091,0.8954041544623084,1.0,1/16,0.29%,SERPINE1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.7998578420564274,1.3835171146413918,0.07142857142857142,1.0,1.0,4/7,15.55%,MFF;PLAAT3;PEX14;TMEM135
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.699707733065824,-1.3814416559406553,0.011363636363636364,0.9214052219867114,1.0,15/56,13.63%,SERPINE1;LAMC1;ADAMTS9;GPM6B;PLOD2;COL18A1;LAMA5;ITGA10;LAMA4;ADAMTS1;VWF;PECAM1;ITGB5;ADAM15;PLEC
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.8367950100531657,-1.3813889159537336,0.014925373134328358,0.9137638855160938,1.0,6/10,12.18%,SERPINE1;SPOCK1;GAPDH;TIMP3;SERPINB6;CST3
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.8026442052850394,-1.3807557601730052,0.04054054054054054,0.9136084441350628,1.0,4/16,5.53%,MAP2;RTN4;GRIA2;GRIN2B
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.8269324846553595,-1.3794790456795067,0.0958904109589041,0.9209336419414881,1.0,3/9,10.25%,RTN4;SCARB2;CD81
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.738139505372138,-1.3787317777080743,0.05,0.9227143354022662,1.0,14/32,17.91%,MAP2;RTN4;ESR2;CDKN1B;BCL6;HYAL2;CRLF3;GJA1;ADAM15;SMAD3;RACK1;CDKN1A;BTG1;ACVRL1
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.8736404205300987,-1.37836916209502,0.047619047619047616,0.9198476586789519,1.0,2/8,2.91%,PCK1;PRKAG2
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.6776450328628371,-1.377903757481493,0.046511627906976744,0.9178706969929274,1.0,15/51,16.07%,DDIT4;BTG2;NDRG1;ATF3;JUN;FOS;RPS12;PPM1D;JAG2;KLF4;CD81;RACK1;CDKN1A;UPP1;BTG1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6599215604065694,-1.3773718957183771,0.022222222222222223,0.915834622316726,1.0,24/60,20.69%,RPS18;RPL23;RPS12;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS15;RPS27;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;RPS28;RPL24;RPL7A;RPL31;RPLP1;RPL37A;RPS19
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.8852146163844743,-1.3771816126901593,0.09836065573770492,0.9096080128805077,1.0,1/5,0.39%,LAMC1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.659756341075241,-1.3756944504695552,0.09302325581395349,0.9178753676152406,1.0,22/52,21.86%,RPL23;RPL34;RPS9;RPL37;RPS15;RPS27;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;RPS28;RPL24;RIOK3;RPL7A;RPL31;RPLP1;RPL37A;RPS19;RPL21
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.7861286862232415,-1.3756723430102924,0.08108108108108109,0.910741242933004,1.0,2/12,4.44%,UFL1;KDM1A
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.8386307019805135,1.375630397034851,0.10810810810810811,1.0,1.0,2/5,4.91%,OFD1;RFX3
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.6533864823668566,-1.3753405517153534,0.010416666666666666,0.9060532568647055,1.0,13/90,8.72%,PIK3R3;SUN2;NEDD9;RTN4;VSIR;HSPA5;ENPP2;HIF1A;ELP3;SEMA6B;PRKCE;FLT1;RREB1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.8868654480811067,-1.3750127887814525,0.05084745762711865,0.9024189113694049,1.0,1/6,4.02%,NES
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.7084889225530827,1.3747937797358474,0.19230769230769232,1.0,1.0,2/7,7.63%,ZNRF3;CHD7
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.9196788459815255,-1.3745915312746926,0.05714285714285714,0.9006941067729909,1.0,1/6,2.91%,PRKAG2
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.8134647597100335,-1.3730364666585002,0.02857142857142857,0.9093141169151181,1.0,1/14,0.21%,TBX3
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.6958929133953435,1.3714069563287592,0.08695652173913043,1.0,1.0,4/12,5.19%,PSMD14;UIMC1;USP25;OTUD4
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.748535916403304,-1.3713424905917633,0.07142857142857142,0.9217006072897632,1.0,5/19,10.85%,SERPINE1;NFKBIZ;CX3CL1;CD81;HYAL2
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.794711532988861,-1.3703218170400122,0.09333333333333334,0.9258026640835896,1.0,5/14,13.84%,SSH1;ARF1;PRKN;PINK1;KIF16B
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.7540230355243561,-1.3695424153728746,0.04225352112676056,0.9267667729301281,1.0,7/20,15.24%,SERPINE1;NFKBIZ;CX3CL1;NPAS2;HYAL2;NFKBIA;RIOK3
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.7247586167301897,-1.3693733173222957,0.05194805194805195,0.9207686552095916,1.0,5/30,7.87%,PKM;PCK1;NR4A1;PPARG;PIK3R1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.8070746889313161,1.3688164575283266,0.1891891891891892,1.0,1.0,4/7,18.90%,INO80;TOP2B;SMC1A;LATS1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.8026931040209094,-1.3685647797712985,0.09859154929577464,0.9228495803788139,1.0,5/9,15.21%,DDIT4;SMAD7;DMD;NCK1;RACK1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.715313052128979,-1.368211678169557,0.0975609756097561,0.9195592517467734,1.0,11/28,18.28%,ENPP2;GLUL;GRIA2;SLC8A1;TNS1;TMEM132C;VWF;GAS7;PLP1;PLXDC2;CHL1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.715259111651252,-1.3666527293929265,0.060240963855421686,0.927496424978434,1.0,2/22,4.52%,CEP57;CEP70
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.7785333400820974,1.3656582572274913,0.14705882352941177,1.0,1.0,1/7,6.13%,SMYD3
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.7913621705945723,-1.3649236082030645,0.0958904109589041,0.9390121108651185,1.0,7/15,14.75%,PCK1;PGK1;PPARG;LGALS3;ERBB4;ANXA1;HNRNPH3
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.8457582906052044,1.3641641202671626,0.06060606060606061,1.0,1.0,2/5,12.64%,DDX60;ANKRD17
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.8457582906052044,1.3641641202671626,0.06060606060606061,1.0,1.0,2/5,12.64%,DDX60;ANKRD17
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.8766277001011958,-1.363438693352384,0.07017543859649122,0.9403208215784453,1.0,2/8,3.66%,VSIR;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.8766277001011958,-1.363438693352384,0.07017543859649122,0.9403208215784453,1.0,2/8,3.66%,VSIR;CX3CL1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.8755918707209894,-1.3631495647216412,0.12121212121212122,0.9367819093678885,1.0,3/6,6.00%,ADM;ATP2B1;KCNMB4
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.877970000835943,-1.3628090592734616,0.03508771929824561,0.9333744357021059,1.0,2/6,2.70%,PGK1;VSIR
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.8227613693871033,1.3627009923655231,0.12121212121212122,1.0,1.0,3/6,12.67%,ABL1;MTERF1;TOP2B
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6715524609871883,-1.362573231139501,0.06172839506172839,0.9287491855720101,1.0,23/53,21.86%,RPL23;RPL34;GLUL;RPS9;RPL37;RPS15;RPS27;NPM1;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;RPS28;RPL24;RPL7A;RPL31;RPLP1;RPL37A;RPS19;RPL21
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.6498227228677498,-1.362162837011232,0.06666666666666667,0.9261561793669737,1.0,11/50,13.14%,DIXDC1;ADAMTS9;AKAP12;NES;MAP1B;NFASC;TPM1;ANK2;LAMA4;GJA1;NAV1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.7733109347630345,-1.3618334305739557,0.0684931506849315,0.9231318194128839,1.0,1/12,0.29%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.9056741660955243,-1.361801413072624,0.013888888888888888,0.9166622976880616,1.0,5/9,6.80%,ATF3;HSPA5;HIF1A;NFE2L2;KLF2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.6710602028462104,-1.36176532214894,0.047619047619047616,0.9108996287319224,1.0,10/36,17.16%,ST18;MAP3K5;PPARG;BCAP31;HIP1R;DLC1;TNFRSF10B;SMAD3;RACK1;MALT1
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.9134409254168384,-1.361735288058122,0.07142857142857142,0.9053704132746513,1.0,1/7,0.13%,MAFF
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.825852321538982,-1.3615028114701517,0.10666666666666667,0.9015877399534831,1.0,5/11,16.04%,DDIT4;MAGI2;RAP1A;BCAR1;GRB2
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.8999128535448903,-1.360795833362286,0.09090909090909091,0.9028319373681438,1.0,1/6,0.29%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.8393604597228063,-1.3607808254137361,0.06557377049180328,0.8967978728137445,1.0,2/7,4.44%,CX3CL1;KDM1A
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.866354852246209,-1.3605330430345641,0.10294117647058823,0.8928533187821867,1.0,1/7,2.02%,PKIG
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.692113705923313,1.3579937767897248,0.05263157894736842,1.0,1.0,2/14,3.17%,FAXDC2;TNRC6C
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.6318566018591615,-1.3579024156974746,0.06315789473684211,0.911706737869839,1.0,20/88,18.59%,LAMC1;ADM;PLS3;EHD4;KIAA1217;PLOD2;SMARCA1;TPM1;MAGI2;ITGB5;GJA1;TRIB2;NEBL;MYO1B;BCAR1;PLSCR4;WWTR1;NAV2;MYO1E;CALD1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.8709831343681249,1.356836360022313,0.07692307692307693,1.0,1.0,2/5,7.09%,PLA2G4A;HADHB
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.6404233552673486,-1.355945939494512,0.0,0.9267129060003876,1.0,23/140,12.62%,PIK3R3;SERPINE1;SUN2;NEDD9;VSIR;HSPA5;CX3CL1;ENPP2;SMAD7;ELP3;SEMA6B;ERBB4;TPM1;MAGI2;FLT1;TMEFF2;TMSB4X;PECAM1;ANXA1;DLC1;AFDN;SDCBP;ADAM15
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.7158844114863575,-1.3550129120759353,0.03529411764705882,0.9310997676328762,1.0,7/22,19.91%,UFL1;COMMD1;TMSB4X;KLF4;NFKBIA;CYLD;ERBIN
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.6643885601666606,1.3531904509786792,0.13333333333333333,1.0,1.0,4/11,18.87%,TLE4;TCF7L1;TCF7L2;TLE1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.6920545476627521,-1.3507449744129085,0.05747126436781609,0.9721971486885402,1.0,11/50,16.36%,TBX3;PPARG;HES1;SMAD7;ABCA5;ZFPM2;TRIB2;SMAD3;NOTCH4;NFKBIA;WWTR1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.8447768287786631,-1.3505790926067505,0.08823529411764706,0.9680301078590142,1.0,3/7,8.62%,DMD;AHNAK;ANK2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.9176985658413432,-1.3499055438102308,0.06451612903225806,0.9691321505929024,1.0,2/5,2.05%,PIK3R3;NR4A1
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.8894281068929661,-1.3486342922982726,0.015384615384615385,0.9776716466832128,1.0,1/6,0.47%,DOK5
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.7931573184972978,-1.3485068575391563,0.09876543209876543,0.9718576669851952,1.0,3/9,13.53%,KDM1A;DMD;NEBL
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.8621019756102315,-1.3475262133607004,0.05714285714285714,0.9763468883543738,1.0,3/7,10.98%,HES1;ERBB4;CRLF3
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.7053301168649483,-1.3465369157037077,0.0975609756097561,0.9811269876746752,1.0,7/26,17.26%,PKM;PCK1;PPARG;PIK3R1;OGT;RAB8B;LPIN2
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.8374652442363129,-1.346142495004769,0.05333333333333334,0.978514293594911,1.0,3/10,3.76%,MAP2;MDGA2;SPOCK1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.766582680958928,-1.3452981937000905,0.0684931506849315,0.981502197888771,1.0,5/16,15.21%,PCK1;HIF1A;PIK3R1;FOXK1;RACK1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.7613831256690937,-1.3450166538659865,0.1282051282051282,0.9781684310565275,1.0,4/12,8.62%,CLIC2;CX3CL1;DMD;ANK2
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.7166561026146343,-1.3444857808122057,0.1,0.9764373997929902,1.0,2/26,4.52%,CEP57;CEP70
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.8886720684256327,-1.3443588715493453,0.05263157894736842,0.9723664802274454,1.0,3/5,8.07%,ADM;PPARG;PRKCE
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.8695347894262477,-1.3443582108024845,0.08108108108108109,0.9664010416984428,1.0,4/7,9.99%,ANGPTL4;TMEM45B;LGALS3;KLF4
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.8645389964286889,-1.3439104955850523,0.10144927536231885,0.9656397714953727,1.0,2/5,8.00%,KIAA1217;SULF2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.7312556817632864,-1.3430100831272185,0.08108108108108109,0.967802197133362,1.0,5/20,10.44%,ADAMTS9;DENND3;LAMP2;PRKN;NGLY1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.6671104853206006,-1.341803033591104,0.03571428571428571,0.9738230641284982,1.0,11/39,13.19%,PSMC6;NDRG1;PGK1;BNIP3L;PSMB9;HIF1A;RPS27A;PSMA1;UBC;EPAS1;PINK1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.8379623234276414,-1.3410699834028166,0.09090909090909091,0.9753870335173107,1.0,3/8,12.72%,PPARG;FLT1;FGFR1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.7054531048972199,-1.3402694883508357,0.03333333333333333,0.9719924312438998,1.0,12/43,12.62%,SERPINE1;LAMC1;ADAMTS9;COL18A1;LAMA5;ITGA10;LAMA4;ADAMTS1;VWF;PECAM1;ITGB5;ADAM15
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.7054531048972199,-1.3402694883508357,0.03333333333333333,0.9719924312438998,1.0,12/43,12.62%,SERPINE1;LAMC1;ADAMTS9;COL18A1;LAMA5;ITGA10;LAMA4;ADAMTS1;VWF;PECAM1;ITGB5;ADAM15
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.7832660685211078,-1.3399944378343218,0.039473684210526314,0.9689107081467582,1.0,2/14,2.88%,ADAMTS9;PPARG
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.6012667196384173,1.3399479543520993,0.15151515151515152,1.0,1.0,6/15,21.91%,THOC1;WRNIP1;WDR70;PARG;SUB1;MPHOSPH8
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.8251085792889883,-1.3399074390249461,0.1044776119402985,0.9643950116770846,1.0,2/8,8.02%,UFL1;RB1CC1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.8171007414607766,-1.33933653180149,0.05555555555555555,0.9643162342285216,1.0,3/8,12.41%,SCARB2;PRKN;FOXK1
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.6370853333611033,-1.3382024691018228,0.021052631578947368,0.9679656860947532,1.0,25/106,13.14%,TBX3;RAPGEF5;NRCAM;ZEB2;GRIK1;HES1;SPOCK1;NES;SPG7;ELP3;NFASC;SEMA6B;FEZ2;GPM6B;BTD;ERBB4;PRX;SLC2A1;MBP;NPAS2;PRKN;LSAMP;DCLK1;GPM6A;NAV1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.8227975517643195,-1.3379027511019488,0.0967741935483871,0.959651148387205,1.0,3/7,10.57%,RFC3;RPS27A;UBC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.8227975517643195,-1.3379027511019488,0.0967741935483871,0.959651148387205,1.0,3/7,10.57%,RFC3;RPS27A;UBC
prerank,PanglaoDB_Augmented_2021__T Cells,-0.7663412042670742,-1.3346530060751076,0.05555555555555555,0.98580649079624,1.0,4/16,12.25%,MAFF;JUNB;CD81;CREM
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.6732590563609888,-1.3344084821565827,0.12359550561797752,0.9827685982195934,1.0,11/37,12.07%,SERPINE1;MAP2;AKAP12;MAP1B;NFASC;GRIA2;CNTN1;ANK2;PTPRD;LSAMP;DCLK1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.61523661505799,-1.3331839531394754,0.020833333333333332,0.9887906856904348,1.0,34/125,16.33%,LAMC1;RPS18;DENND3;ERO1A;RPL23;RPS12;RPL34;SPG7;RPS9;RPS27A;RRBP1;SHISA5;MGAT4A;PLOD2;EEF1A1;RPL37;MSRB3;RPS11;PRKN;RPS15;RPS27;CST3;MSRA;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;RPS28;RPL24;RPL7A;STK38
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.8716506703220436,-1.332726857612979,0.08571428571428572,0.9871133251078854,1.0,1/7,0.21%,TBX3
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.7147217253351645,-1.332459061646368,0.013157894736842105,0.984908139054496,1.0,4/21,13.06%,ADM;GGT5;CD81;PLCG2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.7386622500274229,-1.3323613128736775,0.023809523809523808,0.9802516318263937,1.0,12/23,21.11%,DDIT4;MAP3K5;FOS;GRIN2B;PRKN;PRNP;EFNB2;TBK1;PICALM;CD34;CLU;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.864633901105411,-1.3322606591651935,0.0967741935483871,0.9757063458657043,1.0,3/6,4.65%,PPARG;ABCA5;SCP2
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.8114991344046382,-1.33172425745043,0.11475409836065574,0.9771830063160181,1.0,4/8,12.93%,TSG101;PPARG;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.90335360902397,-1.331520881274082,0.06153846153846154,0.9740105618450897,1.0,1/5,2.41%,ATF3
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.8263108408772862,-1.331465324775462,0.07142857142857142,0.9692182563740533,1.0,3/8,4.44%,CX3CL1;NES;KDM1A
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.8732933362154035,-1.3302838987485868,0.06557377049180328,0.9749954211882598,1.0,2/8,4.47%,MAP2;MAP1B
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.8253116373987094,-1.3298318869984873,0.13559322033898305,0.9746909404433249,1.0,3/6,14.64%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6222410139147787,-1.3294341004178323,0.021505376344086023,0.972529399925392,1.0,31/89,20.69%,RPS18;RFC3;RPL23;RPS12;RPL34;RPS9;POLA1;RPS27A;RRBP1;EEF1A1;RPL37;RPS11;RPS15;RPS27;MEF2A;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;GOLPH3;RPL13A;RPS28;RPL24;RPL7A;PTMA;RPL31;RPLP1;RPL37A;RPS19
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.8359120048975743,1.329334495402654,0.17142857142857143,1.0,1.0,2/5,10.64%,PARD3;TNFRSF1B
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.8468777923904368,-1.3292836665467331,0.06944444444444445,0.9691185442982083,1.0,1/7,2.34%,RFTN1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.7435248878519387,-1.3289528494262053,0.13333333333333333,0.9674117420469673,1.0,5/16,11.89%,RFC3;HMGN1;RPS27A;UBC;CCNH
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.7499406227615604,-1.3285656876405623,0.0684931506849315,0.966695573094795,1.0,4/17,10.44%,ADAMTS9;DENND3;PRKN;NGLY1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.8659288123841005,-1.3283274430870178,0.09523809523809523,0.9639945519053941,1.0,1/6,4.83%,HIF1A
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.6756328840269931,-1.3279580174414387,0.09523809523809523,0.9626239707951434,1.0,9/38,12.72%,TBX3;PLS3;ALPL;KIAA1217;SULF2;TGM2;HYAL2;GJA1;FGFR1
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.77599687325789,1.3277414974882653,0.12903225806451613,1.0,1.0,1/5,1.35%,CWC27
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.77599687325789,1.3277414974882653,0.12903225806451613,1.0,1.0,1/5,1.35%,CWC27
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6585307336832111,-1.3264247013483224,0.08641975308641975,0.9736051849057713,1.0,21/49,21.86%,RPL23;RPL34;RPS9;RPL37;RPS15;RPS27;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;RPS28;RPL24;RPL7A;RPL31;RPLP1;RPL37A;RPS19;RPL21
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.7852830553672596,-1.3252498935571497,0.09210526315789473,0.9788690244035096,1.0,5/14,13.06%,ITPR1;ERO1A;GRIN2B;SLC8A1;PLCG2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.7631762490501018,-1.3242712946715276,0.06329113924050633,0.982239021380728,1.0,5/17,14.23%,TBX3;HIF1A;LIMS1;FGFR1;NOTCH4
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.8495907166692486,-1.3242164670950562,0.10606060606060606,0.9775304287902907,1.0,2/6,12.72%,STOX2;FGFR1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7308980025556058,-1.3238975458277507,0.12,0.9752981213440429,1.0,6/15,9.99%,PKM;ADAMTS9;GLUL;JAK1;KLF2;KLF4
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.6677021965603114,1.3237055607055526,0.14285714285714285,1.0,1.0,2/9,4.88%,IL1R1;HSPD1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.8587230628521572,-1.3230460099521693,0.11538461538461539,0.9771523946749241,1.0,3/7,10.23%,PPARG;HES1;PRKN
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.9224447159689854,-1.3228824458105615,0.109375,0.973742082290294,1.0,1/5,2.91%,PRKAG2
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.8772063681199795,-1.3226735884874612,0.14925373134328357,0.9703657033622273,1.0,1/6,2.91%,PRKAG2
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.7713796672050484,1.322026156790736,0.13333333333333333,1.0,1.0,1/5,12.80%,ROCK1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.7913580156161206,1.3217194242607946,0.24390243902439024,1.0,1.0,1/5,5.22%,HDAC9
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.8247917304839647,-1.3210737353831774,0.10256410256410256,0.9813065343255842,1.0,1/10,0.49%,MAP2
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.7943442052457209,-1.320517382078735,0.07462686567164178,0.9816948659429628,1.0,2/12,10.70%,PPARG;ACOX1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.8227389547616302,-1.3201018943853806,0.057971014492753624,0.9817043668901199,1.0,2/11,5.87%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.8400361982974144,-1.3200385141032005,0.1076923076923077,0.9777152667745282,1.0,2/8,4.62%,GLUL;SLC6A6
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.8583742512308984,-1.3200361394903488,0.109375,0.972969076159118,1.0,2/6,6.78%,CANX;JAK1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.7347105273598318,-1.31964138383918,0.14457831325301204,0.9715422394878234,1.0,4/14,8.20%,PKN3;SEMA6B;ERBB4;PDXDC1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.6904603827382312,-1.3186176095320021,0.04938271604938271,0.9778531640503855,1.0,6/34,10.41%,LAMC1;PLS3;NES;GAPDH;SMARCA1;ADAMTS1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.8036313259462184,1.3183277160741098,0.11428571428571428,1.0,1.0,3/5,16.10%,TTN;CDH2;PKD2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.702033751793473,-1.3181989069894267,0.12345679012345678,0.9768872503042948,1.0,6/23,15.58%,LAMC1;PIK3R1;LAMA5;TMEFF2;ATRNL1;PARVB
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.7767394988563396,-1.3180267123214227,0.08333333333333333,0.9736405963397454,1.0,3/13,4.80%,NEDD9;PLS3;EPS8
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.7878580130080759,-1.31708417775455,0.13513513513513514,0.9777281529626418,1.0,6/13,16.07%,BTG2;CDKN1B;BCL6;CHFR;SMAD3;BTG1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.7295771728401395,-1.316992036252441,0.09333333333333334,0.9740441834290097,1.0,6/19,14.82%,HES1;KIAA1217;EPAS1;EFNB2;SHC2;BCAR1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.6646425287536124,-1.3168259376763238,0.10344827586206896,0.9704461162206365,1.0,4/39,4.52%,CEP57;PSMC6;PSMB9;CEP70
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.5444801726572384,1.3167729954679568,0.09523809523809523,1.0,1.0,2/18,2.93%,RC3H1;CPEB3
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.7823358306636838,-1.3165482893858365,0.15873015873015872,0.9682095293671826,1.0,1/10,0.83%,UFL1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.8544533293067577,-1.3164167150328003,0.1206896551724138,0.9651295742257622,1.0,2/5,12.49%,PRKAG2;LPGAT1
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.7532267839324276,-1.31611347022896,0.1794871794871795,0.9625335228630417,1.0,3/13,4.41%,DDIT4;PRKAG2;SMAD7
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.5821713778218417,1.315842840933631,0.09523809523809523,1.0,1.0,4/25,11.45%,RSAD2;EIF2AK2;FAM111A;OAS3
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.8217532386247948,-1.3156766459448614,0.10294117647058823,0.9625300252772081,1.0,4/9,9.11%,PCK1;VSIR;BCL6;PNP
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.6286441887317736,-1.3154614037252332,0.11956521739130435,0.960420923261232,1.0,15/58,12.82%,ANGPTL4;MGLL;PPARG;ENPP2;SCP2;CAVIN2;DHRS7B;BCL6;RREB1;IFNGR1;LAMA4;UBC;ACOX1;PLIN2;ATP1B3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.9121231652101682,-1.3143414761218832,0.04918032786885246,0.9670146010858055,1.0,2/5,6.00%,RIMS1;KCNMB4
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.8748543284062751,-1.3140542659135714,0.09375,0.9653017157876783,1.0,2/5,6.75%,TBX3;ERBB4
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.8219143449497057,1.3140236923333481,0.11428571428571428,1.0,1.0,1/5,2.78%,RC3H1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.8521170866050045,-1.3134393618960423,0.140625,0.9625622408786162,1.0,1/6,0.57%,B3GNT2
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.8521170866050045,-1.3134393618960423,0.140625,0.9625622408786162,1.0,1/6,0.57%,B3GNT2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.8228409528237715,-1.3116441206392198,0.08064516129032258,0.9752033189449499,1.0,3/6,10.57%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.880839834228194,-1.311568703074239,0.12903225806451613,0.9716303938577259,1.0,2/6,8.02%,ATG12;RB1CC1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.8282241684905175,-1.3115613234547132,0.08860759493670886,0.9673120365516915,1.0,1/9,0.21%,TBX3
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.69631239615936,-1.3103653404619677,0.12048192771084337,0.9747349036622024,1.0,7/28,10.83%,ADM;MGLL;FOS;CX3CL1;GGT5;REL;ANXA1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.8047674964906245,-1.3098222312513974,0.10810810810810811,0.975207421113379,1.0,1/10,1.19%,MAP3K5
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.8153008983400797,-1.3092911540112755,0.1323529411764706,0.9752923110004953,1.0,3/8,12.93%,TSG101;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.7890777802543814,-1.3090881579560454,0.13432835820895522,0.9730856110273737,1.0,1/12,0.49%,MAP2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.6229973612708818,-1.309087482532418,0.030612244897959183,0.9688548040229069,1.0,24/142,16.61%,PIK3R3;CEP57;DDIT4;NEDD9;GRIN2B;FES;ERBB4;PIK3R1;SULF2;FLT1;ANKS1B;ARPC2;VAV3;EFNB2;SDCBP;FGFR1;SHC2;KIF16B;NCK1;BCAR1;PAK2;TIE1;GRB2;RAB14
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.7847421008696893,-1.3084287899941398,0.09722222222222222,0.9696757839127199,1.0,3/12,4.80%,NEDD9;PLS3;EPS8
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.8138274293301082,-1.3082950973774972,0.14285714285714285,0.9667209773507512,1.0,2/8,10.23%,PSMC6;PRKN
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.7041201713188953,-1.3068366879881252,0.075,0.9760810838398963,1.0,4/18,5.71%,TMEM45B;HES1;LGALS3;KIAA1217
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.6975795593887653,-1.306611760577589,0.13095238095238096,0.9742918145365593,1.0,2/22,4.85%,YTHDC1;KHDRBS3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.8433987171254577,-1.306333727752602,0.10144927536231885,0.9731688776825311,1.0,3/10,8.70%,PIK3R3;PIK3R1;FLT1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.8138593222674637,-1.3063192365351397,0.10144927536231885,0.9691379015585623,1.0,2/6,4.41%,DDIT4;SMAD7
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.7534821609011729,1.3058737648042402,0.2,1.0,1.0,1/5,8.31%,ATM
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.77319530710267,-1.3057216128796478,0.1388888888888889,0.9702135926737043,1.0,10/16,15.91%,HES1;MAP1B;GRIA2;ANK2;STOX2;EFR3B;CTNND2;LRRC4C;ADGRL3;CADM2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.8395997215699852,-1.305623683801337,0.109375,0.9668258836422765,1.0,3/5,12.93%,TSG101;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.6412076087475098,1.3048217592455909,0.10344827586206896,1.0,1.0,2/11,7.63%,SOBP;CHD7
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.8140677476327438,-1.3046731296879566,0.07352941176470588,0.9717892208401984,1.0,5/10,14.69%,CLIC2;DMD;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.8127778839553517,-1.3038954781196888,0.14516129032258066,0.9735690357335894,1.0,1/6,1.69%,SLCO4A1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.7974028963354793,-1.3036828629556965,0.08955223880597014,0.9715247130681743,1.0,7/11,16.23%,CX3CL1;HIF1A;SNX6;PRKN;PINK1;CPEB4;SOD2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.6957200066039924,-1.3035676500246087,0.12162162162162163,0.9688198523950611,1.0,5/23,15.84%,BTG2;NDRG1;CDKN1B;CNOT6L;CDKN1A
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.7063295009113516,-1.3033261786045287,0.05,0.9666319939428875,1.0,6/27,12.90%,PCK1;PPARG;HIF1A;PIK3R1;FOXK1;RPS6
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.8141815731292279,-1.3011782991401406,0.1323529411764706,0.9828268025571173,1.0,2/8,6.75%,SEMA6B;ERBB4
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.8668533508778135,-1.3006632572152466,0.08955223880597014,0.9791902720845649,1.0,2/6,7.53%,GRIN2B;INSYN2A
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.8668533508778135,-1.3006632572152466,0.08955223880597014,0.9791902720845649,1.0,2/6,7.53%,GRIN2B;INSYN2A
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.7957011636719804,1.3005213643723856,0.2,1.0,1.0,3/5,14.77%,SLC44A1;SLC25A29;SLC25A26
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.7601270378972892,-1.3004704155816953,0.10126582278481013,0.9770401070345456,1.0,5/18,8.36%,MTHFD1L;SLC2A3;BTD;SLC2A1;SLC52A3
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.8401627299466092,-1.3000170962501243,0.208955223880597,0.9776836656599864,1.0,1/5,2.86%,GLUD1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.7529562161969092,-1.2997667200644811,0.08139534883720931,0.9758201772115823,1.0,6/20,10.31%,ATF3;PPARG;CD9;LGALS3;LSS;STARD4
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.6782860427202226,-1.2995838835800215,0.1111111111111111,0.9737092945216552,1.0,7/21,16.20%,NDRG1;PGK1;BNIP3L;HIF1A;EPAS1;PINK1;CPEB4
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.8397911766349699,-1.299493081085171,0.13333333333333333,0.9704831174247316,1.0,1/5,0.29%,SERPINE1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.6365285654982573,-1.298065449480772,0.06593406593406594,0.9782551711852013,1.0,21/50,21.78%,ADM;CD9;SCARB2;CANX;AP1G1;HIP1R;SCARF1;CD81;LRP1B;GRB2;SGIP1;PICALM;SPARC;DNM2;PIP5K1C;PIKFYVE;ITGB1;HSPH1;CLTA;SCARB1;CAV2
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.7234936644737069,-1.298004666425808,0.17073170731707318,0.9750365295725874,1.0,4/15,8.18%,HSPA5;GLUD1;CCDC14;MBP
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.8372061586519377,-1.297611771111458,0.10606060606060606,0.9744249456607628,1.0,1/5,10.31%,STARD4
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8178690468773172,-1.2974110637225644,0.1267605633802817,0.9724037841520646,1.0,2/5,6.80%,ADAMTS9;KLF2
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.6747385045691406,-1.2968381572309409,0.09090909090909091,0.9740272675695999,1.0,19/43,21.16%,PIK3R3;MTMR12;ARF1;PIK3R1;SYNJ2;EFR3B;PLCG2;TTC7A;PIGN;RAB14;PIK3C3;PIGC;INPP5D;SACM1L;MTMR2;PIP5K1C;PIKFYVE;SOCS3;MTM1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.7027892116061702,1.2967736871324875,0.2222222222222222,1.0,1.0,4/8,24.12%,OAS3;STAT2;ISG15;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.8790913963532387,-1.2955044124856454,0.16176470588235295,0.9810389555482483,1.0,1/5,0.49%,MAP2
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.6199149239593732,-1.2949648195407166,0.05154639175257732,0.9815149862535074,1.0,22/101,12.90%,TBX3;LAMC1;UFL1;RPL23;HES1;CX3CL1;NES;KDM1A;GRK5;RPS9;S100A6;ERBB4;FLT1;CD81;ZFPM2;GJA1;NPM1;EFNB2;CNOT6L;SDCBP;FGFR1;RPS6
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.8636549075581699,-1.2947110845656487,0.12307692307692308,0.9729131756744518,1.0,4/6,12.41%,PKM;PGK1;GAPDH;FOXK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.8636549075581699,-1.2947110845656487,0.12307692307692308,0.9729131756744518,1.0,4/6,12.41%,PKM;PGK1;GAPDH;FOXK1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.8636549075581699,-1.2947110845656487,0.12307692307692308,0.9729131756744518,1.0,4/6,12.41%,PKM;PGK1;GAPDH;FOXK1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.6660620723303662,-1.2947093094569933,0.12658227848101267,0.969199766606992,1.0,14/35,14.88%,UFL1;MAP3K5;ITPR1;ATF3;HSPA5;ERO1A;JUN;BCAP31;PIK3R1;PRKN;TNFRSF10B;NCK1;HERPUD1;CREB3L2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.7157668890239874,-1.293737749584497,0.13333333333333333,0.9739920422755438,1.0,2/25,2.88%,SERPINE1;PPARG
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.9155328636977124,-1.2927183575169532,0.04918032786885246,0.9788308102209469,1.0,1/5,0.91%,ANGPTL4
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.6945169651233012,-1.2926662724107778,0.06578947368421052,0.9755082913367784,1.0,3/20,13.06%,ADM;GGT5;PLCG2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.7186229130034881,-1.2925990944881038,0.14285714285714285,0.9724983658032069,1.0,10/22,21.83%,ADM;CD9;CD81;KIF16B;GRB2;PICALM;DNM2;ITGB1;ARFGEF2;SNX25
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7538517423895041,-1.2901678961651957,0.0967741935483871,0.9904689609890484,1.0,5/14,9.42%,PPARG;CDC37;JAK1;IFNGR2;IFNGR1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.6779739398082997,-1.2898757930618898,0.13414634146341464,0.9890976872694495,1.0,3/22,4.05%,PSMC6;HSPA5;NPLOC4
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.7528350122510142,-1.2894854397106084,0.1232876712328767,0.9887929682300557,1.0,2/15,1.74%,NEDD9;DOCK3
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.7706396985071344,1.2890079809871209,0.20588235294117646,1.0,1.0,4/6,20.87%,ABL1;MSH3;MCM9;XPC
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8576122400331303,-1.2886280353332042,0.125,0.9925383790401843,1.0,2/5,8.72%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.8685945261925688,-1.288528662873578,0.1038961038961039,0.9898841097644753,1.0,1/6,1.95%,TSG101
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.6960462494632661,-1.2879008875854463,0.14864864864864866,0.9917094580556257,1.0,1/20,0.60%,DDIT4
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.7345644645129863,-1.2873145022711527,0.19696969696969696,0.9941619763204922,1.0,7/12,17.78%,JUNB;FES;MBP;PRNP;MSRA;SOD2;TXNRD1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.6411301252562767,-1.2867972545943025,0.1,0.9946420909687056,1.0,9/46,12.62%,SERPINE1;CX3CL1;SMAD7;TPM1;MAGI2;TMEFF2;DLC1;AFDN;ADAM15
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.7996514076539376,-1.2861237878305372,0.14492753623188406,0.9968276521182254,1.0,2/10,3.66%,NR4A1;CX3CL1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.7479178765184052,1.286111073615155,0.2,1.0,1.0,2/6,8.31%,ATR;ATM
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.8667945461493558,-1.2859414776629072,0.12903225806451613,0.991405851487702,1.0,2/5,8.52%,LBR;LSS
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.8667945461493558,-1.2859414776629072,0.12903225806451613,0.991405851487702,1.0,2/5,8.52%,LBR;LSS
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.7823525204628361,-1.2859150898982648,0.1323529411764706,0.9881934682302509,1.0,4/10,14.41%,SSH1;HIP1R;TMSB4X;KANK3
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.7306171836392559,-1.285840500376593,0.1282051282051282,0.985317496500464,1.0,2/17,3.53%,ZEB2;PKN3
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.6574635652797438,-1.2855541532058181,0.11627906976744186,0.9837891913946016,1.0,9/34,14.82%,PLS3;GAPDH;KIAA1217;PEBP1;SMARCA1;ADAMTS1;ITGB5;MYO1B;BCAR1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.767462110475293,-1.2851180376565012,0.14084507042253522,0.9833608001114209,1.0,2/12,13.06%,PPP1R9A;PLCG2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.9094033042142058,-1.2841329955977514,0.10909090909090909,0.9875086819335284,1.0,2/5,6.52%,SERPINE1;DUSP1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.8970707541022507,-1.28371299739291,0.06557377049180328,0.9873018907538986,1.0,1/5,4.83%,HIF1A
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.7398216947532038,-1.2833510986840932,0.10588235294117647,0.9868656560710358,1.0,2/16,3.50%,TBX3;HES1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7718138892260096,1.283282049917533,0.14705882352941177,1.0,1.0,1/5,1.56%,ARHGAP12
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.7073827012956683,-1.2829544206464374,0.16216216216216217,0.9862790896145379,1.0,5/20,10.85%,JUN;FOS;HIF1A;TPM1;HYAL2
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.7640220604259134,-1.2828688260560195,0.18840579710144928,0.9834419882501751,1.0,6/8,20.33%,CX3CL1;IFNGR1;DYSF;PLCG2;CRTC3;CLU
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.6930748045253429,-1.2826087911870632,0.12987012987012986,0.9821478989110584,1.0,5/24,17.16%,MAP3K5;BCAP31;KLF4;XIAP;MALT1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.8564967617008423,-1.2823112276234514,0.18181818181818182,0.9813561307852963,1.0,1/6,4.62%,SLC6A6
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.7278870469091671,-1.2821068415707382,0.13253012048192772,0.9794353171573332,1.0,5/18,10.85%,SERPINE1;TMSB4X;KLF4;ANXA1;HYAL2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.6779337303814963,-1.2817626166781544,0.15,0.9789221728643152,1.0,10/27,11.34%,PSMC6;ATF3;PSMB9;HIF1A;NFE2L2;RPS27A;KLF2;PSMA1;UBC;EPAS1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.8306343294497379,-1.2815375482488813,0.13333333333333333,0.9774736157990049,1.0,2/8,3.50%,BHLHE40;HES1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.7809519017539892,-1.2814382153928858,0.125,0.9748746826087974,1.0,4/8,12.93%,TSG101;SNX6;HYAL2;ZFYVE28
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.8172842965390583,-1.2804655380279315,0.10606060606060606,0.9794553229996871,1.0,2/5,15.97%,DDX18;RPL7A
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.62925351936264,-1.2804481461636774,0.1,0.9762353653317929,1.0,17/57,16.07%,RTN4;NRG3;SPOCK1;CHPT1;ESR2;CDKN1B;BCL6;HYAL2;CRLF3;GJA1;SDCBP;ADAM15;SMAD3;BCAR1;RACK1;CDKN1A;BTG1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.7911881230484696,-1.280234924547795,0.15714285714285714,0.9748526058665052,1.0,1/8,3.50%,HES1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.5864838217998144,-1.280197876134257,0.05154639175257732,0.9718914933666735,1.0,33/123,19.86%,RPS18;YTHDC1;RPL23;RPS12;RPL34;RPS9;RPS27A;RRBP1;EEF1A1;RPL37;RPS11;RPS15;RPS27;MEF2A;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;GOLPH3;RPL13A;TPR;HNRNPH3;RPS28;RPL24;RPL7A;SRRM1;PTMA;RPL31;RPLP1;NUP54;RPL37A
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.6882077544088314,-1.279839213293899,0.10588235294117647,0.9715998376760338,1.0,9/25,19.60%,MAP2;UFL1;KDM1A;AFDN;TPR;RACK1;RAB14;PICALM;DLG1
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.8494323244799393,-1.2798190419949775,0.1323529411764706,0.968449461605439,1.0,1/5,2.83%,HSPA5
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.6825655317008188,-1.2785086212081518,0.1875,0.9752990443919308,1.0,5/19,20.64%,DENND3;BNIP3L;PRKN;MALT1;CLTA
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.7636037837179365,-1.2781871430027636,0.22413793103448276,0.9744524839441339,1.0,3/8,14.64%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.7541931563939055,-1.2771516707668935,0.15789473684210525,0.9786949234654555,1.0,5/13,20.77%,HSPA5;RPL13A;RIOK3;CLU;PPM1A
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.8398003933101008,-1.276554162238202,0.09210526315789473,0.9802312376927412,1.0,3/6,13.42%,FLT1;FGFR1;GNA13
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.9068786542107814,-1.276490693737931,0.11940298507462686,0.9777536243025716,1.0,1/5,3.17%,ATG12
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.83715384855797,-1.2756990386539497,0.06944444444444445,0.9803614725992519,1.0,2/9,5.87%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.6930880032514981,-1.275604343069401,0.1038961038961039,0.9777563443468598,1.0,8/24,11.34%,PSMC6;PSMB9;HIF1A;NFE2L2;RPS27A;PSMA1;UBC;EPAS1
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.6952141064321395,-1.2749390563185266,0.13924050632911392,0.9799899737586811,1.0,12/24,16.15%,CCDC3;CX3CL1;NFASC;GPM6B;CNTN1;ANK2;TMEM132C;PTPRD;DCLK1;SHC2;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6567952604274042,1.2745252926147919,0.18518518518518517,1.0,1.0,1/8,0.60%,HOMER1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.7602088539653042,-1.2741946374456667,0.16666666666666666,0.9823514525712451,1.0,3/11,8.93%,MAP2;SSH1;HIP1R
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.833590663999747,-1.2739880461407076,0.21212121212121213,0.9811491372964153,1.0,1/6,0.83%,UFL1
prerank,MSigDB_Hallmark_2020__Complement,-0.597548888633246,-1.2738255622904298,0.14736842105263157,0.9792472087733368,1.0,12/60,14.49%,MAFF;SERPINE1;HSPA5;PSMB9;LGALS3;LAMP2;ZFPM2;DGKG;CD55;CFH;NOTCH4;DUSP5
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.7231486682077906,-1.2732044585169002,0.19230769230769232,0.9810946512683744,1.0,6/14,16.23%,SNX6;PRKN;PRNP;PINK1;CPEB4;SOD2
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.7060408626349906,-1.2721337717034664,0.1388888888888889,0.985425316612696,1.0,2/17,8.07%,SERPINE1;PRKCE
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.5334101702583245,1.272117289640929,0.15789473684210525,1.0,1.0,3/22,7.74%,ATG10;HSPB1;NDUFS4
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.6491317737251894,-1.271476922557405,0.11235955056179775,0.9861201655447752,1.0,9/39,11.76%,UFL1;BHLHE40;HES1;SMAD7;KDM1A;COMMD1;TMSB4X;KLF4;PRNP
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.8522444209023241,-1.2714501170032733,0.15384615384615385,0.9831092928908037,1.0,3/5,13.63%,LAMA5;REL;PLEC
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.8873263576126318,-1.271386224242166,0.12903225806451613,0.9806745025448408,1.0,1/5,4.44%,KDM1A
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.832764783687935,-1.2711704341807781,0.16393442622950818,0.9793307487807589,1.0,1/6,0.60%,DDIT4
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.7501120588126386,-1.2710190357722027,0.10666666666666667,0.977372947218245,1.0,4/12,10.83%,SERPINE1;PRKCE;RREB1;ANXA1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.6498414616693339,-1.2709756165419526,0.16279069767441862,0.9745655689926461,1.0,14/39,19.63%,PIK3R3;MTMR12;ARF1;PIK3R1;SYNJ2;LPGAT1;PLCG2;RAB14;PIK3C3;INPP5D;SACM1L;MTMR2;PIP5K1C;PIKFYVE
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.6315994123733225,-1.2702767188058341,0.14444444444444443,0.9761750447032272,1.0,11/47,12.51%,SERPINE1;LAMC1;JUN;SPOCK1;TIMP3;PLOD2;TPM1;TGM2;ITGB5;GJA1;WIPF1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.660786413965508,1.2700789550947749,0.25,1.0,1.0,3/11,12.64%,BMP6;DDX60;ANKRD17
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.7976089375055858,-1.2699123307710822,0.11940298507462686,0.9752733772947974,1.0,1/5,1.38%,NRCAM
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.632569737550893,-1.269731427805605,0.14102564102564102,0.9737967285713586,1.0,7/31,11.89%,PSMC6;PSMB9;RPS27A;PSMA1;UBC;NPM1;CCNH
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.7598100820990041,-1.269671735413948,0.12857142857142856,0.9712738068100579,1.0,4/14,11.79%,SPOCK1;GRIN2B;PRNP;EFNB2
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.685418974791528,-1.269156881191937,0.1590909090909091,0.9723983268447365,1.0,6/23,11.34%,CD9;TINAGL1;LGALS3;MT1L;EMP1;EPAS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.8225419897125305,-1.2686051756250871,0.14492753623188406,0.972737639656608,1.0,5/8,14.69%,CLIC2;DMD;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.7937541870370912,-1.2683988069443957,0.18309859154929578,0.9710509216092231,1.0,1/7,4.00%,SRGN
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.6743169126119282,-1.268168267076247,0.12941176470588237,0.9699126390556894,1.0,7/26,15.21%,TSG101;CX3CL1;LGALS3;SDCBP;SMAD3;TPR;RACK1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.8578957212392524,-1.2679687422509283,0.1388888888888889,0.9680102573371552,1.0,3/6,12.54%,TSG101;PRKN;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.7658174257703518,-1.2676939884706377,0.2,0.9667879670183013,1.0,4/11,14.25%,PPARG;RREB1;AAMDC;ZFP36
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.8068156675837501,-1.266025674605319,0.1864406779661017,0.9757026842280023,1.0,2/5,17.08%,KPNB1;SREBF2
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.6258237137109989,-1.2659928185205482,0.12643678160919541,0.9699549294177254,1.0,14/45,18.48%,PSMC6;JUN;FOS;PSMB9;PIK3R1;PSMA1;VAV3;PLCG2;PAK2;TEC;GRB2;MALT1;PSMA7;LCP2
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.6258237137109989,-1.2659928185205482,0.12643678160919541,0.9699549294177254,1.0,14/45,18.48%,PSMC6;JUN;FOS;PSMB9;PIK3R1;PSMA1;VAV3;PLCG2;PAK2;TEC;GRB2;MALT1;PSMA7;LCP2
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.7243856063349366,-1.2659193552981949,0.1927710843373494,0.9676188922044773,1.0,3/19,10.28%,CCDC3;PLCL1;LAMA4
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.7068910256823261,-1.265648893058362,0.2153846153846154,0.9668770609329362,1.0,1/18,0.83%,UFL1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.630467737307418,-1.2652488585092914,0.1,0.9673868674951313,1.0,7/51,10.57%,CEP57;PSMC6;PSMB9;CEP70;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.8562100365506338,-1.2650493410113028,0.0967741935483871,0.9657012256160383,1.0,2/6,7.92%,PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.699224634856468,-1.2645370243996916,0.08,0.9677122322020751,1.0,5/20,11.27%,LAMC1;DMD;MBP;PECAM1;GJA1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.7276559125224153,-1.2636848474802616,0.1527777777777778,0.9724110550157917,1.0,5/12,17.50%,CDC37;SDCBP;OGT;PELI1;CYLD
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.8317293276537343,-1.263209769119978,0.23076923076923078,0.9728010960320805,1.0,1/6,2.86%,GLUD1
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.8254201323574638,-1.2625048064453757,0.18333333333333332,0.975031928533884,1.0,2/5,11.27%,KDM1A;GJA1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.7886710053715531,-1.2623787990082294,0.2318840579710145,0.9729939601946573,1.0,1/6,2.67%,RTN4
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.893722235773829,-1.2621891112198345,0.07692307692307693,0.9715144427151308,1.0,1/5,0.49%,MAP2
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.8130970261558856,-1.2620016682789752,0.17391304347826086,0.9699474509432883,1.0,1/7,2.00%,MTFR1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.8097635380072907,-1.261976124284086,0.16393442622950818,0.9673030886226281,1.0,2/8,15.21%,DYSF;RACK1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.8424004081837941,-1.2619431456313526,0.1267605633802817,0.9645466904412966,1.0,1/6,3.50%,HES1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.7537660336390335,-1.261663552048451,0.13924050632911392,0.9639985232920993,1.0,2/13,6.20%,SLC4A10;ANO2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.8376063378312507,-1.260752482063364,0.13333333333333333,0.9678252364086459,1.0,4/5,15.21%,UFL1;HSPA5;NCK1;RACK1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.7084368224648911,-1.2605117805776391,0.11842105263157894,0.9669864752779886,1.0,4/20,13.37%,UFL1;RPL23;COMMD1;RPS7
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.7271457508378427,-1.2596481833847555,0.17333333333333334,0.9703730681957257,1.0,3/12,10.83%,SERPINE1;PRKCE;ANXA1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.7009195455108381,-1.2596398464665914,0.20270270270270271,0.9675846398388414,1.0,6/15,15.99%,DTNA;PIAS2;BTNL9;CTNNA3;CADM2;LRP1B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.7100013889935051,-1.2592465920012759,0.16455696202531644,0.9678185193706514,1.0,8/21,18.12%,BTG2;NR4A1;DUSP1;CDKN1B;IPO7;SMAD3;BTG1;CDK6
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.6811093037156664,-1.2587800864522716,0.17647058823529413,0.9687068178207691,1.0,13/29,16.15%,MAP1B;NFASC;GRIA2;GPM6B;CNTN1;MAGI2;ANK2;PTPRD;LSAMP;EFR3B;DCLK1;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.8259738407940301,-1.2585681931396817,0.17391304347826086,0.9670990561742089,1.0,2/5,13.19%,PRKN;PINK1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.7447182091827735,-1.2585649454959782,0.13157894736842105,0.9644447627437105,1.0,1/11,2.18%,YTHDC1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7220425423853356,-1.257845986685243,0.19718309859154928,0.966759278324341,1.0,8/12,20.69%,RPS15;RPS27;NPM1;RPS6;RPS7;RPS28;RIOK3;RPS19
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8256272554018929,-1.2573110589809489,0.15151515151515152,0.9679801413665152,1.0,3/5,10.57%,PGK1;RPS27A;UBC
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.7243864394184203,-1.2566225885831055,0.2073170731707317,0.9700561521491895,1.0,7/23,12.54%,TSG101;RFC3;BCAP31;POLA1;PNP;CSTF3;SDCBP
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.7868104865338978,-1.2552218821414924,0.13636363636363635,0.9777079286880055,1.0,2/6,8.23%,VSIR;BCL6
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.8056018475015991,-1.2550823861554792,0.17647058823529413,0.9755509201147771,1.0,2/5,11.34%,HIF1A;EPAS1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.7122909559560118,-1.2543116513111405,0.15384615384615385,0.9786263607861191,1.0,3/15,10.83%,MAP3K5;NFE2L2;ANXA1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.6552591013875062,-1.2534679130177384,0.11842105263157894,0.9822326530744248,1.0,7/26,14.64%,PSMC6;ST18;PSMB9;TMSB4X;PSMA1;LIMS1;NFKBIA
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.7372344507797733,-1.252575866432009,0.2222222222222222,0.9847259847842808,1.0,5/7,24.79%,SMAD7;PAK2;TBCD;PIP5K1C;VCL
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.7491117583844886,-1.2523787220519451,0.15584415584415584,0.9833000347354479,1.0,6/15,14.02%,PPARG;JUN;FOS;HIF1A;KLF4;SMAD3
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.788290457803771,-1.251559849490669,0.1875,0.9869842951840777,1.0,3/7,14.69%,GRIN2B;SLC8A1;CACNA1C
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.6890678009190152,-1.2514740307731953,0.2,0.9845965197657806,1.0,7/18,20.25%,ADM;CD9;CD81;GRB2;PICALM;DNM2;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.7465053666146266,-1.2512381225098612,0.14666666666666667,0.9840534151711778,1.0,1/11,0.60%,DDIT4
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.6942300817168592,-1.251195757348519,0.14285714285714285,0.9816568100943505,1.0,3/17,6.75%,NES;MAP1B;ERBB4
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5967156017296078,-1.2511759710471353,0.1326530612244898,0.9791837171528097,1.0,22/105,17.39%,TBX3;ANGPTL4;HSPA5;BNIP3L;CX3CL1;GRK5;RPS27A;PIK3R1;CFL1;UBC;ANXA1;NPM1;RPL10;TMBIM6;GOLPH3;NFKBIA;PAK2;XIAP;NAA16;MALT1;MCL1;PTMA
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6501460095923933,-1.2510079864807826,0.18666666666666668,0.9778557411648771,1.0,7/27,13.06%,RTN4;ENPP2;GLUL;HIF1A;PRKCE;RREB1;PLCG2
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.7943881506675513,-1.2508836963832488,0.19230769230769232,0.9758816029902366,1.0,5/8,17.08%,SMAD7;NFE2L2;KLF2;KLF4;SREBF2
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.7691244117334475,-1.2495700318992347,0.2702702702702703,0.9831295432941005,1.0,6/8,23.05%,KCNIP4;ANK2;DPP10;ANK3;DLG1;CD63
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.6807829766679208,-1.2490216879667926,0.25333333333333335,0.9850213700873326,1.0,4/13,18.82%,SPOPL;CST3;OGT;PLAT
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.7815414320149957,-1.2489469360922494,0.10144927536231885,0.9799899737586812,1.0,2/9,3.04%,ITPR1;ERO1A
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.7815414320149957,-1.2489469360922494,0.10144927536231885,0.9799899737586812,1.0,2/9,3.04%,ITPR1;ERO1A
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.6305303990739416,-1.2488309621793323,0.12790697674418605,0.9785346929939578,1.0,12/40,16.23%,BTG2;NR4A1;ATF3;FOS;JUNB;PLCL1;PTPRD;HYAL2;TMBIM6;NFKBIA;BTG1;SOD2
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.7775398590374729,-1.2486875094631464,0.22058823529411764,0.9767949683773633,1.0,5/8,20.25%,PPARG;CD9;CD81;SREBF2;ITGB1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.8053882808763144,-1.248547095588131,0.15254237288135594,0.9749187988758853,1.0,1/6,2.18%,YTHDC1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.78305492180614,-1.2485237479089075,0.18181818181818182,0.972500332754613,1.0,7/10,13.53%,HES1;KDM1A;DMD;SLC8A1;ANK2;DYSF;NEBL
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.758334832011314,1.248478911369905,0.2,1.0,1.0,1/8,2.65%,RHBDD1
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.6039143440364857,-1.2476947809200065,0.14444444444444443,0.9752549290687325,1.0,14/51,18.82%,LAMC1;PPARG;EPS8;ZC3H7A;TIMP3;EMP1;PRKN;LAMA4;EPAS1;WWTR1;NAV2;HMCN1;CALD1;PLAT
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.661883663962216,-1.2471182689260294,0.09411764705882353,0.9766071087403956,1.0,14/35,19.94%,RTN4;ESR2;CDKN1B;BCL6;HYAL2;CRLF3;GJA1;ADAM15;SMAD3;RACK1;CDKN1A;BTG1;ACVRL1;MT1M
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.683516382977315,-1.246728332134434,0.18292682926829268,0.9769716919197563,1.0,11/21,24.33%,SERPINE1;ARF1;HIP1R;RAB21;LRPAP1;SGIP1;PICALM;CLU;TF;PIK3CB;B2M
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.6123474477636364,-1.2457914587616037,0.18823529411764706,0.9811595959148008,1.0,17/48,18.56%,PSMC6;NFKBIZ;RFTN1;PSMB9;PIK3R1;PSMA1;VAV3;PLCG2;NCK1;BTNL9;BCAR1;PAK2;TEC;MALT1;PSMA7;LCP2;INPP5D
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.8265566308365839,-1.2451380160566548,0.15151515151515152,0.9826577449602605,1.0,5/8,15.50%,RFTN1;VAV3;PLCG2;BCAR1;TEC
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.7040165857583698,-1.2447827669220648,0.1411764705882353,0.982488634428651,1.0,6/20,14.02%,PPARG;JUN;FOS;HIF1A;KLF4;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.6848883649324231,-1.244726774127445,0.17105263157894737,0.9801516772883763,1.0,2/24,5.61%,SERPINE1;LGALS3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.6243447929093171,-1.244446879290869,0.14285714285714285,0.9794776648737004,1.0,3/34,3.04%,MAP3K5;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.8516136747046922,-1.2435842829267203,0.13846153846153847,0.9839169359477398,1.0,2/6,6.67%,HES1;FOXF1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.5978620523102062,-1.243345522558063,0.10526315789473684,0.9828685775107892,1.0,4/78,4.52%,CEP57;EHD4;RAB11FIP3;CEP70
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.6837377881447947,-1.2431523258343733,0.18840579710144928,0.9817691550026452,1.0,4/18,15.84%,BTG2;CDKN1B;CNOT6L;CDKN1A
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.7280235806285282,1.2428831722168279,0.23076923076923078,1.0,1.0,1/6,2.47%,NKD1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.712278731202197,-1.2423110416079917,0.18181818181818182,0.9849851320965458,1.0,5/12,19.24%,PRKN;SDCBP;PINK1;LRPAP1;MTMR2
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.7123519280093008,-1.241901204327377,0.20253164556962025,0.9851221352022811,1.0,6/21,10.80%,UFL1;RPS27A;RB1CC1;PRKN;UBC;CALCOCO2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.6850194096273511,-1.2413220242305578,0.21518987341772153,0.9872481208334166,1.0,8/21,17.42%,MAP2;NES;KDM1A;TMBIM6;ADAM15;RACK1;CDKN1A;LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.6897784768213016,-1.240797576357386,0.1875,0.9889998550527098,1.0,1/18,0.29%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.8232153447197565,-1.2406521016500605,0.1774193548387097,0.9874527226863821,1.0,4/6,17.08%,PPARG;ABCA5;NFKBIA;SREBF2
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.6482680677235064,-1.2406419606736736,0.19047619047619047,0.9850235497753196,1.0,7/25,12.82%,ITPR1;SMAD7;ATP2B1;TPM1;SLC8A1;ANK2;ATP1B3
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.6670672955538673,-1.240590182335173,0.19444444444444445,0.982828621522951,1.0,3/16,4.10%,PSMC6;PRKAG2;PSMB9
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.8171059180669824,-1.2405862694066618,0.16129032258064516,0.9803681168006473,1.0,2/7,4.47%,MAP2;MAP1B
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.6561029161672117,-1.2405506702669051,0.2235294117647059,0.9781684310565275,1.0,4/27,10.23%,SEC22B;VSIR;CDKN1B;PRKN
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.674709292785062,-1.2402563403430937,0.18421052631578946,0.9773563074840307,1.0,7/27,11.89%,RFC3;HMGN1;POLA1;RPS27A;COMMD1;UBC;CCNH
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.8154877601137591,-1.2402490979429455,0.13432835820895522,0.9749006383697492,1.0,3/6,8.62%,ATP2B1;LGALS3;ANK2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.7181042465674208,-1.2400094506406605,0.13513513513513514,0.973607726396248,1.0,6/14,17.50%,CDC37;YBX3;SDCBP;OGT;PELI1;CYLD
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.7788499500994567,-1.2378808311176852,0.22857142857142856,0.9863653732162191,1.0,1/8,1.45%,NEDD9
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.7648108576167534,-1.2374459742550163,0.2,0.9872034645592298,1.0,4/10,14.12%,PCK1;ADAM15;GOLPH3;MSN
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.7552659072960876,-1.2370495069531617,0.14285714285714285,0.9874392677943544,1.0,3/11,10.83%,MAP3K5;NFE2L2;ANXA1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.6656824076058208,-1.2368715241224177,0.175,0.9865077518641541,1.0,7/21,10.67%,ADM;PCK1;ENPP2;NFASC;PTPRD;LAMA4;LSAMP
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.6225464937249584,-1.2367347947406349,0.13793103448275862,0.9849045320392443,1.0,13/49,11.58%,LAMC1;NR4A1;ZEB2;KLF6;HIF1A;FOXF1;KLF2;TIMP3;TNS1;FOSL2;KLF4;LAMA4;CD55
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.868488010903492,-1.2367029229771447,0.21428571428571427,0.9827155413574592,1.0,2/5,9.61%,MAGI2;RAP1A
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.7982636305320843,-1.2365606218644571,0.18518518518518517,0.9815871885418502,1.0,1/7,2.80%,PBX3
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.6036978586863824,-1.2362004330781495,0.0851063829787234,0.9813236831573098,1.0,15/89,11.60%,TBX3;ST18;BTG2;PPARG;HES1;PPM1D;ERBB4;CDKN1B;COL18A1;PBRM1;MAGI2;KLF4;ADAMTS1;DLC1;NPM1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5905063833513773,-1.2360374169375419,0.10416666666666667,0.9798560367952875,1.0,27/85,20.69%,RPS18;RPL23;RPS12;RPL34;RPS9;RPS27A;RPL37;RPS11;RPS15;RPS27;CNOT6L;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;RPL13A;ZFP36;RPS28;RPL24;RPL7A;DCP2;RPL31;RPLP1;RPL37A;RPS19
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.8363245422722174,-1.235965366402581,0.1323529411764706,0.9779680168227941,1.0,2/5,7.04%,PKM;YBX3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.8561504474804815,-1.2356964950725031,0.1746031746031746,0.9775020129947638,1.0,2/5,10.18%,BCAP31;TGM2
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.6353827880345604,1.2356158665443668,0.1875,1.0,1.0,3/10,15.68%,TNRC6C;HELZ;TNRC6A
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.7456711510599018,-1.235319917134811,0.2054794520547945,0.9776498897033596,1.0,3/9,7.14%,MAP2;RTN4;CDKN1B
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.6903464628573117,-1.23488214786409,0.20588235294117646,0.9784867589073892,1.0,4/16,15.84%,BTG2;CDKN1B;CNOT6L;CDKN1A
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7267174993851059,-1.234611934132774,0.1780821917808219,0.9781287364213715,1.0,3/11,18.48%,NR4A1;S1PR1;LCP2
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.5929226052844462,-1.2339420455766816,0.09574468085106383,0.980966743033749,1.0,4/102,1.45%,CEP57;RAPGEF5;SUN2;NEDD9
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.7781647916438021,-1.2334351906289454,0.21428571428571427,0.9791142320749534,1.0,2/8,3.40%,JUN;FOS
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.7781647916438021,-1.2334351906289454,0.21428571428571427,0.9791142320749534,1.0,2/8,3.40%,JUN;FOS
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.714227068343928,-1.232959718391659,0.21739130434782608,0.9798327182736031,1.0,5/14,22.66%,SCP2;LSS;ACSL5;AGPAT4;CBR4
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.7663484428612508,-1.2326079045939413,0.15714285714285714,0.9798418099982188,1.0,4/7,22.33%,RIMS1;SYT1;ARHGAP17;RIMS2
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.6655971848477984,-1.2324695797107317,0.19718309859154928,0.9784423145654431,1.0,5/17,13.19%,MAP2;KDM1A;FES;PRKN;PINK1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.6994659353106176,-1.2324695358756097,0.21052631578947367,0.976112690006954,1.0,1/14,1.84%,NDRG1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.7713207292035809,-1.232350895634022,0.2153846153846154,0.9742354564335876,1.0,3/8,11.89%,RPS27A;UBC;CCNH
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.7886646682832597,-1.2321430555345567,0.2,0.9732735746009769,1.0,1/7,3.01%,SYTL4
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.6219098371545496,-1.2318284618132853,0.20238095238095238,0.9726004530095186,1.0,16/37,20.02%,NES;GRIA2;GPM6B;NPAS3;ANK2;LSAMP;EFR3B;DCLK1;PPFIA2;CTNND2;LRRC4C;ATRNL1;ADGRL3;CADM2;ROBO2;HIVEP2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.6655371551176534,-1.2312991117162417,0.2073170731707317,0.9736317586662578,1.0,4/22,6.52%,SERPINE1;CX3CL1;SPOCK1;DUSP1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.7180318969953619,1.2310959327326974,0.2777777777777778,1.0,1.0,2/5,2.93%,RC3H1;CPEB3
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.7275147726199926,1.230860882445727,0.25,1.0,1.0,1/6,5.76%,EZH1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.7479854223292308,-1.2303825430517965,0.22666666666666666,0.9774098120958657,1.0,1/12,0.29%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.736114401724383,-1.2303033668594128,0.17105263157894737,0.9755259113618537,1.0,8/13,16.23%,PPARG;JUN;CDKN1B;TPM1;ADAMTS1;GJA1;CDKN1A;SOD2
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.7224917017641389,-1.230171511668766,0.19047619047619047,0.9742395298183927,1.0,5/16,15.34%,RPS27A;REL;UBC;NFKBIA;TBK1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.7512345770151532,1.2300070305466908,0.358974358974359,1.0,1.0,1/5,10.62%,MSH3
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.6431938717603416,-1.2284516512842598,0.14814814814814814,0.9833777027094156,1.0,10/33,12.31%,PSMC6;RFC3;PSMB9;POLA1;RPS27A;BAZ1A;PSMA1;UBC;PURA;NOC3L
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.7976108156728461,-1.2283498980600869,0.22641509433962265,0.9816204455480215,1.0,2/5,11.58%,CD81;CD55
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.7460114723155185,-1.2277227452796333,0.28378378378378377,0.9837855604124711,1.0,3/9,14.25%,PCK1;ANXA1;ZFP36
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.6169059970503681,-1.2275541250341848,0.13978494623655913,0.9822637323984923,1.0,21/64,20.25%,PIK3R3;CX3CL1;NFASC;ACTN1;CNTN1;ITGA10;MYL12B;ARPC2;VWF;PECAM1;ADAM15;MSN;RSU1;CADM2;MYH10;CTNNA1;CLDN5;B4GALT1;DLG1;CD34;ITGB1
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.8285028294580031,-1.2270739227883039,0.24285714285714285,0.983127075079057,1.0,3/6,14.38%,MAGI2;RAP1A;ACAP2
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8242222494948365,-1.2269537352678763,0.1694915254237288,0.9818157232569137,1.0,2/7,6.78%,CANX;JAK1
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.6086304104538273,-1.2265881327089585,0.17073170731707318,0.9819206411388439,1.0,16/44,18.56%,PSMC6;NFKBIZ;RFTN1;PSMB9;PIK3R1;PSMA1;PLCG2;NCK1;BTNL9;BCAR1;PAK2;TEC;MALT1;PSMA7;LCP2;INPP5D
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.7631292144607011,-1.226453497463077,0.17333333333333334,0.9805175930241324,1.0,2/12,7.61%,SLC4A10;COL18A1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6927386585990702,1.2261419404465739,0.3125,1.0,1.0,2/7,10.33%,MOB3B;WWC3
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.7329459890397904,-1.225906939665137,0.18309859154929578,0.9819284962673952,1.0,1/14,0.49%,MAP2
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.6280904958264689,-1.22551271468294,0.1511627906976744,0.9823325527028696,1.0,17/53,19.65%,PIK3R3;CHPT1;MTMR12;ARF1;PIK3R1;SYNJ2;DGKG;PLCG2;RAB14;LPIN2;PIK3C3;INPP5D;SACM1L;MTMR2;PIP5K1C;PIKFYVE;AGPAT4
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.7477646246272812,-1.225333631402451,0.208955223880597,0.9814871321440128,1.0,5/9,18.64%,DMD;SLC8A1;ANK2;CACNA1C;ATP1A1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.7439842654833975,-1.225289104137422,0.24285714285714285,0.9795252521581316,1.0,5/13,14.12%,COL18A1;RAPGEF3;RAP1A;PECAM1;MSN
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.6085600670612422,-1.224701181338417,0.18181818181818182,0.9806275137044349,1.0,12/42,14.64%,PSMC6;ST18;CX3CL1;PSMB9;NFE2L2;YBX3;TMSB4X;PSMA1;HYAL2;LIMS1;ZFP36;NFKBIA
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.6406162105589364,1.2244924543339444,0.23076923076923078,1.0,1.0,3/12,14.88%,PRIMPOL;ERCC6;CIRBP
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.6820271439312787,-1.22401301091077,0.11842105263157894,0.9827904407701554,1.0,8/22,17.16%,SMAD7;KDM1A;NDFIP1;COMMD1;PINK1;PTTG1IP;XIAP;MALT1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.811613571520545,-1.2238789282785698,0.21428571428571427,0.9814570986500085,1.0,1/5,1.82%,LBR
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.6554631009360254,-1.2236531943675997,0.15853658536585366,0.98094391937245,1.0,4/30,6.13%,NPLOC4;GAPDH;LRRFIP1;POLA1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.8430290182326567,-1.2232441892407206,0.17567567567567569,0.9766736224713519,1.0,2/6,10.88%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.8430290182326567,-1.2232441892407206,0.17567567567567569,0.9766736224713519,1.0,2/6,10.88%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.8430290182326567,-1.2232441892407206,0.17567567567567569,0.9766736224713519,1.0,2/6,10.88%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.6487771052407438,-1.222800389203645,0.1927710843373494,0.9772759973836602,1.0,7/32,15.58%,LAMC1;ACTN1;PIK3R1;LAMA5;TMEFF2;ATRNL1;PARVB
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.6003125535308067,1.2225579483316447,0.3,1.0,1.0,3/14,11.71%,ATR;ATM;NEK7
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.7025451804436557,-1.2225013052856002,0.28,0.9771438132865661,1.0,4/12,9.35%,LBR;ABCA5;LSS;SCARF1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.793415027680758,-1.2224854177205382,0.17647058823529413,0.975040570425435,1.0,1/8,3.12%,JUN
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.7882435790338534,1.2218163626774945,0.17857142857142858,1.0,1.0,1/5,0.39%,BMP6
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.7367138197090811,-1.2215405251545048,0.22388059701492538,0.9782170055285848,1.0,3/12,10.83%,ALPL;GGT5;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.6051917917552158,-1.2213353937952858,0.1368421052631579,0.977526246378828,1.0,17/65,21.05%,CCDC3;HIF1A;NDFIP1;REL;KLF4;PRKN;SDCBP;PINK1;RACK1;LRPAP1;ACVRL1;CLDN5;PICALM;MTMR2;CD34;GATA2;MECP2
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.6452366574027806,-1.2207725750981067,0.12195121951219512,0.9784102287603531,1.0,9/38,11.79%,UFL1;MGLL;CX3CL1;BCL6;CAMKMT;TMSB4X;ANXA1;CD55;EFNB2
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.7212452784430148,-1.2205901987607595,0.17142857142857143,0.9773843232708321,1.0,5/15,11.60%,RFC3;KDM1A;ALPL;GMPS;NPM1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.6619747550597029,-1.2205145296932411,0.17073170731707318,0.9758092524026367,1.0,9/30,14.64%,BHLHE40;EHD4;JUNB;LGALS3;NFE2L2;FOSL2;KLF4;ZFP36;NFKBIA
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.5011982741355202,1.2204642220652706,0.125,1.0,1.0,5/23,13.91%,RSAD2;GBP2;XAF1;OAS3;STAT2
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.5011982741355202,1.2204642220652706,0.125,1.0,1.0,5/23,13.91%,RSAD2;GBP2;XAF1;OAS3;STAT2
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.7089693429749727,1.219764403744677,0.25925925925925924,1.0,1.0,1/7,1.14%,HABP4
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7027666762759902,-1.2182105243414147,0.27941176470588236,0.9890376364111367,1.0,4/11,9.42%,CDC37;JAK1;IFNGR2;IFNGR1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4853366099733041,1.2178955467106582,0.15789473684210525,1.0,1.0,3/23,3.19%,BMP6;IL6R;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.7123785130262812,-1.2178409827256813,0.2571428571428571,0.9894092669421864,1.0,6/10,24.38%,MAGI2;HYAL2;RACK1;DAG1;PIK3CB;PHLPP1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.7153734635195297,-1.2177352724607158,0.23376623376623376,0.9880095446924518,1.0,3/13,14.25%,JUNB;CD55;ZFP36
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.6175833263248613,-1.2175017741881182,0.16666666666666666,0.9874034139263983,1.0,4/33,7.89%,TBX3;NES;TIMP3;TPM1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.7556589708629716,-1.2174985790992074,0.20833333333333334,0.9852760192472839,1.0,4/10,19.21%,HES1;SMAD7;ACVRL1;ROBO2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.5787521229601336,-1.2174916321796947,0.1326530612244898,0.9831578741102527,1.0,28/129,17.39%,TBX3;ANGPTL4;HSPA5;BNIP3L;CX3CL1;GRK5;RPS27A;PIK3R1;CFL1;KLF4;SNX6;PRKN;UBC;ANXA1;NPM1;RPL10;TMBIM6;PINK1;GOLPH3;NFKBIA;PAK2;XIAP;CPEB4;SOD2;NAA16;MALT1;MCL1;PTMA
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.7020076178771728,-1.2173853537666979,0.23170731707317074,0.9817127343186356,1.0,6/15,21.63%,SERPINE1;DLC1;ADAM15;ACVRL1;DUSP22;ACER2
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.7464766767801336,-1.217217005815355,0.21621621621621623,0.9806996657205591,1.0,1/10,4.80%,EPS8
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.7649819393878978,-1.2171920097763294,0.23943661971830985,0.978675945113931,1.0,3/10,17.73%,SUN2;MYO1B;MYO1E
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.7185178914431259,-1.2170734935703962,0.2361111111111111,0.9772026993652995,1.0,6/15,16.64%,RAPGEF3;RAP1A;PECAM1;AFDN;MSN;RAB1A
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.5887997078746375,-1.2169828750194354,0.16666666666666666,0.9755947674967104,1.0,9/52,9.35%,SERPINE1;ADM;BTG2;KLF6;CX3CL1;HIF1A;ATP2B1;IFNGR2;SCARF1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.8407319733043239,-1.2167700969095774,0.1864406779661017,0.9749553235432863,1.0,1/5,4.70%,SPG7
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.6408677825112811,-1.2162145483911073,0.24096385542168675,0.976027045738578,1.0,4/32,3.04%,DDIT4;ATF3;HSPA5;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.7658774351755756,-1.2161705979126476,0.2054794520547945,0.9743151676481254,1.0,5/11,19.60%,DUSP1;PRKN;PINK1;CYLD;DLG1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.858490280997794,-1.2161119843839658,0.140625,0.9726338929956126,1.0,2/6,5.87%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.6432805841901503,-1.2156824815288327,0.2125,0.9736572061516191,1.0,7/22,17.50%,LGALS3;BCL2L14;HYAL2;TNFRSF10B;FGFR1;PAK2;CYLD
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.6847607943789379,-1.215610087014786,0.14814814814814814,0.9720076719810904,1.0,6/17,21.16%,SEC22B;FEZ2;PINK1;PIKFYVE;CHMP4B;MTM1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.7773314876138885,-1.2154349498085713,0.16883116883116883,0.9686371029638629,1.0,3/8,16.28%,PPA1;PPA2;LARS1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.7773314876138885,-1.2154349498085713,0.16883116883116883,0.9686371029638629,1.0,3/8,16.28%,PPA1;PPA2;LARS1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.775626884257544,-1.2149720977641085,0.2,0.9689223725304056,1.0,4/7,19.60%,KCNMB4;ANK2;NOS1AP;DLG1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.6924027018624083,1.2148954865215384,0.3,1.0,1.0,2/6,13.40%,MVB12B;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6703348635490658,1.2145241962353637,0.22727272727272727,1.0,1.0,2/7,10.41%,EIF2AK2;KLHDC10
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.7340839870859766,-1.2145054827704076,0.1518987341772152,0.9701498083403097,1.0,3/13,6.75%,CCDC60;CX3CL1;ERBB4
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.812081323736682,-1.2137954543951495,0.22058823529411764,0.9726349210831783,1.0,1/5,6.05%,GPM6B
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.7420652029728627,-1.2135318183656563,0.2236842105263158,0.9725892405159686,1.0,6/11,21.16%,SEC22B;FEZ2;PINK1;MTOR;CHMP4B;MTM1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.7736178266962337,1.2132721954431522,0.2571428571428571,1.0,1.0,3/5,12.15%,CLYBL;DISP1;PNPT1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.7736178266962337,1.2132721954431522,0.2571428571428571,1.0,1.0,3/5,12.15%,CLYBL;DISP1;PNPT1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.8614326757993495,-1.2125692314018832,0.13846153846153847,0.9763164022840448,1.0,2/6,13.03%,SYTL4;DYSF
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.6302704358373814,-1.2124145387681011,0.2247191011235955,0.9749854848316785,1.0,7/30,9.61%,CX3CL1;SCARB2;FES;LRRC7;MAGI2;SCARF1;RAP1A
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.7058859716365037,-1.2122772144874667,0.24096385542168675,0.9739105749902432,1.0,3/15,10.57%,MAP3K5;RPS27A;UBC
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.8096726772126488,-1.2121957960358059,0.2608695652173913,0.9725220273789575,1.0,2/7,9.61%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.6203433591468634,-1.2115644651494528,0.12941176470588237,0.9744497629674834,1.0,9/35,17.65%,DDIT4;SMAD7;DMD;RAPGEF3;PINK1;NCK1;RACK1;TBK1;SH2D3C
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.7129230119638053,-1.210064765077695,0.30666666666666664,0.9817775746713536,1.0,2/12,6.78%,ST18;JAK1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.7946754773446251,-1.2099745181587724,0.21052631578947367,0.9802233118734198,1.0,3/7,17.50%,HYAL2;PAK2;CYLD
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.7008042571542479,-1.2092012495269053,0.21518987341772153,0.9831372990873508,1.0,4/14,14.64%,SSH1;KLF4;RPL10;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.7480705158232704,-1.2090087999833443,0.18309859154929578,0.9824636737245688,1.0,2/8,8.93%,RTN4;HIP1R
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.6610363118218668,-1.2089970843427218,0.2077922077922078,0.9804687365222862,1.0,8/25,19.52%,ADM;AKAP12;GRK5;S1PR1;GNA13;ADGRL3;GNAI3;PSAP
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.7901798091897521,-1.2085509403323573,0.2463768115942029,0.9809455371434176,1.0,1/7,3.58%,AKAP12
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.7563353913625519,-1.2078623210261625,0.18055555555555555,0.9822920461307282,1.0,2/10,3.04%,HSPA5;ERO1A
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.6307879688194052,1.2077146257497944,0.2916666666666667,1.0,1.0,3/12,11.71%,ATR;ATM;NEK7
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.7199481092586164,-1.2074325297503203,0.22388059701492538,0.9826739611687932,1.0,1/13,0.60%,DDIT4
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.6595930931214524,-1.207292053448567,0.2328767123287671,0.98160747399929,1.0,5/17,10.57%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.7469652338213217,-1.2072496813470994,0.2537313432835821,0.9778026445909834,1.0,4/6,23.16%,RIMS1;SYT1;RIMS2;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.7469652338213217,-1.2072496813470994,0.2537313432835821,0.9778026445909834,1.0,4/6,23.16%,RIMS1;SYT1;RIMS2;NEDD4L
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.5788056941028922,-1.2066987397197586,0.15463917525773196,0.9788985230707509,1.0,33/90,26.64%,SUN2;SCARB2;RIMS1;RPS27A;ANK2;HIP1R;SUN1;ARPC2;UBC;SYNJ2;DYSF;SH3KBP1;SYT1;GRB2;SGIP1;PICALM;DNM2;PIP5K1C;ANK3;TOR1AIP2;USO1;CLTA;CHMP4B;REEP3;EGFR;VAPB;TF;SYNJ1;CCDC88A;SNX9;FCHO2;SERP1;SPTBN1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.8214132631570119,-1.206659377821708,0.2835820895522388,0.9771196640461964,1.0,1/5,8.46%,AP1G1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.7395438984865129,-1.206472249491688,0.19718309859154928,0.9760751259351007,1.0,3/10,13.21%,PRKN;FOXK1;OGT
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.7850216217911468,-1.2055266667919995,0.20588235294117646,0.980004634062119,1.0,3/6,19.89%,WNT2B;ARIH2;CD34
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.6047659440229056,-1.2054562101751418,0.15853658536585366,0.9783440014374578,1.0,8/38,11.27%,ADAMTS9;NES;MAP1B;TIMP3;SMARCA1;ANK2;LAMA4;GJA1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.6741241050182167,-1.2051316256586666,0.2345679012345679,0.9782888938003572,1.0,6/18,16.17%,PSMC6;UFL1;COMMD1;PRKN;PINK1;TMF1
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.7237970983452975,-1.2049044949485148,0.24675324675324675,0.9777312608080105,1.0,3/9,17.42%,JAG2;FGFR1;LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.7205511297641394,1.2046045269031784,0.36,1.0,1.0,1/7,1.56%,ARHGAP12
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.6116087190415542,-1.2045916927721354,0.2,0.9773067431914368,1.0,4/29,13.06%,ADM;LGALS3;GGT5;PLCG2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7195390843609901,-1.204409571851234,0.2647058823529412,0.976448488345729,1.0,5/7,25.23%,RPS15;RPS27;RPS28;RPS19;RPS14
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7632469001898191,-1.2042806615462085,0.2361111111111111,0.9752459957471079,1.0,2/5,17.91%,TIE1;ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.6295102028834275,-1.204183997865218,0.24096385542168675,0.9738097395906596,1.0,8/35,9.99%,SERPINE1;ANGPTL4;PKM;HIF1A;JAK1;FLT1;RAPGEF3;KLF4
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.6048590113954976,-1.2040387194494624,0.12087912087912088,0.9727903713161095,1.0,26/61,24.58%,SERPINE1;ANGPTL4;PGK1;PPARG;GLUL;HIF1A;FLT1;RAPGEF3;KLF4;ADAMTS1;TIE1;BTG1;CLDN5;SPARC;VEGFC;ATF2;CD34;EMP2;ITGB1;GATA2;MECP2;SPRED1;CDH5;RHOJ;PPP1R16B;ANXA3
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.6256763253519694,-1.2030281151268294,0.21348314606741572,0.9765484820131102,1.0,5/35,10.23%,PPARG;CLIC2;HES1;HIP1R;PRKN
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.847136663114465,-1.2024930507900689,0.22580645161290322,0.9778343019218128,1.0,1/5,5.53%,GRIN2B
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.6282475898160451,-1.2022723738917593,0.2289156626506024,0.9773508882689466,1.0,15/34,16.15%,DOK5;MAP2;MAP1B;NFASC;GRIA2;GPM6B;NPAS3;ANK2;PTPRD;GJA1;DCLK1;PPFIA2;LRRC4C;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.6767902692297854,-1.2020914313868443,0.2916666666666667,0.9763111016608148,1.0,3/19,4.70%,VSIR;SRGN;SPG7
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.7403466191434247,-1.2020276534987135,0.27631578947368424,0.9747610747077928,1.0,7/10,24.33%,COMMD1;PRKN;XIAP;PICALM;FTL;TF;B2M
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.7490066301818196,-1.2019687773814798,0.26229508196721313,0.9731315624887326,1.0,2/5,14.04%,NPLOC4;HERPUD1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.6708158032356365,-1.2014615554154586,0.2261904761904762,0.9744541916404171,1.0,8/15,23.16%,KCNIP4;KCNMB4;DPP10;NOS1AP;DLG1;STK39;CD63;NEDD4L
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.5934121217439232,1.2012422439729686,0.2,1.0,1.0,3/16,2.57%,SAMD9L;GBP2;IL6R
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.765535865027341,-1.2011914209816807,0.27419354838709675,0.9743442566116551,1.0,3/9,8.18%,VSIR;GRIN2B;MBP
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.5712917352018976,-1.2008491347032417,0.18681318681318682,0.9746174859445469,1.0,22/63,21.86%,RPL23;RPL34;RPS9;RPL37;RPS15;RPS27;RPL10;RPLP2;RPS6;RPL8;RPL15;RPS7;SMAD3;RPL13A;RPS28;RPL24;RPL7A;RPL31;RPLP1;RPL37A;RPS19;RPL21
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.6526414986372933,-1.200568129070496,0.21951219512195122,0.9741893329207548,1.0,6/26,10.85%,PKIG;DUSP1;CDKN1B;SLC8A1;IPO7;HYAL2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6822966164273219,-1.200336269853282,0.19444444444444445,0.9736145743011432,1.0,5/17,16.04%,TSG101;SNX6;ZFYVE28;SH3KBP1;GRB2
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.7665860335793088,-1.2001479336682737,0.3114754098360656,0.9728517812740325,1.0,3/5,20.38%,LGALS3;MSN;STK10
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.6095862186404264,-1.2001364318670473,0.2375,0.9710369858828447,1.0,9/29,21.70%,CDC37;JAK1;IFNGR2;IFNGR1;VRK2;RACK1;CYLD;SOCS3;CBFB
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.6973021725815054,-1.1992541484404877,0.2375,0.9742200003437665,1.0,5/13,17.60%,ENPP2;NFASC;GRIA2;CTNND2;SCN3A
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.736513416283401,-1.199107135196562,0.25333333333333335,0.9734184081639882,1.0,4/9,15.60%,RPS27A;UBC;AMFR;UGGT2
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5880831740764045,-1.199087968317353,0.18681318681318682,0.9716968849112559,1.0,21/57,18.82%,BTG2;NEDD9;ATF3;JUN;BCAP31;BNIP3L;SMAD7;LGALS3;CDKN1B;TIMP3;EMP1;IFNGR1;ANXA1;SLC20A1;XIAP;CDKN1A;SOD2;MCL1;CYLD;GADD45B;PLAT
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.6740086226988599,-1.1987213822002256,0.2345679012345679,0.9719081865974015,1.0,7/27,9.84%,DDIT4;WNT2B;PBX3;SPOCK1;SMARCA1;PTPRD;IL1RAPL1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.6892850621506675,1.198597769433058,0.26666666666666666,1.0,1.0,1/5,2.10%,DCP1A
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.652766059407311,-1.1982857202510042,0.273972602739726,0.9723485498800479,1.0,1/15,1.38%,NRCAM
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.6164946022277671,1.1974861257507408,0.2857142857142857,1.0,1.0,3/10,8.02%,RSAD2;SLC25A37;FBXO7
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.7195084626757513,-1.1964413135164984,0.3235294117647059,0.9811927481383474,1.0,2/6,14.04%,NPLOC4;HERPUD1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.7511817245849118,-1.1956696197641365,0.2647058823529412,0.9839453236262149,1.0,1/7,2.26%,RFC3
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.6303208896351737,-1.1953425489817389,0.2235294117647059,0.9837992835920824,1.0,5/40,6.05%,MAP2;BTG2;PPP1R9A;PBX3;GPM6B
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.7566940760669972,-1.1952397134781294,0.2711864406779661,0.9825546505803092,1.0,1/8,1.35%,SUN2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.6151896713284835,-1.1950570511986054,0.2289156626506024,0.9816252223208418,1.0,9/25,29.05%,RAB11FIP3;PRKCE;PIK3C3;ECT2;CSPP1;RAB11A;PRPF40A;RHOA;BCL2L1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.6644878326998752,-1.1950367567915918,0.2345679012345679,0.9799762002788917,1.0,6/16,17.26%,PPARG;GGT5;ACOX1;ACSL5;PON2;LPIN2
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.7580209638499669,-1.1944815182773958,0.2923076923076923,0.9814265866822666,1.0,3/5,17.29%,CX3CL1;SCARF1;ANKS1A
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.7884850214118511,-1.1938522221502172,0.23076923076923078,0.9836742239698167,1.0,4/5,19.24%,PRKN;RAB21;MSN;MTMR2
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.6163029912717025,-1.1929506051702385,0.19767441860465115,0.9871460343742848,1.0,15/40,24.04%,NEDD9;FES;ERBB4;FLT1;PTPRD;FGFR1;SHC2;BCAR1;TIE1;LCP2;CASS4;AHI1;EGFR;PIK3CB;ABI1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.7823865544193914,-1.1922206232143353,0.3235294117647059,0.9894360225931141,1.0,3/5,16.07%,APOLD1;NOTCH4;BTG1
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.594691478721997,-1.1912655267506467,0.20652173913043478,0.9934161761475891,1.0,14/61,18.72%,LBR;YTHDC1;HIF1A;DMD;RAD21;CDKN1B;PURA;SMAD3;MTF2;EWSR1;KPNB1;PAFAH1B1;SMARCC1;NSD2
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.6856195447445623,-1.1909914832233044,0.2602739726027397,0.9931731762684737,1.0,3/11,19.13%,PPARG;LCP2;IL18R1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.706498912135807,-1.1908407276705133,0.3026315789473684,0.9924009326173849,1.0,4/13,16.07%,CD9;HIF1A;ANXA1;BTG1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.5745657011870764,-1.1908369958263276,0.17894736842105263,0.9905732386203562,1.0,11/86,7.92%,LAMC1;NEDD9;PLS3;RTN4;HES1;SPG7;EPS8;RIMS1;RAD21;GPM6B;SLC2A1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.6779129271802169,-1.1906027105933223,0.23880597014925373,0.9899305859771257,1.0,6/17,14.64%,PPARG;JUN;HES1;KDM1A;PRKN;NFKBIA
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6613284321995716,-1.1905978110887099,0.2625,0.9881142569794186,1.0,3/18,5.94%,SEC24D;BCAP31;CANX
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.8212567826206791,-1.190369726662339,0.2727272727272727,0.9876606924710839,1.0,1/5,0.52%,MTHFD1L
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.6518711048513495,-1.1902816220745043,0.2345679012345679,0.9863603227281355,1.0,5/32,13.06%,DIXDC1;WNT2B;RPS27A;UBC;PLCG2
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.7638074149179064,-1.1899875715722545,0.27941176470588236,0.9861738087623025,1.0,2/6,12.88%,POLA1;CDK14
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.7278830348652031,-1.189945103308462,0.3382352941176471,0.9827490752045903,1.0,5/9,21.21%,PIK3R1;HYAL2;SMAD3;TPR;ECT2
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.7278830348652031,-1.189945103308462,0.3382352941176471,0.9827490752045903,1.0,5/9,21.21%,PIK3R1;HYAL2;SMAD3;TPR;ECT2
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.6806061819834157,1.189897648705471,0.21212121212121213,1.0,1.0,2/5,4.15%,PGM5;TTN
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.7275712694340148,-1.1894590389559794,0.2318840579710145,0.9834726297139915,1.0,3/7,17.29%,CX3CL1;SCARF1;ANKS1A
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.7859058912080579,-1.1893827069775755,0.21875,0.9819916690357731,1.0,2/5,7.89%,KCNMB4;TPM1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.6593283996736048,-1.1890902621455997,0.29411764705882354,0.9819746893902782,1.0,4/12,17.08%,PRKN;ARIH2;PINK1;SREBF2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.8098321241880267,-1.1886697118474285,0.19298245614035087,0.9828552471332367,1.0,2/5,6.13%,RFC3;POLA1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.7104046270468519,-1.1884944938778637,0.19736842105263158,0.9819807308102152,1.0,5/15,14.67%,PRKAG2;SCARB2;HIF1A;OGT;TPR
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.5637436209866917,-1.1879840685190164,0.13402061855670103,0.9833349885389997,1.0,18/91,14.49%,PSMC6;MAP3K5;PSMB9;GRIN2B;RPS27A;ERBB4;JAK1;LRRC7;PEBP1;PIK3R1;MBP;PSMA1;UBC;MEF2A;FGFR1;SHC2;ZFP36;DUSP5
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.7940435501743044,-1.1879772389772982,0.30357142857142855,0.9815503515362065,1.0,1/5,4.70%,SPG7
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.6427422023439691,-1.1878876620773118,0.27586206896551724,0.9802275662850489,1.0,8/25,20.43%,PPARG;AAMDC;ZFPM2;TRIB2;SMAD3;ZFP36;WWTR1;GATA2
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.7388901190264932,-1.1875686164072186,0.36619718309859156,0.9802337245000182,1.0,4/10,14.88%,WNT2B;SULF2;HYAL2;CREB3L2
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.6276670573455072,-1.1873664084958995,0.24050632911392406,0.9795888398062212,1.0,6/27,13.91%,PCK1;PPARG;ALPL;GGT5;ANXA1;PELI1
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.7403238869826457,1.1869291949556755,0.3333333333333333,1.0,1.0,1/5,0.86%,PLA2G4A
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7038859786665238,1.1863525068444252,0.29545454545454547,1.0,1.0,1/5,4.91%,RFX3
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.7761871857521265,-1.1862660009667552,0.24242424242424243,0.983672443870062,1.0,1/7,5.61%,LGALS3
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.6716401817290973,-1.186039877825066,0.2564102564102564,0.9830630080295806,1.0,2/19,2.88%,PCK1;PPARG
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.6373699327021648,-1.185969050847457,0.21176470588235294,0.9817101379621512,1.0,8/27,18.12%,POLA1;CDKN1B;CRLF3;CCNH;CDK14;MAX;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.7511522713154786,-1.185671324578416,0.2328767123287671,0.9817331705381616,1.0,1/7,2.88%,PPARG
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6103848915662062,1.1855912432224327,0.23076923076923078,1.0,1.0,2/9,3.17%,CPEB3;TNRC6C
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6103848915662062,1.1855912432224327,0.23076923076923078,1.0,1.0,2/9,3.17%,CPEB3;TNRC6C
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.592127744022206,-1.1853854505164878,0.1797752808988764,0.9814041947474732,1.0,14/57,17.34%,PSMC6;LDHA;PGK1;RPL34;CANX;PSMA1;NPM1;RPS6;DDX18;RACK1;KPNB1;CNBP;SMARCC1;PSMA7
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7731713012720373,-1.1848277662676834,0.23333333333333334,0.9809056155447905,1.0,2/6,10.57%,RPS27A;UBC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7731713012720373,-1.1848277662676834,0.23333333333333334,0.9809056155447905,1.0,2/6,10.57%,RPS27A;UBC
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.6251880341429682,1.1847030281677249,0.3333333333333333,1.0,1.0,2/6,5.87%,HSPD1;HSPA1A
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.8094503564161601,-1.1841333389466107,0.19402985074626866,0.9830301998345176,1.0,2/5,14.80%,SULF2;HS6ST3
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7625267905406461,-1.1839677327202882,0.24358974358974358,0.9820994690371966,1.0,3/8,11.71%,RPS27A;UBC;CHFR
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.6437926488016303,-1.1837080496790162,0.2857142857142857,0.9820052975993618,1.0,3/23,6.20%,MAP2;SPOCK1;ANO2
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.8008000277692232,-1.1830054820788343,0.373134328358209,0.9843100927337004,1.0,2/7,6.80%,KCNMB4;KLF2
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.723010893530805,-1.1830028581282628,0.20588235294117646,0.9825903386055719,1.0,4/10,19.96%,ITGB5;ARHGAP15;LCP2;KPNA4
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.7163505430980704,1.1829999718251505,0.35714285714285715,1.0,1.0,3/7,15.50%,HERC5;RNF216;TRAF3
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.677697137821288,-1.1828109540743368,0.23170731707317074,0.9817055007480111,1.0,6/15,14.69%,ITPR1;SLC2A1;RAPGEF3;RAP1A;ENSA;CACNA1C
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.6667244293574859,-1.1824627875091702,0.23684210526315788,0.9821514522468001,1.0,5/19,13.58%,ADAMTS9;HIF1A;MGAT4A;NGLY1;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.7578127388481308,-1.1823769329096174,0.2698412698412698,0.9807710922460723,1.0,2/6,17.86%,JUN;CHD1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.7790550053105731,-1.1814588422191694,0.29411764705882354,0.9841124125056605,1.0,4/6,19.42%,KCNMB4;ANK2;NOS1AP;ANK3
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.6578804714963133,-1.181170889961056,0.3076923076923077,0.9840732919001114,1.0,8/24,14.69%,PPP1R9A;BCAP31;SLC8A1;ANK2;PRNP;PLCG2;PPP3CC;CACNA1C
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.6823294924140764,-1.1811678791065443,0.2625,0.9823528840471393,1.0,4/15,20.30%,RIMS1;DYSF;DNM2;USO1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.6599953536121622,-1.18073008507187,0.24675324675324675,0.9828128881033799,1.0,9/20,19.00%,FOXF1;TIMP3;TPM1;MSRB3;LAMA4;ADAMTS1;CALD1;PLAT;VEGFC
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.5588554823177879,-1.1805555421437517,0.1414141414141414,0.9819194127184536,1.0,33/180,12.90%,TBX3;ST18;UFL1;BTG2;JUN;RPL23;HES1;CX3CL1;JUNB;PPM1D;GRK5;RPS9;FES;JUND;ERBB4;CDKN1B;COL18A1;PBRM1;MAGI2;BCL6;JAG2;FLT1;KLF4;CD81;ADAMTS1;DLC1;NPM1;EFNB2;CNOT6L;LIMS1;SDCBP;FGFR1;RPS6
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.6728215030153532,-1.180515478280447,0.2835820895522388,0.9803827934022761,1.0,4/15,10.57%,RFC3;NPLOC4;RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.638570267510035,-1.1804513185773748,0.2289156626506024,0.9789463815855722,1.0,5/25,18.04%,BNIP3L;CALCOCO2;PINK1;TBK1;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.7728685027662634,-1.1796880311983995,0.2608695652173913,0.9810001880822327,1.0,5/7,21.16%,SEC22B;FEZ2;PINK1;CHMP4B;MTM1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.6971854770749185,-1.1794620989190687,0.25,0.9805698420237265,1.0,5/14,20.74%,NEDD9;HYAL2;PRNP;CASS4;GPRC5B
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.6905424655661957,-1.1791175514498833,0.2602739726027397,0.9808205217265025,1.0,2/14,6.78%,ST18;JAK1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.8150680892306847,-1.1788609971102584,0.2714285714285714,0.980410812934696,1.0,2/5,12.59%,SULF2;CHST11
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.7760163594356061,-1.1788117146835526,0.24,0.9789867144390783,1.0,3/7,13.29%,KDM1A;PRKN;PTTG1IP
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.7742806318350952,-1.1781157591393343,0.2923076923076923,0.9805533374809967,1.0,3/5,16.67%,PPA1;PPA2;SULT1C4
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.736405664329597,-1.1780789149794044,0.23880597014925373,0.9790776401925938,1.0,6/9,21.99%,PPM1D;DUSP1;DUSP16;DUSP5;PPM1A;DUSP6
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6841050394429322,-1.1776483589100382,0.2923076923076923,0.9798340197602089,1.0,5/12,22.33%,RIMS1;KCNMB4;SLC30A1;PREPL;RIMS2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.6935428120833903,1.1773251949597436,0.3125,1.0,1.0,1/5,1.14%,HABP4
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.6165858418101804,-1.1766245969752116,0.2345679012345679,0.9840067089480458,1.0,8/25,17.16%,SMAD7;NDFIP1;WDR48;COMMD1;PINK1;PTTG1IP;XIAP;MALT1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.677110414142593,-1.1764444395045908,0.2916666666666667,0.9832786976134227,1.0,4/15,16.04%,TSG101;ZFYVE28;SH3KBP1;GRB2
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.7392477326270273,-1.175734794765061,0.2638888888888889,0.9855694180150223,1.0,2/12,3.04%,HSPA5;ERO1A
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.6990508560704851,-1.1751581975483696,0.2564102564102564,0.9871460343742849,1.0,7/13,22.30%,SUN2;SUN1;TPR;NUP54;RPS19;CHMP4B;REEP3
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.7306601748889769,-1.1751554171124194,0.234375,0.985470064876196,1.0,1/8,4.05%,NPLOC4
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.7461628851335138,1.1750670167927992,0.32,1.0,1.0,2/5,6.31%,ZNRF3;RNF213
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.5608760281825403,-1.1746898876025338,0.12121212121212122,0.9865413527654102,1.0,39/147,18.12%,ST18;BTG2;NR4A1;RTN4;BNIP3L;CD9;PPM1D;ESR2;ACTN1;DUSP1;ERBB4;CDKN1B;COL18A1;PBRM1;MAGI2;BCL6;NPAS2;KLF4;PRKN;ADAMTS1;HYAL2;DLC1;CRLF3;GJA1;NPM1;TMBIM6;ADAM15;DYSF;NCK1;SMAD3;NOTCH4;RACK1;PLPP1;CDKN1A;BTG1;SOD2;LRPAP1;ACVRL1;CDK6
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.5678097020155676,-1.174556880892485,0.21839080459770116,0.9853343985396192,1.0,9/48,16.54%,CEP57;NES;CEP70;ENSA;CCNH;CDK14;ARPP19;CDKN1A;PAFAH1B1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.7495357193053681,-1.1743216539826855,0.2318840579710145,0.9850176777710443,1.0,5/8,21.08%,DMD;KCNMB4;SCN3A;ANK3;SCN2A
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6598853562303679,1.174249954758092,0.4230769230769231,1.0,1.0,2/6,12.15%,MFF;PNPT1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.7388120507371567,-1.1742007162970884,0.22666666666666666,0.9839279463457993,1.0,2/9,8.10%,SCARB2;LAMP2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.7269880288519551,-1.1740367511636738,0.3424657534246575,0.9830994759472059,1.0,4/9,11.27%,JUN;CX3CL1;ADAMTS1;GJA1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.6947227725842107,-1.1739321945875452,0.2716049382716049,0.9819798943576725,1.0,4/10,8.28%,DTNA;DMD;TPM1;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.6162791251497748,-1.1736659712855337,0.23376623376623376,0.9819459927677053,1.0,5/32,13.06%,ADM;PPARG;GGT5;KLF4;PLCG2
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.669570875424977,-1.172246657804656,0.31645569620253167,0.9876972046894017,1.0,6/20,17.94%,SYN3;GLUL;RIMS1;PPFIA2;SYT1;SLC38A2
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.5687461143272674,-1.171881488195538,0.22988505747126436,0.987873171941246,1.0,9/47,16.54%,CEP57;NES;CEP70;ENSA;CCNH;CDK14;ARPP19;CDKN1A;PAFAH1B1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.7583032847541067,-1.1716961072581034,0.28125,0.9874099473701251,1.0,2/6,15.24%,NPM1;RIOK3
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.6324889481176945,-1.1716344525379465,0.26136363636363635,0.9861103572379174,1.0,7/30,14.98%,ZEB2;SCARB2;PRKN;PINK1;GOLPH3;MSN;PAK2
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.5878523910707383,-1.1716016039998338,0.2375,0.9846150555614873,1.0,16/34,27.15%,SCARB2;KIAA1217;COL18A1;LAMA5;SUN1;EPAS1;BCAR1;CTNNA1;ATP1A1;DAG1;TMEM50B;TMEM117;DSP;APLP2;CADPS2;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.5621219523744059,-1.1715764378566274,0.2087912087912088,0.9831610314860183,1.0,11/58,12.62%,SERPINE1;CX3CL1;SMAD7;TPM1;MAGI2;TMEFF2;HYAL2;DLC1;GJA1;AFDN;ADAM15
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.7254663286721954,-1.171496108870002,0.273972602739726,0.98196557728639,1.0,1/6,2.88%,PPARG
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.7450611999595363,-1.1711295831008801,0.31666666666666665,0.9823302339190642,1.0,1/8,4.70%,SPG7
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.6533131724795753,-1.1709494105147404,0.25,0.9815917270108228,1.0,5/13,26.19%,RIMS1;SYT1;RIMS2;NEDD4L;MAP3K13
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.692774136819328,-1.1704006864758465,0.2597402597402597,0.9828936210363717,1.0,6/15,19.31%,PRKAG2;HIF1A;PINK1;OGT;TPR;NUP54
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.6420094092567907,-1.1695790699799036,0.26506024096385544,0.9853435687844507,1.0,5/21,10.18%,CX3CL1;KDM1A;PTPRD;IL1RAPL1;TGM2
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.6997111794752667,-1.1694243331810503,0.273972602739726,0.9845677981811988,1.0,3/15,8.10%,TSG101;RPL23;LAMP2
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.6735577451656614,-1.169288529298479,0.273972602739726,0.9833997581272446,1.0,4/12,15.21%,BCAP31;RPS7;NCK1;RACK1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.7425022331372255,-1.1692840549113352,0.2857142857142857,0.9818055441896801,1.0,1/8,1.90%,PCK1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.7732119822873245,-1.1691519184925507,0.2597402597402597,0.9806458483813878,1.0,4/8,15.47%,ARF1;COMMD1;PRNP;XIAP
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.7122343567487766,-1.1690770941577076,0.2876712328767123,0.9795078006904641,1.0,3/15,13.16%,MAP2;MEF2A;CTNND2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.7196393844544984,-1.1690559786587438,0.25,0.9780347125873644,1.0,6/7,27.26%,PRKCE;COMMD1;STK39;NEDD4L;NEDD4;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.5790884438309677,-1.16836990295561,0.20430107526881722,0.9801976414934543,1.0,21/63,24.45%,DDIT4;ITPR1;DUSP1;PEBP1;MAGI2;TMSB4X;HYAL2;DGKG;PINK1;HERPUD1;RACK1;RIOK3;MCL1;CYLD;PDE10A;PPM1A;DAG1;SPRED1;PIK3CB;PHLPP1;UBR1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.7116746873380242,1.1682421400126302,0.4166666666666667,1.0,1.0,4/7,12.25%,CLASP1;BICD1;PCM1;PEX14
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.6687085302947997,-1.1680452237083259,0.25675675675675674,0.9802387698350726,1.0,5/15,17.32%,HSPA5;PRKAG2;SIK2;CPEB4;PIK3C3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.7389607718685459,-1.167716221381822,0.35714285714285715,0.9806346106240537,1.0,4/7,19.89%,HIF1A;LRRC32;SMAD3;CD34
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6753822170498542,-1.1672871909998117,0.3114754098360656,0.9812948714480685,1.0,4/11,15.97%,NPM1;RPL10;RPL24;RPL7A
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.6792599255661886,-1.1663579997339997,0.27631578947368424,0.9846941519991945,1.0,3/12,12.12%,TAF1D;CCNH;CSTF3
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.6958385885596395,-1.1657982327938958,0.23076923076923078,0.9861579115675891,1.0,4/12,10.59%,PPARG;CD9;VWF;PECAM1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.703067887964205,-1.1655471761092566,0.2857142857142857,0.9855368650839492,1.0,4/8,23.13%,FOXF1;NOTCH4;ACVRL1;CDH5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.683800242351308,-1.1655144073822647,0.29577464788732394,0.9841258436621217,1.0,5/11,21.99%,DUSP1;DUSP16;DUSP5;DUSP22;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.7674236364451217,-1.1654879240870233,0.3333333333333333,0.9826842169837317,1.0,2/6,7.89%,ADM;TPM1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.5359086193191352,1.1652562234678385,0.2,1.0,1.0,10/47,12.15%,SAMD9L;RSAD2;GBP2;GBP4;IL15;EIF2AK2;NCOA7;IFI44;DDX60;PNPT1
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.5773049091792029,-1.1652434231366846,0.23157894736842105,0.9824401387416744,1.0,14/62,20.43%,MAP2;ATG12;GRIA2;ARHGAP21;OXR1;NCALD;LPGAT1;PPFIA2;CTNND2;SYT1;CADM2;TRIM9;HIVEP2;GATA2
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.8043117924597043,-1.1643824933625715,0.265625,0.9849992161896037,1.0,1/5,6.33%,ARHGAP21
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.6115607563861699,-1.164115881871302,0.2891566265060241,0.9848571358588358,1.0,5/29,9.09%,SERPINE1;ANGPTL4;HIF1A;FLT1;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.6797164725374527,-1.164061327994154,0.32432432432432434,0.9835806825357699,1.0,3/14,6.83%,GRIA2;GRIN2B;LRRC7
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.6822914447397885,-1.1640599733942663,0.30666666666666664,0.9789068943141573,1.0,6/12,28.79%,LBR;KPNB1;CHMP4B;REEP3;PPP2R2A;NUP98
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.6822914447397885,-1.1640599733942663,0.30666666666666664,0.9789068943141573,1.0,6/12,28.79%,LBR;KPNB1;CHMP4B;REEP3;PPP2R2A;NUP98
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.6822914447397885,-1.1640599733942663,0.30666666666666664,0.9789068943141573,1.0,6/12,28.79%,LBR;KPNB1;CHMP4B;REEP3;PPP2R2A;NUP98
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.7237382063079874,-1.1637405926731372,0.2923076923076923,0.9792440086520848,1.0,2/7,21.75%,KMT2A;SETD3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.8096170383499808,-1.1635485277739173,0.22727272727272727,0.9785581430451021,1.0,1/5,11.84%,CNOT6L
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.6329714711830201,-1.1634862826181858,0.3246753246753247,0.9773383609644067,1.0,5/21,10.57%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.7363683851870477,1.1632497976339933,0.3,1.0,1.0,3/5,21.63%,GMDS;PARG;UGP2
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.6722137164125486,-1.1630516326776275,0.25,0.9779526084614856,1.0,3/16,10.57%,MAP3K5;RPS27A;UBC
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.7204415391955672,-1.1628991406809408,0.27941176470588236,0.9771685937373642,1.0,1/9,1.90%,PCK1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.5748910285458312,-1.1625520558849374,0.25316455696202533,0.9770755054352351,1.0,13/38,26.95%,SERPINE1;FES;ADAM15;MSN;ZFP36;ATP1A1;EGFR;VIM;MAPK8;TFPI;ADCY2;RHOA;PDE4B
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5477349653700835,1.1618175979551044,0.3448275862068966,1.0,1.0,4/18,17.83%,TNRC6C;PPP3CA;TNRC6A;TCF7L2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.5850285096044369,-1.1614120138380726,0.23595505617977527,0.9810897731260193,1.0,9/58,13.16%,MAP2;BTG2;PPP1R9A;GRM7;GPM6B;GAS7;DCLK1;GPM6A;CTNND2
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.7876352139452123,-1.161206921442802,0.3561643835616438,0.9803731554260102,1.0,4/5,17.08%,NFE2L2;KLF2;KLF4;SREBF2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.7278711655005056,-1.1610848936951739,0.3246753246753247,0.9793504352551037,1.0,2/7,4.18%,AKAP12;GRM7
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.7655353543523761,-1.1608076410406056,0.3,0.9792887225775702,1.0,1/6,4.49%,ABCA5
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.6107986472449485,-1.1607354514602344,0.2808988764044944,0.9781001232051967,1.0,11/39,13.11%,MAP2;PPP1R9A;NFASC;GRIA2;ERBB4;CNTN1;ANK2;PTPRD;STOX2;SHC2;PPFIA2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.7923018472360407,-1.1607347900675828,0.35384615384615387,0.9765742259771075,1.0,1/6,2.34%,RFTN1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.7610306820000698,-1.160732437489376,0.2878787878787879,0.9750871298500805,1.0,2/5,16.43%,ARPC2;SPIRE1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.7422943042328335,-1.1605966762461273,0.3275862068965517,0.9742675534502047,1.0,3/7,20.25%,GJA1;PAFAH1B1;ITGB1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.566342405693104,-1.1604207952268901,0.1935483870967742,0.9736711439502787,1.0,18/72,21.26%,CEP57;NES;CEP70;EPS8;CDKN1B;CRLF3;ENSA;CCNH;CDK14;ARPP19;MAX;CDKN1A;PAFAH1B1;CDK6;DNM2;DYNC1I2;CHMP4B;CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.7989209463786884,-1.1599761456255284,0.2777777777777778,0.9744490950274788,1.0,2/5,15.47%,PRKN;XIAP
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.611486551624776,-1.1591958875725363,0.24050632911392406,0.9768149627948653,1.0,5/26,10.90%,PSMC6;SEC22B;PSMB9;PSMA1;ITGB5
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.7724184657291078,-1.1591923030771472,0.29508196721311475,0.9753220946239504,1.0,2/5,14.56%,KCNMB4;SYT1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.7488724661874007,-1.1590448448805442,0.26666666666666666,0.9744916133799579,1.0,3/8,13.29%,KDM1A;PRKN;PTTG1IP
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.7570278674667044,-1.1587624586290621,0.26229508196721313,0.9741857359958865,1.0,2/6,10.44%,ADAMTS9;NGLY1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.5397575829304305,-1.1586404607576863,0.1414141414141414,0.9733427440825142,1.0,40/209,17.39%,TBX3;ANGPTL4;MAP3K5;NDRG1;RTN4;HSPA5;JUN;BNIP3L;CX3CL1;GRK5;RPS27A;ACTN1;BCL2L14;PIK3R1;BCL6;HIP1R;CFL1;TGM2;PRKN;VAV3;UBC;ANXA1;NPM1;TNFRSF10B;RPL10;TMBIM6;RPS6;PINK1;GNA13;GOLPH3;FGD4;NFKBIA;BCAR1;PAK2;RACK1;XIAP;NAA16;MALT1;MCL1;PTMA
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.7202908409201887,-1.1585136161256882,0.35384615384615387,0.9723176694740339,1.0,5/10,21.21%,PIK3R1;HYAL2;SMAD3;TPR;ECT2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.7507188664986701,-1.1584441792963218,0.265625,0.9711951632887736,1.0,3/6,13.37%,RPL23;SMAD7;RPS7
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.6239373219588732,-1.1581863847739338,0.25609756097560976,0.9711807366171783,1.0,13/30,20.25%,HIF1A;LRRC32;SLC2A1;TNS1;VWF;ITGB5;EFNB2;CST3;DYSF;ACVRL1;EGFL7;PSAP;ITGB1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.7741870670277422,-1.1580673809039002,0.2857142857142857,0.9700801130029277,1.0,2/5,14.67%,RTN4;TPR
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.7625120744102967,-1.1580151762266606,0.3181818181818182,0.9688159911979887,1.0,1/6,5.45%,ESR2
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7656925746714979,-1.1565048942586615,0.28125,0.9745197921683721,1.0,3/5,11.76%,RFTN1;VSIR;PRNP
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.770140875348567,-1.1564068070612425,0.2676056338028169,0.973485652329073,1.0,2/5,15.24%,RFTN1;RIOK3
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.6881497420262762,-1.1561288701378827,0.32926829268292684,0.9734512444843848,1.0,5/14,21.16%,SEC22B;FEZ2;PINK1;CHMP4B;MTM1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.7225103065572791,-1.156038961721937,0.23529411764705882,0.9723555261966955,1.0,3/14,11.79%,RTN4;SPOCK1;EFNB2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.5418749062552856,-1.1559415585089783,0.14,0.9714949609750009,1.0,55/264,17.26%,MAFF;TBX3;SERPINE1;ST18;NR4A1;ZEB2;KLF6;ATF3;PPARG;JUN;FOS;HES1;CX3CL1;PHF10;JUNB;SMAD7;KDM1A;HIF1A;NFE2L2;RPS27A;JUND;FOXF1;KLF2;SMARCA1;PIK3R1;NPAS2;REL;RREB1;FOSL2;KLF4;PRKN;CD81;CEBPZ;UBC;HYAL2;ZFPM2;CRLF3;EPAS1;NPM1;MEF2A;OGT;NCK1;SMAD3;MTF2;NOTCH4;NFKBIA;MAX;TBK1;TMF1;WWTR1;CRTC3;SREBF2;ZBTB38;CNBP;LPIN2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.66094283314662,-1.155694231932587,0.3373493975903614,0.9713975832211392,1.0,9/19,26.64%,LGALS3;PIK3R1;PRKCE;DPP10;DLG1;ITGB1;EGFR;PRKCH;SPTBN1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.5983685999511539,-1.1555479208492327,0.2840909090909091,0.9706071027400345,1.0,5/42,7.89%,MAP2;BTG2;PPP1R9A;GPM6B;TPM1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.6622946958631876,-1.155244043797894,0.3170731707317073,0.9708080797758792,1.0,4/13,14.51%,ANO2;SLC20A2;SLC26A2;SLC20A1
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.5972381917081787,-1.1551932871877042,0.27058823529411763,0.9695435360933179,1.0,11/35,18.90%,ADM;PDE5A;ALPL;TIMP3;TNS1;LAMA4;PECAM1;MYO1B;PLSCR4;ACVRL1;SPARC
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.7206294498994006,-1.1545239369298457,0.3157894736842105,0.9712410904644273,1.0,1/9,6.52%,DUSP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.7185615453385639,-1.154484698588273,0.30985915492957744,0.9700945661064408,1.0,6/9,26.95%,PNP;ANXA1;PLCG2;MALT1;SPTBN1;PDE4B
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.5475656162042685,-1.1544557686326435,0.2857142857142857,0.9687220799219703,1.0,15/65,13.37%,RTN4;RPL23;SMAD7;GAPDH;CDC37;PIK3R1;LAMP2;ANK2;HIP1R;PRKN;RAB21;CCNH;ATP1B3;PINK1;RPS7
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.6599169267416345,1.1542956091222452,0.3793103448275862,1.0,1.0,2/5,12.15%,MFF;PNPT1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.6102087069861383,-1.1542938667127725,0.2875,0.9681390387533517,1.0,9/27,12.95%,LAMC1;NDRG1;NFASC;GRIA2;PRX;ANK2;TMEM132C;DCLK1;SHC2
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.5492238788575915,-1.153586442166408,0.26881720430107525,0.9698775528382046,1.0,9/73,10.18%,SERPINE1;JUN;SSH1;FOS;FES;TPM1;RAPGEF3;RAP1A;TGM2
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.7809349857890132,-1.153368333103546,0.2727272727272727,0.9694087137634839,1.0,2/6,11.76%,ARF1;PRNP
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.7065766400866842,-1.1531375603209482,0.2535211267605634,0.9692181683307439,1.0,3/9,14.67%,RTN4;AFDN;TPR
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.769545934844176,-1.152988417749223,0.27419354838709675,0.9685565405478415,1.0,1/6,1.35%,SUN2
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.734842981430869,-1.1528873474430203,0.3333333333333333,0.9675396075924004,1.0,1/8,5.79%,RAD21
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5794035757251641,1.152760149073129,0.3225806451612903,1.0,1.0,1/9,0.39%,BMP6
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.6772586458154216,1.1524874594021108,0.25806451612903225,1.0,1.0,3/6,16.67%,SLC23A2;ABCG2;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.7625144681794706,-1.1521189916463197,0.25333333333333335,0.9701579673040296,1.0,1/6,2.88%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5070092732700827,1.1516148601793574,0.25,1.0,1.0,8/16,15.52%,HABP4;RBM20;HSPA1A;HNRNPLL;TRA2A;CIRBP;NCL;RBMX
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.7803117482548119,-1.15131505710235,0.2903225806451613,0.9723637816456643,1.0,3/5,19.39%,NEDD9;BCAR1;CASS4
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.6905850338771722,-1.1510010440588636,0.2948717948717949,0.9727038029500664,1.0,6/12,27.31%,PPARG;FLT1;SPARC;CAV2;DLL4;ATOH8
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.6988710209048451,-1.1500661165924597,0.2898550724637681,0.9758033852142924,1.0,4/10,17.58%,KCNMB4;ANK2;ATP1B3;NOS1AP
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.6007142950478743,-1.1498766985909983,0.19767441860465115,0.9751378998352453,1.0,11/32,17.16%,UFL1;SMAD7;SPOPL;NDFIP1;COMMD1;PRKN;PINK1;OGT;PTTG1IP;XIAP;MALT1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.7175788803628294,-1.1498570957487486,0.33783783783783783,0.9738949148201049,1.0,3/8,15.78%,LGALS3;PRNP;SLC30A1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.7513585874567803,-1.14956130140751,0.2753623188405797,0.9724951681031238,1.0,2/8,12.54%,ZEB2;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.7513585874567803,-1.14956130140751,0.2753623188405797,0.9724951681031238,1.0,2/8,12.54%,ZEB2;SDCBP
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.6122476287924429,-1.1495137400833655,0.3058823529411765,0.9714378040632322,1.0,8/32,16.36%,SERPINE1;JUNB;SMAD7;IFNGR2;SMAD3;SLC20A1;XIAP;WWTR1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.7260989883785891,-1.1494822177660364,0.3466666666666667,0.9702395197044001,1.0,3/8,16.64%,RPL23;RPS7;RAB1A
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7844035452882513,-1.149178009652249,0.32857142857142857,0.9702431224576833,1.0,1/5,10.41%,ADAMTS1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.6111947564717283,-1.1488837548228572,0.24050632911392406,0.9702148044548607,1.0,5/27,10.90%,PSMC6;SEC22B;PSMB9;PSMA1;ITGB5
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.6274881577299405,-1.1479642054343249,0.2625,0.9731020994592837,1.0,9/20,24.79%,SMAD7;AFDN;PAK2;CADM2;CTNNA1;TBCD;PIP5K1C;CDH5;VCL
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.6977176262514252,-1.1475329405375425,0.29577464788732394,0.9738810445217638,1.0,5/9,19.63%,CX3CL1;LGALS3;PECAM1;PIP5K1C;PIKFYVE
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7328536002900756,-1.1474006830420087,0.3076923076923077,0.9730532849801308,1.0,4/7,17.34%,PSMB9;NFE2L2;PSMA1;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.7921774259085853,-1.1466128325219114,0.2753623188405797,0.9753052514535776,1.0,3/5,15.78%,RAP1A;PRKN;SLC30A1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.629260233867343,-1.1465151253039945,0.3013698630136986,0.9743511111328835,1.0,4/18,15.68%,ADM;S1PR1;GNA13;ADGRL3
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.7595484024118371,-1.146420941440932,0.3225806451612903,0.9732573832213433,1.0,2/5,9.42%,CX3CL1;IFNGR1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.5863737480554777,-1.146054319800922,0.25,0.9720414237856467,1.0,2/37,3.32%,DDIT4;BNIP3L
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.5863737480554777,-1.146054319800922,0.25,0.9720414237856467,1.0,2/37,3.32%,DDIT4;BNIP3L
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.5498846196125253,1.145701416390951,0.3448275862068966,1.0,1.0,4/13,11.01%,ALS2;EEA1;TMCC1;RAB27A
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.7810338204975827,-1.1455551557043047,0.3384615384615385,0.9729400260670605,1.0,1/5,1.58%,ADAMTS9
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.7645106318840156,-1.1451582863585594,0.32786885245901637,0.9734900803754564,1.0,1/5,12.72%,FGFR1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.6842243455384747,-1.1449412307686662,0.35802469135802467,0.9731591886256048,1.0,3/11,20.25%,PRKCE;HYAL2;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.7098956785364091,-1.144510664845831,0.3424657534246575,0.9736603088740095,1.0,3/9,10.18%,PTPRD;IL1RAPL1;TGM2
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.5939677341438184,-1.1442150201917176,0.33766233766233766,0.9738781499643487,1.0,7/30,15.24%,SERPINE1;NFKBIZ;CX3CL1;SCARF1;HYAL2;NFKBIA;RIOK3
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.5696627610505667,-1.1437233724805336,0.2808988764044944,0.974908416864261,1.0,11/42,15.21%,UFL1;SMAD7;RNF19A;COMMD1;PRKN;ARIH2;SDCBP;OGT;TRIB2;HERPUD1;RACK1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.7569513330361888,-1.1432012580009834,0.36231884057971014,0.9759201269212977,1.0,1/6,6.67%,FOXF1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.651653469614442,-1.1430252622401804,0.2631578947368421,0.9751671731093271,1.0,10/22,16.15%,MAP2;GRIA2;S100A6;GPM6B;NPAS3;STOX2;DCLK1;CTNND2;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.69833255152874,1.142788698050538,0.2857142857142857,1.0,1.0,4/5,29.72%,PDCD4;PDGFB;NFATC2;NFATC3
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.610396711522522,-1.1424410633006574,0.3026315789473684,0.9764870070237702,1.0,3/27,4.65%,SPNS2;ABCA5;SCP2
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6616181054403688,1.1419210853432946,0.3793103448275862,1.0,1.0,3/7,19.42%,CPEB3;NLGN1;CAPRIN1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.6190199372507093,-1.1416614744199824,0.2564102564102564,0.9783938566825408,1.0,9/28,23.13%,MAP2;SSH1;HIP1R;PRKN;KANK3;TBCD;CLU;LIMA1;CDH5
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.7525039492669426,-1.1414788097828785,0.3181818181818182,0.9779045143582039,1.0,1/7,6.26%,FES
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.6760554031942678,-1.1413515453334258,0.3382352941176471,0.9771065104173996,1.0,5/10,18.82%,TIMP3;PRNP;CST3;TMEM59;PLAT
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7443785465772051,-1.1406361572318686,0.3225806451612903,0.9789579382333815,1.0,4/6,18.64%,SLC8A1;GJA1;CACNA1C;ATP1A1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.7336217550681531,-1.1405378865895035,0.3181818181818182,0.9780679499173703,1.0,1/5,9.16%,CAMKMT
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.6692201812022561,-1.1402952608614045,0.25675675675675674,0.9776744533745875,1.0,5/19,17.73%,PPFIA2;MYO1B;PAFAH1B1;RAB1A;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.5865093242486811,-1.1401715106068528,0.27058823529411763,0.9767733708488131,1.0,8/37,18.04%,UFL1;BNIP3L;PRKN;DHRSX;PINK1;TBK1;TMEM59;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.646541330673337,-1.1401645604341117,0.345679012345679,0.9754130270253824,1.0,5/13,14.98%,PIK3R1;TMEFF2;PRKN;DLC1;PAK2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6700120205927123,-1.1392489338376048,0.3387096774193548,0.9783759485795576,1.0,6/10,32.14%,ARIH2;PINK1;SREBF2;UBE2D3;NPEPPS;MICALL2
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.6043049905132412,1.1391903382619852,0.32142857142857145,1.0,1.0,2/7,3.79%,UGCG;ATP2A2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.6604432878087386,-1.138716106955104,0.3076923076923077,0.9795959883989457,1.0,4/22,9.16%,MGLL;GRK5;GIT2;CAMKMT
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.7056945485470822,1.1380147914151986,0.3103448275862069,1.0,1.0,2/5,12.69%,MDM4;ACVR1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.7595426346986139,-1.1379237566026938,0.3,0.981701661851869,1.0,2/7,14.69%,NES;CACNA1C
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.7709668876169709,-1.1373447627823796,0.359375,0.9832656892062515,1.0,3/5,21.00%,ABCA5;CLU;SCARB1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.5830180879861905,-1.137266177127321,0.30864197530864196,0.9823184912828329,1.0,4/29,14.25%,SERPINE1;GGT5;PELI1;ZFP36
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.7165365752949711,-1.136925574726553,0.34210526315789475,0.9826714067308459,1.0,2/8,5.43%,B3GNT2;GPC5
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.7754091791746316,-1.1366273114152776,0.3230769230769231,0.9828099352641072,1.0,2/6,8.85%,CDKN1B;IPO7
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.7278956933897139,-1.1362325950206855,0.3225806451612903,0.9805819751368811,1.0,4/6,20.33%,CD81;CD55;CFH;CLU
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.7278956933897139,-1.1362325950206855,0.3225806451612903,0.9805819751368811,1.0,4/6,20.33%,CD81;CD55;CFH;CLU
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.7278956933897139,-1.1362325950206855,0.3225806451612903,0.9805819751368811,1.0,4/6,20.33%,CD81;CD55;CFH;CLU
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5612282413709495,1.1359311697006618,0.34615384615384615,1.0,1.0,3/9,12.28%,UIMC1;ATM;BABAM2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.6325123305984595,-1.1358814826825683,0.3013698630136986,0.9807529500361436,1.0,6/17,21.21%,PIK3R1;HYAL2;SMAD3;TPR;WWTR1;ECT2
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.7687090411603695,-1.1358140413965272,0.3484848484848485,0.9796216285585226,1.0,1/5,10.23%,PRKN
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.6523290716265839,1.135483686359309,0.25,1.0,1.0,2/5,7.50%,DTWD1;CDKAL1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.6738731193811434,-1.135448718789162,0.26666666666666666,0.9802016052759438,1.0,5/14,26.64%,AFDN;GOLPH3;ANK3;PREPL;SPTBN1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.5638719826262149,-1.135396611191332,0.25882352941176473,0.9790288835484287,1.0,5/48,7.55%,DDIT4;PBX3;NES;GRIN2B;SMARCA1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5589369107178748,-1.1352653009588394,0.28888888888888886,0.9782965671638514,1.0,9/54,8.18%,DTNA;GRIK1;SYN3;GRM7;RIMS1;GRIA2;GRIN2B;KCNMB4;MBP
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.713442396014278,-1.1345335227386768,0.32857142857142857,0.9803362174128095,1.0,6/12,20.04%,EPS8;VAV3;MSN;LARS1;PICALM;MTOR
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.6291290545116484,1.1344416832079312,0.3793103448275862,1.0,1.0,2/11,8.31%,ATR;ATM
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.6948674505461783,-1.1341616466474358,0.3333333333333333,0.9804910859188334,1.0,3/10,8.62%,HSPA5;BCAP31;ANK2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.5777029007361911,-1.1331009477400988,0.3218390804597701,0.9833478175860029,1.0,10/42,17.50%,PSMC6;BTG2;PSMB9;CDKN1B;PSMA1;SDCBP;SMAD3;BTG1;PSMA7;CYLD
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.7340678302383978,-1.1317790760491864,0.3582089552238806,0.9884155457637047,1.0,1/5,21.75%,SETD3
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.6892857448039256,-1.131722694909391,0.3918918918918919,0.9872711540393446,1.0,2/9,12.41%,PRKN;FOXK1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.7732356831631606,-1.1317150726925693,0.3181818181818182,0.9859654312138995,1.0,1/5,10.80%,CALCOCO2
prerank,PanglaoDB_Augmented_2021__Platelets,-0.5938689390344898,-1.13142619613712,0.2988505747126437,0.9858577301680777,1.0,10/35,12.51%,SERPINE1;SLC2A3;ERO1A;CD9;SRGN;CAVIN2;LRRC32;VWF;PECAM1;WIPF1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.6440983246675029,-1.1313349602705913,0.39080459770114945,0.9849451663208836,1.0,4/19,15.55%,MTHFD1L;BTD;MTHFD2L;PLPP1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.6650283616299303,-1.1311161993075738,0.3333333333333333,0.9845115688585776,1.0,5/8,27.26%,ANK2;CTNNA3;CACNA1C;DSP;CAMK2D
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.612966691871572,-1.130993873736222,0.2976190476190476,0.9838858446808384,1.0,8/24,14.69%,ITPR1;GLUD1;SLC2A1;RAPGEF3;RAP1A;PRKN;ENSA;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5864095781803091,-1.1303260739425338,0.3076923076923077,0.9854892507752374,1.0,8/27,17.42%,JUN;NES;KDM1A;TMBIM6;NFKBIA;RACK1;CDKN1A;LRPAP1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.47126303951540105,1.1303029358123016,0.18181818181818182,1.0,1.0,6/29,9.45%,ATR;PRIMPOL;RHBDD1;INO80;ERCC6;TAF1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.617252270832968,-1.1302732692382904,0.2804878048780488,0.984359698992613,1.0,4/27,5.35%,MAP2;NRCAM;MAP1B;S100A6
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.5852573630854695,-1.1301060691629687,0.3333333333333333,0.9811222840870468,1.0,7/29,17.34%,PSMC6;PSMB9;PSMA1;PLCG2;PAK2;MALT1;PSMA7
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.5852573630854695,-1.1301060691629687,0.3333333333333333,0.9811222840870468,1.0,7/29,17.34%,PSMC6;PSMB9;PSMA1;PLCG2;PAK2;MALT1;PSMA7
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.5852573630854695,-1.1301060691629687,0.3333333333333333,0.9811222840870468,1.0,7/29,17.34%,PSMC6;PSMB9;PSMA1;PLCG2;PAK2;MALT1;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.7022046954353337,-1.1290299502928762,0.36486486486486486,0.9828082096374849,1.0,6/10,25.26%,KLF2;KLF4;SMAD3;NOS1AP;CLU;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.7022046954353337,-1.1290299502928762,0.36486486486486486,0.9828082096374849,1.0,6/10,25.26%,KLF2;KLF4;SMAD3;NOS1AP;CLU;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.7112482589650269,-1.1286769468238906,0.38461538461538464,0.9828828679559104,1.0,3/7,14.12%,CD81;PTTG1IP;MSN
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.7024058039955947,-1.1284936415602815,0.3472222222222222,0.9825313196253955,1.0,3/7,17.58%,ANK2;PRNP;NOS1AP
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.7169120164650697,-1.1280047271624325,0.3972602739726027,0.9834130070244731,1.0,3/9,14.88%,WNT2B;SULF2;CREB3L2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.5572537411879906,-1.1270545879557918,0.26666666666666666,0.9859185336525539,1.0,15/70,17.16%,SERPINE1;RFTN1;HIF1A;GAPDH;LRRFIP1;SULF2;MBP;PNP;ANXA1;HYAL2;PLCG2;TMED10;TBK1;RAB1A;MALT1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.6814091381073967,-1.1266014804642237,0.30666666666666664,0.9865738630435741,1.0,5/14,19.31%,PRKAG2;HIF1A;OGT;TPR;NUP54
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.7544379752613353,-1.126478320837287,0.37662337662337664,0.9857224757919295,1.0,1/6,4.83%,HIF1A
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.6698898815942841,-1.126337372118877,0.3333333333333333,0.9850922388976909,1.0,5/9,23.16%,ANK2;GJA1;CACNA1C;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.6845980718376197,-1.1262892834153535,0.36585365853658536,0.9839536506785675,1.0,3/11,7.89%,SMAD7;FOXF1;TPM1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.5824069268041825,-1.1258995133913239,0.2988505747126437,0.9841860707955997,1.0,11/37,17.78%,ERO1A;JUN;FOS;HIF1A;NFE2L2;TPM1;MSRA;PINK1;VRK2;SOD2;TXNRD1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.462352281019473,1.125859582083088,0.25,1.0,1.0,3/26,4.15%,PGM5;EPB41L5;TTN
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.5977446389020759,-1.125827976553878,0.3157894736842105,0.9831389172597446,1.0,8/27,20.90%,VSIR;CX3CL1;IFNGR1;PLCG2;ZFP36;CD34;CLU;ARFGEF2
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.608064687605323,-1.125643894186022,0.3157894736842105,0.9826460878183952,1.0,7/21,17.34%,PSMC6;PSMB9;REL;PSMA1;TNFRSF10B;MALT1;PSMA7
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.5941292185702208,-1.1252688170662455,0.3058823529411765,0.9830822478419128,1.0,7/27,15.60%,PSMC6;HSPA5;NPLOC4;PRKN;HERPUD1;AMFR;UGGT2
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.7594112497028931,-1.1248036000540365,0.35714285714285715,0.983618583326945,1.0,2/5,12.82%,KCNMB4;ATP1B3
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.6907353890713807,-1.1247728970702444,0.38961038961038963,0.9824476107377772,1.0,2/10,10.23%,CX3CL1;PRKN
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.7609936510839246,-1.124486369251308,0.37333333333333335,0.9825791150367754,1.0,2/6,11.76%,ARF1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.7581592361792414,-1.1244344016678478,0.328125,0.9801771678703649,1.0,2/5,13.91%,YBX3;PELI1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.7581592361792414,-1.1244344016678478,0.328125,0.9801771678703649,1.0,2/5,13.91%,YBX3;PELI1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7787991882773931,-1.124373977113245,0.37142857142857144,0.9791894536764189,1.0,1/5,4.83%,HIF1A
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.5860500218633234,-1.123198315735605,0.32926829268292684,0.9832165697672266,1.0,9/36,20.04%,PRKAG2;BNIP3L;GAPDH;RB1CC1;SNX6;PINK1;TBK1;GNAI3;MTOR
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.7163605763095147,-1.1231901148178025,0.3787878787878788,0.9819836307319045,1.0,5/9,22.09%,DMD;ANK2;ATP1B3;ANK3;STK39
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6684896779841445,-1.1228176939225043,0.3939393939393939,0.9822293014842647,1.0,1/12,0.83%,UFL1
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.7480996951649874,-1.1223337777744111,0.3230769230769231,0.9830608467958196,1.0,1/6,2.91%,PRKAG2
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.6745465629925448,-1.121690227647814,0.3835616438356164,0.9848045611361382,1.0,4/8,23.21%,RPS27A;UBC;USP45;RNF111
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.7701321468435118,-1.121222902544711,0.3333333333333333,0.9858017888553698,1.0,1/6,3.66%,CX3CL1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.7477927519886574,-1.1211547186928172,0.3055555555555556,0.9847445089473534,1.0,2/8,10.18%,BCAP31;TGM2
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.6241310570057311,1.1209808639014045,0.35714285714285715,1.0,1.0,4/10,16.10%,IL15;PIAS1;STAT2;PKD2
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.6316991620139665,-1.120727542771772,0.3424657534246575,0.9850561393990461,1.0,9/15,28.30%,RPS15;RPS27;NPM1;RPL10;RPS28;RPL24;RPS19;RPS14;RPL3
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.6292829186712987,-1.1205918146814058,0.3924050632911392,0.9843863108915774,1.0,2/20,4.23%,PCK1;GLUL
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.5539277611479004,1.1204631734455244,0.36,1.0,1.0,2/9,5.19%,USP25;OTUD4
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.7524592985645051,-1.1202624126105505,0.3770491803278688,0.9844704956780046,1.0,2/5,17.24%,RPL23;SMARCC1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.5958726434942064,-1.1197922146141441,0.3170731707317073,0.9851073038402179,1.0,4/26,10.51%,PSMC6;PSMB9;MAGI2;PSMA1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6895587113714206,-1.1197916747894727,0.37333333333333335,0.9838595722451214,1.0,6/11,23.31%,SYN3;RIMS1;SYT1;PIP5K1C;RIMS2;DNAJC5
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.6910215965809907,-1.1196043205794985,0.3,0.9836330591629885,1.0,4/12,13.06%,RPS27A;UBC;ALPK1;PLCG2
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.6512176025570334,-1.1187548745444416,0.3375,0.9860759032519233,1.0,7/16,25.26%,KLF2;KLF4;SMAD3;NOS1AP;CD34;CLU;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.6163744992524585,-1.1176214446974524,0.34831460674157305,0.9900918970281734,1.0,9/24,22.12%,PGK1;PPARG;KLF4;ADAMTS1;CLDN5;SPARC;ATF2;MECP2;SPRED1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7374715309133264,-1.1172089377480583,0.37681159420289856,0.990815946622512,1.0,2/5,21.42%,PIK3R1;GIGYF2
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.57445579151298,-1.1167459096482284,0.2808988764044944,0.991341208975963,1.0,9/41,9.84%,CX3CL1;SCARB2;FES;LRRC7;MAGI2;PTPRD;SCARF1;RAP1A;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.7277509621319597,-1.1166864590418701,0.40298507462686567,0.9903339013398058,1.0,3/7,15.84%,CDKN1B;IPO7;CDKN1A
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.6083200874266654,-1.1163907536990663,0.3493975903614458,0.9904094786120788,1.0,10/25,30.87%,RAB11FIP3;PIK3C3;ECT2;CAV2;RAB11A;PRPF40A;RPRD1B;BCL2L1;DYNC1H1;CSNK2A1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.6330797085370642,-1.1163844861391463,0.3614457831325301,0.9891537347372081,1.0,5/20,11.79%,ADM;HES1;SMAD7;FLT1;EFNB2
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.666016338223237,-1.116324205090566,0.3116883116883117,0.9868195942225106,1.0,3/11,15.34%,RPS27A;UBC;TBK1
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.666016338223237,-1.116324205090566,0.3116883116883117,0.9868195942225106,1.0,3/11,15.34%,RPS27A;UBC;TBK1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.5449545344663964,-1.1163237567650206,0.30337078651685395,0.985559288227335,1.0,15/60,21.99%,PPP2R3A;SSH1;PPM1D;DUSP1;PTPRD;PPP2R2B;DUSP16;NCK1;PPP3CC;DUSP5;MTMR2;DUSP22;PPM1A;MTM1;DUSP6
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.7563704677824921,-1.1161996183621516,0.40298507462686567,0.9848598124113777,1.0,3/6,10.83%,IL1RAPL1;PRKN;ANXA1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.6898971988956336,-1.1160947609201253,0.3835616438356164,0.984050737744374,1.0,5/10,14.69%,CLIC2;DMD;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.7307013596670758,-1.1160420982049677,0.33766233766233766,0.9830212432935628,1.0,2/7,9.84%,PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6402109418230209,-1.116010537428392,0.3150684931506849,0.9819110416656539,1.0,4/9,24.33%,CD55;PLCG2;MALT1;B2M
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.7153652419876185,-1.1158897160425965,0.29411764705882354,0.9811920070139094,1.0,5/6,27.26%,PRKCE;STK39;NEDD4L;NEDD4;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.6583572121483109,-1.1157236081948931,0.33766233766233766,0.9806964275823301,1.0,7/16,27.99%,PPARG;KLF4;ACVRL1;MECP2;DLL4;RHOA;MAP2K5
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.7558147333008649,-1.1155916608097913,0.39655172413793105,0.9798147367392335,1.0,1/5,3.50%,HES1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.7213795801401268,-1.1154637027140542,0.3448275862068966,0.9791977984242426,1.0,1/5,11.60%,NPM1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.5523306360588374,-1.1149693450483724,0.31521739130434784,0.9800313724564574,1.0,18/65,20.15%,EHD4;RFTN1;KCNIP4;LRRC7;MAGI2;ANK2;PACS1;RAP1A;CD81;DPP10;EFR3B;ATP1B3;TTC7A;RAB8B;NUP54;ANK3;DLG1;EMP2
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.3931118924641087,1.1149564125254652,0.2,1.0,1.0,17/81,12.59%,ARID5B;SAMD9L;RSAD2;PLA2G4A;GBP4;GCH1;IL15;EIF2AK2;RNF213;VCAM1;IFI44;XAF1;DDX60;NCOA3;OAS3;PNPT1;NOD1
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5089769427987463,1.1145746412460447,0.37142857142857144,1.0,1.0,2/8,11.42%,PDZRN3;ZC4H2
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.6249282415206479,-1.1143381741323042,0.32098765432098764,0.9816622096819697,1.0,6/20,14.69%,BCAP31;ATP2B1;SLC8A1;CD55;SMAD3;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.6186143636086174,1.114283675855497,0.34782608695652173,1.0,1.0,1/8,0.39%,BMP6
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.6756487573812573,-1.1142217915272714,0.3582089552238806,0.9809351571255417,1.0,2/9,11.53%,MGLL;DGKG
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.6789474508493106,-1.1140741070195692,0.3974358974358974,0.9804161460135247,1.0,1/9,3.50%,HES1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.6171736758415982,-1.113815230419512,0.3974358974358974,0.9803789966975831,1.0,7/25,17.50%,UFL1;MGLL;BCL6;TMSB4X;ANXA1;XIAP;CYLD
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.5180633011505984,-1.1136698306375938,0.32978723404255317,0.9796014389288616,1.0,12/85,12.18%,LAMC1;PSMC6;PSMB9;HIF1A;SHISA5;MGAT4A;FEM1C;COMMD1;PSMA1;EPAS1;RAB2A;CST3
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.6688186035904784,-1.1126728835769613,0.390625,0.98257848180911,1.0,2/8,14.64%,PPARG;NFKBIA
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.752326052390007,-1.112213304686147,0.3770491803278688,0.9833047711165427,1.0,1/5,13.58%,GOLPH3
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.7324384679934892,-1.1119826811238087,0.3225806451612903,0.9828816727983501,1.0,1/7,6.33%,ARHGAP21
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.6876658412119164,-1.1117662197178597,0.34782608695652173,0.9826233650808958,1.0,2/12,3.01%,TSG101;SYTL4
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.6217121023960872,-1.1115088407296407,0.352112676056338,0.982256681510239,1.0,4/17,12.18%,RPS27A;PRKN;UBC;CST3
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.6734249973130761,-1.1109890540695164,0.323943661971831,0.9833064064243707,1.0,1/9,2.91%,PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.7675734309843607,-1.1106819451534147,0.38461538461538464,0.9831708766863226,1.0,2/5,9.84%,PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.7273534977706148,-1.110634175355652,0.352112676056338,0.9822210807205737,1.0,2/6,15.55%,ESR2;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7319261980128149,-1.11039425879737,0.3787878787878788,0.981693997576825,1.0,3/5,19.42%,DMD;ATP1B3;ANK3
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.6020558049351494,-1.1102008312606477,0.34177215189873417,0.9812494791215086,1.0,5/21,15.78%,ITPR1;NDFIP1;SLC8A1;CACNA1C;SLC30A1
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.6684736070249864,-1.1092150091072475,0.4142857142857143,0.9840659009932031,1.0,5/9,26.35%,HIP1R;SGIP1;PICALM;CLTA;FCHO2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.6033842152150515,-1.1091653318675383,0.34523809523809523,0.9830116181422289,1.0,8/27,13.03%,DTNA;DMD;TPM1;SLC8A1;MYL12A;MYL12B;ITGB5;DYSF
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.6768677353006163,-1.1091352698681274,0.3582089552238806,0.9819734313676928,1.0,2/8,14.77%,RAD21;PPHLN1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.7097108924605404,-1.1090241577323294,0.38461538461538464,0.9811803777440591,1.0,3/9,6.83%,GRIA2;GRIN2B;LRRC7
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.7278523320859867,-1.1086957848622954,0.3472222222222222,0.9816275675672674,1.0,4/8,17.08%,NFE2L2;KLF2;KLF4;SREBF2
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.5282011813798428,-1.1085402979611192,0.25510204081632654,0.9809175490092243,1.0,20/135,12.90%,TBX3;UFL1;RPL23;HES1;CX3CL1;SLC6A6;GRK5;RPS9;ERBB4;CDKN1B;TPM1;FLT1;TGM2;CD81;NPM1;EFNB2;CNOT6L;SDCBP;FGFR1;RPS6
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.52950884829448,-1.108355262389101,0.2828282828282828,0.9806657795277849,1.0,27/113,21.42%,CCDC3;BTG2;SRGN;PPM1D;HIF1A;ATP2B1;GAPDH;NDFIP1;REL;KLF4;PRKN;TMBIM6;PINK1;MTF2;RPL13A;ZFP36;PPHLN1;RACK1;ACVRL1;CLDN5;PTBP2;PICALM;DCP2;CD34;GATA2;MECP2;GIGYF2
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.6972999601263823,-1.107832841638587,0.2878787878787879,0.9816349497449205,1.0,5/9,19.63%,CX3CL1;LGALS3;ANXA1;PIP5K1C;PIKFYVE
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.5443586943756569,-1.1073678489623129,0.2804878048780488,0.9823874454034275,1.0,12/46,15.34%,VSIR;CX3CL1;SRGN;NPLOC4;ATP2B1;TMSB4X;KLF4;ANXA1;PRNP;TRIB2;ZFP36;TBK1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.7077051245447905,-1.107285396919255,0.3287671232876712,0.9813722950259213,1.0,4/8,27.21%,KIF16B;MTOR;SNX25;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.5563413575159671,-1.1071909471873338,0.3258426966292135,0.9805333190145803,1.0,11/69,15.32%,PIK3R3;HIF1A;ERBB4;RB1CC1;FLT1;PECAM1;SDCBP;FGFR1;PINK1;RACK1;TIE1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.6807283778892665,-1.1069893518140328,0.3835616438356164,0.9801767986512098,1.0,2/7,10.25%,PCK1;CD81
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.6898768438923244,-1.1069408559152996,0.3384615384615385,0.979181386510408,1.0,5/12,19.63%,PRKN;PINK1;CDKN1A;GRB2;PIKFYVE
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6336929372431331,-1.1067132895571548,0.34328358208955223,0.9789205662283058,1.0,3/13,10.57%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.7064383519383233,-1.1065134832416939,0.40625,0.9784476456313101,1.0,4/6,25.34%,PNP;CD55;HSPH1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.6522289687771772,-1.1063641870498522,0.34615384615384615,0.9778696360810829,1.0,3/15,4.78%,UFL1;SMAD7;SPOPL
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.5485370766165184,-1.1059297653884863,0.3595505617977528,0.9785000225678419,1.0,11/45,25.26%,YTHDC1;RPS15;RPS27;RPL10;RPS28;RPL24;STRAP;RPS19;USP39;RPS14;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.6656026491308279,-1.105795314286168,0.40789473684210525,0.9777908749328083,1.0,3/10,8.62%,SMAD7;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.6023317819328747,-1.1057428111786292,0.33766233766233766,0.976845276551331,1.0,5/25,8.72%,LAMC1;NR4A1;RTN4;HIF1A;RREB1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.6217251176842323,-1.105422013825874,0.3333333333333333,0.9767741909955079,1.0,4/15,17.50%,NPLOC4;REL;TBK1;CYLD
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.7248134825177449,-1.1052591187343732,0.3442622950819672,0.976122495412804,1.0,1/7,3.12%,JUN
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.4016599986111969,1.1050235289807173,0.3125,1.0,1.0,7/60,8.52%,IVNS1ABP;THOC1;NOVA1;CDK12;TENT2;BICD1;WBP4
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.6309400970669958,-1.1046652726886594,0.2911392405063291,0.9772653501752425,1.0,9/16,14.95%,TMEM45B;PCK1;PPARG;COL18A1;SLC26A2;CD55;ACSL5;PLIN2;TTC7A
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.6776275622134661,-1.104191798037522,0.38028169014084506,0.9780367532708295,1.0,4/8,25.23%,RPS28;RIOK3;RPS19;RPS14
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.5946430309788319,-1.1040232085034756,0.3614457831325301,0.9775174103795844,1.0,7/30,15.84%,TSG101;CDC37;CDKN1B;SLC8A1;CCNH;TRIB2;CDKN1A
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.6941461399974975,-1.103675554584182,0.40625,0.9775247609189877,1.0,4/7,29.23%,NPM1;CENATAC;CHMP4B;ALMS1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.7123914771138534,-1.1028705434895885,0.40540540540540543,0.9796313507056761,1.0,2/7,13.29%,KDM1A;PTTG1IP
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.7139553037818123,-1.1026396829832141,0.3611111111111111,0.9795706257984731,1.0,4/6,25.99%,FES;RASSF1;GATA2;GUK1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.5038154618639914,1.1025206777663301,0.22727272727272727,1.0,1.0,4/22,4.80%,INO80;OFD1;CLASP1;STARD9
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.7225412983779251,-1.1016906959312638,0.4411764705882353,0.9822456326257792,1.0,3/5,27.26%,SLC8A1;ANK3;CAMK2D
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.6140232806484585,-1.101259338901462,0.3780487804878049,0.9829009558759985,1.0,5/18,15.63%,SSH1;SPOPL;KLF2;KLF4;CENATAC
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.5907788306191553,-1.1012400199579586,0.28205128205128205,0.9817527570188298,1.0,2/28,4.49%,SPNS2;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.6361931754984617,-1.1011695524771763,0.3880597014925373,0.9807898874990063,1.0,1/12,1.58%,ADAMTS9
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.7271603187012121,-1.1009510958224755,0.35,0.9805197191929188,1.0,2/5,15.21%,CFL1;RACK1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.5580535958656315,-1.1008772722788587,0.36470588235294116,0.9796126541989494,1.0,9/30,16.36%,PRKAG2;CDKN1B;SLC8A1;HYAL2;NPM1;TRIB2;PAK2;CDKN1A;WWTR1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.6179417315147575,-1.1008654925626526,0.4024390243902439,0.9784868219925756,1.0,5/20,13.11%,GRIA2;GRIN2B;MAGI2;LSAMP;PPFIA2
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.5727743966148213,1.100651671820897,0.2608695652173913,1.0,1.0,2/9,7.50%,DTWD1;CDKAL1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6855204280214086,-1.1002586436346378,0.3918918918918919,0.9797779652256513,1.0,5/10,23.31%,SYN3;RIMS1;SYT1;PIP5K1C;DNAJC5
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.7098641925222718,-1.1000690915491569,0.417910447761194,0.9793028437713919,1.0,5/7,16.23%,HIF1A;NFE2L2;PRKN;PINK1;SOD2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.6564669738232484,-1.1000510049241574,0.38271604938271603,0.9782202284793375,1.0,2/13,3.50%,TBX3;HES1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.503446131790981,1.0990902064908963,0.2608695652173913,1.0,1.0,3/17,11.71%,ATR;ATM;NEK7
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.6083139581639655,1.0988522906903977,0.41025641025641024,1.0,1.0,2/6,11.34%,HSPD1;NFAT5
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.6302099507694355,1.0987647334384236,0.3870967741935484,1.0,1.0,2/8,4.54%,PLPPR4;MBOAT2
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.6738162862100592,-1.098511892370544,0.3225806451612903,0.9834907848217552,1.0,3/7,26.82%,GOLPH3;ALG11;GCNT1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.5441653283645906,-1.0985088750287517,0.3516483516483517,0.9823282661635734,1.0,14/63,14.98%,CX3CL1;SPOCK1;SCARB2;FES;LRRC7;MAGI2;CFL1;SCARF1;RAP1A;IL1RAPL1;EFNB2;PPFIA2;LRRC4C;PAK2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5751865184367289,-1.0984793454093735,0.35802469135802467,0.9813749483751946,1.0,8/29,15.34%,SRGN;ATP2B1;GAPDH;POLA1;BCL6;ANXA1;BTNL9;TBK1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.6631345799208902,-1.0983665807752525,0.31645569620253167,0.9806172030853662,1.0,7/14,20.33%,RTN4;IFNGR1;PRNP;TMED10;PICALM;SLC2A13;CLU
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.7417754129425769,-1.0972944087086727,0.3880597014925373,0.9833755972969597,1.0,1/5,15.71%,KPNB1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.6844583034489187,-1.0968444292370618,0.43037974683544306,0.9827982746108852,1.0,5/13,16.85%,ATG12;RB1CC1;PRKN;PINK1;GABARAPL1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.6844583034489187,-1.0968444292370618,0.43037974683544306,0.9827982746108852,1.0,5/13,16.85%,ATG12;RB1CC1;PRKN;PINK1;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.6082730623014266,1.09623706160418,0.375,1.0,1.0,2/7,8.31%,LDB2;ATM
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.6791981108777699,-1.0959076174408104,0.3283582089552239,0.9851082521964228,1.0,4/7,10.83%,CX3CL1;LGALS3;FLT1;ANXA1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.6713725604982976,-1.0956615787640893,0.410958904109589,0.9847990173287281,1.0,5/10,23.31%,RIMS1;SYT1;PIP5K1C;RIMS2;DNAJC5
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.6925848213270381,-1.0949103243210592,0.34545454545454546,0.9864869515932948,1.0,1/5,11.27%,GJA1
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.6525016909572758,-1.0946931947941978,0.4025974025974026,0.9861640448122968,1.0,3/8,11.94%,TMEM45B;RAP1A;ACSL5
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.5849356943840504,-1.0941452042971451,0.375,0.9868505504780077,1.0,8/33,14.64%,PSMC6;ST18;PSMB9;RPS27A;PSMA1;UBC;PELI1;NFKBIA
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.6323257714353085,-1.0940407530395262,0.38961038961038963,0.9861963969678862,1.0,5/18,14.02%,SYTL4;TPM1;DYSF;PLEC;SMAD3
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.645628050658448,-1.093648149602527,0.29411764705882354,0.9866010273420222,1.0,4/10,29.05%,SPG7;MFN1;HSPA9;BCL2L1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.7030805468070326,-1.0935320731489941,0.44642857142857145,0.9859232409072562,1.0,1/7,4.62%,SLC6A6
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.610614530701725,1.0935108050262197,0.35714285714285715,1.0,1.0,4/8,18.43%,ZDHHC2;ABL1;EPHA4;APP
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.5882160559890472,1.0934048960152127,0.42424242424242425,1.0,1.0,2/7,8.75%,SLCO1A2;NCOA2
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.5457575164116785,1.0931828802507286,0.3,1.0,1.0,2/10,0.86%,PLPPR4;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.7078348419271513,-1.0930994554788558,0.38095238095238093,0.9866195419653567,1.0,3/6,21.00%,PPARG;SREBF2;SCARB1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.736142470093298,-1.0929474955066047,0.31343283582089554,0.9860448578627041,1.0,3/6,19.31%,RTN4;TPR;NUP54
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.5732769733059399,-1.0928814915927676,0.3176470588235294,0.9852052491518541,1.0,6/28,11.94%,LDHA;MGLL;GLUL;ACOX1;XIST;ACSL5
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.6255971750184667,-1.0923954959003825,0.3902439024390244,0.9858619688889146,1.0,10/20,29.88%,EPS8;MYO9B;CFL1;GNA13;ARHGAP29;RHOJ;ADGRG1;RHOA;ARHGEF3;RHOB
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.40301604545645614,1.0921554759620529,0.25,1.0,1.0,9/54,15.78%,FASTKD1;THOC1;NOVA1;TENT2;BICD1;PNPT1;DDX17;RBMX;HNRNPR
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.6803529667760435,-1.092098440826364,0.39705882352941174,0.9857075939071079,1.0,5/9,16.23%,PPARG;CDKN1B;TPM1;CDKN1A;SOD2
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.5253281050065053,1.0913304611176544,0.32,1.0,1.0,6/14,23.57%,ABL1;MSH3;BCAS3;WRN;ABL2;PSEN1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.6254556095169322,-1.0913184458375922,0.379746835443038,0.9877394271042598,1.0,7/14,27.26%,DMD;PRKCE;ANK3;STK39;NEDD4L;NEDD4;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.6107672351966994,-1.0913084286390557,0.3411764705882353,0.9866619523397797,1.0,6/24,14.36%,SMAD7;TPM1;TGM2;AFDN;LIMS1;RSU1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.6053117563326346,-1.0910276863444626,0.38095238095238093,0.9866710646385528,1.0,6/22,18.12%,CDKN1B;CRLF3;CCNH;MAX;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.6509200746724884,-1.0907340645216992,0.36363636363636365,0.9864661036882274,1.0,5/15,19.31%,PRKAG2;HIF1A;OGT;TPR;NUP54
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.793726227726874,-1.0904454743918226,0.43859649122807015,0.9863496521917471,1.0,1/5,2.34%,RFTN1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.7212636871290989,-1.090383429229123,0.39655172413793105,0.985454601865142,1.0,2/5,14.64%,TMSB4X;NFKBIA
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.5506751316489003,-1.0902129498714115,0.3595505617977528,0.9848878532172849,1.0,14/46,16.74%,DOK5;HES1;NES;SPC25;GLUL;NFASC;TIMP3;ANK2;PTPRD;GJA1;DCLK1;PLSCR4;PLP1;NAV2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.6215930005321146,-1.0902070409969737,0.4411764705882353,0.9837834617714232,1.0,2/16,6.26%,MAP2;FES
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.49091685129187546,1.0900809869163988,0.25,1.0,1.0,4/13,12.38%,UIMC1;ATM;BABAM2;STK33
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.6974529614537975,-1.0897350833623785,0.417910447761194,0.9846596330569858,1.0,1/7,4.70%,SPG7
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.6909730671602865,-1.0896631022733942,0.4024390243902439,0.9838456419497388,1.0,6/10,25.26%,NOSTRIN;NOS1AP;DNM2;ZDHHC21;EGFR;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.614057085843712,-1.089462071722945,0.43037974683544306,0.9834956627991689,1.0,4/11,14.98%,PIK3R1;TMEFF2;DLC1;PAK2
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7483074058448222,1.08938727671983,0.34285714285714286,1.0,1.0,3/5,24.66%,NLGN1;BTRC;THRAP3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.7439512508264128,-1.0892086754074404,0.38095238095238093,0.9832213406070222,1.0,4/5,24.82%,CTNNA3;CACNA1C;DLG1;DSP
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.6874690699318033,-1.0873995585420464,0.40298507462686567,0.9893157739099582,1.0,6/8,26.95%,CX3CL1;LGALS3;PIP5K1C;PIKFYVE;BSG;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.47448940714272353,1.0869496491361712,0.391304347826087,1.0,1.0,6/16,12.41%,UIMC1;MGMT;SLF2;ERCC6;BABAM2;FAM168A
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.5615252970454596,-1.0868493532200547,0.34146341463414637,0.9901557587707004,1.0,7/29,15.21%,PSMC6;SMAD7;RNF19A;PRKN;ARIH2;TRIB2;RACK1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5487725773922053,-1.086749051794612,0.39361702127659576,0.9894023138646902,1.0,11/60,11.27%,BHLHE40;FOS;HES1;KAZN;CHPT1;SLC2A1;KLF4;SLC26A2;TGM2;DLC1;GJA1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.6984775545022518,-1.086716454513284,0.31343283582089554,0.9883649303188105,1.0,4/5,29.93%,CD55;CFH;MAPK8;RAC1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.7589647570757632,-1.0861101884466762,0.40298507462686567,0.9893395947565687,1.0,2/5,11.76%,BCAP31;PRNP
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.7111130173272149,-1.085888504999127,0.4,0.9889489899060084,1.0,3/8,15.24%,HIF1A;ARF1;RIOK3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.7387099079925425,-1.0858172928499341,0.4,0.9881013054742738,1.0,2/5,7.89%,SERPINE1;TPM1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.6665820636169828,-1.0854471139372237,0.4666666666666667,0.9884671532571656,1.0,1/8,6.20%,ANO2
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.6835333613205115,-1.0850041978640488,0.38461538461538464,0.9888692225915523,1.0,1/6,4.44%,KDM1A
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.696181836866339,-1.0847612676654652,0.4375,0.9887029511534072,1.0,1/5,9.11%,PNP
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.7291804519857314,-1.0840892296245543,0.4117647058823529,0.9898801086556057,1.0,4/5,24.66%,GATA2;JCAD;PPP1R16B;DLL4
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.6491602687524636,-1.0839668558124114,0.35135135135135137,0.989257687641936,1.0,1/12,2.67%,RTN4
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.5277122235266378,-1.0837683597704217,0.36904761904761907,0.9890300709486721,1.0,19/50,25.26%,NDRG1;RTN4;BNIP3L;ACTN1;BCL2L14;BCL6;TGM2;PRKN;TNFRSF10B;PINK1;BCAR1;MALT1;CHM;CLU;ACER2;ACER3;ZNF420;PHLPP1;HSP90AA1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.6315476954343057,-1.0836537819271992,0.4189189189189189,0.9882012426587268,1.0,4/15,10.72%,SLCO4A1;SLC4A10;SLC52A3;SLC4A7
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.7095642885434148,-1.083627649905253,0.38571428571428573,0.9872025468823603,1.0,1/8,3.63%,SLC4A10
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.697845596864896,1.0833644629870316,0.4634146341463415,1.0,1.0,2/5,10.31%,BICD1;PCM1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.5386474176083025,-1.082973575021711,0.39285714285714285,0.9886320911527555,1.0,11/43,16.54%,DTNA;GRIK1;GRM7;GRIA2;GRIN2B;KCNMB4;MBP;SDCBP;SYT1;PLP1;PAFAH1B1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.6477688355140473,-1.0826956053029118,0.4057971014492754,0.9885163438538686,1.0,6/11,27.08%,NRCAM;FGFR1;GPRC5B;ECT2;RHOA;ARHGEF2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7433449943142114,-1.0820699747647204,0.44285714285714284,0.9896722678533503,1.0,3/5,13.37%,PRKN;PTTG1IP;RPS7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.6105252234481741,-1.0819298599213907,0.4050632911392405,0.9891404273775447,1.0,10/22,23.49%,LGALS3;PIK3R1;PRKCE;DPP10;CNST;RACK1;DLG1;ITGB1;EGFR;PRKCH
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.5439965133216985,-1.0818071089018606,0.4111111111111111,0.9885731805538741,1.0,21/52,27.15%,EHD4;KCNIP4;ANK2;PACS1;RAP1A;CD81;DPP10;AFDN;EFR3B;ATP1B3;TTC7A;RAB8B;ANK3;DLG1;EMP2;RAB11A;CCDC88A;FCHO2;BSG;SPTBN1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.6754851662369921,-1.0811955890834295,0.37681159420289856,0.9897739121521888,1.0,3/9,19.24%,ARF1;SLC30A1;MTMR2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.7517208179697237,-1.0809669933287993,0.4057971014492754,0.9894993191792786,1.0,3/6,10.83%,TMSB4X;KLF4;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.6635303729642933,-1.0807306559592715,0.36619718309859156,0.9895657366178339,1.0,1/7,4.41%,SMAD7
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.5501162394008088,-1.0804965591071627,0.38461538461538464,0.989619862844067,1.0,16/51,20.15%,NEDD9;PLS3;PPP1R9A;EPS8;ACTN1;TPM1;HIP1R;NEBL;MYO1B;BCAR1;SPIRE1;ARHGAP17;MYO1E;CASS4;DLG1;EMP2
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.5897575682478564,1.0799115077058719,0.4375,1.0,1.0,2/6,8.75%,SLCO1A2;NCOA2
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5455309428323805,-1.079839006594572,0.375,0.9910688350326015,1.0,10/42,18.30%,NES;KDM1A;HIP1R;PRKN;TMBIM6;AMFR;RACK1;CDKN1A;LRPAP1;CLDN5
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.5999870147045109,-1.079748592918888,0.4266666666666667,0.9902851230885918,1.0,5/22,17.32%,RFTN1;RPS27A;UBC;PLCG2;PIK3C3
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6668859878561016,-1.0797379661595472,0.43661971830985913,0.9892852880128606,1.0,3/8,17.16%,SMAD7;CD55;MALT1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.7011906312999183,-1.079482194601473,0.48484848484848486,0.9891944063509799,1.0,1/6,2.93%,CLIC2
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.6527651168252587,-1.079151942850122,0.44155844155844154,0.9892969499517844,1.0,4/12,19.24%,ARF1;PRNP;CTNND2;MTMR2
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.6447284144960294,-1.0789248726383602,0.3611111111111111,0.9891097504661526,1.0,2/11,10.57%,RPS27A;UBC
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.6893933913049028,-1.0784538924980502,0.4626865671641791,0.9899110552897057,1.0,1/8,1.79%,TMEM45B
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.5743106846720152,-1.0783531950968939,0.375,0.9891097238952347,1.0,3/24,10.51%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.6978092148126126,-1.0777700050321852,0.4411764705882353,0.9900415229270011,1.0,3/8,19.42%,ANK2;TMSB4X;ANK3
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.543943485099259,-1.0775960086172605,0.41975308641975306,0.9894099517326758,1.0,9/29,25.26%,CDC37;ERBB4;PIK3R1;KIF16B;BCAR1;GRB2;ERBIN;EGFR;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.6316862317467106,-1.077496260897165,0.410958904109589,0.9886957881661204,1.0,8/12,27.21%,ANK2;ATP1B3;DLG1;ITGB1;STK39;NEDD4L;ATP1B1;NEDD4
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.7178452040917352,-1.077322988210652,0.42424242424242425,0.9881389805841054,1.0,3/5,23.23%,ATP2B1;SETD3;ZDHHC21
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.7162766167494434,-1.0770667401037268,0.4067796610169492,0.9879664553832269,1.0,3/8,13.86%,DUSP1;PPP2R2B;NCK1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.49400534754806585,-1.07671903708307,0.2727272727272727,0.9882247816857042,1.0,59/279,20.43%,PIK3R3;CCDC3;BHLHE40;YTHDC1;NFKBIZ;VSIR;RPL23;HIF1A;RIMS1;ESR2;NFE2L2;ZC3H7A;NDFIP1;AHNAK;YBX3;PRX;BCL6;SLC8A1;REL;ANK2;RREB1;IFNGR1;KLF4;PRKN;AFF4;GJA1;AFDN;SBNO1;CREM;LIMS1;PLCG2;ZNF280D;PINK1;RPS7;BTNL9;SMAD3;MTF2;MSN;HNRNPH3;RACK1;BTG1;WWTR1;ZBTB38;CNBP;NOS1AP;ACVRL1;SLC38A2;CDK6;CLDN5;PTBP2;PICALM;NSD2;DNM2;ATF2;ANK3;CD34;MTOR;CLU;GATA2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.6830523759655758,-1.076641613642393,0.4050632911392405,0.9874792017865522,1.0,3/7,8.28%,DMD;TPM1;SLC8A1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.5659299533607969,-1.0763796356907214,0.4230769230769231,0.9874630714384776,1.0,12/26,26.38%,CD9;SMAD7;GJA1;CTNND2;PAK2;CTNNA1;CLDN5;TBCD;PIP5K1C;CDH5;VCL;RHOA
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.5193995613581723,-1.0762201289149396,0.30526315789473685,0.9869821551235458,1.0,16/74,15.34%,UFL1;CX3CL1;GAPDH;SHISA5;NDFIP1;REL;PRKN;GJA1;ALPK1;TNFRSF10B;PLCG2;PINK1;PELI1;SLC20A1;RIOK3;TBK1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.5634869400860096,-1.075844278603683,0.39285714285714285,0.9873951996458679,1.0,8/38,15.68%,NRCAM;CX3CL1;PTPRD;GPM6A;PPFIA2;CTNND2;LRRC4C;ADGRL3
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.6676455166680393,-1.0754447037305181,0.36231884057971014,0.9876884197381859,1.0,2/7,17.19%,PRNP;MCL1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.6754583783355308,-1.075374085813567,0.43283582089552236,0.9869831137847754,1.0,2/8,6.75%,SEMA6B;ERBB4
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.6960821300338031,-1.074919499439931,0.37142857142857144,0.9871456105625812,1.0,2/10,6.52%,CX3CL1;DUSP1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.7184231503297613,-1.074915641028972,0.36363636363636365,0.9860868075752172,1.0,4/6,15.21%,HIF1A;PRKN;PINK1;RACK1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.6058425646793844,-1.0747618564335002,0.34328358208955223,0.9854447343532128,1.0,4/17,10.57%,RFC3;POLA1;RPS27A;UBC
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.6166460361387025,1.0746714802444766,0.3793103448275862,1.0,1.0,2/7,12.10%,HSD17B4;FAR2
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.647097846798339,-1.0744985866810914,0.4153846153846154,0.9851470686816617,1.0,3/12,16.54%,HIF1A;RAB21;PAFAH1B1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.5581305101319098,-1.0741772482850926,0.35555555555555557,0.9849327544964172,1.0,13/57,16.04%,JUN;EPS8;MYO9B;RASSF1;RREB1;CFL1;RAPGEF3;RAP1A;SHC2;GNA13;KPNB1;CDKN1A;GRB2
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.7212385152781519,-1.0738266582096376,0.4473684210526316,0.98520281194519,1.0,1/7,1.90%,PCK1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.560486347537063,-1.0735838511857576,0.38461538461538464,0.9851185891336769,1.0,12/36,18.90%,CX3CL1;SLC6A6;HIF1A;ALPL;TIMP3;EMP1;GJA1;EFNB2;FGFR1;HMCN1;CALD1;SPARC
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.6575575852875526,1.0734740762657227,0.35294117647058826,1.0,1.0,1/6,1.82%,MLLT3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.5857069708413966,-1.0730654557989376,0.4,0.9856351858399247,1.0,8/25,20.33%,CX3CL1;LGALS3;PRKN;TMBIM6;PINK1;HERPUD1;MCL1;CLU
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.7218460720120536,-1.07303611885186,0.46153846153846156,0.9847153966996826,1.0,2/7,13.94%,OGT;ARPP19
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.6818944816783903,-1.0728487502842579,0.35714285714285715,0.984232405471439,1.0,1/8,6.23%,ZC3H7A
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.5201057916953002,-1.0723835860157485,0.3333333333333333,0.9850182924960978,1.0,18/73,21.63%,UFL1;ITPR1;PRKAG2;GAPDH;EEF1A1;RB1CC1;SNX6;PRKN;DHRSX;FOXK1;PINK1;TMEM59;SREBF2;MCL1;PSAP;MTOR;TLK2;ACER2
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.587647234731278,-1.0723131521724218,0.4050632911392405,0.9841373059625116,1.0,3/21,15.47%,CDC37;RIOK3;XIAP
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.5942239134326406,1.0721590956318972,0.4230769230769231,1.0,1.0,1/11,0.13%,THSD1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.587219225221745,1.0717374164450029,0.34375,1.0,1.0,1/7,8.07%,SLTM
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.5924885456464465,-1.071721333192918,0.3835616438356164,0.9849098961696429,1.0,5/20,13.86%,CX3CL1;NES;FES;PRKCE;NCK1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.6410991050660283,-1.071288210165204,0.359375,0.9852946805572442,1.0,3/9,18.69%,CDKN1A;ACVRL1;DCP2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.6469338667084963,-1.0706220122411503,0.35714285714285715,0.9866955887114223,1.0,4/11,26.64%,GOLPH3;ANK3;PREPL;SPTBN1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.7090677436171903,-1.0700161477681627,0.453125,0.9879417082469291,1.0,1/5,5.53%,GRIN2B
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.6510624183360116,-1.069427853367984,0.45,0.9892668166345374,1.0,2/13,14.69%,PBX3;CACNA1C
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.6596944771031029,-1.0689869967404813,0.4444444444444444,0.9898433934502886,1.0,4/11,15.84%,CDC37;CDKN1B;CCNH;CDKN1A
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.7199912497717169,-1.0687258591187099,0.4098360655737705,0.9888418961665939,1.0,2/5,26.69%,POLR2B;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.7199912497717169,-1.0687258591187099,0.4098360655737705,0.9888418961665939,1.0,2/5,26.69%,POLR2B;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.5704450755997681,-1.068617372074051,0.3707865168539326,0.9880698029178623,1.0,7/37,15.32%,RFC3;ERBB4;FLT1;KLF4;FGFR1;PINK1;TIE1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5946042460140226,-1.0682676798067878,0.4375,0.9882507279238621,1.0,4/17,13.37%,RPL23;SDCBP;OGT;RPS7
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.7570446560181301,-1.0676960750981015,0.463768115942029,0.9889991732951018,1.0,3/5,17.26%,ENPP2;ACOX1;LPIN2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.7162046827863535,-1.0676320628833385,0.4142857142857143,0.9881020135042894,1.0,2/6,16.69%,ARID5A;ZNF366
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.5556425182850412,-1.0676319627594808,0.37349397590361444,0.9870564029079885,1.0,8/27,22.82%,SPG7;ATP2B1;GRIN2B;SLC8A1;CACNA1C;MICU2;RYR3;TMEM165
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.7166695272880432,-1.0672788541439204,0.417910447761194,0.9872491872757206,1.0,2/6,7.92%,PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.5525294352455165,-1.0672462353651828,0.4,0.9863682584475317,1.0,12/25,25.70%,PPARG;MAGI2;KLF4;STARD4;NFKBIA;CDKN1A;GRB2;RAB1A;CD63;AHI1;SCYL2;INPP5F
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.5645660475122902,-1.0671935667400907,0.3717948717948718,0.9854430731138627,1.0,9/25,22.12%,SMAD7;RPS27A;SNX6;UBC;SMAD3;STRAP;PPM1A;SNX25;SPRED1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.6170609985779472,-1.0669952712196122,0.4444444444444444,0.9851417341512844,1.0,3/10,4.49%,LBR;PRKAG2;ABCA5
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.591898269832738,-1.0665001448826583,0.4266666666666667,0.9861065224111761,1.0,1/14,0.57%,B3GNT2
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.6107876884362152,-1.0662884348365544,0.4342105263157895,0.9860464595885549,1.0,10/18,24.97%,SERPINE1;MAGI2;RAB21;SGIP1;CLU;CD63;AHI1;TF;B2M;SCYL2
prerank,PanglaoDB_Augmented_2021__Basophils,0.47588291221828116,1.0661973526956472,0.38461538461538464,1.0,1.0,5/18,12.10%,JAZF1;SLC26A3;H2AC6;ID1;FAR2
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.5812795593552099,-1.066099454121715,0.4431818181818182,0.9857339561030776,1.0,5/27,17.65%,MAP3K5;RPS27A;UBC;ZFP36;SH2D3C
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.6515860429052684,-1.065404596034169,0.3939393939393939,0.9861076077394992,1.0,4/6,27.26%,SLC8A1;ATP1A1;ATP1B1;CAMK2D
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.6515860429052684,-1.065404596034169,0.3939393939393939,0.9861076077394992,1.0,4/6,27.26%,SLC8A1;ATP1A1;ATP1B1;CAMK2D
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.6946387690665745,-1.0648502755497196,0.37681159420289856,0.986986223634597,1.0,4/10,17.50%,RPS27A;UBC;ALPK1;CYLD
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.7427367792233428,-1.0644111862576582,0.35384615384615387,0.9876343558936608,1.0,1/5,5.50%,SEMA6B
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.6503857086710075,-1.0640439825830483,0.4594594594594595,0.9883039743051882,1.0,3/9,8.28%,DMD;TPM1;SLC8A1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5839558580194628,-1.0639762824948467,0.36666666666666664,0.9874548763146888,1.0,5/24,16.64%,SEC22B;GOLPH3;TMED10;COPA;RAB1A
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.6873431450070712,-1.0638806985918765,0.4805194805194805,0.986835479388047,1.0,2/8,13.53%,CCDC60;NEBL
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.6771781685569744,-1.0637964051406015,0.4383561643835616,0.9860807571690076,1.0,2/5,23.94%,ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.6869163325616552,-1.0637128326086576,0.4153846153846154,0.9842919956082583,1.0,2/5,19.24%,PRNP;MTMR2
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.6869163325616552,-1.0637128326086576,0.4153846153846154,0.9842919956082583,1.0,2/5,19.24%,PRNP;MTMR2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.5275816002811847,-1.063051481778453,0.4069767441860465,0.9856191649130003,1.0,13/55,20.04%,MAP3K5;HSPA5;PRKAG2;LAMP2;SIK2;CDKN1A;CPEB4;LARS1;GABARAPL1;SREBF2;PIK3C3;ATF2;MTOR
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.658618147757033,-1.0627037855520516,0.4675324675324675,0.985775828275273,1.0,3/9,10.93%,HES1;SMAD7;ZFPM2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.6797978144504464,-1.0626551388849066,0.5081967213114754,0.9828306008474585,1.0,5/6,27.15%,SLC8A1;ATP1B3;ATP1A1;NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.6797978144504464,-1.0626551388849066,0.5081967213114754,0.9828306008474585,1.0,5/6,27.15%,SLC8A1;ATP1B3;ATP1A1;NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6797978144504464,-1.0626551388849066,0.5081967213114754,0.9828306008474585,1.0,5/6,27.15%,SLC8A1;ATP1B3;ATP1A1;NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.6003878817922164,-1.062366538775656,0.43243243243243246,0.9828540109411996,1.0,3/13,11.76%,SNX6;GJA1;PRNP
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.5825071834177031,-1.0618881555080668,0.4,0.983384923315017,1.0,4/20,10.33%,ENPP2;PIK3R1;RREB1;ARPC2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.6003516302509717,-1.061732005446137,0.46987951807228917,0.9829344881473172,1.0,4/17,14.69%,BCAP31;SLC8A1;CD55;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.7065021168966761,-1.061625009767553,0.4657534246575342,0.98231614569552,1.0,3/6,9.99%,PKM;JAK1;KLF4
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.5697917785204896,-1.061108825745489,0.4375,0.982834728719452,1.0,7/15,25.26%,CDC37;ERBB4;PIK3R1;GRB2;ERBIN;EGFR;HSP90AA1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.4934954208660665,1.0605535307116771,0.3333333333333333,1.0,1.0,1/15,0.39%,BMP6
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.5243073098379497,-1.0604985256598607,0.4157303370786517,0.9840486629449804,1.0,6/65,10.88%,PIK3R3;ERBB4;RB1CC1;RAPGEF3;PECAM1;DLC1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.7299759019683683,-1.0603286255092772,0.5166666666666667,0.9835657331493565,1.0,3/5,19.42%,SLC8A1;PRKN;ANK3
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.6944884220874851,-1.0602168134901262,0.5079365079365079,0.9829380705627822,1.0,2/5,10.85%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.542191630207235,-1.0601070212490262,0.38823529411764707,0.982289298153203,1.0,7/40,16.04%,RAPGEF5;JUN;RASSF1;RREB1;SHC2;CDKN1A;GRB2
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.5535082276983417,1.060083380599623,0.4642857142857143,1.0,1.0,4/10,14.02%,COL8A1;RTF1;ITGA5;LAMA3
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.6635713342072771,-1.0597355217434639,0.4857142857142857,0.9824696582969251,1.0,4/9,20.33%,IFNGR1;PICALM;SLC2A13;CLU
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.6942966443967851,-1.0592004868679503,0.39705882352941174,0.9833425063393322,1.0,3/6,23.42%,FLT1;FGFR1;EGFR
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.5034429735795323,-1.0589232229866674,0.38144329896907214,0.9833428031246474,1.0,38/120,27.54%,PKM;SLC2A3;NFASC;LGALS3;LRRC7;EEF1A1;LAMP2;PNP;RAP1A;PECAM1;CD55;SERPINB6;BRI3;CST3;SDCBP;TMEM30A;KPNB1;RAB14;PSAP;B4GALT1;STK10;STOM;FTL;CD63;DNAJC5;CYSTM1;SCAMP1;B2M;ANXA3;VCL;DSP;HSP90AA1;DNAJC3;PDXK;RHOA;TUBB4B;HLA-B;PSMD12
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.5380571358037307,-1.058576136312107,0.4444444444444444,0.9834880792336335,1.0,9/51,13.16%,MAP2;NRCAM;MAP1B;S100A6;GAS7;MEF2A;DCLK1;GPM6A;CTNND2
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.5823500200919509,-1.0584379861501514,0.3902439024390244,0.9828309119180034,1.0,7/19,16.98%,RIMS1;KCNMB4;ANXA1;RAB21;SYT1;STXBP5L;RAB8B
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.5116470942880176,-1.0584260256174327,0.3894736842105263,0.9818857137195783,1.0,9/62,11.27%,ADM;RAB11FIP3;SRGN;SMAD7;ATP2B1;PLCL1;IFNGR1;LAMA4;GJA1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.5110246524701961,1.0584052296134723,0.36363636363636365,1.0,1.0,1/13,1.58%,UBE3D
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.6287553283874968,-1.0580305761333453,0.4,0.9812006332375517,1.0,3/11,10.51%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.6287553283874968,-1.0580305761333453,0.4,0.9812006332375517,1.0,3/11,10.51%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.5060714759646779,-1.0577489232847244,0.3711340206185567,0.9801303766444455,1.0,38/118,27.54%,PKM;SLC2A3;NFASC;LGALS3;LRRC7;EEF1A1;LAMP2;PNP;RAP1A;PECAM1;CD55;SERPINB6;BRI3;CST3;SDCBP;TMEM30A;KPNB1;RAB14;PSAP;B4GALT1;STK10;STOM;FTL;CD63;DNAJC5;CYSTM1;SCAMP1;B2M;ANXA3;VCL;DSP;HSP90AA1;DNAJC3;PDXK;RHOA;TUBB4B;HLA-B;PSMD12
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.5060714759646779,-1.0577489232847244,0.3711340206185567,0.9801303766444455,1.0,38/118,27.54%,PKM;SLC2A3;NFASC;LGALS3;LRRC7;EEF1A1;LAMP2;PNP;RAP1A;PECAM1;CD55;SERPINB6;BRI3;CST3;SDCBP;TMEM30A;KPNB1;RAB14;PSAP;B4GALT1;STK10;STOM;FTL;CD63;DNAJC5;CYSTM1;SCAMP1;B2M;ANXA3;VCL;DSP;HSP90AA1;DNAJC3;PDXK;RHOA;TUBB4B;HLA-B;PSMD12
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.7130889969238532,-1.0574220935408793,0.4626865671641791,0.9803332432040717,1.0,2/5,19.42%,SLC8A1;ANK3
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.5101569791954371,-1.0566283324089099,0.37755102040816324,0.9818078291274296,1.0,29/112,20.43%,PIK3R3;VSIR;RPL23;HIF1A;RIMS1;NFE2L2;KLF2;MAGI2;ANK2;IFNGR1;KLF4;PRKN;GJA1;AFDN;LIMS1;PLCG2;RPS7;SMAD3;MSN;PPHLN1;NOS1AP;SLC38A2;CLDN5;ATF2;ANK3;CD34;MTOR;CLU;GATA2
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.5255834970106696,-1.0564100685762554,0.42045454545454547,0.9815997091698867,1.0,11/46,16.36%,DDIT4;PRKAG2;SMAD7;DMD;PRKN;PRNP;TRIB2;NCK1;PAK2;RACK1;WWTR1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.49019289775693403,-1.0556761152154228,0.33,0.9831693937478947,1.0,64/334,17.26%,MAFF;TBX3;SERPINE1;ST18;MAP3K5;NR4A1;ZEB2;KLF6;ATF3;PPARG;JUN;FOS;HES1;CX3CL1;PHF10;JUNB;SMAD7;KDM1A;HIF1A;ESR2;HMGN1;NFE2L2;RPS27A;JUND;FOXF1;ERBB4;KLF2;NPAS3;SMARCA1;PIK3R1;NPAS2;REL;RREB1;FOSL2;KLF4;PRKN;CD81;CEBPZ;UBC;HYAL2;ZFPM2;CRLF3;EPAS1;NPM1;MEF2A;FOXK1;OGT;NCK1;SMAD3;MTF2;NOTCH4;NFKBIA;CREB3L2;MAX;TBK1;TMF1;WWTR1;CRTC3;NAA16;SREBF2;ZBTB38;CNBP;SMARCC1;LPIN2
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.5296700637117748,-1.0537854574407528,0.4318181818181818,0.9888164601923259,1.0,10/56,14.64%,DDIT4;RTN4;GAPDH;BCL2L14;PRKCE;DLC1;TNFRSF10B;ADAM15;OGT;NFKBIA
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.5349079502811797,-1.0536641052085851,0.4235294117647059,0.9882273130347511,1.0,2/36,9.45%,UFL1;SIN3B
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.6910569237804205,-1.0536199137327216,0.417910447761194,0.9873091634682413,1.0,1/7,3.50%,HES1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.5352727050589269,-1.0534640416046703,0.4157303370786517,0.9868326703883008,1.0,14/49,20.15%,EHD4;KCNIP4;ANK2;PACS1;RAP1A;CD81;DPP10;EFR3B;ATP1B3;TTC7A;RAB8B;ANK3;DLG1;EMP2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5386022727675638,-1.05324060334921,0.42857142857142855,0.9865218977398713,1.0,9/44,10.85%,PSMC6;ST18;CX3CL1;PSMB9;HIF1A;RPS27A;PSMA1;UBC;HYAL2
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.6595935762861449,-1.0529979315848774,0.5147058823529411,0.9863324537697945,1.0,4/8,23.57%,TGM2;GRB2;ERBIN;SHOC2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.5972246329118861,-1.052879074126363,0.4444444444444444,0.9858145255485166,1.0,9/18,16.15%,MAP2;NFASC;GRIA2;ANK2;DCLK1;CTNND2;LRRC4C;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.5056792689451431,1.0528200970756014,0.4375,1.0,1.0,1/10,0.86%,PLA2G4A
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.5056792689451431,1.0528200970756014,0.4375,1.0,1.0,1/10,0.86%,PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.6105918322790564,-1.0524059305301603,0.4473684210526316,0.9865570184904937,1.0,2/12,10.83%,CALCOCO2;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.7095429733188022,-1.0522400664210503,0.4861111111111111,0.9860399023730414,1.0,2/6,20.04%,MAGI2;MTOR
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.6617762008116571,1.051678231858124,0.5,1.0,1.0,3/6,16.64%,DISP1;ABCG2;TAP1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.6029235989842486,-1.051424573315142,0.44594594594594594,0.9876987424741954,1.0,7/13,28.87%,MAGI2;DLC1;MTOR;CDH5;PPP1R16B;PTBP1;SPPL3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.7216492035334938,-1.0511833932792005,0.42105263157894735,0.9873343757026294,1.0,4/5,27.26%,COMMD1;NEDD4L;NEDD4;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.6499962299238069,-1.0509260310558917,0.45161290322580644,0.9872652371259657,1.0,3/8,16.04%,PLCG2;CDKN1A;GRB2
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.6678748398113156,-1.050853273692478,0.43478260869565216,0.9865206492890347,1.0,4/8,20.33%,IFNGR1;PICALM;SLC2A13;CLU
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.43363732603646715,1.0508272020707519,0.3888888888888889,1.0,1.0,7/29,16.51%,EVI5;TBC1D5;VPS50;GBF1;TBC1D23;TRAPPC10;RIC1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.45954970081367347,1.050476847007163,0.3333333333333333,1.0,1.0,2/15,14.88%,BICD1;CIRBP
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.61522246585722,-1.0504613312536444,0.4567901234567901,0.9868116874639579,1.0,4/16,16.61%,EHD4;RAB11FIP3;ACAP2;RAB14
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.6036732416195877,-1.0497715135067405,0.417910447761194,0.9879286374755301,1.0,3/16,10.57%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.5997073460435646,-1.0495696040769789,0.4939759036144578,0.9875658531481553,1.0,3/16,13.91%,PRKN;ARIH2;PELI1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.6864772301850202,-1.0493995238078517,0.4444444444444444,0.9871061097966877,1.0,4/9,24.82%,JAK1;PAK2;CDH5;DSP
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.6430674473613409,-1.0492337523393425,0.49230769230769234,0.9866364361183251,1.0,5/8,27.26%,PRKCE;STK39;NEDD4L;NEDD4;CAMK2D
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.666435445780291,-1.049229520089432,0.44,0.9856802637459838,1.0,3/9,17.50%,RPS27A;UBC;CYLD
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.5681546900986021,-1.0487150614076208,0.47674418604651164,0.9866088467457149,1.0,2/25,4.85%,YTHDC1;KHDRBS3
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.5779098810710221,-1.0486730317922515,0.4266666666666667,0.9857410759399615,1.0,3/17,8.39%,TIMP3;TPM1;TNS1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.5470711798403136,-1.0486332379553156,0.4235294117647059,0.9848642204359855,1.0,14/45,16.15%,UFL1;ZEB2;NFASC;GRIA2;GRIN2B;GPM6B;NPAS3;MAGI2;LSAMP;GJA1;PPFIA2;LRRC4C;CADM2;PLP1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.5843580218186875,-1.0485526421931985,0.4473684210526316,0.9841185641280245,1.0,1/16,3.79%,TAF1D
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.6952240863139602,1.0484683008174918,0.45161290322580644,1.0,1.0,3/5,5.48%,RSAD2;MIA3;IL15
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4778453837599415,1.0483515968751826,0.3125,1.0,1.0,5/20,12.28%,ATR;UIMC1;ATM;ERCC6;BABAM2
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.5469771026314652,-1.047613702223731,0.42857142857142855,0.9863707623958111,1.0,9/36,17.34%,PSMC6;PPARG;PSMB9;LSS;SIN3B;PSMA1;PLPP1;SREBF2;PSMA7
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.593650594063984,-1.047417929429589,0.4507042253521127,0.9858835168462404,1.0,4/19,11.76%,RPL23;SNX6;GJA1;PRNP
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.6085563533673229,-1.0472511440151537,0.4264705882352941,0.9856016161383474,1.0,7/12,21.24%,CX3CL1;SMAD7;JAK1;AFDN;DENND6A;ANK3;PODXL
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.5972387167512815,-1.047227888504268,0.4025974025974026,0.9846862224952071,1.0,4/17,11.71%,PSMC6;PSMB9;PSMA1;CHFR
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.6226790842914609,-1.0471565299965448,0.41025641025641024,0.9838907233566134,1.0,1/11,4.83%,HIF1A
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.594767971033261,-1.0470098250395126,0.4383561643835616,0.9832362166900952,1.0,3/14,11.76%,SNX6;GJA1;PRNP
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.7146836476541669,-1.046991822908786,0.463768115942029,0.9823686942285524,1.0,2/6,21.73%,KPNB1;BLCAP
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.6517503965823425,-1.0468242412767939,0.4406779661016949,0.9819203451629225,1.0,3/9,10.57%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.6059637312779439,-1.0465619301876812,0.41333333333333333,0.9818364691005903,1.0,5/18,12.82%,ITPR1;ATP2B1;SLC8A1;ANK2;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.6741290126992947,-1.0462417234604093,0.5,0.9819771112519398,1.0,3/8,14.25%,SMAD7;CDKN1B;ZFP36
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.7301774706248022,-1.0458263149397777,0.4411764705882353,0.9824696910700114,1.0,3/5,14.04%,BCAP31;NFE2L2;HERPUD1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5486704145944462,-1.0453693627597966,0.4025974025974026,0.9830359485796484,1.0,14/33,26.79%,PBX3;TIMP3;EMP1;LAMA4;GJA1;CREB3L2;HMCN1;GADD45B;CALD1;SPARC;BOC;RHOJ;GLI3;NID1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6811577173905685,-1.0452644396222655,0.47619047619047616,0.9824186973615527,1.0,1/6,1.22%,ITPR1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.6752633940892259,-1.0450671789482482,0.4782608695652174,0.9821325478426164,1.0,1/9,1.95%,TSG101
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.6591537644385894,-1.04505454975957,0.417910447761194,0.9812196922755047,1.0,3/9,21.00%,TGM2;ANXA1;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.6926955898486422,-1.0448150243258807,0.5211267605633803,0.9811370677052269,1.0,1/5,6.54%,NDFIP1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.662300521366938,-1.0446523071813438,0.4583333333333333,0.9805771117947151,1.0,2/8,21.75%,CAMKMT;SETD3
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.6619570108768384,-1.0437089915771487,0.4647887323943662,0.9826578006066463,1.0,2/7,9.48%,SUN2;SUN1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.4859357551694972,1.0434358431868225,0.6,1.0,1.0,1/10,1.01%,UGCG
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.5982052745396984,1.0420995128571362,0.4166666666666667,1.0,1.0,2/5,13.47%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.5982052745396984,1.0420995128571362,0.4166666666666667,1.0,1.0,2/5,13.47%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.5667761253880506,-1.042022674000104,0.4069767441860465,0.9869902047245159,1.0,8/29,20.15%,NEDD9;CX3CL1;RREB1;LIMS1;RSU1;CDK6;CASS4;EMP2
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.6178461374308101,-1.0419947458877057,0.43902439024390244,0.9860770651505828,1.0,3/15,4.78%,UFL1;SMAD7;SPOPL
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.6072714458984595,-1.0419885619913922,0.4657534246575342,0.9851656918040655,1.0,4/14,14.41%,SSH1;HIP1R;PRKN;KANK3
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6698319419971093,-1.041905497906378,0.4861111111111111,0.9844461535865585,1.0,1/7,4.00%,SRGN
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.558330608495672,-1.0418758787226143,0.41379310344827586,0.9836119602127704,1.0,5/34,13.53%,RAPGEF5;PPP1R9A;HIP1R;SHC2;NEBL
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.6905585224211787,-1.0415809645435503,0.45454545454545453,0.9834117338202003,1.0,3/5,27.15%,DMD;ANK3;ATP1B1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.7007550810242669,-1.0412897891545332,0.4931506849315068,0.9834224761916412,1.0,3/5,22.33%,ANXA1;RAB1A;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.5599254535357384,-1.0409876128985351,0.45454545454545453,0.9834226788701508,1.0,8/23,24.27%,NR4A1;HIF1A;FGFR1;EGFL7;VEGFC;GATA2;JCAD;PPP1R16B
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.6555083543099176,-1.040864577346477,0.5072463768115942,0.9827503115457908,1.0,3/13,9.99%,NR4A1;PPARG;KLF4
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.5172548658015692,-1.0405105247961424,0.42857142857142855,0.9827721571366104,1.0,7/42,13.19%,MTFR1;BCAP31;BNIP3L;SPG7;PRKN;MEF2A;PINK1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.7153340134157222,-1.0402000804266442,0.463768115942029,0.9828778706338807,1.0,3/5,21.57%,SLC8A1;TGM2;RYR3
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.6849774823899436,-1.0398350865182306,0.546875,0.9830357747870185,1.0,4/5,27.26%,COMMD1;STK39;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.6492816426308523,-1.0397831008166591,0.4507042253521127,0.9823035423631407,1.0,2/10,4.44%,NES;KDM1A
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.6200437386043716,-1.0396079910037253,0.4875,0.9820119733132249,1.0,1/14,1.38%,NRCAM
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.5917418201459455,-1.039040508748305,0.4507042253521127,0.9828807585441257,1.0,3/16,10.51%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6712285593970784,-1.0389993323341975,0.40625,0.9820985790643261,1.0,2/7,6.41%,CD9;ACTN1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.6020168850414512,-1.038951157405588,0.4520547945205479,0.9813387496526421,1.0,2/16,9.99%,PPARG;KLF4
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.5776670024419873,-1.038879678127142,0.4318181818181818,0.9806428813430565,1.0,15/30,33.33%,GRIA2;MAGI2;LSAMP;PPFIA2;CADM2;SGIP1;RNPC3;SCN2A;KIF1B;SLC1A2;CNTNAP2;ADGRB3;GRIA4;NRXN1;SNAP25
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.6938951969554273,-1.0387289421787773,0.4583333333333333,0.9801356971748534,1.0,2/5,19.94%,PRNP;MT1M
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.6903110300568304,-1.0384620228376393,0.4805194805194805,0.9798270574751393,1.0,3/6,18.61%,PRNP;TMED10;PICALM
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.6112851307710587,-1.0379979192421793,0.43478260869565216,0.9803916827956579,1.0,5/14,10.83%,MGLL;GRK5;SLC8A1;ANK2;ANXA1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5581827684743824,-1.0379584071650612,0.46511627906976744,0.9795644281701438,1.0,8/29,22.90%,SUN2;SPC25;RPS27;KPNB1;PAFAH1B1;DYNC1I2;MECP2;EML4
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.6743806285492924,-1.0379127678253321,0.4666666666666667,0.9787491126010469,1.0,3/8,17.50%,RPS27A;UBC;CYLD
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.5859924687764266,-1.0372790096240523,0.4166666666666667,0.9798414878132923,1.0,1/13,4.47%,MAP1B
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.5831378332525967,-1.0372106053471168,0.5056179775280899,0.9791206011053804,1.0,10/26,24.51%,SEC24D;CANX;ARF1;AP1G1;DNM2;PIKFYVE;CLTA;DYNC1I2;CAPZA2;KLC1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.6427223049770843,-1.0366750493937604,0.5131578947368421,0.9798900215574275,1.0,4/13,10.72%,PPARG;SLC4A10;ACOX1;SLC4A7
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.6768039925177814,-1.0365031503221955,0.47058823529411764,0.9794287044572614,1.0,2/6,21.78%,CFL1;CAV2
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.5715093235816924,-1.036178876685092,0.43037974683544306,0.9795255577722962,1.0,5/25,5.35%,NRCAM;RTN4;GRM7;MAP1B;S100A6
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.557262225030635,-1.0357405038581986,0.4358974358974359,0.9803027292037678,1.0,4/24,10.51%,PSMC6;PSMB9;CDKN1B;PSMA1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.5843670327483074,-1.0350018469355957,0.4523809523809524,0.981459569001889,1.0,5/26,16.20%,PCK1;SLC8A1;NEBL;FGD4;CPEB4
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.5277961500388121,-1.0348910581464132,0.48148148148148145,0.97904153893068,1.0,8/35,16.04%,PIK3R1;PRKCE;ARPC2;VAV3;WIPF1;PLCG2;NCK1;GRB2
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5277961500388121,-1.0348910581464132,0.48148148148148145,0.97904153893068,1.0,8/35,16.04%,PIK3R1;PRKCE;ARPC2;VAV3;WIPF1;PLCG2;NCK1;GRB2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.5277961500388121,-1.0348910581464132,0.48148148148148145,0.97904153893068,1.0,8/35,16.04%,PIK3R1;PRKCE;ARPC2;VAV3;WIPF1;PLCG2;NCK1;GRB2
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.5241260932173267,-1.0347454500497562,0.4945054945054945,0.9785327395969582,1.0,13/52,22.04%,PPARG;FES;REL;CALCOCO2;ALPK1;ADAM15;PLCG2;TBK1;MALT1;CYLD;SERINC3;IFITM3;CAPZA2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.5755364595793675,-1.0344607371368442,0.47126436781609193,0.9784349982812329,1.0,5/24,12.33%,NEDD9;RREB1;PTPRD;IL1RAPL1;LIMS1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.5711965980387352,-1.0338584157764397,0.4625,0.9794641676178533,1.0,9/21,27.73%,SMIM3;TINAGL1;EMP1;WWTR1;CAV2;EGFR;DSP;CD109;PXN
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.5516687197994267,-1.033803519009312,0.4875,0.9786391668110166,1.0,3/27,4.10%,PSMC6;HES1;PSMB9
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.7312487573039097,-1.0336575568323947,0.3939393939393939,0.9773615046632369,1.0,2/5,11.89%,TAF1D;CCNH
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.7312487573039097,-1.0336575568323947,0.3939393939393939,0.9773615046632369,1.0,2/5,11.89%,TAF1D;CCNH
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5344751936577048,1.0328260955592943,0.4444444444444444,1.0,1.0,1/10,1.14%,HABP4
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4889290820092693,-1.032779006937045,0.3958333333333333,0.9789082733305114,1.0,19/106,15.84%,PIK3R3;PRKAG2;CX3CL1;ENPP2;ERBB4;RB1CC1;RAPGEF3;RAP1A;CD81;PECAM1;PRNP;SDCBP;PLCG2;PINK1;PAK2;RACK1;TBK1;TEC;CDKN1A
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.5637240588014398,-1.0325811982356752,0.42528735632183906,0.9788005335613792,1.0,3/21,10.23%,ITPR1;SCARB2;PRKN
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.556112790854672,-1.0322280048829986,0.4473684210526316,0.9789578228146835,1.0,10/18,32.06%,LGALS3;ANXA1;RAB30;LCP2;ZBTB46;FTL;CAMK2D;HLA-B;CD74;FGR
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.4825430674659349,-1.0320668100910586,0.38636363636363635,0.978483893759135,1.0,10/59,11.79%,TAMALIN;PKN3;CLEC1A;TIMP3;TMEM184B;LAMA4;HYAL2;ITGB5;EPAS1;EFNB2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.6553313595561163,-1.031835454816465,0.4507042253521127,0.9775589929777401,1.0,1/9,4.80%,EPS8
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.6553313595561163,-1.031835454816465,0.4507042253521127,0.9775589929777401,1.0,1/9,4.80%,EPS8
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.5711483861830015,-1.031445768147696,0.47126436781609193,0.9778792167556284,1.0,10/29,24.51%,SEC24D;CANX;ARF1;AP1G1;DNM2;PIKFYVE;CLTA;DYNC1I2;CAPZA2;KLC1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.5561148732594651,-1.03120925946362,0.4268292682926829,0.9777831697057936,1.0,10/33,20.25%,NEDD9;LAMA5;ITGA10;ADAMTS1;ITGB5;ADAM15;BCAR1;TEC;ERBIN;ITGB1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.7435177595401214,-1.0306049155155057,0.5,0.9789433041800571,1.0,3/5,20.15%,RAP1A;CD34;EMP2
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.658568986084648,-1.0298196890129447,0.44594594594594594,0.9808197876563288,1.0,2/8,9.99%,KLF2;KLF4
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.6218992575070595,-1.0294138964582893,0.4722222222222222,0.9812065822979549,1.0,4/10,14.04%,PRKN;TMBIM6;NCK1;HERPUD1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6658068058626487,-1.0287886900041716,0.5142857142857142,0.9823805381182543,1.0,4/8,27.99%,KLF4;DLL4;RHOA;MAP2K5
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.6418417362184444,-1.0285239474389976,0.4507042253521127,0.9822404115569098,1.0,1/7,10.31%,STARD4
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.5235851361116636,-1.028381518134823,0.4691358024691358,0.9817879910015819,1.0,6/32,16.80%,B3GNT2;MGAT4A;PLOD2;OGT;ALG11;PMM2
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.4845514997774289,1.0281363924672602,0.32142857142857145,1.0,1.0,5/19,8.90%,PSMD14;UIMC1;HERC2;ATM;ERCC6
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.640129192626401,-1.0278888675875204,0.5223880597014925,0.9824041474044847,1.0,2/7,11.27%,KDM1A;GJA1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5977107390520675,-1.0278854239612403,0.4794520547945205,0.9815096033057817,1.0,5/16,18.90%,TIMP3;LAMA4;GJA1;CALD1;SPARC
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.6239290453407591,-1.0275197682229429,0.4722222222222222,0.9816221564559192,1.0,4/9,19.24%,SDCBP;LRPAP1;PICALM;MTMR2
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.6514145080106721,1.02721010882159,0.5517241379310345,1.0,1.0,2/7,4.21%,PRKD1;STXBP4
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.49695890316750163,-1.0272005138601918,0.4787234042553192,0.9816742310733563,1.0,22/90,21.99%,MAP3K5;JUN;BNIP3L;RPS27A;BCL6;HIP1R;TGM2;VAV3;UBC;TNFRSF10B;RPS6;GNA13;FGD4;RACK1;GADD45B;DNM2;RASGRF2;ITGB1;CLU;PREX1;ECT2;DUSP6
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.5882803188156895,1.0265339282116868,0.4411764705882353,1.0,1.0,1/5,6.31%,RNF213
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5107571337873823,1.025690394721895,0.41935483870967744,1.0,1.0,2/12,8.02%,HOMER1;FBXO7
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.6236498605431062,-1.025684804944356,0.5466666666666666,0.9856503048000843,1.0,2/8,18.48%,BCL6;LCP2
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.6374317703284206,-1.025484583316833,0.4444444444444444,0.9852373536529588,1.0,1/9,1.90%,PCK1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.668855394028348,-1.0253915428264593,0.532258064516129,0.9845847359184675,1.0,3/5,30.32%,PLCG2;GPRC5B;CD74
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.4984847116878026,-1.0253197376751737,0.45652173913043476,0.9839233049781668,1.0,11/72,14.02%,SERPINE1;RTN4;KDM1A;GAPDH;RREB1;CFL1;GJA1;EPAS1;SDCBP;OGT;SMAD3
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5867568750067987,-1.0253142551265868,0.4342105263157895,0.983093095910017,1.0,6/20,16.23%,JAK1;ARF1;CFL1;MSN;PAK2;SOD2
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.5656777285969622,-1.0252078143738994,0.44155844155844154,0.9824342376405473,1.0,6/20,19.24%,LGALS3;NDFIP1;PRKN;DYSF;RACK1;MTMR2
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.4205003145770503,1.0251211037107664,0.4,1.0,1.0,4/29,8.52%,IVNS1ABP;NOVA1;CDK12;WBP4
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.5246837548086646,-1.0245969960534973,0.45454545454545453,0.9834434191008465,1.0,9/29,15.21%,BCAP31;SMAD7;NFE2L2;RNF19A;PRKN;ARIH2;TRIB2;HERPUD1;RACK1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.6318791889169896,1.0244013412116584,0.4634146341463415,1.0,1.0,3/5,22.17%,PIAS1;UBA2;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.5239351167781203,-1.0241889810251097,0.46511627906976744,0.9837427506030816,1.0,13/39,23.42%,PSMC6;ZEB2;PSMB9;GPC5;PSMA1;XIAP;PSMA7;USP34;GPRC5B;PPM1A;CSNK1D;TNKS2;EGFR
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.5472858995427445,-1.0241456418978692,0.4523809523809524,0.9829356590400126,1.0,6/28,10.28%,SEC24D;TIMP3;TPM1;TNS1;MSRB3;LAMA4
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.4820520167452522,-1.023597518017591,0.46938775510204084,0.9836131515924732,1.0,29/128,16.04%,FOS;CX3CL1;JUNB;HIF1A;GAPDH;NFE2L2;RPS27A;DUSP1;JAK1;YBX3;CDKN1B;PIK3R1;IFNGR2;BCL6;LAMA5;IFNGR1;IL1RAPL1;UBC;ANXA1;HYAL2;S1PR1;SMAD3;RPL13A;ZFP36;TPR;TBK1;TEC;CDKN1A;GRB2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.6721180323910346,-1.0226471072820342,0.5970149253731343,0.9855026680510952,1.0,4/8,17.13%,PKM;YBX3;CPEB4;CNBP
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5905217633527157,1.0224637152970968,0.43243243243243246,1.0,1.0,1/5,8.67%,MFHAS1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.591593762492002,-1.0222986078441632,0.5263157894736842,0.9855605825314494,1.0,2/13,3.66%,PPARG;CX3CL1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6697093554537398,-1.0211113630533453,0.5211267605633803,0.9880107176460934,1.0,2/6,9.99%,MBP;KLF4
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.4864352177902378,-1.0210511636163062,0.3958333333333333,0.9872530033714426,1.0,9/86,13.19%,PIK3R3;ATF3;ERBB4;RB1CC1;PRKN;PECAM1;NPM1;PRNP;PINK1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5694642238857579,-1.0208528565163781,0.4691358024691358,0.9868038315910348,1.0,4/15,18.48%,PPARG;LGALS3;DUSP5;LCP2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.5219567654552502,-1.020741786472398,0.4675324675324675,0.986276276018831,1.0,6/24,15.21%,PPARG;HIP1R;DLC1;TNFRSF10B;SMAD3;RACK1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.6542854527943976,-1.0207095678668505,0.5079365079365079,0.9854529534102081,1.0,2/7,8.62%,CX3CL1;ANK2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.7147263778702891,-1.0205596525949259,0.5540540540540541,0.9841168293115279,1.0,1/6,9.61%,RAP1A
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.7147263778702891,-1.0205596525949259,0.5540540540540541,0.9841168293115279,1.0,1/6,9.61%,RAP1A
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.6314415234284365,-1.020553761512551,0.4861111111111111,0.9832483651266131,1.0,3/12,13.94%,PRKAG2;PIK3R1;ARPP19
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.5138997856016179,-1.0203641129665038,0.49411764705882355,0.9829037850784472,1.0,14/48,23.42%,PSMC6;ZEB2;PSMB9;GPC5;SULF2;PSMA1;XIAP;PSMA7;USP34;GPRC5B;PPM1A;CSNK1D;TNKS2;EGFR
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.5094312720345223,-1.0199895999810424,0.4782608695652174,0.9832589044457893,1.0,8/49,13.84%,NFKBIZ;SCARB2;HIF1A;YBX3;ARF1;SLC8A1;AFF4;KIF16B
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.5394074773006003,-1.0196820641127509,0.4470588235294118,0.98309200687522,1.0,2/29,5.61%,PSMC6;LGALS3
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.6691194983544255,-1.0194376513067154,0.5238095238095238,0.9830630080295806,1.0,1/5,4.44%,KDM1A
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.5749005992549987,-1.019311784240377,0.5405405405405406,0.9825528990700672,1.0,2/15,11.76%,PRKN;PRNP
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.48021100570573916,-1.0191008804677855,0.4897959183673469,0.9823282197767061,1.0,21/136,14.12%,PIK3R3;VSIR;RPL23;TAF1D;HIF1A;RIMS1;GAPDH;NFE2L2;PIK3R1;ANK2;IFNGR1;KLF4;PRKN;GJA1;AFDN;NPM1;LIMS1;PLCG2;RPS7;SMAD3;MSN
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.5384180475376519,-1.0190795774758254,0.4625,0.9815452281554975,1.0,8/31,19.60%,PSMC6;PSMB9;KLF4;PSMA1;CDKN1A;PSMA7;CDK6;DLG1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.4286796705606431,1.018412726291539,0.34782608695652173,1.0,1.0,4/18,6.98%,BMP6;HSD17B4;SLCO1A2;SLC23A2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.6100826552891983,-1.0177249929473444,0.5063291139240507,0.9843577589477164,1.0,3/10,28.50%,DUSP1;CAV2;TOM1L2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.5618586818073452,-1.0175060340214424,0.4533333333333333,0.9841320672801408,1.0,1/22,0.73%,SPNS2
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.35492231880326325,1.017340179551886,0.3,1.0,1.0,10/50,8.62%,ANKRD6;ZNRF3;PSMD14;MLLT3;NKD1;TLE4;RNF213;UBAC2;INVS;PSMB1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.6052476079447853,-1.0173094124900577,0.5068493150684932,0.9838285735854022,1.0,3/10,14.07%,UFL1;GPM6A;MTF2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.6142867063095644,-1.0172930700275362,0.4927536231884058,0.9830470400630998,1.0,1/8,8.46%,AP1G1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.6765089163580539,-1.017133960564501,0.4794520547945205,0.9825986831285511,1.0,1/6,12.59%,CHST11
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.6396743724660092,-1.0165056207127274,0.49230769230769234,0.983467316651285,1.0,2/7,24.66%,NOTCH4;DLL4
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.6978263206832078,-1.015790328286947,0.5,0.9837985064965769,1.0,2/5,19.34%,CHST11;CHSY1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.6978263206832078,-1.015790328286947,0.5,0.9837985064965769,1.0,2/5,19.34%,CHST11;CHSY1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.6997985858055806,-1.015637659761655,0.5588235294117647,0.9834191413367568,1.0,2/5,18.12%,FES;CDK6
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.49816197948290797,-1.0155529199325406,0.47191011235955055,0.9828364378212465,1.0,10/53,15.55%,PPP2R3A;SSH1;PPM1D;ALPL;DUSP1;PTPRD;DUSP16;PPP3CC;DUSP5;PLPP1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5912326642774881,-1.015521342435583,0.5,0.9820994690371966,1.0,2/11,4.44%,JUN;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.4506179088507559,1.0151458708090482,0.43478260869565216,1.0,1.0,2/13,5.40%,BMP6;MIA3
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.6050649728403195,-1.0148199962630682,0.52,0.9831384788019778,1.0,7/12,36.29%,SDCBP;OGT;TLK2;EIF3H;RPL11;USP7;FHIT
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.6372818249351816,-1.0146453717259272,0.5147058823529411,0.9827416659257644,1.0,4/6,32.01%,KIF16B;INPP5F;ECE1;ANXA2
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5823218974385446,-1.0145916170598752,0.4722222222222222,0.9819776979473908,1.0,3/17,16.17%,ESR2;PLPP1;TMF1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.5996757475805078,-1.0145895693958427,0.4857142857142857,0.981108691135048,1.0,4/14,11.21%,RPS27A;UBC;ANXA1;PURA
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.6193097133224241,1.0142510554764117,0.5161290322580645,1.0,1.0,1/6,0.86%,PLA2G4A
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5868448339696943,-1.0141166178037866,0.42105263157894735,0.9816327443653979,1.0,6/19,16.23%,JAK1;ARF1;CFL1;MSN;PAK2;SOD2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.48733748691402395,-1.0136033339210146,0.41836734693877553,0.9823489681061699,1.0,30/104,15.42%,SPNS2;MGLL;APOLD1;CD9;SRGN;CAVIN2;LRRC32;FOXF1;TIMP3;GGT5;SLC2A1;TNS1;FLT1;EMP1;SCARF1;LAMA4;ADAMTS1;VWF;PECAM1;HYAL2;EPAS1;CD55;GPM6A;PLEC;NOSTRIN;CFH;BTNL9;NOTCH4;TIE1;PLSCR4
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.6380739988827274,-1.013373090839869,0.5671641791044776,0.9822150532818769,1.0,1/6,9.09%,RAPGEF3
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.5594814982821061,-1.0131003620725085,0.4342105263157895,0.9820620990547819,1.0,1/22,0.73%,SPNS2
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.5819265376729356,1.0129728665697129,0.6,1.0,1.0,2/8,7.50%,DTWD1;CDKAL1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.6132736769394711,-1.0126715018292793,0.5151515151515151,0.982525689590754,1.0,4/11,24.33%,SOD2;RYR3;CBR4;B2M
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.5159282271166281,-1.0124238041004345,0.5529411764705883,0.9825459060361749,1.0,3/30,8.62%,ITPR1;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.5675050522298314,-1.0124229749726985,0.4875,0.9816817495664861,1.0,6/22,8.62%,GRIA2;GRIN2B;DMD;LRRC7;AHNAK;ANK2
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.6643959108871818,-1.012066366673269,0.5,0.9820676208829303,1.0,1/7,22.27%,PRKAR1A
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.6223035043301417,-1.0116634604700019,0.5675675675675675,0.9823376688304648,1.0,3/8,19.24%,RAB21;MSN;MTMR2
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.6815426844455793,-1.0110874245442834,0.5151515151515151,0.9831345316866095,1.0,2/5,19.60%,ANK2;DLG1
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.5272620447066797,-1.0109039752178524,0.532608695652174,0.9827230860339548,1.0,14/38,20.92%,BHLHE40;DTNA;DMD;ITGB5;PRNP;MEF2A;CDKN1A;WWTR1;NAV2;GADD45B;SPARC;ITGB1;CLU;CNN3
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6016381737348299,-1.010758684254095,0.4666666666666667,0.9822645095671498,1.0,9/12,38.99%,KLF4;PAK2;XIAP;MAP2K5;CSNK2A1;RPS6KA3;YWHAE;DNAJB6;DDX3X
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.5366261935769342,-1.0101711819579826,0.4880952380952381,0.9830306592142448,1.0,13/36,16.46%,MAP2;MAP1B;NFASC;GRIA2;MAGI2;ANK2;PTPRD;LSAMP;DCLK1;PPFIA2;CADM2;PLP1;RUFY2
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.5786792870422517,-1.0100291077601982,0.4492753623188406,0.982534401414312,1.0,3/7,27.26%,CACNA1C;ATP1A1;CAMK2D
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.47986239496269206,-1.0100218746479261,0.44565217391304346,0.9816858379687209,1.0,11/72,14.02%,LAMC1;PLS3;HES1;CD9;NES;SMARCA1;KLF4;PECAM1;GJA1;MYO1B;SMAD3
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.6274049728314903,-1.009289175537455,0.5,0.983070383668606,1.0,5/10,27.02%,RPS6;PINK1;MTOR;CCDC88A;MAPKAP1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.5544270253914839,-1.0090917607174734,0.5316455696202531,0.9826992604630177,1.0,5/21,14.41%,SSH1;PRKCE;HIP1R;NCK1;KANK3
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5742942534612696,-1.0090410699552206,0.4722222222222222,0.98198605452463,1.0,2/14,10.23%,HIF1A;PRKN
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.5069301701562642,-1.008264923629546,0.47058823529411764,0.9833476999929384,1.0,17/47,25.26%,RTN4;CX3CL1;ERBB4;PIK3R1;MAGI2;HYAL2;FGFR1;PINK1;RACK1;GRB2;CASS4;ITGB1;DAG1;EGFR;PIK3CB;PHLPP1;HSP90AA1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.6273008254904893,-1.0082191790210158,0.5070422535211268,0.9826351705522436,1.0,3/9,7.92%,SLC2A3;GLUD1;SLC2A1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5358848411579368,-1.0081020984798752,0.5256410256410257,0.9821137880995067,1.0,5/23,16.04%,TSG101;HIP1R;ZFYVE28;SH3KBP1;GRB2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.6963674702123062,-1.0080241683758464,0.546875,0.9814604900026073,1.0,2/5,4.41%,NFKBIZ;SMAD7
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.6531872484807562,-1.0077193282824561,0.5245901639344263,0.9816329957970504,1.0,3/8,21.26%,CCDC14;NUDCD3;CSNK1D
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.7252885171037916,-1.007254403327024,0.515625,0.9820798546405283,1.0,1/5,10.70%,ACOX1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.6337662752798394,1.007207357204632,0.46808510638297873,1.0,1.0,2/5,18.54%,MCM9;PARN
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.5553156512821795,-1.007098725104111,0.5111111111111111,0.9816269965507466,1.0,11/24,29.88%,SEPTIN11;SPIRE1;MYH10;ANK3;CHMP4B;ECT2;SNX9;RASA1;RHOA;SPTBN1;RHOB
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.6628747758677045,-1.0070906770691792,0.5138888888888888,0.9808062013708917,1.0,1/6,11.94%,ACSL5
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.6494547119630226,-1.0070076642901515,0.5223880597014925,0.9802418724901802,1.0,1/5,7.87%,PIK3R1
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4330054412168361,1.0068711790189486,0.4,1.0,1.0,1/19,2.91%,YEATS2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.6225838734173246,-1.0067656957681983,0.5466666666666666,0.979989973758681,1.0,1/8,2.91%,PRKAG2
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.5598095120708763,1.0064732986321028,0.46153846153846156,1.0,1.0,1/8,3.09%,GCH1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.4567459958017875,-1.0064686814702628,0.51,0.9801345655866347,1.0,51/324,17.34%,LAMC1;B3GNT2;PSMC6;UFL1;PPP2R3A;MAP3K5;PRKAG2;ERO1A;SSH1;PKN3;PSMB9;PPM1D;HIF1A;GRK5;SHISA5;DUSP1;MGAT4A;JAK1;PLOD2;MACROD2;FEM1C;PRKCE;PTPRD;ZDHHC6;COMMD1;TGM2;NGLY1;PSMA1;ANXA1;SIK2;EPAS1;RAB2A;DUSP16;DCLK1;CST3;MSRA;FGFR1;CDK14;PINK1;TRIB2;PPP3CC;DUSP5;PAK2;VRK2;TBK1;TEC;STK38;RAB1A;PMM2;PIK3C3;PSMA7
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.6551352539399279,-1.00643558210429,0.5671641791044776,0.9794403703571692,1.0,2/6,21.16%,MEF2A;MTM1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.546103101771399,-1.0059222839334427,0.5316455696202531,0.9800841103324357,1.0,6/28,15.21%,BTG2;RTN4;GAPDH;PRNP;RPL13A;RACK1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.6372493873716865,-1.0056472019130092,0.578125,0.9798049978216293,1.0,3/8,24.82%,MYO1B;EMP2;DSP
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.5939910620409944,1.0054182217056638,0.5172413793103449,1.0,1.0,2/7,2.75%,MMRN1;SLC26A3
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.596396815652712,-1.0052046960592693,0.5384615384615384,0.9802875602706408,1.0,5/13,30.71%,ZFP36;EGFR;AGO2;MAP2K1;STAT3
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.4576845677585263,1.0046326517922457,0.2727272727272727,1.0,1.0,3/29,2.96%,EVI5;TBC1D5;RALGAPA2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.6165762541142569,-1.004582655078331,0.5394736842105263,0.9809570814819896,1.0,3/11,10.93%,HES1;SMAD7;ZFPM2
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.4866445521312539,1.0037688062283756,0.3793103448275862,1.0,1.0,4/10,18.54%,TENT2;CIRBP;LARP1;PARN
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.5076360444125092,-1.0032369138374917,0.4642857142857143,0.9841021259532426,1.0,6/34,6.00%,GRIK1;SYN3;NRG3;GRM7;RIMS1;KCNMB4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.47782875887548293,1.0030665555901461,0.4444444444444444,1.0,1.0,2/16,2.78%,DCP1A;RC3H1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.5614352807844701,-1.0023181553448754,0.547945205479452,0.9856295699463095,1.0,1/15,4.47%,MAP1B
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.6612808335545232,-1.0019329111852768,0.5714285714285714,0.9859275473996344,1.0,3/7,8.52%,LBR;PRKAG2;LSS
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.595735255933962,-1.0018615690667252,0.5128205128205128,0.9852612189070367,1.0,3/15,15.68%,NRCAM;GPM6A;ADGRL3
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.6131169076513655,-1.0014919540578915,0.5588235294117647,0.9854935570127502,1.0,3/8,30.76%,HIP1R;CCDC88A;AFAP1L2
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.4718036008789466,-1.0014070629346048,0.5108695652173914,0.9848661034536772,1.0,9/68,12.31%,BTG2;RFC3;RAD21;POLA1;RPS27A;UBC;PURA;NPM1;NOC3L
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.5140380512216607,-1.0012004845179963,0.5316455696202531,0.9845850524454123,1.0,7/29,18.59%,WNT2B;TIMP3;TPM1;TNS1;LAMA4;PLSCR4;CALD1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.5689556710626358,-1.0009044040763144,0.47297297297297297,0.9846495172920059,1.0,5/10,29.54%,PDE7A;RAPGEF3;RIMS2;ADCY2;CAP1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5998809650944099,-1.0002520912005808,0.5606060606060606,0.9855990208517578,1.0,10/14,38.99%,KLF4;XIAP;MAP2K5;CSNK2A1;RPS6KA3;YWHAE;CAST;DNAJB6;CARD8;DDX3X
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3108731994557432,1.0,1.0,1.0,1.0,11/109,5.58%,PGM5;PACS2;EXOC5;RC3H1;INO80;ATP2A2;WDPCP;OFD1;STARD9;RFX3;UBQLN1
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.6566331342095808,-0.9999208965385588,0.5064935064935064,0.985662512190601,1.0,3/8,24.82%,JAK1;PAK2;DSP
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3656651579803474,0.9998504544909459,0.46153846153846156,1.0,1.0,6/42,2.49%,ANKRD6;ZNRF3;PSMD14;MLLT3;NKD1;TLE4
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.6486078576641273,-0.9995571434253129,0.4696969696969697,0.985818910405573,1.0,2/5,29.80%,ZDHHC21;ADCY9
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.5451514207936214,-0.998821168427407,0.5,0.9869694562551986,1.0,9/26,24.27%,NR4A1;HIF1A;TIE1;ACVRL1;EGFL7;SPARC;VEGFC;CAV2;PPP1R16B
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.47829391194244597,-0.9986765526907171,0.5,0.9865301941998887,1.0,8/82,8.33%,DOK5;NRCAM;MAP1B;S100A6;SEMA6B;FEZ2;PIK3R1;LAMA5
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.39982110659851916,0.9983216834860681,0.5,1.0,1.0,1/32,0.03%,CREB5
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.5377168399785113,-0.9981008552270093,0.475,0.987288514976139,1.0,4/17,13.63%,LAMC1;ACTN1;DLC1;PLEC
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.6618086140817909,0.9972181807833411,0.5333333333333333,1.0,1.0,1/7,1.84%,ATR
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.4682359238710242,-0.9970987372625194,0.5625,0.9893433406109613,1.0,15/141,12.41%,TBX3;BHLHE40;PPARG;JUN;HES1;PHF10;KDM1A;ARID5A;CDKN1B;BCL6;KLF4;SNX6;ZFPM2;LIMS1;FOXK1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6593672811689489,-0.9970700690549208,0.5294117647058824,0.9885975348664854,1.0,3/6,31.28%,EGFR;MAP2K1;NCOR2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.613795923195738,-0.9964957789131154,0.5405405405405406,0.9892873991681498,1.0,2/10,9.09%,FES;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.5956683224041395,0.9963354487272646,0.5185185185185185,1.0,1.0,1/5,6.88%,CDK12
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.36438034350084963,0.9961523803879646,0.25,1.0,1.0,19/101,11.58%,SCFD2;PACS2;STX8;PIGU;EVI5;TBC1D5;HERC2;OCLN;WLS;VPS45;ITSN1;COG3;BICD1;CEP68;ID1;SYNRG;RAB28;TBC1D4;TRAPPC8
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.49605160888420136,-0.996111196180828,0.47126436781609193,0.989338093920495,1.0,5/39,10.46%,RFC3;PRKAG2;RPL23;RPL37;RPS15
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.4490829538623632,0.996081954460171,0.5,1.0,1.0,5/24,12.28%,UIMC1;OTUD4;TOX;ERCC6;BABAM2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.5566753823269547,-0.9956560277951675,0.45,0.9895088046840521,1.0,7/21,23.42%,CDC37;CDKN1B;IPO7;CCNH;CDKN1A;CCNY;EGFR
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.6680472344660441,-0.9951680348118045,0.5303030303030303,0.9899838431786053,1.0,2/7,21.60%,RAPGEF3;KMT2A
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5604656935184732,-0.9937640646759779,0.5125,0.9928560601865514,1.0,1/20,0.29%,SERPINE1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.6374907223115159,-0.9934779194220414,0.5606060606060606,0.9926271182387153,1.0,2/6,10.25%,RTN4;CD81
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.5522559162367721,-0.9933510492284656,0.48148148148148145,0.9921223382095886,1.0,1/18,2.05%,NR4A1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5796713925222315,-0.9933123654328483,0.5064935064935064,0.9913700157918331,1.0,2/12,14.25%,YBX3;ZFP36
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.5518581207759857,-0.9931389497539509,0.5694444444444444,0.9910877494814744,1.0,4/16,18.07%,GLUL;TPR;WWTR1;CTNNA1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.47557949578147574,-0.9929365385684559,0.53125,0.9907232993280102,1.0,9/91,7.92%,LAMC1;SEC22B;SEC24D;HES1;CX3CL1;SPG7;RIMS1;DMD;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.4712810775437074,-0.9929187416322697,0.5416666666666666,0.9899281639170311,1.0,32/149,17.58%,RTN4;BCAP31;RPL23;CX3CL1;GAPDH;SHISA5;NDFIP1;ERBB4;PIK3R1;RPL37;REL;FLT1;TGM2;PRKN;RPS15;VWF;GJA1;ALPK1;TNFRSF10B;LIMS1;FGFR1;PLCG2;PINK1;GOLPH3;PELI1;SLC20A1;RACK1;TBK1;GRB2;LARS1;MALT1;NOS1AP
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.6089426480718974,-0.9928210893232836,0.5416666666666666,0.9894277654772226,1.0,4/10,8.52%,LBR;PRKAG2;SCP2;LSS
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.5366716987573401,-0.992628162525788,0.5632183908045977,0.9890747843855162,1.0,8/23,18.90%,MSRB3;LAMA4;ADAMTS1;DLC1;GJA1;HMCN1;CALD1;SPARC
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5664719964596853,0.9925077331484988,0.4,1.0,1.0,1/6,2.08%,IGFBP3
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.592497742809205,-0.9923840243651056,0.5230769230769231,0.9889054641702272,1.0,4/10,22.33%,RIMS1;SYT1;PREPL;RIMS2
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.5859376300967818,-0.9923362442832911,0.5694444444444444,0.9882151155334269,1.0,4/11,19.89%,VSIR;PLCG2;TRIB2;CD34
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.6091067073642872,-0.992170235652002,0.5066666666666667,0.9878183428966996,1.0,8/11,26.71%,GRIA2;CTNND2;ATRNL1;SMAD3;HS6ST3;SCN2A;NOL4;CADPS2
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.46455291234048723,-0.9921268432236323,0.52,0.9870844032302271,1.0,34/165,17.34%,PSMC6;ST18;FOS;CX3CL1;JUNB;PSMB9;HIF1A;CANX;RPS27A;JAK1;CDKN1B;ARF1;PIK3R1;IFNGR2;BCL6;LAMA5;CFL1;IFNGR1;TMSB4X;PSMA1;UBC;ANXA1;S1PR1;LIMS1;PELI1;MSN;NFKBIA;PAK2;TEC;CDKN1A;GRB2;SOD2;MCL1;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.5904479129799688,-0.9920880943727282,0.5245901639344263,0.9863425659202821,1.0,1/8,3.66%,CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.6602553843263234,-0.9920548234385138,0.5396825396825397,0.9855837354178386,1.0,1/5,8.46%,AP1G1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.5595243301203898,-0.9917485941200325,0.52,0.9855274635732283,1.0,9/15,27.21%,SNX6;PRKN;SYT1;ATP1A1;ANK3;NEDD4L;TF;B2M;NEDD4
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.4960300816796068,-0.9908900275024397,0.524390243902439,0.9870911085892254,1.0,4/29,14.72%,PRKN;ARIH2;PELI1;AMFR
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.5416078515501391,-0.9907635343425371,0.5365853658536586,0.986606326036221,1.0,12/31,27.08%,DENND3;EPS8;MYO9B;DLC1;OGT;GRB2;ARHGAP17;ERBIN;SHOC2;BCR;MAPKAP1;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.5186530855846133,-0.9905455859326803,0.4731182795698925,0.9863858144684876,1.0,7/39,16.64%,SEC22B;KLF2;CDKN1B;KLF4;PRKN;NFKBIA;RAB1A
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.5021449548575133,-0.990511884108527,0.5443037974683544,0.9856482542454376,1.0,5/49,7.84%,ADAMTS9;SRGN;SPG7;TINAGL1;GGT5
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6049400261223545,-0.9902839734451605,0.47619047619047616,0.9853563443749845,1.0,4/11,22.33%,RIMS1;RAP1A;PREPL;RIMS2
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.6005883082708162,-0.9902581893764971,0.5671641791044776,0.9845936737223332,1.0,3/8,10.85%,FOXF1;SULF2;HYAL2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.49220029127515996,-0.9900008547487444,0.5,0.9845113838130743,1.0,2/27,7.29%,B3GNT2;PLOD2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.6659261022635223,-0.9897043659793354,0.5,0.9844201827478595,1.0,2/6,16.67%,SLC26A2;SULT1C4
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5498808535849299,-0.9895645348003405,0.5540540540540541,0.9839856158150182,1.0,5/19,14.67%,PIK3R1;RAPGEF3;HYAL2;SMAD3;TPR
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.49762493332236335,-0.989084439340605,0.47191011235955055,0.9844640439328967,1.0,10/42,10.59%,SERPINE1;SYTL4;CD9;SRGN;ACTN1;TIMP3;LAMP2;TMSB4X;VWF;PECAM1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.5063651234204458,-0.9887944430322751,0.47674418604651164,0.9842738330615165,1.0,6/33,14.82%,SLC4A10;SCARB2;KIAA1217;SMARCA1;SHC2;BCAR1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.6430057072135488,0.9886775789593597,0.5555555555555556,1.0,1.0,1/5,10.05%,TMTC4
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.6423402524820045,0.9884662242791274,0.6451612903225806,1.0,1.0,1/5,6.75%,CARMIL1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.5902418577830081,-0.9882948960818583,0.5142857142857142,0.9847151637385254,1.0,3/12,18.12%,SPOCK1;ANXA1;CDK6
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6672254100871102,-0.9877349557326065,0.5384615384615384,0.985498150701385,1.0,3/6,20.77%,TMSB4X;CYLD;PPM1A
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.6336218759732057,-0.9875397621426252,0.5147058823529411,0.9852085285511774,1.0,1/10,1.95%,TSG101
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.6392644434467012,-0.9873953311686859,0.53125,0.9847394776931854,1.0,3/7,17.08%,PRKN;PINK1;SREBF2
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.5495520100803023,-0.9869809749019803,0.5211267605633803,0.9842167910067353,1.0,4/12,26.38%,PRKCE;ECT2;CSPP1;RHOA
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5495520100803023,-0.9869809749019803,0.5211267605633803,0.9842167910067353,1.0,4/12,26.38%,PRKCE;ECT2;CSPP1;RHOA
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.6508447021808037,-0.9868533766711789,0.47692307692307695,0.983713817213823,1.0,3/6,23.31%,RIMS1;PIP5K1C;DNAJC5
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5701842612567822,0.9864826484104612,0.5,1.0,1.0,2/6,22.64%,CDC16;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.5701842612567822,0.9864826484104612,0.5,1.0,1.0,2/6,22.64%,CDC16;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5701842612567822,0.9864826484104612,0.5,1.0,1.0,2/6,22.64%,CDC16;NSMCE2
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.6726173756744808,-0.9861987045945805,0.5737704918032787,0.984682052581292,1.0,1/5,5.56%,GAPDH
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.4931436778113358,-0.9858671834249166,0.5384615384615384,0.9846005670900341,1.0,17/54,21.21%,CX3CL1;GAPDH;SHISA5;NDFIP1;REL;PRKN;GJA1;ALPK1;TNFRSF10B;PINK1;PELI1;SLC20A1;TBK1;MALT1;GPRC5B;PPM1A;ECT2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.598142240640797,-0.9856784480751688,0.5454545454545454,0.9843580958159341,1.0,1/11,1.25%,ADM
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.6132439014871605,-0.985562814390811,0.581081081081081,0.9839013715086412,1.0,9/14,36.63%,EEF1A1;ZFP36;DUSP22;EGFR;STAT5B;DAB2IP;FOXC1;ZFP36L1;IQGAP1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.5732402372508117,-0.985514212975487,0.5405405405405406,0.9832666654551147,1.0,6/15,17.50%,BCAP31;PINK1;HERPUD1;RACK1;MCL1;CYLD
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.5392988643043704,-0.9847115486101193,0.5125,0.9845170431213868,1.0,8/29,18.48%,PRKAG2;ERBB4;FLT1;RAP1A;FGFR1;TIE1;CDKN1A;LCP2
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5413926721464908,-0.9843111442642628,0.569620253164557,0.9848018204396357,1.0,4/27,15.34%,GAPDH;LRRFIP1;RIOK3;TBK1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.3125439578062032,0.9842851589988002,0.6666666666666666,1.0,1.0,7/82,6.65%,BMP6;HOMER1;TPD52L1;CTBP2;WLS;LIMS2;NPTN
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.620578981132558,-0.9842209893187215,0.5,0.9841590184750295,1.0,1/8,6.13%,POLA1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.49466850933860174,0.9840002889185467,0.5,1.0,1.0,1/9,1.01%,UGCG
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.5157409998048301,-0.9839425304453164,0.5421686746987951,0.9840695168275633,1.0,4/31,8.20%,SPNS2;ENPP2;ESYT2;PDXDC1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.6951216449076699,-0.983799304767447,0.5245901639344263,0.9835885589341086,1.0,3/5,14.04%,BCAP31;NFE2L2;HERPUD1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.6344282648241608,-0.9837729135166186,0.5342465753424658,0.9828415995999698,1.0,1/7,1.95%,TSG101
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.4759189067906356,-0.983752253012949,0.5212765957446809,0.9820958548338538,1.0,25/95,21.99%,MAP3K5;JUN;BNIP3L;RPS27A;BCL6;HIP1R;TGM2;VAV3;UBC;DLC1;PRNP;TNFRSF10B;RPS6;GNA13;FGD4;RACK1;BTG1;GADD45B;DNM2;RASGRF2;ITGB1;CLU;PREX1;ECT2;DUSP6
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.6431138615657821,-0.9833284875240433,0.5733333333333334,0.9822924274098191,1.0,3/6,25.93%,ZFP36;CDK6;HSPA9
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.5915458677983378,-0.9830938470604528,0.525,0.9821072214449507,1.0,5/12,15.60%,RPS27A;EDEM3;UBC;AMFR;UGGT2
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.5996625469196829,-0.9828700423946486,0.5263157894736842,0.9819045879857623,1.0,8/15,18.54%,MAP2;GRIA2;ANK2;PPFIA2;CTNND2;HS6ST3;CADM2;GADD45B
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.6396711936049951,-0.9827595825102171,0.5138888888888888,0.981472006881017,1.0,4/6,35.90%,SYT1;REST;STXBP1;STXBP3
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.5037188116949003,0.982263532616675,0.5161290322580645,1.0,1.0,2/6,18.43%,ENTPD1;APP
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.5468716976175386,-0.9822122478861918,0.4457831325301205,0.9819693343305761,1.0,10/23,20.33%,NFE2L2;YBX3;PRKN;TMBIM6;PINK1;PTTG1IP;HERPUD1;SOD2;MCL1;CLU
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.5856477150968098,-0.9816080307046035,0.5217391304347826,0.9828018697746271,1.0,4/13,12.72%,KIAA1217;FOXF1;SULF2;FGFR1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.6201384147606935,-0.9808184861379886,0.5373134328358209,0.9839599649672554,1.0,3/8,4.65%,LBR;PRKAG2;SCP2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.4538617103195415,-0.9799901440675564,0.57,0.9853545494388526,1.0,40/199,17.45%,TBX3;BHLHE40;MAFK;ZEB2;ATF3;PPARG;JUN;RPL23;HES1;SMAD7;KDM1A;ESR2;LRRFIP1;RPS27A;ARID5A;KLF2;BCL6;RREB1;SIN3B;KLF4;PRKN;UBC;ZFPM2;PURA;MEF2A;CREM;RPL10;SDCBP;CBX5;SMAD3;MTF2;NOTCH4;ZFP36;TPR;MAX;KLF12;ZNF366;SREBF2;CNBP;MBD2
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.5481810714717283,-0.979747513252514,0.4931506849315068,0.9850885291187046,1.0,4/19,16.80%,B3GNT2;CHST11;GOLPH3;PMM2
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.656487286785947,-0.979549365337464,0.631578947368421,0.9848141239472881,1.0,1/6,4.54%,CCDC14
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.6740852199811034,-0.979055280725737,0.5555555555555556,0.9851742516184769,1.0,2/6,8.15%,SMAD7;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.6637734862137138,-0.9790286463450866,0.6212121212121212,0.9844162345276826,1.0,3/5,31.28%,PIAS2;SMARCA4;NCOR2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.532419973622873,-0.9785411407326075,0.46987951807228917,0.9848552366477803,1.0,7/25,21.05%,PPARG;HIF1A;TMSB4X;FGFR1;ACVRL1;GATA2;MECP2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.4247276313034911,0.9784528226388174,0.5,1.0,1.0,3/18,10.41%,TGFBR3;EIF2AK2;KLHDC10
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.5536218539713104,-0.977888691362403,0.6056338028169014,0.9857064550361796,1.0,7/17,22.82%,MGAT4A;ALG11;UGGT2;PMM2;B4GALT1;UBE2J1;TMEM165
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.6141275661655691,-0.9778316416919586,0.5584415584415584,0.9849937296151998,1.0,3/10,10.93%,SMAD7;TPM1;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.4851029500346668,-0.9774920163675607,0.4606741573033708,0.9850803523212005,1.0,14/36,24.12%,LGALS3;PIK3R1;PRKCE;PRKN;CD81;DPP10;PRNP;PPP3CC;ANK3;DLG1;ITGB1;EGFR;PRKCH;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.6378079585742451,-0.9768966105071125,0.5068493150684932,0.9858066401900971,1.0,4/7,24.66%,EGFL7;GATA2;EGFR;DLL4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.5617296369443249,-0.976534683890503,0.5128205128205128,0.9859099875406805,1.0,4/14,19.60%,KLF4;CDKN1A;CDK6;DLG1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.649561428404372,-0.9762887243169871,0.6212121212121212,0.9857594076495698,1.0,1/8,2.83%,HSPA5
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.566935796934762,-0.975886063131766,0.5061728395061729,0.9860549823397722,1.0,7/22,17.24%,SCP2;ESR2;ACOX1;ACSL5;SOD2;CNBP;SMARCC1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.5705426003708441,-0.9757740675544171,0.53125,0.9855201249839246,1.0,4/13,5.53%,GRIK1;GRM7;GRIA2;GRIN2B
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.6139216562386378,-0.9756688572835623,0.5753424657534246,0.9850559575357569,1.0,2/7,22.72%,SRRM1;TRA2B
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.5629943713187705,-0.9753362501359197,0.527027027027027,0.9850286545293632,1.0,5/11,30.53%,NOTCH4;TIE1;DLL4;RASIP1;LRP6
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.5214772354835681,-0.975011845501966,0.5783132530120482,0.9851844208901815,1.0,5/24,14.30%,ADM;DMD;TPM1;ZFPM2;CTNNA3
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.528239909509608,-0.9748229453714328,0.5068493150684932,0.9848958019126887,1.0,10/24,23.94%,DUSP1;PEBP1;TIMP3;HYAL2;STK38;DLG1;DAG1;DUSP6;SPRED1;PIK3CB
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.4426537649863302,-0.974773344021926,0.5612244897959183,0.9842508753979547,1.0,14/108,14.72%,PSMC6;HSPA5;NPLOC4;PSMB9;SPOPL;NFE2L2;RPS27A;FEM1C;PRKN;PSMA1;UBC;PELI1;HERPUD1;AMFR
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.5713827537248689,-0.9741654295957408,0.5569620253164557,0.9848329297734763,1.0,4/17,15.32%,RAP1A;PINK1;MSN;TIE1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.697756837572923,-0.9741217976565717,0.609375,0.9841717029509067,1.0,2/5,8.20%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6507615359049709,-0.9739945716366671,0.582089552238806,0.9837285490901865,1.0,1/7,3.63%,SLC4A10
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6300566034117941,-0.9739382246981435,0.5657894736842105,0.9830865963523423,1.0,4/8,31.28%,TMBIM6;PTBP2;PTBP1;NCOR2
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.6509978027867952,-0.97388299484949,0.5172413793103449,0.9824023261080838,1.0,1/5,4.41%,SMAD7
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.5408524900654826,0.97376998154849,0.5428571428571428,1.0,1.0,1/5,12.80%,ROCK1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.5502007457357424,-0.9734685429048311,0.5679012345679012,0.982689090123996,1.0,2/16,8.41%,KDM1A;WDR48
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.44904635639450313,0.9725177345585739,0.44,1.0,1.0,2/21,2.13%,EVI5;TBC1D5
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.3619319335262486,0.972420102389981,0.45454545454545453,1.0,1.0,15/53,16.80%,IVNS1ABP;TAF3;MLLT3;ERCC6;BAZ2A;TAF1;MTERF1;RTF1;FUBP3;NFX1;SOX5;SNAPC3;RBMX;FOXO3;TAF2
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.5854880343933564,-0.972400455433949,0.6081081081081081,0.9843859057904819,1.0,5/15,20.43%,ZFPM2;TRIB2;SMAD3;WWTR1;GATA2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.6755663856846446,-0.9712288576552186,0.5857142857142857,0.9865642441757896,1.0,1/6,11.79%,EFNB2
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.5841092547376742,0.9705408396944478,0.5,1.0,1.0,1/5,3.53%,MRPS31
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.5027511112841734,-0.9704235885590015,0.5681818181818182,0.9880652397457782,1.0,12/40,15.91%,MAP2;MAP1B;GRIA2;GPM6B;INSYN2A;ANK2;DCLK1;PPFIA2;ATRNL1;SYT1;ADGRL3;CADM2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.5350592581996727,-0.9700945039629494,0.4342105263157895,0.9880013084866366,1.0,2/13,10.83%,ADAMTS1;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6173904885600906,-0.9700508329405569,0.6056338028169014,0.9873077735644917,1.0,2/6,14.07%,KDM1A;MTF2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.6400212227519362,-0.9700422344721098,0.5972222222222222,0.9865549975353707,1.0,3/6,21.24%,MAGI2;MYO1E;PODXL
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.489988120706781,0.9694918850925497,0.5555555555555556,1.0,1.0,3/12,8.88%,SLC23A2;SLC38A3;SLC38A6
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5925400486291128,-0.9688845968899525,0.582089552238806,0.9886283062894619,1.0,4/7,35.12%,RIOK3;RPS19;UBE2K;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.548201079791467,-0.968878275185193,0.6075949367088608,0.9878670702313016,1.0,7/15,30.35%,GPM6B;COMMD1;CTNNA1;PICALM;NEDD4L;DNAJA1;OTUD7B
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.44986866592056596,-0.9686258181420504,0.6185567010309279,0.987614369648105,1.0,22/168,15.84%,TBX3;BHLHE40;BTG2;PPARG;JUN;HES1;PHF10;KDM1A;GAPDH;ARID5A;CDKN1B;BCL6;KLF4;SNX6;ZFPM2;LIMS1;FOXK1;CBX5;RPL13A;RACK1;RCOR1;CDKN1A
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.5165472908393619,0.96803308195446,0.4642857142857143,1.0,1.0,1/12,1.09%,ATP10D
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.639937456838793,-0.967964937644728,0.5441176470588235,0.9883157986567328,1.0,4/5,34.63%,CD55;CD46;STAT3;BACH2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5880970488002404,-0.9679032371324963,0.5625,0.987728310705458,1.0,3/15,13.21%,PCK1;ANXA1;OGT
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.5004224172753292,-0.9678772881130552,0.5543478260869565,0.9870559580868157,1.0,5/40,7.92%,LAMC1;HES1;SPG7;RIMS1;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.5023280460098872,-0.9675654973519151,0.5977011494252874,0.987061845425866,1.0,15/50,23.70%,ZEB2;HIF1A;KLF2;KLF4;STARD4;NPM1;LPGAT1;ARPP19;SMAD3;NOS1AP;MTOR;CLU;SCARB1;EGFR;VIM
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.6274295871429609,-0.9674820390438849,0.6612903225806451,0.9865109824290871,1.0,1/7,4.44%,KDM1A
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.5336793976343034,-0.9674286889312065,0.569620253164557,0.9858240455298704,1.0,4/23,13.21%,KDM1A;GJA1;EPAS1;OGT
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.5330598578155432,-0.967261652273765,0.4939759036144578,0.9854888092398304,1.0,5/23,15.50%,FES;ERBB4;FLT1;FGFR1;TEC
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.6368744826454931,-0.9671951894494268,0.5294117647058824,0.9849062876037432,1.0,1/7,5.79%,RAD21
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.620137747441559,-0.966912370566159,0.6153846153846154,0.9847089078214479,1.0,1/6,3.66%,CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.510629902578752,-0.9667570114278703,0.5647058823529412,0.984358263517476,1.0,3/20,9.09%,CX3CL1;TPM1;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.5293582049399338,-0.9667003275821572,0.5466666666666666,0.9837438862540712,1.0,1/14,3.66%,CX3CL1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.6016711309995151,-0.9662490322484397,0.5942028985507246,0.9842634293576542,1.0,3/9,10.98%,HES1;ERBB4;CRLF3
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.39952890534227803,0.9660508813737348,0.42424242424242425,1.0,1.0,1/14,0.60%,HOMER1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.6412106640505293,-0.9658386716570534,0.6231884057971014,0.9844161522872787,1.0,1/8,4.44%,KDM1A
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.45424386875567696,-0.9658344319504687,0.5348837209302325,0.9836585749362482,1.0,7/69,10.51%,PSMC6;PSMB9;SPOPL;NFE2L2;FEM1C;PRKN;PSMA1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.5847853678647814,-0.9656602025962857,0.6164383561643836,0.9833865984863364,1.0,3/15,15.47%,CX3CL1;CD55;XIAP
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6307619255922186,-0.9656579983736958,0.59375,0.9818680861099702,1.0,2/7,26.40%,CCNH;POLR2B
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6307619255922186,-0.9656579983736958,0.59375,0.9818680861099702,1.0,2/7,26.40%,CCNH;POLR2B
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.5909893813923864,-0.9650136492398879,0.5441176470588235,0.9827427784008808,1.0,1/7,14.67%,TPR
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.5741761152016094,-0.9649592443161417,0.5662650602409639,0.9820995743765243,1.0,1/12,2.80%,PBX3
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.4890891089755457,-0.9641438756663344,0.5666666666666667,0.9833536901040989,1.0,10/47,20.04%,NRG3;SPOCK1;CHPT1;HIP1R;RAP1A;PINK1;BCAR1;RUFY2;PICALM;MTOR
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.6650730987031889,-0.9640550505992732,0.6,0.9827871414994497,1.0,4/7,20.33%,RTN4;PRNP;PICALM;CLU
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.6362159062131536,-0.9632948127143814,0.5522388059701493,0.9837598486782198,1.0,3/7,25.70%,HYAL2;SOCS3;INPP5F
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.5384302290007771,-0.9632815836492225,0.5432098765432098,0.9830080476021257,1.0,3/17,13.19%,FES;PRKN;PINK1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5412814047202712,-0.9630518027706397,0.5,0.9827975407343558,1.0,5/16,13.86%,PNP;CD81;VAV3;ANXA1;NCK1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.5084070436826957,-0.9626764999819711,0.5681818181818182,0.9830596105345326,1.0,5/37,14.12%,SEC22B;CDKN1B;PRKN;PTTG1IP;MSN
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.5289980473201153,0.9625861124783469,0.4482758620689655,1.0,1.0,2/10,1.71%,RSAD2;IL1R1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.6300496215740901,-0.9625316561913115,0.6231884057971014,0.982638724364897,1.0,5/6,35.80%,PLPP1;ACER2;ACER3;SPTLC2;SGPP2
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.6366635239773873,-0.9612080693555697,0.6176470588235294,0.984946590726329,1.0,2/8,17.73%,MYO1B;MYO1E
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.6489776258490587,-0.9611903919406616,0.6153846153846154,0.9834481025193852,1.0,2/5,10.23%,TGM2;PRKN
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.6489776258490587,-0.9611903919406616,0.6153846153846154,0.9834481025193852,1.0,2/5,10.23%,TGM2;PRKN
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.5886868585925431,-0.9610392489318854,0.6133333333333333,0.9830198111202957,1.0,2/12,12.02%,KDM1A;PIAS2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.5644594878626592,-0.9609147596817641,0.5555555555555556,0.9826761196789077,1.0,4/10,17.55%,CANX;GOLPH3;RAB8B;MIA2
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.5266509717917708,-0.9604601198621845,0.6352941176470588,0.9828781604222647,1.0,10/31,17.26%,SERPINE1;SLC6A6;ACOX1;TMBIM6;PINK1;ARPP19;BCAR1;UPP1;GABARAPL1;LPIN2
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.49113234086763713,-0.9602297665451631,0.6022727272727273,0.9827614006920193,1.0,17/52,23.81%,SEC22B;TSG101;SEC24D;ARF1;LAMP2;AP1G1;RAB2A;TMED10;RAB14;ATP1A1;USO1;CLTA;ARFGEF2;CAV2;CD63;EGFR;SCAMP1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.5365259199640642,-0.9600300434252966,0.5316455696202531,0.9824773217243805,1.0,9/24,21.11%,BNIP3L;NPAS2;PRKN;PINK1;NCK1;LRPAP1;CD34;CLU;CHMP4B
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.49327142001053853,0.9596998099628238,0.6,1.0,1.0,1/11,1.04%,ZNRF3
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.5014038396523901,-0.9592114058711366,0.5747126436781609,0.983917588038363,1.0,4/35,10.23%,SEC22B;CDKN1B;EEF1A1;PRKN
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.6046111632202502,-0.959197519662814,0.6129032258064516,0.983173144020134,1.0,6/9,26.35%,CANX;SYNJ2;SYT1;PIP5K1C;SYNJ1;FCHO2
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.5210870210482866,0.9588342540166245,0.4473684210526316,1.0,1.0,1/6,3.09%,GCH1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.6235575097024437,-0.9586022102551102,0.6515151515151515,0.9832489905718546,1.0,3/5,27.15%,ATP1B3;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.6235575097024437,-0.9586022102551102,0.6515151515151515,0.9832489905718546,1.0,3/5,27.15%,ATP1B3;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.6384811215639534,-0.9585317085837961,0.5942028985507246,0.9826319059221101,1.0,3/5,24.82%,MTM1;VIM;DSP
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.4643871907814953,0.9584673369904534,0.625,1.0,1.0,3/17,12.15%,RC3H1;HSPA1A;PNPT1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.6185079022548667,-0.9583788267069615,0.6119402985074627,0.9823658990223597,1.0,6/7,37.49%,PIK3R1;STAT5B;PXN;STAT3;PTPN1;JAK2
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.5047338863504057,-0.958283842078449,0.5714285714285714,0.9818670512993151,1.0,8/26,18.90%,LRRC32;TIMP3;TNS1;LAMA4;PECAM1;CFH;ACVRL1;SPARC
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.5639345238505626,-0.9575928491893301,0.5074626865671642,0.98250101129935,1.0,7/9,38.76%,LPGAT1;MTOR;SCARB1;MFSD2A;LDLR;SORBS1;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.6326571729614172,-0.9561632791960325,0.6142857142857143,0.9849888192563724,1.0,2/7,10.54%,CD81;VAV3
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.5550083489401059,0.9559430807491225,0.5,1.0,1.0,1/6,3.53%,MRPS31
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5903131226831115,-0.9558291641412252,0.5945945945945946,0.9849794770386487,1.0,2/9,10.57%,RPS27A;UBC
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.5577818247344253,-0.9556642065337525,0.6,0.9846545625932235,1.0,2/12,4.23%,GLUD1;GLUL
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.5933524981172418,-0.9556103719551323,0.5526315789473685,0.9840479891634791,1.0,3/10,19.21%,PTPRD;IL1RAPL1;ROBO2
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.48315727737927205,-0.9554020750475325,0.6,0.9837574437177637,1.0,13/48,15.91%,MAP2;MAP1B;NFASC;GRIA2;CNTN1;ANK2;LSAMP;DCLK1;PPFIA2;LRRC4C;ATRNL1;ADGRL3;CADM2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.4401210424646185,0.9553191062682606,0.4666666666666667,1.0,1.0,1/17,0.39%,BMP6
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6499800710300352,-0.9549534126555986,0.6833333333333333,0.9840059299208213,1.0,3/5,28.27%,GJA1;AGO2;CALR
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5609177776623357,-0.9544365138283728,0.56,0.9842209206714109,1.0,7/13,26.17%,DUSP1;CYLD;GADD45B;DLG1;RELL1;PHLPP1;SASH1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.6212381315321097,-0.9539884399881118,0.5909090909090909,0.9845183206427635,1.0,2/6,13.19%,SMAD7;PINK1
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.6508737509008097,-0.95373480313135,0.6363636363636364,0.9843357723082974,1.0,2/7,15.84%,CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.4950212219684762,0.9537027567578975,0.5185185185185185,1.0,1.0,2/14,8.31%,ATR;ATM
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.6141040130813941,-0.9535104359239743,0.5846153846153846,0.9840295854654982,1.0,3/6,25.08%,UGGT2;DNAJB14;ATXN3
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.528828124349024,-0.9532364902840381,0.5555555555555556,0.983880700920079,1.0,7/24,21.60%,WNT2B;FLT1;ARIH2;NOTCH4;ZNF160;CD34;KMT2A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.4935906978562364,-0.9528106028987302,0.5333333333333333,0.9842599448023713,1.0,7/29,21.42%,BTG2;GAPDH;CST3;RPL13A;RACK1;PLAT;GIGYF2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.5823545657558351,-0.9526651124484776,0.6176470588235294,0.9839215387764517,1.0,2/11,16.64%,PAFAH1B1;RAB1A
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.6059215016421111,-0.9523161241249212,0.5352112676056338,0.9839460295745115,1.0,4/6,37.12%,RPS19;ETS1;CAVIN1;ACTN4
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5034769490450963,-0.9521237149525763,0.525,0.9836248293013824,1.0,2/29,2.86%,LDHA;GLUD1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5395970366074585,0.9518995931217797,0.6388888888888888,1.0,1.0,3/5,29.52%,IGF1R;GSPT1;CLEC16A
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6315993995926772,-0.9513572228950238,0.5733333333333334,0.9847103598130208,1.0,1/6,5.11%,RIMS1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.6540374817108034,-0.9513222124333331,0.5846153846153846,0.9840685859143306,1.0,1/6,12.12%,CSTF3
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.6373179013986946,-0.9506847275777708,0.6065573770491803,0.9847908541487299,1.0,2/5,8.52%,SCP2;LSS
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.5890072284390503,-0.9506571020037786,0.6338028169014085,0.9841171628541013,1.0,5/8,30.43%,TINAGL1;ATP8B1;DSP;EFNA1;TM4SF1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.5253331324772065,-0.9506291861551436,0.5714285714285714,0.9834526813410198,1.0,7/21,16.33%,TSG101;DUSP1;FLT1;HYAL2;FGFR1;TRIB2;STK38
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5314047745610625,-0.9505256470128681,0.5857142857142857,0.9830022100412532,1.0,3/20,7.32%,RFC3;POLA1;BAZ1A
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.5355591761852008,-0.9501517169091943,0.589041095890411,0.9831009230926964,1.0,5/11,29.54%,PDE7A;RAPGEF3;RIMS2;ADCY2;CAP1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.5998758815362291,-0.9500132414463018,0.5970149253731343,0.9827495564152372,1.0,2/8,22.66%,ACSL5;CBR4
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.5750198104252014,0.9499488906847116,0.52,1.0,1.0,3/5,22.72%,VCAM1;GIMAP4;GIMAP8
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.6041907571763278,-0.9494645468806492,0.5972222222222222,0.9831589403444772,1.0,5/9,22.56%,ATP2B1;ANK2;ANK3;DLG1;AHCYL1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.5829917945236677,-0.9493845557231898,0.5675675675675675,0.9826528568120536,1.0,5/12,30.09%,PTPRD;IL1RAPL1;NEDD4L;NEDD4;ADGRB3
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.6132749849642424,-0.9491096699280005,0.5733333333333334,0.9825964530845411,1.0,2/9,10.23%,MTFR1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.5509444660190642,-0.948555045687308,0.53125,0.9832578757407539,1.0,3/10,18.12%,S100A6;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.6068763415000542,0.9481131834693349,0.6060606060606061,1.0,1.0,2/5,4.57%,PRKD1;HSPB1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.6498586600072469,-0.948021644956264,0.640625,0.9837797605886652,1.0,3/5,18.12%,CD9;ANXA1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.38156338129587275,0.9477256603455111,0.5882352941176471,1.0,1.0,2/28,3.66%,TPD52L1;CEMIP
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.47168706171689373,-0.9467621472722508,0.5529411764705883,0.9860029649438828,1.0,12/39,22.12%,PPARG;SMAD7;RPS27A;MAGI2;SNX6;UBC;SMAD3;STRAP;SMAD5;PPM1A;SNX25;SPRED1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.48215359604471153,0.9465866570033207,0.53125,1.0,1.0,2/6,10.46%,SMYD3;KDM6A
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.5810576301877683,0.9458365571661701,0.5925925925925926,1.0,1.0,1/6,5.74%,RCSD1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.33284728617715,0.9451701138207111,0.5384615384615384,1.0,1.0,9/46,14.72%,STX8;EVI5;TBC1D5;EEA1;MON2;VPS50;GBF1;VPS13A;TBC1D23
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5450321533075897,-0.9444148368920758,0.5476190476190477,0.9908351379034471,1.0,1/13,6.59%,CDC37
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.45676287791339215,0.9443953532518168,0.4444444444444444,1.0,1.0,4/7,15.52%,TRA2A;CIRBP;NCL;RBMX
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.6061434193184383,-0.9441860554783502,0.6338028169014085,0.9906915371338341,1.0,3/8,21.75%,OGT;KMT2A;SETD3
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.6044518043979659,-0.9439229106751952,0.609375,0.9905887791022162,1.0,1/7,9.09%,RAPGEF3
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.6135299743385261,0.9438707672285938,0.65,1.0,1.0,2/5,23.57%,DYRK1A;PSEN1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.5742909540270992,-0.9438614099442865,0.6231884057971014,0.9900071053198561,1.0,5/10,30.71%,ANXA1;PRNP;ERBIN;STAT5B;STAT3
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.5684314666147738,-0.9434467989454453,0.5492957746478874,0.9900348283923837,1.0,4/11,13.86%,LGALS3;PNP;ANXA1;NCK1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.4804462623037111,-0.9432658402984294,0.6,0.9896652302478653,1.0,7/32,19.39%,NEDD9;ANXA1;S1PR1;BCAR1;PARVB;GRB2;CASS4
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.5096945086651493,-0.9425085183390515,0.5342465753424658,0.9907706979499301,1.0,2/19,12.54%,RFTN1;SDCBP
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.5571000356949863,0.9424864728257554,0.54,1.0,1.0,1/6,5.22%,HDAC9
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.6146252071174377,-0.9423686187537174,0.6081081081081081,0.9902634745988278,1.0,1/6,14.80%,HS6ST3
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.6078370244708831,-0.9422529526022719,0.6285714285714286,0.9897327328747156,1.0,3/8,28.82%,AGO2;TUT7;PRKRA
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.6055200756077863,-0.9421310153021003,0.5967741935483871,0.9892916977347677,1.0,6/8,26.35%,CANX;SYNJ2;SYT1;PIP5K1C;SYNJ1;FCHO2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.5234666550020992,-0.9417911352877104,0.573170731707317,0.9894813825171316,1.0,11/29,23.75%,BNIP3L;CDKN1B;NPAS2;PRKN;NCK1;TBK1;LRPAP1;CLU;CHMP4B;ACER2;ACER3
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.46452773179878165,-0.9409120381856473,0.6067415730337079,0.9908250586354505,1.0,11/59,13.19%,RTN4;ENPP2;SLC6A6;RREB1;CFL1;RAPGEF3;ZDHHC6;PRKN;GJA1;FGFR1;PINK1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.62551586607668,-0.9407858210951251,0.6164383561643836,0.9903922596843381,1.0,1/5,10.23%,PRKN
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.5794929549947937,-0.9407027383679254,0.6153846153846154,0.9884055546963189,1.0,2/9,4.67%,FOS;PPM1D
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.5794929549947937,-0.9407027383679254,0.6153846153846154,0.9884055546963189,1.0,2/9,4.67%,FOS;PPM1D
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.5794929549947937,-0.9407027383679254,0.6153846153846154,0.9884055546963189,1.0,2/9,4.67%,FOS;PPM1D
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.4667900687960942,0.9404633890580666,0.5454545454545454,1.0,1.0,4/18,8.10%,HABP4;RBM20;HSPA1A;HNRNPLL
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.5833703509748129,-0.9403115941775942,0.589041095890411,0.9884422535819196,1.0,2/13,7.61%,SLC4A10;COL18A1
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.5362500355061017,-0.9402748036827523,0.6052631578947368,0.9878360010742814,1.0,5/18,18.20%,GRIA2;DPP10;CDK14;NARF;MTUS2
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.5932039451733678,-0.9402594063869737,0.6666666666666666,0.9871744272672491,1.0,3/7,24.97%,HIP1R;PIK3CB;SCYL2
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.47978275068617404,-0.9401040852415661,0.6097560975609756,0.9867946795358897,1.0,2/42,4.10%,PSMC6;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.5980870691235783,0.9388968416869216,0.65625,1.0,1.0,1/6,3.19%,PRKD1
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.5802979529781815,-0.9386208640213887,0.6,0.9894384747889279,1.0,4/10,13.19%,HIF1A;PRKN;EPAS1;PINK1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.40363122795473033,0.9385621214736212,0.4,1.0,1.0,6/25,12.93%,UIMC1;INO80;ATM;COP1;BABAM2;XRRA1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.5415676987212517,-0.9383024598134685,0.618421052631579,0.9893380668049243,1.0,7/19,21.11%,SNX6;PRKN;PINK1;CPEB4;SOD2;CD34;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.4937439946312424,-0.9376446041699289,0.5949367088607594,0.990262673920717,1.0,6/34,16.20%,BTG2;GAPDH;RPL13A;TPR;RACK1;CPEB4
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.46888539268763335,-0.9371546229401221,0.6344086021505376,0.9904018371689417,1.0,25/55,23.52%,SERPINE1;SYTL4;CD9;SRGN;RIMS1;ACTN1;TIMP3;LAMP2;TMSB4X;VWF;PECAM1;TMED10;SYT1;ARHGAP17;SPARC;VEGFC;PCDH7;PIP5K1C;PSAP;CLU;RIMS2;CD63;DNAJC5;ANXA5;TF
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.42990703182303985,-0.9367998832033215,0.77,0.9904368609458684,1.0,82/490,17.45%,MAFF;TBX3;ST18;BHLHE40;MAP3K5;MAFK;NR4A1;ZEB2;KLF6;ATF3;PBX3;PPARG;JUN;ZNF43;FOS;HES1;PHF10;JUNB;SMAD7;KDM1A;HIF1A;ELP3;ESR2;LRRFIP1;RAD21;NFE2L2;POLA1;JUND;ARID5A;FOXF1;ERBB4;KLF2;NPAS3;CDKN1B;BAZ1A;SMARCA1;BCL6;NPAS2;REL;RREB1;FOSL2;KLF4;SNX6;ZFPM2;CRLF3;PURA;EPAS1;NPM1;SBNO1;CCNH;MEF2A;PIAS2;CREM;LIMS1;FOXK1;CDK14;ZNF280D;OGT;CBX5;SMAD3;MTF2;NOTCH4;ELP4;CREB3L2;CCNL1;MAX;RCOR1;KLF12;CDKN1A;BTG1;SOD2;WWTR1;ZNF160;ZNF366;BRWD3;ZNF586;NAA16;SREBF2;ZBTB38;CNBP;SMARCC1;MBD2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.48474425899777734,-0.9367190013335203,0.5853658536585366,0.989848674172969,1.0,5/31,10.88%,EPS8;GPM6B;HIP1R;RAPGEF3;DLC1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.612052705381017,0.9362887871928585,0.6046511627906976,1.0,1.0,1/5,0.86%,PLA2G4A
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.5171557966575072,-0.9359993505641762,0.6233766233766234,0.9907861735287871,1.0,4/23,16.87%,RFTN1;ZFP36;TPR;SRRM1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.5994647451698316,-0.9354307639438066,0.578125,0.9912117404785183,1.0,2/7,16.17%,PLPP1;TMF1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.4797500521590988,0.9350875966778357,0.59375,1.0,1.0,2/7,14.43%,SEMA6A;ZNF609
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.473743828817247,0.9348891343830017,0.5142857142857142,1.0,1.0,2/9,7.45%,STX8;EEA1
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.466562431682434,-0.9346014127060235,0.6206896551724138,0.9924338606648601,1.0,10/35,20.92%,PLS3;NES;TPM1;GJA1;EFNB2;WWTR1;CALD1;PLAT;VEGFC;CNN3
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.5915429357810237,-0.9345602987314008,0.6197183098591549,0.9918459331830488,1.0,3/9,21.99%,RAB14;SPAAR;DUSP6
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.582192395958203,0.9334808793039148,0.6774193548387096,1.0,1.0,1/6,6.13%,SMYD3
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.4797367512289721,0.9324183186004745,0.5833333333333334,1.0,1.0,4/11,10.64%,IL1R1;GBP2;ENTPD1;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.6512570325219007,-0.9321443153382833,0.6721311475409836,0.9948723088248589,1.0,1/5,22.09%,STK39
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.6512570325219007,-0.9321443153382833,0.6721311475409836,0.9948723088248589,1.0,1/5,22.09%,STK39
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.6512570325219007,-0.9321443153382833,0.6721311475409836,0.9948723088248589,1.0,1/5,22.09%,STK39
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.38716468293286554,0.9320293972448309,0.48,1.0,1.0,3/24,4.78%,BMP6;TTN;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.5418513816437911,-0.931619539098717,0.625,0.9952374511158077,1.0,3/15,12.72%,MAP3K5;FLT1;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.5560572445472836,-0.9315427682440489,0.618421052631579,0.9946258114178158,1.0,1/10,4.83%,HIF1A
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.44191744734946786,-0.9311497580757431,0.6263736263736264,0.9947685277572864,1.0,17/104,17.19%,UFL1;BTG2;RFC3;POLA1;MACROD2;BCL6;WDR48;VAV3;NPM1;CBX5;XIAP;CDKN1A;GRB2;SMC6;USP45;ZBTB38;MCL1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.4910883828488418,-0.9310724689398104,0.6470588235294118,0.9941898171583562,1.0,19/41,29.93%,RTN4;ENPP2;HIF1A;PRKCE;RREB1;PLCG2;BCAR1;SPARC;MTOR;SCARB1;PIK3CB;RAB11A;ANXA3;SASH1;ATOH8;CALR;ADAM9;RHOB;RAC1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.5677646507395522,-0.9309952982282417,0.6323529411764706,0.9936594637757127,1.0,3/9,25.08%,NGLY1;UGGT2;ATXN3
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.4296511225932864,0.9303376464088802,0.5217391304347826,1.0,1.0,6/19,15.71%,PSMD14;INO80;RAD51B;MCM9;SEM1;SPIDR
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.5784136455039462,-0.9298459101855083,0.6027397260273972,0.9954803412417318,1.0,2/10,10.23%,MTFR1;PRKN
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.48664059404600246,-0.9289916384912033,0.6136363636363636,0.9966659204067625,1.0,2/25,4.10%,PSMC6;PSMB9
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.5706947273525025,-0.9289835550814882,0.5846153846153846,0.9959531679380758,1.0,3/8,21.16%,SCARB2;PIKFYVE;MTM1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.4599636544366966,-0.9288942104122725,0.6063829787234043,0.9954388669941434,1.0,15/52,20.25%,JUN;FOS;SMAD7;LRRC32;RPS27A;UBC;HYAL2;ITGB5;LIMS1;SMAD3;ACVRL1;CLDN5;DUSP22;SMAD5;ITGB1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.3649944558242231,0.9288809340584434,0.6190476190476191,1.0,1.0,3/24,5.24%,PLPPR4;PDZRN3;LDB2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.5225502614035762,-0.9276189125886882,0.6385542168674698,0.9975215002711061,1.0,4/27,6.75%,CD9;FES;ACTN1;ERBB4
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.5661331282886422,-0.9273870115879691,0.6025641025641025,0.997337999493478,1.0,2/9,9.99%,CD9;KLF4
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.6004447801403423,-0.9273318476714355,0.6461538461538462,0.9967213753631785,1.0,2/7,19.21%,SEMA6B;ROBO2
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.5225624801379453,-0.9270205707097531,0.6235294117647059,0.996751316260055,1.0,6/19,19.42%,SYTL4;CAVIN2;ANK2;DYSF;PLSCR4;ANK3
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.5327831578173107,-0.9269168039785958,0.5394736842105263,0.996269765770586,1.0,4/15,19.60%,KLF4;CDKN1A;CDK6;DLG1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.4961105257130714,-0.9266316759877311,0.64,0.996111281903929,1.0,2/27,4.10%,PSMC6;PSMB9
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.47728924920818705,-0.9266014906043394,0.6105263157894737,0.9954501701221795,1.0,15/56,15.21%,NR4A1;SMAD7;EEF1A1;MAGI2;FLT1;RAP1A;KLF4;ANXA1;HYAL2;LIMS1;SMAD3;ZFP36;ACAP2;BCAR1;RACK1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.4872311184615232,-0.9265003947476488,0.6046511627906976,0.9949784436656268,1.0,2/25,4.10%,PSMC6;PSMB9
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.4924459711994345,-0.9263043678875147,0.6162790697674418,0.9947898447586634,1.0,8/28,20.95%,JUN;CD9;IFNGR2;IFNGR1;GRB2;ACVRL1;IL18R1;SOCS3
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.6331716001005949,-0.9262920475396808,0.5909090909090909,0.993379291943544,1.0,4/5,31.02%,JAK1;STAT5B;STAT3;SMARCA4
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.6331716001005949,-0.9262920475396808,0.5909090909090909,0.993379291943544,1.0,4/5,31.02%,JAK1;STAT5B;STAT3;SMARCA4
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.49474563347153894,-0.9261260633531396,0.627906976744186,0.9930200062971529,1.0,7/28,23.16%,LGALS3;RAPGEF3;TMEM30A;RACK1;CLU;CDH5;NEDD4L
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.5546349155915735,-0.9260077781957341,0.6973684210526315,0.9924969441230749,1.0,2/13,20.04%,MAGI2;MTOR
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.42610037497289904,-0.9257444265767407,0.81,0.9923186125625282,1.0,93/514,17.45%,MAFF;TBX3;SERPINE1;ST18;BHLHE40;MAFK;NR4A1;ZEB2;KLF6;ATF3;PBX3;PPARG;JUN;ZNF43;FOS;RPL23;HES1;CX3CL1;PHF10;JUNB;SMAD7;KDM1A;PPM1D;HIF1A;ELP3;ESR2;LRRFIP1;RAD21;NFE2L2;RPS27A;JUND;ARID5A;FOXF1;KLF2;NPAS3;BAZ1A;SMARCA1;PIK3R1;BCL6;NPAS2;REL;RREB1;FOSL2;SIN3B;KLF4;PRKN;CD81;CEBPZ;UBC;HYAL2;ZFPM2;CRLF3;PURA;EPAS1;NPM1;CCNH;MEF2A;PIAS2;CREM;RPL10;FOXK1;SDCBP;OGT;NCK1;CBX5;SMAD3;MTF2;NOTCH4;ZFP36;ELP4;NFKBIA;TPR;CREB3L2;CCNL1;MAX;RCOR1;TBK1;KLF12;CDKN1A;TMF1;SOD2;WWTR1;ZNF160;CRTC3;ZNF366;BRWD3;ZNF586;SREBF2;ZBTB38;CNBP;SMARCC1;LPIN2;MBD2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.3498152760759647,0.9249213077983307,0.6666666666666666,1.0,1.0,9/42,13.60%,PSMD14;UIMC1;HERC2;INO80;ATM;RAD51B;BABAM2;MCM9;SEM1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.5599291691615679,-0.9238011694616199,0.6805555555555556,0.9956013368743514,1.0,3/9,10.83%,PRKCE;SCARF1;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.6545448886929451,-0.9234107521214613,0.7014925373134329,0.9957098872782674,1.0,2/6,11.76%,RTN4;PRNP
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.39148144427189446,0.9232452245957222,0.65,1.0,1.0,3/22,3.66%,DSE;GCNT2;CEMIP
prerank,PanglaoDB_Augmented_2021__Neurons,-0.4605452014314142,-0.9229463798637911,0.6483516483516484,0.9960133087061058,1.0,13/61,24.17%,PPP1R9A;GRIA2;RB1CC1;NCALD;PPFIA2;CADM2;SGIP1;RNPC3;MECP2;SCN2A;CSPP1;SCAMP1;NOL4
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.4246320307463241,-0.9227301957196379,0.6666666666666666,0.9957316366540406,1.0,17/131,14.72%,PSMC6;TSG101;NPLOC4;PSMB9;SPOPL;NFE2L2;NDFIP1;RNF19A;FEM1C;PRKN;ARIH2;PSMA1;CHFR;PINK1;PELI1;HERPUD1;AMFR
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.5032327373506351,-0.9225805430180318,0.5875,0.9952634080766684,1.0,2/22,3.50%,NRCAM;HES1
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.4627328107096925,-0.9222419607969781,0.6363636363636364,0.9952784774639369,1.0,18/50,22.20%,NDRG1;SEC24D;AKAP12;ACTN1;ELL2;MYL12A;SLC26A2;ADAMTS1;NGLY1;PLPP1;SLC38A2;GNAI3;CDK6;B4GALT1;TSC22D1;SPCS3;STK39;UBE2J1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5997212048795988,-0.9218415196167403,0.671875,0.9946478216478465,1.0,3/5,39.12%,PTBP1;SPPL3;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5997212048795988,-0.9218415196167403,0.671875,0.9946478216478465,1.0,3/5,39.12%,PTBP1;SPPL3;AKAP6
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.538710297161143,-0.921691455988242,0.6268656716417911,0.9942205333763593,1.0,3/12,10.57%,RPS27A;WDR48;UBC
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.46421503770664074,-0.9214638243391085,0.6744186046511628,0.9940344819792638,1.0,9/52,13.03%,MAFF;LRRC32;FES;TNS1;SCARF1;VWF;PECAM1;PRNP;DYSF
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.514715325915634,-0.9214175602636431,0.6578947368421053,0.9933832898653612,1.0,3/17,13.86%,SIK2;OGT;NCK1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.49879623432695763,-0.9213013462898012,0.6024096385542169,0.9929500563033661,1.0,7/25,19.96%,RPL23;IPO7;PTTG1IP;TPR;KPNB1;NUP54;KPNA4
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.47513669137261283,-0.9211456864871523,0.6373626373626373,0.9925716570862428,1.0,16/51,26.38%,NEDD9;PRKAG2;RAP1A;PRNP;PAK2;CDKN1A;LCP2;CASS4;EMP2;CLU;GPRC5B;ECT2;HSP90AA1;CCDC88A;SNX9;RHOA
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.5474149523149516,-0.9209501270557537,0.6119402985074627,0.9923408589077033,1.0,6/10,32.87%,DLC1;CDH5;PPP1R16B;PTBP1;SPPL3;MTMR9
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.5084454404462647,-0.9209123836791229,0.5679012345679012,0.9917313827687417,1.0,2/22,2.05%,LAMC1;NR4A1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.533931158186598,-0.9208332267460443,0.65,0.9911846032365562,1.0,2/13,5.35%,PCK1;S100A6
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.46882413450532123,-0.9207140990632101,0.6022727272727273,0.9907158350974405,1.0,8/46,15.58%,CX3CL1;ARID5A;TIMP3;TNS1;VWF;EPAS1;PLSCR4;PARVB
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.4698985529005839,-0.9206825118735725,0.6666666666666666,0.9900933610346098,1.0,10/46,18.64%,SSH1;FES;RAPGEF3;RAP1A;TGM2;GOLPH3;MSN;RIOK3;CTNNA1;ATP1A1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.5884189042819017,-0.9199081452467857,0.640625,0.991068347087658,1.0,2/7,30.87%,SMC6;CSNK2A1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.5845752782123589,-0.919630430035771,0.6216216216216216,0.991009150979467,1.0,4/9,23.16%,GPM6B;COMMD1;PICALM;NEDD4L
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.569415543263484,-0.9179671766666612,0.6571428571428571,0.9935225341294381,1.0,2/9,10.23%,TGM2;PRKN
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.5652900316379819,-0.9177831858755332,0.6617647058823529,0.9931769167010331,1.0,2/10,3.71%,GRIK1;NRG3
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.5281771726250996,0.9172563205534285,0.6046511627906976,1.0,1.0,3/6,23.36%,ATM;CREB1;ABL2
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.4901426185450387,-0.916892216884055,0.675,0.9943238868448757,1.0,7/26,21.11%,RPS27A;PRKN;NGLY1;UBC;CHFR;MALT1;CHMP4B
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.48280493603249736,-0.9167203174250341,0.6172839506172839,0.9939705061435652,1.0,11/26,23.44%,ATP2B1;SLC8A1;ANK2;ATP1B3;SLC30A1;ATP1A1;ATP13A3;TMEM165;CDH5;NEDD4L;VAPB
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.42222736646326786,-0.9166889618189539,0.78,0.9933334460898476,1.0,47/272,17.45%,TBX3;BHLHE40;MAFK;ZEB2;ATF3;PPARG;JUN;RPL23;HES1;PHF10;SMAD7;KDM1A;ESR2;LRRFIP1;RPS27A;ARID5A;KLF2;CDKN1B;BCL6;RREB1;SIN3B;KLF4;SNX6;PRKN;UBC;ZFPM2;PURA;MEF2A;CREM;LIMS1;RPL10;FOXK1;SDCBP;CBX5;SMAD3;MTF2;NOTCH4;ZFP36;TPR;MAX;RCOR1;KLF12;ZNF366;SREBF2;ZBTB38;CNBP;MBD2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.48608379167818194,-0.9165478448245642,0.6282051282051282,0.9929735822045097,1.0,8/25,18.90%,TIMP3;TPM1;TNS1;LAMA4;GJA1;PLSCR4;CALD1;SPARC
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5320726027756564,-0.9165416343877277,0.6296296296296297,0.9922997675984987,1.0,3/18,12.33%,NEDD9;RREB1;LIMS1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.5591405540117391,0.9164045082749167,0.5714285714285714,1.0,1.0,2/6,3.66%,MFF;CEMIP
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.5591405540117391,0.9164045082749167,0.5714285714285714,1.0,1.0,2/6,3.66%,MFF;CEMIP
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.562549005287398,-0.9159961996963838,0.6708860759493671,0.9926002609646146,1.0,3/10,10.02%,ADSS2;GMPS;SLC26A2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5775023362498822,-0.9153798799721669,0.6338028169014085,0.9933215729046468,1.0,4/5,42.26%,NEDD4;DAB2IP;PTPN1;MMRN2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.49664757583501035,-0.9150050659925046,0.5443037974683544,0.9934908196687613,1.0,3/20,16.36%,RTN4;PRKN;WWTR1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5541051511556148,0.9148570661417206,0.5526315789473685,1.0,1.0,1/5,3.50%,MFF
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.49114877197043144,-0.9146062318003355,0.611764705882353,0.9935909958944262,1.0,16/34,29.93%,ADAMTS9;GLUL;BCAR1;ACVRL1;SPARC;EMP2;SCARB1;RHOJ;PIK3CB;ANXA3;DLL4;SASH1;ATOH8;CALR;RHOB;RAC1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.4791598613088193,-0.9138344216748224,0.6547619047619048,0.9945852438854481,1.0,16/36,24.33%,JUN;FOS;CDKN1B;PRKN;PRNP;MEF2A;PLCG2;SYT1;ANK3;MT1M;ECT2;RYR3;EGFR;TF;MAPK8;B2M
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.5399038824057819,-0.9132332204401202,0.625,0.9952726024673164,1.0,4/19,13.21%,KDM1A;GJA1;EPAS1;OGT
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.37430726519755153,0.9131063986682011,0.5625,1.0,1.0,6/34,6.78%,PLPPR4;ZNF385D;NREP;PDZRN3;PRKG1;NOVA1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.48622098576702194,-0.9129934201032364,0.5443037974683544,0.995088934564941,1.0,4/20,13.06%,CX3CL1;MBP;HYAL2;PLCG2
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3954339895561504,0.9124959618555251,0.6666666666666666,1.0,1.0,3/25,6.31%,HOMER1;ALS2;RNF213
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.5360500093001812,-0.9122994923972706,0.6231884057971014,0.9949510127726044,1.0,3/9,19.83%,DLC1;ACVRL1;DUSP22
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.5360500093001812,-0.9122994923972706,0.6231884057971014,0.9949510127726044,1.0,3/9,19.83%,DLC1;ACVRL1;DUSP22
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.46952447050355395,-0.9122607434838237,0.5977011494252874,0.9943109805640455,1.0,10/42,24.25%,SUN2;SPC25;RPS27;KPNB1;SMC3;PAFAH1B1;DYNC1I2;MECP2;EML4;RAB11A
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.6272153671097243,-0.9118275988963983,0.5666666666666667,0.9945851480838763,1.0,1/5,9.71%,TMEFF2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5669629775450669,0.9118154935416861,0.5862068965517241,1.0,1.0,3/5,19.78%,CDH2;TAPT1;FBXL17
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.40585143446039884,0.911761072697553,0.5454545454545454,1.0,1.0,2/25,2.13%,EVI5;TBC1D5
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5957716666238022,-0.9117555153527672,0.6911764705882353,0.9939995005117794,1.0,1/5,4.41%,SMAD7
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.527441522608854,-0.911283251456494,0.5952380952380952,0.9942431020511937,1.0,8/17,29.88%,MYH10;ANK3;CHMP4B;ECT2;SNX9;RASA1;SPTBN1;RHOB
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.4442860951188175,-0.9112622601937451,0.6395348837209303,0.9935673657137196,1.0,13/63,17.08%,DOK5;MGLL;CX3CL1;GRK5;GIT2;SIK2;CD55;PRNP;OGT;NCK1;AMFR;WWTR1;SREBF2
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.4920647268712356,0.9109060593600505,0.59375,1.0,1.0,2/11,1.53%,HOMER1;HOMER2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.5547098615766737,-0.9106730762553301,0.6891891891891891,0.9940765706553364,1.0,7/14,29.72%,DMD;SPCS3;BACE2;CPM;NPEPPS;SPPL3;ERAP1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.55767343839474,-0.9105421567321335,0.647887323943662,0.9936825140430174,1.0,2/11,14.25%,CNOT6L;ZFP36
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5610793436889013,-0.9100897673040776,0.6619718309859155,0.9939408181432757,1.0,4/8,24.25%,KPNB1;CHMP4B;EML4;RAB11A
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.4810470480638059,-0.9100345281424287,0.5617977528089888,0.9933732001815732,1.0,9/27,15.91%,RIMS1;NFASC;GRIA2;CNTN1;LSAMP;CTNND2;LRRC4C;ERO1B;CADM2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.5469666623110656,-0.9099907507087348,0.6567164179104478,0.9927760934463749,1.0,8/12,34.99%,DUSP1;HYAL2;STK38;PIK3CB;DNAJA1;HIPK3;DAB2IP;PTPN1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.46330554141837854,0.9098985077554407,0.5555555555555556,1.0,1.0,6/12,11.99%,ACAT1;HSD17B4;HADHB;DECR1;AUH;PPARD
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.5456581173238015,0.9095378618994224,0.6206896551724138,1.0,1.0,1/7,4.78%,CLASP1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.6101731235681582,-0.9093961984169956,0.6617647058823529,0.9931706315398015,1.0,2/7,17.71%,DMD;SAMD8
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.4833592663915456,-0.9082687778929597,0.6477272727272727,0.9948344130409625,1.0,9/34,17.32%,TSG101;PRKAG2;ATG12;RB1CC1;LAMP2;PRKN;PINK1;GABARAPL1;PIK3C3
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.3160875717751066,0.908185815607426,0.7857142857142857,1.0,1.0,7/42,8.77%,GBP2;DCP1A;GBP1;COG3;UBAC2;BICD1;CEP68
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5814170540889417,-0.9076920627784456,0.6779661016949152,0.9953327259728132,1.0,1/8,8.62%,ANK2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.4683543630967122,-0.9073387761292822,0.6428571428571429,0.9953548374079249,1.0,14/48,22.66%,ANGPTL4;ERO1A;AKAP12;EMP1;KLF4;PECAM1;TRIB2;CFH;PTBP2;PLAT;TOR1AIP2;GPRC5B;DUSP6;CBR4
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.6023067482925446,0.9073146120065714,0.6923076923076923,1.0,1.0,1/5,3.09%,GCH1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5214149141767168,-0.9069647973777414,0.6666666666666666,0.9954523445223045,1.0,2/17,9.11%,LBR;PNP
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.6301978155416943,-0.9068088406066358,0.6875,0.9950145604605832,1.0,1/5,11.60%,NPM1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.572086716769032,-0.9067869041299492,0.5692307692307692,0.9944192031305311,1.0,7/8,36.92%,ANXA1;ZFP36;ADAM9;FAM107A;REST;ZFP36L1;HNRNPU
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.545783007275104,-0.9066645531582637,0.6216216216216216,0.9940053147149214,1.0,3/13,10.57%,RPS27A;PRKN;UBC
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.5107323510502451,-0.9065895111848015,0.631578947368421,0.9934716463113037,1.0,8/19,26.38%,PLCL1;PIK3R1;FGFR1;OGT;PIK3C3;PIK3CB;INPP5F;RHOA
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.5318182618367995,-0.9064525194067609,0.5735294117647058,0.9930289121658444,1.0,4/11,29.70%,GOLPH3;LARS1;WDR59;SIK3
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.5054195666670498,-0.9064114778620131,0.5925925925925926,0.9923989986822187,1.0,3/23,14.23%,HES1;JAG2;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.45746749495644096,-0.9063477394311014,0.6741573033707865,0.9918375076799691,1.0,16/50,21.78%,CX3CL1;RAPGEF3;RAP1A;TGM2;AFDN;LIMS1;PINK1;RSU1;RGS7;RACK1;LARS1;PICALM;PSAP;ITGB1;ECT2;CAV2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.5256513732712025,-0.9062263474659765,0.5945945945945946,0.9913292958647443,1.0,2/11,10.83%,GGT5;ANXA1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.48600077743310066,-0.9061798730129473,0.6097560975609756,0.9907917969430575,1.0,5/18,21.57%,MEF2A;PLCG2;SYT1;ECT2;RYR3
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.505846213446546,0.9061553699786715,0.6176470588235294,1.0,1.0,3/8,19.65%,EVL;KANK1;ODF2L
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.5375817608392225,-0.9058752562853117,0.6329113924050633,0.9907644175692268,1.0,9/15,25.26%,HIF1A;NOSTRIN;NOS1AP;DNM2;SCARB1;ZDHHC21;EGFR;PIK3CB;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.5303406716287274,-0.905656008017525,0.6578947368421053,0.9905050161516614,1.0,5/15,11.55%,SRGN;ATP2B1;GPM6B;SLC8A1;S1PR1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.6128944963080619,-0.9054852231214544,0.6521739130434783,0.9901861244898329,1.0,3/7,19.00%,SDCBP;ANKS1A;VEGFC
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.5710469964959045,-0.9049494623028338,0.6923076923076923,0.9905554198012689,1.0,3/11,17.50%,PRKN;PINK1;CYLD
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.5531733784455302,-0.9049410841899017,0.6619718309859155,0.9898858188692194,1.0,4/9,27.02%,PINK1;MTOR;CCDC88A;MAPKAP1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.55679760849729,-0.9043234943676098,0.6805555555555556,0.9902996068393131,1.0,2/9,8.28%,DMD;SLC8A1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.5030640050879271,-0.9040891768993109,0.6585365853658537,0.9901756924044443,1.0,10/24,21.08%,SPOCK1;NFASC;GRIA2;LSAMP;PPFIA2;LRRC4C;CADM2;PLP1;PDE10A;SCN2A
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.5063641670884909,-0.9037735377040986,0.6538461538461539,0.9901339537180144,1.0,4/19,12.51%,DMD;TPM1;MEF2A;WIPF1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5427301121467997,-0.9034928536163022,0.6716417910447762,0.9900177712110283,1.0,4/12,13.37%,RPL23;RPL37;RPS15;RPS7
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.4517985351511034,-0.9033655050254714,0.6444444444444445,0.9895220521224036,1.0,17/64,19.65%,BTG2;CLIC2;BNIP3L;RNF19A;GMPS;ELL2;SLC2A1;LAMP2;TNS1;SDCBP;RIOK3;NARF;SLC30A1;CDR2;LPIN2;PICALM;AGPAT4
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.4787959665670458,-0.9028976557329043,0.6823529411764706,0.9898082005222296,1.0,5/30,19.31%,YTHDC1;ZFP36;TPR;SRRM1;NUP54
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.5001607561788742,-0.9028589004003965,0.5921052631578947,0.9892092102920303,1.0,9/20,26.38%,CX3CL1;SPOCK1;LIMS1;RSU1;TBCD;EMP2;PIK3CB;ATXN3;RHOA
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.4430188219506507,-0.9028395076259257,0.6741573033707865,0.988566455577251,1.0,13/66,22.48%,DOK5;SEMA6B;FEZ2;PIK3R1;LAMA5;EFNB2;SH3KBP1;GRB2;ROBO2;DAG1;NRXN3;PLXNA2;UNC5C
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.6195723406489616,-0.9025090706333433,0.7105263157894737,0.9886150774502649,1.0,4/7,33.07%,MAGI2;MTOR;MTMR9;ITGA1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.42152537632610676,0.9023936938267593,0.6,1.0,1.0,2/13,4.62%,HOMER1;WLS
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.5245864600553483,0.90227292379887,0.6875,1.0,1.0,3/8,16.10%,PIAS1;STAT2;PKD2
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.6075652080244889,-0.9020777061905318,0.6949152542372882,0.9888788053561561,1.0,2/5,16.54%,DHRS7B;PAFAH1B1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.5672601824880958,-0.90176299646387,0.6756756756756757,0.9888307583524447,1.0,2/8,17.91%,FOXF1;ACVRL1
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.5946909677923082,-0.9012751707033155,0.6805555555555556,0.9890124761193148,1.0,3/6,19.89%,ACVRL1;DLG1;CD34
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.5341173461409507,-0.9006723204709959,0.6056338028169014,0.9894975381065075,1.0,2/13,9.29%,GLUL;ZDHHC6
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.5921100274920482,-0.9002476084168918,0.6714285714285714,0.9896711587362752,1.0,4/9,26.38%,DUSP1;STK39;LRCH1;RHOA
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.5146634548482677,-0.9001245330568088,0.675,0.9893047367782194,1.0,7/20,16.98%,SYTL4;IL1RAPL1;ANXA1;RAB21;SYT1;STXBP5L;RAB8B
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.46347184235935546,-0.9001049529092423,0.6470588235294118,0.9886801734249397,1.0,12/38,25.26%,RTN4;CX3CL1;ERBB4;PIK3R1;FGFR1;PINK1;GRB2;CASS4;ITGB1;EGFR;PIK3CB;HSP90AA1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.5052986243909997,-0.9000972322523222,0.6463414634146342,0.9880416848110387,1.0,10/17,33.90%,PRKN;GAS7;SPIRE1;PREX1;CHMP4B;RAC1;FAM107A;MICALL2;UBE2K;HDGFL3
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.5513979836089697,-0.9000539611924494,0.6268656716417911,0.98749261419294,1.0,2/11,8.10%,TSG101;LAMP2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.4578898125874628,-0.9000446692837297,0.6744186046511628,0.9868410392254858,1.0,14/41,26.30%,YTHDC1;KHDRBS3;AHNAK;PRX;PIK3R1;TMBIM6;HNRNPH3;SLC38A2;PTBP2;ZNF326;TRA2B;CLK1;CLK4;PTBP1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.4654431331639169,-0.8998787037891932,0.6219512195121951,0.9864188034977723,1.0,13/35,27.99%,IL1RAPL1;KLF4;SMAD3;RACK1;TBK1;ACVRL1;IL18R1;ROBO2;MAPK8;ACVR2A;RHOA;STAT5B;MAP2K5
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.3870266631300944,0.8994627020511209,0.6,1.0,1.0,2/21,0.80%,ANKRD6;TPD52L1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.4444838050523196,-0.8994200643623415,0.6263736263736264,0.9867630685231582,1.0,13/48,21.70%,SMAD7;SLC6A6;LGALS3;FES;BCL6;PLEKHB2;KLF4;FGFR1;NOTCH4;CDK6;EMP2;DAG1;CBFB
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.49525732886246515,-0.8990591507076819,0.6666666666666666,0.9869007963741248,1.0,7/17,28.87%,DLC1;ENSA;ARPP19;CDH5;PPP1R16B;PTBP1;SPPL3
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.5644876758979719,0.8985738544598711,0.5945945945945946,1.0,1.0,1/5,3.09%,GCH1
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.31525740620951104,0.8984741697466574,0.8888888888888888,1.0,1.0,4/42,3.45%,PKHD1L1;GBP2;IGFBP3;PTPN21
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.4714121487544606,-0.8984627586967491,0.6129032258064516,0.9874722729874469,1.0,14/44,24.38%,CX3CL1;DUSP1;PEBP1;FLT1;FGFR1;PLCG2;PAK2;VRK2;DAG1;CAV2;SPRED1;JCAD;EGFR;PHLPP1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.4100895839970135,0.8983419973608596,0.6923076923076923,1.0,1.0,4/19,3.27%,IL1R1;GBP2;RC3H1;GBP1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.45297850224666536,-0.8980262576664988,0.6304347826086957,0.9875431898323055,1.0,5/33,15.24%,HSPA5;LGALS3;PINK1;RACK1;RIOK3
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4505212775856952,-0.897920640040046,0.6629213483146067,0.9870925213110303,1.0,13/45,20.25%,JUN;FOS;SMAD7;LRRC32;RPS27A;UBC;ITGB5;SMAD3;ACVRL1;CLDN5;DUSP22;SMAD5;ITGB1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.538206118387239,-0.8979007641081036,0.6216216216216216,0.9864442781888778,1.0,6/12,27.99%,KLF4;RACK1;ACVRL1;ACVR2A;STAT5B;MAP2K5
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.48701386871150454,-0.8971955936961186,0.6329113924050633,0.987139223236664,1.0,2/20,4.41%,PPARG;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.5213432392758035,0.8971300091122635,0.5945945945945946,1.0,1.0,2/7,3.27%,HOMER2;GBP1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.4809566933841941,-0.8971118396297056,0.6666666666666666,0.986741043491814,1.0,3/29,10.88%,EPS8;MYO9B;DLC1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5784433176724361,-0.8967206050186518,0.6935483870967742,0.9869367418386104,1.0,2/7,11.76%,TRAM1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.4325095128291186,-0.8966877233618318,0.6666666666666666,0.9863049804742521,1.0,18/62,28.48%,DDIT4;CX3CL1;SULF2;TMBIM6;NCK1;RACK1;LRPAP1;EGFL7;MTMR2;GATA2;EGFR;PIK3CB;DLL4;GLI3;NEDD4;CALR;GPC3;TNS2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.45255419710680034,-0.8964550685160437,0.6704545454545454,0.9860764136309377,1.0,12/38,23.21%,ZEB2;SMAD7;RPS27A;SNX6;UBC;SDCBP;SMAD3;STRAP;PPM1A;SNX25;SPRED1;RNF111
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5619042927422245,0.8963634151122185,0.6551724137931034,1.0,1.0,1/5,12.62%,PDGFC
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.5168659852781474,-0.896154750947815,0.6867469879518072,0.9860309160444858,1.0,4/19,14.23%,HIF1A;LIMS1;FGFR1;NOTCH4
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.5344779344798728,-0.896124284449824,0.6818181818181818,0.985415638384882,1.0,1/9,3.66%,CX3CL1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5933435435323469,-0.8960999977785922,0.6388888888888888,0.9847792804224599,1.0,2/7,10.41%,TPM1;ADAMTS1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.6081776779556176,-0.8954705245267763,0.6712328767123288,0.9853184117565699,1.0,2/6,8.15%,LRRC7;MAGI2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.571323343926204,-0.8953982338551757,0.6567164179104478,0.984821497296882,1.0,1/6,4.80%,EPS8
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.5923376710517457,-0.8946304105934302,0.676056338028169,0.9856513284769749,1.0,2/6,23.18%,LAMA5;AHI1
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.4264141383332004,-0.8942343013060673,0.7083333333333334,0.9857227970264852,1.0,16/88,17.50%,PSMC6;PSMB9;SMAD7;HIF1A;RPS27A;WDR48;PRKN;PSMA1;UBC;FOXK1;OGT;SMAD3;NFKBIA;USP45;PSMA7;CYLD
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6121665511818764,-0.8940693358622572,0.7076923076923077,0.985284817591972,1.0,2/5,25.23%,RPS19;RPS14
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.557237095397073,-0.893517633978453,0.625,0.9856400283677565,1.0,3/9,22.33%,RIMS1;MTMR2;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.5867213005625288,-0.8934816305576109,0.7183098591549296,0.9850355501530775,1.0,3/8,29.93%,ADGRG1;ARHGEF3;RAC1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.46475269137250663,0.893362832126038,0.47368421052631576,1.0,1.0,4/11,27.70%,CDC16;PHIP;NSMCE2;PDGFB
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.4876633094546659,-0.8932117157510994,0.627906976744186,0.9849547366585046,1.0,5/24,15.50%,FES;ERBB4;FLT1;FGFR1;TEC
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.5726465636727441,-0.8932047594651105,0.6060606060606061,0.9843224876757558,1.0,2/7,14.25%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.4458879383102141,0.8928141180997587,0.56,1.0,1.0,3/12,5.61%,STX8;GBP1;ZDHHC2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.5105956942165253,-0.8925777508089231,0.6623376623376623,0.9849747395872688,1.0,4/13,19.83%,DLC1;ACVRL1;ROBO2;DUSP22
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.5200124840298914,0.8924184141378859,0.5945945945945946,1.0,1.0,1/7,1.38%,SLC4A4
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.42534496028853286,-0.8923846108917414,0.6979166666666666,0.984611474009636,1.0,16/88,17.50%,PSMC6;PSMB9;SMAD7;HIF1A;RPS27A;WDR48;PRKN;PSMA1;UBC;FOXK1;OGT;SMAD3;NFKBIA;USP45;PSMA7;CYLD
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5254660858214768,0.892051149225562,0.5625,1.0,1.0,2/7,17.39%,NCOA3;ZNF706
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.5510845966393075,-0.8920141313995184,0.6216216216216216,0.9847049809121683,1.0,8/12,26.92%,MTMR12;SYNJ2;SACM1L;MTMR2;MTM1;SYNJ1;INPP5F;MTMR6
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4592191704057623,0.8919937154079235,0.5555555555555556,1.0,1.0,1/10,1.19%,PSMD14
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5493668575783549,-0.8918179650630531,0.6619718309859155,0.9844654197354957,1.0,5/10,16.23%,PPARG;CDKN1B;TPM1;CDKN1A;SOD2
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.5270885214321529,-0.8916496725448005,0.6388888888888888,0.9841321449860803,1.0,3/11,14.69%,ATP2B1;SLC8A1;CACNA1C
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.5901743353790088,-0.8913273730197175,0.7402597402597403,0.9841968699993693,1.0,3/7,11.55%,SMAD7;TPM1;S1PR1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.4980748177998484,-0.891239060398512,0.6046511627906976,0.9836764005623788,1.0,11/22,24.25%,RFTN1;ZDHHC6;AFDN;SDCBP;PIKFYVE;CHM;ZDHHC14;ZDHHC21;EGFR;VPS37A;RAB11A
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.521638537449949,0.8911234958281539,0.5555555555555556,1.0,1.0,1/6,2.23%,MSL2
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.4603781172636585,0.8906437825359761,0.6956521739130435,1.0,1.0,1/9,6.88%,CDK12
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5493624806349662,-0.8897279003806698,0.6216216216216216,0.9856831970523345,1.0,4/9,24.79%,CLDN5;CDH5;ZDHHC21;VCL
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.45912111211807555,-0.889548692823604,0.6593406593406593,0.9853572124533438,1.0,15/44,30.30%,NEDD9;TPM1;CFL1;SH3KBP1;FGD4;BRWD3;PRPF40A;KLHL20;RHOA;LARP4;PPP2R3C;ABI2;RHOB;RAC1;SIPA1L3
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.4658809851540484,-0.8893424006515324,0.6162790697674418,0.9850604950008239,1.0,6/27,14.25%,CX3CL1;NFE2L2;YBX3;GGT5;HYAL2;ZFP36
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.5455822015615255,-0.8887691855786068,0.6753246753246753,0.9854990297359263,1.0,4/10,29.98%,TIE1;ROBO2;DLL4;EFNA1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.4134981806370388,0.8887638862703803,0.5862068965517241,1.0,1.0,1/14,2.65%,RHBDD1
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.5729067626485935,-0.8887636417323049,0.6857142857142857,0.9848570206624593,1.0,2/7,9.29%,GLUL;ZDHHC6
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.5418406613671123,0.888708846106226,0.7083333333333334,1.0,1.0,2/7,12.69%,MDM4;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.4751221662847171,0.8885966890873593,0.5882352941176471,1.0,1.0,1/6,4.78%,CLASP1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.562137863970587,-0.887081014950599,0.6338028169014085,0.9873744766947328,1.0,2/6,30.71%,ZFP36;STAT3
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.4823417041737569,-0.885927956490947,0.6172839506172839,0.9887956946635661,1.0,8/17,27.99%,KLF4;ANXA1;GATA2;JCAD;RHOJ;DLL4;RHOA;MAP2K5
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.4617091826035899,-0.8854256481966272,0.75,0.9892162492204774,1.0,4/38,9.97%,ENPP2;FES;ERBB4;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.529294454448114,-0.8853002072901828,0.6794871794871795,0.988824814906709,1.0,1/9,1.27%,BTG2
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.508249666538583,-0.8848104379215431,0.6351351351351351,0.9891371560213674,1.0,3/15,12.36%,PBX3;NES;RPL10
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.5069137099449039,0.8844605355169818,0.5172413793103449,1.0,1.0,3/6,18.64%,MBOAT2;SOX5;TRPS1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.4761076238966398,-0.8844389459946107,0.6790123456790124,0.9891980872609067,1.0,7/20,20.59%,TIMP3;CST3;FOXK1;MCL1;MTMR2;MTOR;TLK2
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.46550894628374995,-0.884394048874434,0.6551724137931034,0.9886211000313123,1.0,10/33,23.81%,SCARB2;SLC6A6;SLC52A3;TMEM30A;LRP1B;SLC38A2;ARRDC3;CD320;SLC3A2;SCAMP1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.5778897168469119,-0.8843603555611191,0.6666666666666666,0.987994734807595,1.0,1/6,2.99%,SEC24D
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.5049437001958491,-0.8843451814411172,0.6615384615384615,0.986730158600289,1.0,4/13,22.46%,ABCA5;CNBP;SCARB1;LIMA1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.5049437001958491,-0.8843451814411172,0.6615384615384615,0.986730158600289,1.0,4/13,22.46%,ABCA5;CNBP;SCARB1;LIMA1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.5572403995930129,-0.8842383264581699,0.676056338028169,0.9862563665731535,1.0,1/8,5.50%,SEMA6B
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.45646009237717866,-0.8833696016579109,0.7204301075268817,0.9871118485588664,1.0,2/42,4.85%,YTHDC1;KHDRBS3
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.5785550706969049,-0.8827807176438307,0.7333333333333333,0.9876806674404064,1.0,1/9,4.65%,SCP2
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.621323685615919,-0.882753524878167,0.6833333333333333,0.9864348841412521,1.0,3/5,29.80%,PRKAR1A;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.621323685615919,-0.882753524878167,0.6833333333333333,0.9864348841412521,1.0,3/5,29.80%,PRKAR1A;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.5185860324452527,-0.8826318187822064,0.6533333333333333,0.9859770782595018,1.0,2/12,4.70%,BCAP31;SPG7
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.46334858939682455,-0.8818258653264694,0.6785714285714286,0.9867160350197932,1.0,3/28,8.00%,PPARG;SMAD7;SULF2
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.4512084965784128,-0.8814648073277611,0.7333333333333333,0.9867496048799546,1.0,8/46,14.72%,FOS;CD9;CHPT1;JAK1;KLF4;SLC26A2;ZFP36;AMFR
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4198364403984608,0.8809726255817895,0.6129032258064516,1.0,1.0,1/10,1.53%,HOMER2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.4574035183866005,-0.880620171851833,0.7012987012987013,0.9878995222259379,1.0,14/39,26.82%,SRGN;HIF1A;RPS9;IFNGR2;IFNGR1;NPM1;NCK1;LCP2;RPS19;EGFR;ABI1;B2M;ACVR2A;GCNT1
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5755740011649622,-0.8806164640924012,0.7096774193548387,0.9872714071350405,1.0,4/7,26.51%,TRAM1;PRNP;EGFR;SERP1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.4044244416132081,0.8802468780875937,0.625,1.0,1.0,3/11,12.28%,UIMC1;ATM;BABAM2
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.43442981543974557,0.8800801203270888,0.625,1.0,1.0,2/10,4.49%,NREP;TGFBR3
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.42482379364794093,0.8800235773164105,0.6896551724137931,1.0,1.0,2/14,9.32%,PLA2G4A;PLA1A
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.32829406996567645,0.8798410193478273,0.6923076923076923,1.0,1.0,5/32,12.36%,ATR;HSPA1A;ATM;NUP58;NUP214
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.40977649476225814,-0.878904877816236,0.7777777777777778,0.9896977666391648,1.0,29/152,19.08%,MAP3K5;KLF6;PPARG;JUN;FOS;HES1;HIF1A;ESR2;FOXF1;ERBB4;KLF2;NPAS3;SMARCA1;NPAS2;RREB1;KLF4;CRLF3;NPM1;FOXK1;SMAD3;NOTCH4;CREB3L2;NAA16;CNBP;SMARCC1;ACVRL1;RLF;PICALM;DNM2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.5589547501609442,-0.8781777203705227,0.65625,0.990311260524261,1.0,2/6,17.26%,CHPT1;LPIN2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.5191874839936339,-0.8778357006391018,0.6363636363636364,0.9901579882453301,1.0,3/16,16.64%,ARHGAP21;PAFAH1B1;RAB1A
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4223971461140545,0.8775229241289352,0.5652173913043478,1.0,1.0,4/15,12.28%,UIMC1;WRNIP1;ERCC6;BABAM2
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5689177387140874,-0.8772860760397718,0.68,0.9904018267916141,1.0,3/9,17.37%,PTPRD;IL1RAPL1;HMCN1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.5201085886805826,-0.8771508211043625,0.6521739130434783,0.9901141151803727,1.0,9/13,40.71%,NEDD4L;NEDD4;ADGRB3;MFSD2A;DAB2IP;CDKL5;LRP8;CSMD3;CAMSAP2
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.4108273322147159,0.8770203052239885,0.6086956521739131,1.0,1.0,2/9,11.71%,ATM;NEK7
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5344706635947873,-0.8768292627524464,0.6428571428571429,0.9900320537332485,1.0,4/8,21.81%,OGT;MTF2;KMT2A;RIF1
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.4973671797767868,0.8766466106671418,0.6551724137931034,1.0,1.0,2/8,10.20%,PPIP5K2;TPK1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.48229104324962185,-0.8765727474746732,0.6626506024096386,0.9897591018040178,1.0,8/24,26.38%,PLCL1;PIK3R1;FGFR1;OGT;PIK3C3;PIK3CB;INPP5F;RHOA
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.6176071325829071,-0.8762482603385607,0.7671232876712328,0.9891365437071813,1.0,2/5,33.41%,DNM2;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.6176071325829071,-0.8762482603385607,0.7671232876712328,0.9891365437071813,1.0,2/5,33.41%,DNM2;MX1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.4715287054257527,0.8758489418113291,0.6060606060606061,1.0,1.0,1/10,4.78%,CLASP1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.5548711171552699,-0.8758349232110683,0.7121212121212122,0.9892318318870501,1.0,4/7,36.92%,DCP2;TNKS2;TNKS;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.5207467283136039,-0.8750979526265674,0.6428571428571429,0.9899408416383612,1.0,3/9,37.69%,CD34;FYN;NFKB1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.36127705352690487,0.8750387227778404,0.631578947368421,1.0,1.0,4/28,7.42%,TAF3;GBP2;IPO8;TNPO3
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.5365402884305532,-0.8749632268827282,0.6708860759493671,0.9895701131831693,1.0,4/10,29.93%,PARVB;ITGB1;RHOJ;RAC1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.41643271124347353,-0.8736430679891741,0.7835051546391752,0.9910813014692803,1.0,31/146,22.27%,DDIT4;UFL1;RFC3;PRKAG2;AKAP12;MYO9B;ARHGAP21;TMSB4X;VWF;VAV3;DLC1;ARHGAP15;ARHGAP23;PLCG2;GNA13;FGD4;NFKBIA;PAK2;VRK2;XIAP;ARHGAP17;CYLD;ARHGAP29;PIP5K1C;DLG1;RASGRF2;MTOR;PREX1;ECT2;SPRED1;PRKAR1A
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.42732453417062377,0.873247946334794,0.625,1.0,1.0,2/7,12.69%,MDM4;ACVR1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.4956478659530083,0.8729948032678122,0.5714285714285714,1.0,1.0,1/9,4.78%,CLASP1
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.5314643936979182,-0.8729782745365864,0.7397260273972602,0.9916539501594565,1.0,5/11,30.53%,ADAM15;GOLPH3;CTNNA1;ADCY2;LRP6
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.4211554810931813,-0.8729449167931963,0.6436781609195402,0.9910787469113926,1.0,8/46,17.86%,HMGN1;BAZ1A;SMARCA1;PBRM1;NPM1;MTF2;SMARCC1;CHD1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.5554938026776743,-0.8729031676568699,0.6756756756756757,0.9905605478178973,1.0,3/8,26.38%,TMEFF2;ACVRL1;RHOA
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.5256106530389948,-0.872858815017902,0.6764705882352942,0.9899938159943033,1.0,3/11,18.64%,SLC8A1;ATP1B3;ATP1A1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.5079011898804217,-0.8728243278695333,0.6538461538461539,0.9894418605049463,1.0,7/11,27.26%,ANK2;CTNNA3;CACNA1C;NOS1AP;DLG1;DSP;CAMK2D
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.6014405614904795,-0.8726966757121982,0.7352941176470589,0.9890239832294779,1.0,1/6,28.97%,WTAP
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.5233800311052711,-0.8721154427428923,0.6716417910447762,0.9893221649323595,1.0,6/10,45.04%,TERF2IP;USP7;SMG1;DHX36;PPP1R10;XRCC5
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5277968386257101,-0.871057063214247,0.6973684210526315,0.9905803926504843,1.0,1/10,1.27%,BTG2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.5342532781488915,-0.8709068791117146,0.6486486486486487,0.9901976188242115,1.0,4/11,16.23%,NFE2L2;PRKN;PINK1;SOD2
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.47633681416064144,-0.8703954158390615,0.6875,0.9904244611658933,1.0,5/23,18.82%,ERO1A;PLOD2;MSRA;STK38;PLAT
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.5276878064697517,-0.8701195772052024,0.7164179104477612,0.9902801740171985,1.0,4/6,45.46%,IFITM3;LY6E;TRIM5;GSN
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.45889389876410286,0.8695067972356215,0.6666666666666666,1.0,1.0,1/5,10.33%,WWC3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.5603968124450656,-0.8691501303522055,0.6764705882352942,0.9913877265591053,1.0,4/6,39.38%,ZBTB1;PPP2R3C;ZMIZ1;PRKDC
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.4218640829239868,0.8684736291826374,0.6071428571428571,1.0,1.0,1/11,1.71%,IL1R1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.4869032278341516,0.8681586220356103,0.75,1.0,1.0,3/6,26.92%,TRIM22;NECTIN2;TRIM25
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.5381396162004858,0.8679462043124554,0.6206896551724138,1.0,1.0,1/5,0.39%,BMP6
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.4094406139827921,-0.8677709714917216,0.7835051546391752,0.9933464006821456,1.0,23/179,16.33%,MAP3K5;PCK1;PRKAG2;PKN3;SMAD7;GRK5;FES;ERBB4;JAK1;PRKCE;FLT1;SIK2;CCNH;DCLK1;FGFR1;CDK14;PINK1;TRIB2;PAK2;VRK2;TBK1;TEC;STK38
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5507322965196197,-0.8670894256815437,0.7037037037037037,0.9939058616481056,1.0,2/8,10.93%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.407813008126644,0.8670258250022796,0.6111111111111112,1.0,1.0,4/9,15.52%,TRA2A;CIRBP;NCL;RBMX
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.4417625442366814,0.8668282632266704,0.64,1.0,1.0,3/12,9.03%,PARD3;CLASP1;OPHN1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.591313393084169,-0.8661021859516377,0.7868852459016393,0.9949182490073658,1.0,4/6,35.20%,CLU;BCL2L1;NACC2;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.4345058613784046,0.866056412093672,0.5714285714285714,1.0,1.0,2/10,4.62%,HOMER1;WLS
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5712501256725927,-0.8647538720874594,0.6986301369863014,0.9964175688236689,1.0,1/8,7.50%,ARF1
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.4956302377168301,-0.8647015943426657,0.7435897435897436,0.9958727108912355,1.0,6/25,20.02%,PDE5A;GRIA2;CTNND2;CADM2;PLP1;HIVEP2
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.4628152233096092,-0.8642646576357258,0.6790123456790124,0.9959833276559846,1.0,5/20,21.70%,LGALS3;FES;CDK6;KMT2A;CBFB
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.537525972096167,-0.8642507691679719,0.676056338028169,0.9953628659902327,1.0,3/8,25.26%,PTTG1IP;MSN;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.5373475728830736,-0.8635989808473732,0.7014925373134329,0.9957867260019285,1.0,3/7,29.54%,CACNA1C;GNAI3;CAP1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.45863011204342846,-0.8635578564134242,0.7108433734939759,0.9945901075086835,1.0,4/28,19.31%,YTHDC1;TPR;SRRM1;NUP54
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.45863011204342846,-0.8635578564134242,0.7108433734939759,0.9945901075086835,1.0,4/28,19.31%,YTHDC1;TPR;SRRM1;NUP54
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.4241395428109139,0.8628036395044613,0.6521739130434783,1.0,1.0,4/10,9.84%,THOC1;CDK12;ERCC6;SCAF8
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.4548362156266579,-0.8625128813759937,0.7469879518072289,0.9958607721178525,1.0,4/29,19.31%,YTHDC1;TPR;SRRM1;NUP54
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5255500301337384,-0.8621285482242517,0.6716417910447762,0.9960681240096909,1.0,2/7,19.63%,AP1G1;PIKFYVE
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.4732924525198993,-0.861791470262151,0.6197183098591549,0.9959631464387343,1.0,6/20,23.42%,PIK3R1;KIF16B;BCAR1;GRB2;ERBIN;EGFR
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.5167077919211142,0.8617287716849216,0.5925925925925926,1.0,1.0,1/6,0.73%,RSAD2
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.4589784827920424,0.8608715145856579,0.6875,1.0,1.0,1/9,0.42%,ARID5B
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.5210157716018616,-0.8607268746353124,0.7162162162162162,0.997078054123717,1.0,5/11,29.72%,DAG1;BACE2;SPPL3;ADAM9;ERAP1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.4294844092153817,-0.860685811094166,0.6404494382022472,0.9965362304714003,1.0,19/45,29.02%,RTN4;DMD;HIP1R;NCK1;SMAD3;TPR;SGIP1;TBCD;PICALM;CLU;CLTA;CHMP4B;DNAJB14;HSP90AA1;SNX9;FCHO2;PXN;NUP98;POMP
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.565952692238997,-0.860675810293419,0.7076923076923077,0.9959189551591486,1.0,1/6,5.50%,SEMA6B
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.45655021741653146,-0.8605300434964887,0.6785714285714286,0.9955929857402939,1.0,4/28,11.60%,PKM;RPS9;YBX3;NPM1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.49347998255097936,0.8601960677277425,0.6,1.0,1.0,2/6,8.31%,TENT2;ATM
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.49347998255097936,0.8601960677277425,0.6,1.0,1.0,2/6,8.31%,TENT2;ATM
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.5005731612260726,-0.8601485481855496,0.6857142857142857,0.9956268982075297,1.0,3/14,20.09%,TPM1;ATP1B3;TOR1AIP2
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.50290023955138,-0.8598219137591171,0.6842105263157895,0.9955225976853899,1.0,7/15,29.93%,S1PR1;GOLPH3;PARVB;ITGB1;VCL;CCDC88A;RAC1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.5782742626504429,-0.8596879023205686,0.734375,0.9950801259987591,1.0,1/5,18.12%,CDK6
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.48045223336717635,-0.8594540719756901,0.7380952380952381,0.9948728056092322,1.0,9/32,30.71%,JAG2;NOTCH4;SREBF2;EGFL7;GATA2;EGFR;DLL4;CD46;STAT3
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.46090789485519035,-0.8594496990932549,0.6666666666666666,0.994258916465268,1.0,8/29,17.78%,ERO1A;NFE2L2;SERPINB6;MSRA;PINK1;VRK2;SOD2;TXNRD1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5221765251022044,-0.8590068283465626,0.6774193548387096,0.9943073453381563,1.0,5/12,31.28%,PIAS2;ZNF366;CALR;SMARCA4;NCOR2
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.48405369973807694,-0.8582809232429888,0.6923076923076923,0.9948584451913834,1.0,4/23,14.67%,PRKAG2;HIF1A;OGT;TPR
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.499057839137492,-0.857661458363899,0.627906976744186,0.9952161436758019,1.0,4/17,20.15%,CX3CL1;LIMS1;CDK6;EMP2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.5745056097624481,-0.8575202630231317,0.7230769230769231,0.9948374382509998,1.0,1/6,11.53%,DGKG
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.40373983585998724,0.8574195167281246,0.6451612903225806,1.0,1.0,3/12,5.87%,OCLN;CLASP1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.444470820062121,-0.8573160086957535,0.735632183908046,0.9944867041694062,1.0,12/38,25.70%,FES;HIP1R;RAB21;SYT1;STXBP5L;RUFY2;RAB8B;PICALM;SCARB1;RIMS2;RAB11A;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.5794161400831912,-0.8567755141568449,0.7397260273972602,0.994754659294177,1.0,2/6,24.12%,CACNA1C;MAPK8
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.47213832947269574,0.8565238840822227,0.6206896551724138,1.0,1.0,6/12,11.99%,ACAT1;HSD17B4;HADHB;DECR1;AUH;PPARD
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.4600717293765091,-0.856482224145583,0.6582278481012658,0.9946103711507162,1.0,4/25,14.07%,HMGN1;RPS27A;UBC;MTF2
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.4500482821741362,-0.8557776052008158,0.6774193548387096,0.9950837362624027,1.0,10/31,21.57%,SSH1;RAPGEF3;RAP1A;GOLPH3;CPEB4;LARS1;CTNNA1;MTOR;SPAAR;RYR3
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.5899327810599478,-0.8555032670069128,0.7391304347826086,0.9942676708510482,1.0,2/6,22.64%,GNAI3;MFN1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.5899327810599478,-0.8555032670069128,0.7391304347826086,0.9942676708510482,1.0,2/6,22.64%,GNAI3;MFN1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.5293692347530174,-0.8549004728676053,0.6933333333333334,0.9946307944248639,1.0,4/12,11.94%,MGLL;SCP2;ACOX1;ACSL5
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.4921398928006115,-0.8547491148037747,0.6883116883116883,0.9942338217640005,1.0,5/19,16.36%,PRKAG2;CDKN1B;TRIB2;PAK2;WWTR1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.586997402337684,-0.8538288230061609,0.726027397260274,0.9951231407885887,1.0,3/5,40.45%,DNM2;ASAP1;WASL
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.46909780377731725,0.8537230896466307,0.6,1.0,1.0,1/9,1.01%,UGCG
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.49245993952217343,-0.8535435873253558,0.7012987012987013,0.9950407693689716,1.0,1/12,4.44%,KDM1A
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.4363526806210848,-0.8534096564456533,0.6395348837209303,0.994596469301576,1.0,3/28,7.55%,NES;MAP1B;SMARCA1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.5422294888155414,0.8524333597546755,0.6666666666666666,1.0,1.0,3/6,12.72%,NNT;ATP6V1H;SLC25A27
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.5387924634504488,-0.8513153457716629,0.6842105263157895,0.997395320577886,1.0,2/5,23.94%,PIK3C3;PIK3CB
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.5435859917535044,-0.8511938106821717,0.7222222222222222,0.9970251502653392,1.0,3/7,35.12%,B2M;HLA-B;HLA-E
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.3265587685399932,0.8507845382777304,0.9,1.0,1.0,8/32,18.35%,PRKD1;TAF1;MARK2;ACVR1;ROCK1;HIPK2;GALNT2;DYRK1A
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.40027022199810997,-0.8505884592208686,0.8125,0.997378149946052,1.0,25/152,21.26%,MAP3K5;PGK1;PRKAG2;PKN3;GRK5;JAK1;PRKCE;SIK2;DGKG;DCLK1;FGFR1;CDK14;PINK1;TRIB2;PAK2;VRK2;TBK1;TEC;STK38;ACVRL1;CDK6;MTOR;STK10;TLK2;CSNK1D
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.5320732790508311,-0.8503836535952961,0.7391304347826086,0.9970425206511622,1.0,2/10,11.99%,DMD;MEF2A
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.48792544925620107,-0.850145987684319,0.6710526315789473,0.9967209285967805,1.0,6/17,25.60%,S1PR1;GOLPH3;PARVB;ITGB1;VCL;CCDC88A
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.4441647684625561,-0.8499557414471492,0.7710843373493976,0.9963929317652481,1.0,5/31,11.34%,TINAGL1;KIAA1217;SMARCA1;LAMA5;EPAS1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.5371251761941017,-0.8493468731409278,0.6615384615384615,0.9967726503287417,1.0,3/8,27.99%,KLF4;CBFB;MAP2K5
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.3926625667693888,0.8492281403978067,0.6666666666666666,1.0,1.0,2/11,11.71%,ATM;NEK7
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.4406049842204533,-0.8490387432054485,0.7058823529411765,0.9966829173276716,1.0,9/35,19.63%,PCK1;PPARG;TIMP3;TNS1;EPAS1;CFH;PLSCR4;ACVRL1;PIKFYVE
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.4605556942676069,-0.8486651834883727,0.6805555555555556,0.9966340513267752,1.0,4/18,17.45%,SMARCA1;PBRM1;SMARCC1;MBD2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.529494912692652,-0.8483178456373859,0.7424242424242424,0.9965920343868818,1.0,4/9,27.26%,COMMD1;DLG1;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5014328697604914,-0.8481748577190789,0.7560975609756098,0.996224430690725,1.0,3/16,15.34%,REL;RIOK3;TBK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.49621648093313836,-0.8478145485371974,0.6666666666666666,0.9961488203100445,1.0,7/11,27.26%,ANK2;CTNNA3;CACNA1C;DLG1;DSP;PDE4B;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.543937828999971,-0.8477719900688727,0.71875,0.99561932961597,1.0,3/7,28.35%,RACK1;GLI3;GPC3
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.4841941572143481,-0.8475485817923395,0.7432432432432432,0.9954493863572568,1.0,3/17,18.12%,S100A6;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.4570848172948638,-0.8474226545887392,0.7023809523809523,0.9950089599022591,1.0,10/30,26.38%,CX3CL1;GPM6B;ADAM15;CDK6;EMP2;ACER2;PIK3CB;VCL;RASA1;RHOA
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.4878927596617465,-0.8472267939353562,0.691358024691358,0.993508567558101,1.0,2/20,2.99%,SEC22B;SEC24D
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.4878927596617465,-0.8472267939353562,0.691358024691358,0.993508567558101,1.0,2/20,2.99%,SEC22B;SEC24D
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.4878927596617465,-0.8472267939353562,0.691358024691358,0.993508567558101,1.0,2/20,2.99%,SEC22B;SEC24D
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.4259170805963766,-0.8471264068103327,0.7555555555555555,0.9930569267808015,1.0,18/65,22.30%,SUN2;SRGN;NPLOC4;ARHGAP21;SUN1;RAB2A;DYSF;GOLPH3;TMED10;RAB1A;RAB30;ANK3;TOR1AIP2;ATP8B1;ARFGEF2;CSNK1D;CAV2;REEP3
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.532721818155447,-0.8467747675684617,0.7538461538461538,0.9930038843974013,1.0,3/7,29.80%,PRKAR1A;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.5368453833692924,-0.8464640699686065,0.7647058823529411,0.9929374228729407,1.0,3/8,37.25%,TERF2IP;WAPL;SMG1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.4752776996055633,-0.8462659346652132,0.7108433734939759,0.9926082560036866,1.0,2/20,12.54%,CNOT6L;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.45346216335514333,-0.8461965940307827,0.686046511627907,0.992124613127557,1.0,10/37,15.50%,NEDD9;HES1;ENPP2;ERBB4;CD81;PECAM1;PRNP;PLCG2;PAK2;TEC
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.5630787110882735,-0.8461867665574463,0.75,0.9915338884696205,1.0,2/7,10.93%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.5151204377060927,-0.8458942886556081,0.6986301369863014,0.9908856221726705,1.0,4/9,26.38%,ITGB5;FAM171A1;ITGB1;RHOA
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.5151204377060927,-0.8458942886556081,0.6986301369863014,0.9908856221726705,1.0,4/9,26.38%,ITGB5;FAM171A1;ITGB1;RHOA
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.47439750185451146,-0.8458914572096478,0.7123287671232876,0.9902765959758834,1.0,5/15,17.50%,BCAP31;HYAL2;PAK2;RACK1;CYLD
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.5304842936842374,-0.8456270615445374,0.7567567567567568,0.9900711161090525,1.0,7/13,30.32%,CD81;VAV3;SH3KBP1;RIF1;CD320;PPP2R3C;CD74
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5779627706431006,-0.8454485768701949,0.7846153846153846,0.9897987967072949,1.0,3/7,14.04%,PRKN;TMBIM6;HERPUD1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.4315093623127512,0.8453180471159764,0.6538461538461539,1.0,1.0,1/12,0.60%,HOMER1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.506175846150788,-0.8449398134911922,0.6883116883116883,0.9900766267829996,1.0,8/13,24.97%,ARF1;MAGI2;SDCBP;LRPAP1;MTMR2;CD63;AHI1;SCYL2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.5703835482326729,-0.8447202878108235,0.75,0.9898783484275154,1.0,4/5,28.06%,NPM1;MECP2;RAB11A;BRD4
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.5904041051932518,-0.8445230980683128,0.8059701492537313,0.9895597697931577,1.0,3/8,22.59%,PINK1;RAB1A;ARRDC3
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.46027052778536215,-0.8444098538799032,0.7294117647058823,0.9891478828736118,1.0,7/24,20.33%,LAMP2;IPO7;PTTG1IP;TPR;KPNB1;RAB8B;CLU
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.548433125500557,-0.8441623272093989,0.703125,0.9888635844741911,1.0,1/6,4.80%,EPS8
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.5213502251709325,-0.8440087100865796,0.7096774193548387,0.9884927345555232,1.0,4/10,20.25%,GJA1;KPNB1;PAFAH1B1;ITGB1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.4601416617918568,-0.8436084172057214,0.7435897435897436,0.9885098055171653,1.0,7/25,23.44%,RTN4;TRAM1;PRNP;TOR1AIP2;CAV2;REEP3;VAPB
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.4446055069687082,-0.8431693461092239,0.7802197802197802,0.9883933277517567,1.0,11/48,23.42%,PRKAG2;HIF1A;CDKN1B;SDCBP;OGT;TPR;CDKN1A;NUP54;EMP2;CDH5;EGFR
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.43380878495658437,0.8425956161507008,0.6363636363636364,1.0,1.0,2/10,11.01%,IL15;RAB27A
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4610803632362305,-0.8416127106372536,0.6506024096385542,0.990478857010643,1.0,2/22,4.83%,NDRG1;HIF1A
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.4607898400901238,-0.841400101345339,0.7058823529411765,0.9902412915650665,1.0,9/27,23.42%,ERBB4;CDKN1B;EEF1A1;FLT1;FGFR1;TIE1;EMP2;ECT2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.4995147119161873,-0.8410095295517611,0.7605633802816901,0.9902239337938298,1.0,4/11,26.38%,ROBO2;PLXNA2;MAP3K13;RHOA
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.4619191687713113,-0.8407948843812063,0.7176470588235294,0.9899668328732194,1.0,8/22,30.71%,PPARG;ZFP36;TPR;NUP54;AGO2;POLR2B;NUP98;STAT3
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.5303463012780892,-0.8405885160855368,0.7121212121212122,0.9897100451084196,1.0,4/5,45.46%,IFITM3;LY6E;TRIM5;GSN
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.4454264765382675,-0.8394718284840683,0.7108433734939759,0.9908904045849593,1.0,4/28,14.77%,TAF1D;PPM1D;MTF2;PPHLN1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.5477780850338249,-0.8390312310916378,0.7916666666666666,0.9910588372589946,1.0,3/8,19.94%,PRKN;SLC30A1;MT1M
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.5085317263769803,-0.8384266375445757,0.6415094339622641,0.9914263828941481,1.0,1/7,14.64%,NFKBIA
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5447107798276447,0.8381433922059007,0.6923076923076923,1.0,1.0,1/5,1.97%,PIGU
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.495929685586498,-0.837830452133701,0.7222222222222222,0.991813401601822,1.0,4/13,23.68%,GOLPH3;TMED10;CSNK1D;ARL5B
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.43311018764222453,-0.8374252640334799,0.7176470588235294,0.9919345160678856,1.0,12/44,20.48%,ATF3;NPAS2;PRKN;NPM1;PINK1;TPR;AMFR;MCL1;SLC38A2;NUP54;MTOR;HSPH1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.482335286469417,-0.837237645752965,0.6891891891891891,0.9915912554345336,1.0,8/16,26.35%,CANX;SYNJ2;SYT1;PICALM;DNM2;PIP5K1C;SYNJ1;FCHO2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.5031782851642391,-0.8369444149415565,0.6891891891891891,0.9914273619564369,1.0,3/10,13.86%,PNP;ANXA1;NCK1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.564788758585505,-0.8368269251469812,0.7678571428571429,0.9910185868462661,1.0,2/7,15.16%,RPL10;RPL24
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.44744958363290305,0.8368263314021505,0.72,1.0,1.0,3/17,3.76%,ATR;RHBDD1;INO80
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5218783922419037,-0.8366243880119473,0.7611940298507462,0.9908287596496306,1.0,1/11,4.47%,MAP1B
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.39059774958038407,0.8360911961927657,0.6296296296296297,1.0,1.0,2/12,4.49%,NREP;TGFBR3
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.42480712649329144,-0.8358185215961678,0.7640449438202247,0.9913404341557575,1.0,6/39,18.30%,NRCAM;LIMS1;GPM6A;CTNND2;ADGRL3;CLDN5
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.40853866507353964,-0.8342829306547282,0.7659574468085106,0.9929754905174102,1.0,14/53,18.90%,AKAP12;ACTN1;TIMP3;TPM1;TNS1;LAMA4;DLC1;GJA1;OGT;NOSTRIN;PLSCR4;HMCN1;CALD1;SPARC
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.4099508477534477,0.8334203143632563,0.6818181818181818,1.0,1.0,4/16,3.27%,GBP2;GBP4;GCH1;GBP1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.40180687392449344,0.8331891035611281,0.5769230769230769,1.0,1.0,1/10,0.60%,HOMER1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.4878758356662038,-0.8331511709281303,0.7375,0.9940601246430315,1.0,7/18,21.11%,RFTN1;PTPRD;IL1RAPL1;PICALM;ANK3;EMP2;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.5425413063546608,-0.8330224945605297,0.71875,0.9937500504126541,1.0,1/5,18.69%,DCP2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.5066095393785006,-0.8320392352624876,0.6842105263157895,0.9947273101858881,1.0,5/10,21.37%,KLF2;CPEB4;LARS1;MTOR;SPAAR
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.43780782543728575,-0.8318710843511926,0.7317073170731707,0.9943908243309281,1.0,11/21,26.38%,PECAM1;AFDN;PAK2;CTNNA1;CLDN5;TBCD;DLG1;ECT2;CDH5;VCL;RHOA
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.4623789368333821,-0.8316727652801139,0.7662337662337663,0.9940151933821394,1.0,3/23,17.06%,SRGN;OGT;NAA16
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.43677726052769944,-0.8313645803969512,0.691358024691358,0.9940484624617407,1.0,3/16,13.06%,ADAMTS1;ANXA1;PLCG2
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.2757185392471053,0.8300829152215882,0.6666666666666666,1.0,1.0,14/104,11.37%,SCFD2;STX8;EVI5;TBC1D5;HERC2;WLS;XPO4;VPS45;IPO8;TNPO3;SYNRG;RAB28;XPO7;TBC1D4
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.43889444910295417,-0.8300737991337783,0.6923076923076923,0.9955498987686444,1.0,5/24,22.07%,RAD21;PRKCE;TPR;ECT2;CSPP1
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.5245901390499893,-0.8300534039938109,0.75,0.9943847642821988,1.0,2/7,7.89%,DMD;TPM1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.5245901390499893,-0.8300534039938109,0.75,0.9943847642821988,1.0,2/7,7.89%,DMD;TPM1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.5470310743818193,-0.8299620031617934,0.704225352112676,0.9939314022090792,1.0,1/5,17.06%,NAA16
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.47930592490928814,-0.8297799893525163,0.6962025316455697,0.9936362185453685,1.0,9/17,31.33%,CANX;SGIP1;PICALM;PIP5K1C;CLTA;INPP5F;FCHO2;LMBRD1;DNAJC6
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5286844951549071,-0.8290597474998644,0.7638888888888888,0.9940700065374907,1.0,1/6,8.41%,WDR48
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.4240983916146132,-0.8290577008200957,0.7209302325581395,0.9934733258612977,1.0,8/29,21.26%,SMAD7;RNF19A;PRKN;ARIH2;TRIB2;RACK1;CLU;CSNK1D
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.5187660270336715,-0.8289779139033409,0.7397260273972602,0.992969148453451,1.0,3/8,22.64%,MEF2A;MTM1;MFN1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.5416835548774728,-0.8287257801369672,0.7333333333333333,0.9927735342331481,1.0,2/5,29.41%,MTOR;ADAM9
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.5804756515758469,-0.828171182244477,0.7846153846153846,0.9928859285631436,1.0,3/5,35.38%,MCL1;BCL2L1;ITGAV
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.3342048962794414,0.8280645779899014,0.7777777777777778,1.0,1.0,2/23,2.49%,STRBP;TLE4
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.38092477591781126,0.8273124642069909,0.6071428571428571,1.0,1.0,4/13,18.90%,TEAD4;STK4;FAT4;LATS1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.5094855669874315,-0.8273110643130935,0.7285714285714285,0.9936657236985631,1.0,2/8,11.27%,ADAMTS9;GJA1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.4267515690353655,-0.8272783333364108,0.7586206896551724,0.993136475846038,1.0,3/42,5.58%,SPNS2;CHPT1;DMD
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.4162094915689723,-0.8271046352008058,0.7526881720430108,0.9928039601598363,1.0,14/46,20.77%,PGK1;PPA1;ALPL;PTPRD;DUSP16;PLCG2;DUSP5;SLC20A1;PPA2;PAK2;PLPP1;INPP5D;MTOR;PPM1A
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.465546235210551,0.8269706989901475,0.8095238095238095,1.0,1.0,1/8,4.57%,HSPB1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.5323148023334128,-0.826959279577465,0.782608695652174,0.9918136792554565,1.0,3/5,42.06%,HLA-B;HLA-E;HLA-F
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.5323148023334128,-0.826959279577465,0.782608695652174,0.9918136792554565,1.0,3/5,42.06%,HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.5568039703426508,-0.8268650453090854,0.8095238095238095,0.9913651001255633,1.0,1/5,26.40%,POLR2B
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.3098562204874872,0.826641048039485,0.8666666666666667,1.0,1.0,5/35,7.27%,ZNRF3;ARNT2;PTPN21;SLC23A2;SLC38A3
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.5196837540792757,-0.8260470532552754,0.7611940298507462,0.9919017327178722,1.0,4/6,42.81%,HLA-B;HLA-E;HLA-F;CYRIB
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.464951887436196,-0.8259220320342762,0.704225352112676,0.9915122903862578,1.0,5/16,16.43%,HIP1R;ZDHHC6;PRKN;PINK1;SPIRE1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.4471297739262477,-0.8255718542115912,0.7777777777777778,0.991403382561091,1.0,8/23,23.44%,ATP2B1;SLC8A1;ANK2;SLC30A1;ATP13A3;TMEM165;CDH5;VAPB
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5649159951961404,-0.8246235473208768,0.8051948051948052,0.9922254464179362,1.0,2/6,10.93%,ERBB4;ZFPM2
prerank,PanglaoDB_Augmented_2021__Microglia,-0.48787477191275774,-0.8240960813624374,0.717948717948718,0.9924480247394822,1.0,3/14,10.90%,FOS;PECAM1;ITGB5
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.47274672738553275,0.8236799589015901,0.7931034482758621,1.0,1.0,4/10,16.46%,COG6;COG3;COG5;TRAPPC10
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.517023150389575,-0.8233189675048386,0.8108108108108109,0.9929694136673051,1.0,1/11,7.87%,PIK3R1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.47049813801105994,-0.8228046237422699,0.6923076923076923,0.993145800599206,1.0,6/12,21.08%,SLC6A6;SLC8A1;ATP1B3;SCN3A;ATP1A1;SCN2A
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.42895401154778806,-0.8218440276386374,0.75,0.9940687779592842,1.0,9/30,18.90%,PPARG;FOXF1;TIMP3;SLC8A1;LAMA4;GJA1;PLSCR4;CALD1;SPARC
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.3973298083228052,0.8217073923664032,0.6896551724137931,1.0,1.0,3/12,11.81%,HSPB1;DLG2;DTNBP1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.44967490247074116,0.8216105234034676,0.6785714285714286,1.0,1.0,7/7,55.11%,CDC73;HUWE1;UBE2E1;WAC;USP22;UBR2;UBE2B
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.4396265975840512,-0.821473046675846,0.7777777777777778,0.9940950312622939,1.0,9/20,32.01%,HIP1R;ANXA1;GATA2;KMT2A;NEDD4L;CALR;GPC3;DYNC1H1;ANXA2
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.45578178707041994,-0.8213625064006502,0.7228915662650602,0.9936542466104453,1.0,6/23,15.71%,LAMP2;IPO7;PINK1;PTTG1IP;TPR;KPNB1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.48628044477515486,-0.8213614546413359,0.6973684210526315,0.9930648905922896,1.0,6/13,23.75%,NFASC;MBP;PLP1;SCN2A;CMTM8;ACER3
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.47019566881696173,0.8212930621181942,0.696969696969697,1.0,1.0,4/8,13.40%,TGFBR3;ADGRG6;TEK;RBPJ
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5452575413219439,-0.8207650742480782,0.7123287671232876,0.9934415321365296,1.0,2/7,32.94%,SPCS3;SRP14
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.4926348254689757,-0.8206492093835107,0.7397260273972602,0.9930731394701213,1.0,5/12,22.46%,ABCA5;STARD4;CLU;SCARB1;LIMA1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.4225506127124622,-0.8204934972472705,0.7142857142857143,0.9927245955627253,1.0,7/27,26.19%,RIMS1;SDCBP;SYT1;RIMS2;NEDD4L;EGFR;MAP3K13
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.40426792976018383,-0.8202996592624494,0.7849462365591398,0.9924411342884322,1.0,21/72,23.75%,ADAMTS9;ENPP2;LRRC32;DUSP1;SMARCA1;TNS1;VWF;LSAMP;CD55;GPM6A;CFH;PLSCR4;ACVRL1;SPARC;PCDH7;CD34;LRATD1;SPRED1;LIMA1;CDH5;ACER3
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.42261306971272494,-0.8197705600231556,0.6888888888888889,0.9926427476081767,1.0,10/32,23.13%,PTPRD;IL1RAPL1;PECAM1;LRRC4C;ADGRL3;HMCN1;CLDN5;ROBO2;ITGB1;CDH5
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.513680936659002,-0.8194371285444939,0.7647058823529411,0.9926245039906406,1.0,2/11,6.75%,HES1;ERBB4
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.3983733695309714,0.8192559744597717,0.7333333333333333,1.0,1.0,1/10,4.88%,HSPD1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.4525780826676702,-0.8188417559293633,0.7142857142857143,0.9928386819389051,1.0,4/22,13.53%,PPP1R9A;TMEM132C;SHC2;NEBL
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.48838553022595177,-0.8183380624280353,0.7123287671232876,0.9930074448048868,1.0,2/13,6.75%,HES1;ERBB4
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.4580638931623336,-0.8181051528251434,0.7027027027027027,0.9927697883982161,1.0,6/15,22.33%,CANX;ANXA1;GOLPH3;RAB8B;MIA2;RIMS2
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.4345842453102833,-0.8178872139664098,0.7294117647058823,0.9925259681098236,1.0,5/32,9.42%,CX3CL1;GAPDH;JAK1;IFNGR2;IFNGR1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.47696068230728783,0.8178025514247862,0.6363636363636364,1.0,1.0,1/5,4.88%,HSPD1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.5157543055913449,-0.8177162785904362,0.7222222222222222,0.9921665090640621,1.0,1/8,11.55%,S1PR1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.4389599450458891,-0.8175634332644051,0.7228915662650602,0.9917752906761488,1.0,13/33,30.27%,TNFRSF10B;PINK1;PAK2;MALT1;MTOR;EMP2;ECT2;PRKAR1A;CCDC88A;ADCY2;MAPKAP1;ADCY9;STRADB
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.4421283416376803,0.8168044032051518,0.6875,1.0,1.0,1/8,4.88%,HSPD1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.4421283416376803,0.8168044032051518,0.6875,1.0,1.0,1/8,4.88%,HSPD1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.32898705568751646,0.8167627952044764,0.8,1.0,1.0,4/32,8.36%,RSAD2;IL15;HERC5;VCAM1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.5029101099894098,0.8166681853945024,0.7241379310344828,1.0,1.0,3/5,10.49%,SLC26A3;SLCO1A2;ABCG2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.4179330867762405,-0.816577513535043,0.7692307692307693,0.9927547103165631,1.0,14/53,22.04%,SEC22B;SEC24D;BCAP31;ANK2;RAB2A;CD55;TMED10;COPA;RAB1A;MIA2;ANK3;USO1;DYNC1I2;CAPZA2
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.3928276647930406,-0.8163309412286075,0.8775510204081632,0.9924278959272693,1.0,23/126,21.78%,NEDD9;MTFR1;NPLOC4;ARHGAP21;TPM1;CFL1;PRKN;RAB2A;PINK1;GOLPH3;SH3KBP1;TMED10;FGD4;RAB14;RAB1A;BRWD3;RAB30;PIKFYVE;TOR1AIP2;ATP8B1;CHMP4B;CSNK1D;CAV2
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.49877761496879136,-0.8151030114388921,0.75,0.993611386557855,1.0,3/11,13.19%,HIF1A;TMSB4X;PINK1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.43942919663331903,-0.814155437806869,0.7647058823529411,0.9943504085280691,1.0,11/36,16.93%,ITPR1;SYTL4;SLC2A1;RAPGEF3;RAP1A;ENSA;GOLPH3;TMED10;CACNA1C;STXBP5L;MYH10
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.5329565376694174,-0.813211403898921,0.7333333333333333,0.9950693096453297,1.0,2/5,7.63%,CHPT1;DHRS7B
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.44450744202479986,0.813102128163705,0.59375,1.0,1.0,2/8,13.01%,PCM1;TBC1D32
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.5555459402460085,-0.8126119806205941,0.7868852459016393,0.995325567423644,1.0,1/5,20.04%,MTOR
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.44750871398945247,-0.8122698124297199,0.7469879518072289,0.995286659042808,1.0,2/23,2.99%,SEC22B;SEC24D
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.47176038292242684,0.8121637032142311,0.6363636363636364,1.0,1.0,2/6,26.32%,BCOR;CDC73
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5444042548500421,-0.8119548819616218,0.7941176470588235,0.9945879258181202,1.0,3/5,36.50%,SOCS3;INPP5F;PARP14
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5444042548500421,-0.8119548819616218,0.7941176470588235,0.9945879258181202,1.0,3/5,36.50%,SOCS3;INPP5F;PARP14
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.4003916460814076,-0.8117506434139924,0.8709677419354839,0.9942999620359046,1.0,21/71,21.39%,NRCAM;PPARG;SLC6A6;FES;AAMDC;RAP1A;GJA1;MEF2A;SDCBP;FGFR1;SMAD3;ZFP36;BTG1;WWTR1;ACVRL1;CTNNA1;CD34;MTOR;GPRC5B;ECT2;BOC
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.4415396684774434,0.8115074443984723,0.6956521739130435,1.0,1.0,3/11,13.50%,ASCC3;MTERF1;MCM9
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.40907425518904594,0.8114353213146996,0.7096774193548387,1.0,1.0,2/15,4.78%,OFD1;CLASP1
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.44209718838574213,-0.8111597054693264,0.8072289156626506,0.9946326616710199,1.0,8/24,26.12%,MAP3K5;CDKN1A;LARS1;ATF2;MTOR;MAPK8;ATP6V1E1;WDR59
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.46593359547733254,-0.810508569924445,0.7619047619047619,0.9951183652534101,1.0,4/23,24.66%,JAG2;NOTCH4;ROBO2;DLL4
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.3995025760500996,-0.8104884572827481,0.7439024390243902,0.9945878659456661,1.0,14/52,21.21%,PIK3R1;RAPGEF3;CD81;ARIH2;HYAL2;PRNP;PINK1;TMEM30A;SMAD3;PPP3CC;TPR;SREBF2;ANK3;ECT2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.45199698194518345,-0.8098751699406306,0.8148148148148148,0.9949325822335914,1.0,8/23,26.12%,MAP3K5;CDKN1A;LARS1;ATF2;MTOR;MAPK8;ATP6V1E1;WDR59
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.45140121052964927,0.8097407153879712,0.6666666666666666,1.0,1.0,1/7,1.48%,ACAT1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.5278208259297621,-0.8094962432056858,0.7323943661971831,0.9948366633135379,1.0,6/7,45.74%,CBR4;ABHD2;ABCD3;HACD2;ELOVL5;ELOVL7
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.47632346215480437,-0.8094752434202446,0.759493670886076,0.9942817510390561,1.0,8/15,31.62%,HIF1A;ZFP36;CDK6;HSPA9;ACVR2A;STAT5B;STAT3;ETS1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.48193441222218436,-0.8093611674748149,0.7792207792207793,0.9938549407755406,1.0,2/13,13.37%,RPL23;RPS7
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.4491899044448833,-0.8093402735169122,0.7228915662650602,0.9932948783209156,1.0,5/20,12.95%,NFASC;GRIA2;CNTN1;PTPRD;SHC2
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.47389507548918913,-0.8091786250829948,0.7926829268292683,0.9929009665864099,1.0,4/15,17.08%,PRKN;PINK1;GOLPH3;SREBF2
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),-0.56404621506396,-0.8091014455795089,0.8064516129032258,0.9924757053422444,1.0,1/5,8.62%,ANK2
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.44176621700594676,0.8087370013196326,0.6774193548387096,1.0,1.0,2/9,12.98%,CLASP1;CLIP1
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.4893832816855421,0.80861993938707,0.6944444444444444,1.0,1.0,2/6,6.10%,PRKD1;LIMS2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.39409759632633884,-0.8078514289369966,0.8444444444444444,0.993691280994776,1.0,15/71,24.12%,PCK1;PKN3;PRKCE;PINK1;PAK2;VRK2;TBK1;STK38;PIKFYVE;MTOR;TLK2;CSNK1D;STK39;PRKCH;MAPK8
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.5554941758264604,-0.8070575924730214,0.782608695652174,0.9943335635016866,1.0,4/5,44.44%,LRP6;APC;CTNNB1;GSK3B
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),-0.506276293347615,-0.8068603611976862,0.7402597402597403,0.9940669743040872,1.0,1/8,17.06%,NAA16
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.48138943535298984,-0.8064241239986121,0.7466666666666667,0.9941116898293848,1.0,3/11,19.31%,NPM1;TPR;NUP54
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.46073629329877036,-0.8064143157050663,0.7848101265822784,0.9935474105621743,1.0,3/13,12.56%,HSPA5;PRKN;TMBIM6
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.5299860766592593,-0.8064092795326127,0.7397260273972602,0.9929774464355215,1.0,1/7,2.83%,HSPA5
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5276231923857382,-0.8062851279872619,0.7213114754098361,0.9925095159480921,1.0,2/6,34.03%,BRD7;DIP2A
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.49953515675695037,-0.8060299308455177,0.6875,0.9923080771303716,1.0,2/6,14.04%,NPLOC4;HERPUD1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.4136888432099234,-0.8059772739355643,0.8369565217391305,0.9918157622801329,1.0,28/63,31.93%,MYO9B;ARHGAP21;TGM2;VAV3;DLC1;ARHGAP15;ARHGAP23;GNA13;FGD4;ARHGAP17;ARHGAP29;RASGRF2;PREX1;ECT2;RHOJ;BCR;RHOA;FAM13A;ARHGEF2;KALRN;ARHGEF3;MCF2L;TRIO;RHOB;RAC1;STARD8;SQSTM1;ARAP2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.4504066655021527,-0.8051318519993739,0.7605633802816901,0.9924435070244471,1.0,5/17,21.00%,TGM2;DYSF;RACK1;GATA2;SCARB1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.5354538284039523,0.8046459065568402,0.7333333333333333,1.0,1.0,1/5,3.95%,GAB1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.4148867655412197,0.8045329988802095,0.6756756756756757,1.0,1.0,1/8,1.97%,PIGU
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.5244906777727943,-0.8037186050423252,0.8108108108108109,0.9939428433638421,1.0,1/9,10.23%,PRKN
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.3985790492425877,-0.8036599609764761,0.8369565217391305,0.9934314848197758,1.0,15/69,20.33%,PPARG;CX3CL1;KDM1A;ESR2;RPS27A;UBC;NPM1;PLCG2;SMAD3;NFKBIA;CRTC3;MALT1;IL18R1;ATF2;CLU
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.4859655701870028,-0.8029441381037113,0.726027397260274,0.9938551653494245,1.0,2/14,9.74%,ACTN1;MYL12A
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.38686120167645,-0.8024516439591226,0.7816091954022989,0.9940827406229186,1.0,10/42,14.82%,NES;MAP1B;NFASC;SMARCA1;ANK2;GJA1;EPAS1;DCLK1;SHC2;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.36488065267472775,0.8021646371964394,0.7391304347826086,1.0,1.0,1/15,1.40%,GCNT2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.4384924053638912,-0.8019047462701028,0.7681159420289855,0.9942848270473655,1.0,7/21,28.53%,ARIH2;PINK1;PPP3CC;SREBF2;MAPK8;UBE2D3;NPEPPS
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.5527073299897707,-0.8018378754681407,0.7777777777777778,0.9938122683809062,1.0,2/5,10.72%,SLC4A10;SLC4A7
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.4560256942928799,-0.8017316162339067,0.7837837837837838,0.9934095465649798,1.0,6/17,21.13%,NFKBIZ;PECAM1;DYSF;LCP2;PSAP;IFITM3
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.5065557583766662,-0.8012973293523453,0.7857142857142857,0.993454280183817,1.0,1/6,12.12%,CSTF3
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4114778250668685,0.8012814681294561,0.8333333333333334,1.0,1.0,1/12,0.39%,BMP6
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.5042698318081169,-0.8011119160786562,0.7424242424242424,0.9931843607929343,1.0,2/10,12.18%,TIMP3;CST3
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.39912182177359057,-0.8003593433430515,0.8068181818181818,0.9935750350390701,1.0,5/49,10.57%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.48261348942870536,0.799970757909567,0.75,1.0,1.0,1/8,2.93%,CPEB3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4682657024412862,-0.7999522334662263,0.7285714285714285,0.9935190396247059,1.0,1/8,12.28%,TNFRSF10B
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5038270391169651,-0.799505358718587,0.8169014084507042,0.9934568273911552,1.0,6/12,29.93%,VAV3;MSN;LARS1;MTOR;RHOA;RAC1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.40481100196682857,0.7989126426494093,0.5416666666666666,1.0,1.0,1/16,1.09%,ATP10D
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.5000222605949864,-0.7987538250783893,0.7538461538461538,0.9934204527865008,1.0,1/5,17.50%,CYLD
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.5000222605949864,-0.7987538250783893,0.7538461538461538,0.9934204527865008,1.0,1/5,17.50%,CYLD
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.45335310567837694,-0.7986302359513381,0.7230769230769231,0.9929508300937988,1.0,2/13,8.00%,CX3CL1;SULF2
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.46309143384479834,-0.7984250935313322,0.7183098591549296,0.9926070814662595,1.0,3/9,27.15%,ATP1B3;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.5419503297678278,-0.7982563228630305,0.7971014492753623,0.992307569108488,1.0,3/7,10.70%,MGLL;SCP2;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5533717285595555,-0.7979765475108023,0.7538461538461538,0.9921774089514414,1.0,1/6,6.26%,FES
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.4841929357846534,0.7978357980040346,0.7714285714285715,1.0,1.0,1/5,6.31%,RNF213
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3071515237302549,0.7976071510568561,0.8666666666666667,1.0,1.0,7/29,11.45%,RC3H1;RBM20;NOVA1;NOVA2;HNRNPLL;TNFRSF1B;OAS3
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.5296829560438139,-0.7969971470031705,0.7857142857142857,0.9928669356199279,1.0,3/8,24.84%,RAB14;PIKFYVE;ATP6V1E1
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.40225328875313854,-0.7969484186780743,0.8314606741573034,0.99236771072446,1.0,6/49,15.39%,UFL1;HIF1A;DHRSX;PTTG1IP;MSN;TMEM59
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.519460649743232,-0.7966521389583285,0.7575757575757576,0.9921565042598586,1.0,2/6,12.72%,FLT1;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.4511734669845839,-0.7961917286961768,0.7411764705882353,0.9922328224802421,1.0,2/17,5.53%,RIMS1;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.5004099962261743,-0.7959236986441139,0.75,0.9920032091238842,1.0,3/8,24.27%,ENSA;ARPP19;PPP1R16B
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.4680295077928107,-0.7957034468934422,0.7647058823529411,0.9917177144437801,1.0,4/12,20.25%,KLF6;PLCG2;MALT1;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.4837262486734932,-0.7944314519906371,0.825,0.9929787266262915,1.0,4/9,29.44%,TMBIM6;PTBP2;PTBP1;SRSF7
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3801358531046603,-0.7940068486500805,0.8488372093023255,0.9930855572673231,1.0,9/76,11.60%,BTG2;RFC3;RAD21;POLA1;RPS27A;WDR48;COMMD1;UBC;NPM1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.4811466574325258,-0.793865771482358,0.7027027027027027,0.9927376589255481,1.0,2/15,9.74%,ACTN1;MYL12A
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.5450540034600493,-0.7931157353702313,0.796875,0.9931868224242841,1.0,3/5,15.52%,MGLL;GGT5;PON2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.4782440338870566,0.7928189158920799,0.7647058823529411,1.0,1.0,2/5,4.57%,PRKD1;HSPB1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.46695257670550205,-0.7926351327300091,0.7887323943661971,0.9933368950720143,1.0,2/9,23.42%,CST3;EGFR
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.36835067372622293,0.79257725556568,0.75,1.0,1.0,4/17,5.61%,ATG10;UGCG;PIGU;ZDHHC2
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4694704571301369,0.791778773374223,0.7027027027027027,1.0,1.0,2/5,13.40%,ACVR1;RBPJ
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4846143558860321,-0.791191340483178,0.7714285714285715,0.9948482913632793,1.0,2/13,4.18%,GRIK1;GRM7
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.3600620835558736,-0.790653555775747,0.8526315789473684,0.9949910354888678,1.0,16/105,19.16%,BHLHE40;HIF1A;ESR2;RREB1;SBNO1;CREM;ZNF280D;MTF2;BTG1;WWTR1;ZBTB38;CNBP;ACVRL1;NSD2;DNM2;ATF2
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.36871674073433414,0.7896886677583278,0.782608695652174,1.0,1.0,2/16,4.78%,EFNA5;CLASP1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.4699223367202995,-0.7881199082141176,0.7727272727272727,0.9977355255604579,1.0,3/9,23.78%,SLC6A6;SLC38A2;SLC3A2
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.46428541089038,-0.7874264066877261,0.7746478873239436,0.9981185128830112,1.0,1/12,4.44%,KDM1A
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.4187318184995752,-0.7872190156009606,0.7236842105263158,0.9973209761897224,1.0,3/29,7.92%,SLC2A3;SLC6A6;SLC2A1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.4187318184995752,-0.7872190156009606,0.7236842105263158,0.9973209761897224,1.0,3/29,7.92%,SLC2A3;SLC6A6;SLC2A1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.4112829782150722,-0.786964651297933,0.8111111111111111,0.997059191937026,1.0,6/33,14.98%,PIK3R1;TPM1;RAPGEF3;TMEFF2;DLC1;PAK2
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.4221435131735724,-0.7868701336005526,0.8,0.9966181301423073,1.0,6/17,23.78%,SLC6A6;SLC38A2;SLC16A6;PSAP;SLC16A14;SLC3A2
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.4142140303102924,0.7868621702417145,0.8260869565217391,1.0,1.0,6/15,11.99%,ACAT1;HSD17B4;HADHB;DECR1;AUH;PPARD
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.32164427787220307,0.7862391382239313,0.8888888888888888,1.0,1.0,6/29,15.42%,PRKD1;TAF1;MARK2;ACVR1;ROCK1;HIPK2
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.39541604563708965,-0.7860920749988399,0.7625,0.9969511562016116,1.0,6/30,19.63%,TSG101;TBC1D15;NPM1;MSN;CYLD;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.5065766807993209,-0.786034754160339,0.8055555555555556,0.9964488027244908,1.0,4/13,18.61%,RPL10;TMED10;SAMD8;PICALM
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.4549644227269576,-0.7858092228820112,0.7692307692307693,0.9961819223486399,1.0,1/15,3.50%,HES1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.432481553707181,-0.7843568626622834,0.7391304347826086,0.9975463915493653,1.0,1/12,11.60%,NPM1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.4284401410384515,-0.7838133308930095,0.7816091954022989,0.9976188022829142,1.0,3/28,9.61%,CX3CL1;ERBB4;RAP1A
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.40444826963258773,-0.7837937603753,0.851063829787234,0.9970925215008671,1.0,9/45,17.91%,FOXF1;ERBB4;CDKN1B;ZFPM2;MEF2A;NOTCH4;CACNA1C;CDKN1A;ACVRL1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.4148094404183426,-0.783227117000711,0.8160919540229885,0.9971897776483173,1.0,9/28,23.44%,ATP2B1;SLC8A1;ANK2;SLC30A1;MT1M;ATP13A3;TMEM165;CDH5;VAPB
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3551935660297457,0.7827783405711698,0.625,1.0,1.0,5/25,7.58%,BMP6;IL6R;EFNA5;IL15;ABL1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3312120012977955,0.7826388872255258,0.8666666666666667,1.0,1.0,2/24,6.31%,UBE3D;RNF213
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.3921220340625386,0.7823627710566767,0.7241379310344828,1.0,1.0,1/15,2.23%,MSL2
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.4734963825410531,-0.7823333662785246,0.7941176470588235,0.9977060946588154,1.0,2/9,10.85%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.42081888977759313,-0.7821037651910583,0.8117647058823529,0.9974640513828363,1.0,4/31,12.85%,EPS8;PIK3R1;ARPC2;GPM6A
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.4148456273435291,-0.7813492273744526,0.7901234567901234,0.9978503282309531,1.0,11/25,31.20%,GPM6B;HIP1R;DLC1;ARHGAP17;MTOR;CCDC88A;RHOA;CRK;RHOB;RAC1;FAM107A
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.4290381195892226,-0.781311467843605,0.7564102564102564,0.9973561680339437,1.0,3/19,12.36%,YTHDC1;ZC3H7A;RPL10
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.3594297062901253,-0.780924774710266,0.8333333333333334,0.9972500390478558,1.0,16/132,15.21%,UFL1;HIF1A;NFE2L2;RPS27A;COMMD1;KLHL7;PRKN;ARIH2;UBC;EPAS1;CHFR;PIAS2;PINK1;TPR;AMFR;RACK1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.33278948404004466,0.7807558521028746,1.0,1.0,1.0,2/22,5.11%,BMP6;ELAPOR2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.4036004812814826,-0.780463319173543,0.7849462365591398,0.9973714661572972,1.0,4/47,5.45%,NR4A1;PPARG;TAF1D;ESR2
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.40823250310144876,-0.780128797579228,0.75,0.997136434742529,1.0,11/29,23.86%,BCAP31;CDC37;LAMP2;ZDHHC6;SDCBP;PIKFYVE;CHM;SPCS3;ZDHHC14;ZDHHC21;VPS37A
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.38182972525365744,-0.7799034966212448,0.8351648351648352,0.9969078074395826,1.0,14/70,24.12%,PCK1;PKN3;PRKCE;PINK1;PAK2;VRK2;TBK1;STK38;MTOR;TLK2;CSNK1D;STK39;PRKCH;MAPK8
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.5020161095435015,-0.7794630032062588,0.7313432835820896,0.9969310368235175,1.0,5/6,38.60%,MAP2K1;USP7;DNAJC13;ATP9A;MAPK1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.42597318456951955,-0.7793568207589273,0.7792207792207793,0.996524920307524,1.0,10/23,26.69%,TMSB4X;LIMS1;NFKBIA;CYLD;DLG1;PPM1A;EGFR;SASH1;RHOA;TERF2IP
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.43239457547327986,-0.7787328588035782,0.8452380952380952,0.9970203253262088,1.0,2/17,10.33%,PIK3R1;ARPC2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.46312968577440145,-0.7784807390504169,0.7951807228915663,0.996810654518367,1.0,3/12,8.28%,ATP2B1;GPM6B;SLC8A1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.5076844025264101,-0.7782913744414139,0.782608695652174,0.99646651631833,1.0,2/7,13.19%,HSPA5;PINK1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.39665883937360497,0.7780502223496953,0.6551724137931034,1.0,1.0,2/7,12.69%,MDM4;ACVR1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.4252532053476559,-0.7777178476961093,0.8,0.9966490322676275,1.0,3/22,20.04%,LAMP2;SREBF2;MTOR
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.42878613385705316,-0.7774467933170152,0.7951807228915663,0.9965010810275594,1.0,2/25,4.67%,JUN;PPM1D
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3562328415463621,-0.7771101980851508,0.8842105263157894,0.9963227324840321,1.0,18/118,19.16%,BHLHE40;HIF1A;ESR2;RREB1;SBNO1;CREM;RPL10;ZNF280D;MTF2;BTG1;WWTR1;SMC3;ZBTB38;CNBP;ACVRL1;NSD2;DNM2;ATF2
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.4072965068676079,-0.7764799847163961,0.7976190476190477,0.9965172410260699,1.0,7/30,23.42%,KLF4;ADAMTS1;ANXA1;CDKN1A;CDK6;DLG1;EGFR
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4184083751051725,-0.7763910749577091,0.8205128205128205,0.9961131707267944,1.0,15/35,29.93%,PIK3R1;FLT1;VAV3;SHC2;NCK1;BCAR1;PAK2;VEGFC;PIK3CB;ABI1;HSP90AA1;RHOA;PXN;CRK;RAC1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.41028230155921125,-0.7762254081083959,0.8023255813953488,0.995764472536126,1.0,7/33,13.11%,ADAMTS9;ACTN1;ITGA10;DLC1;ITGB5;ADAM15;PPFIA2
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.44407640062500636,-0.7757243838425729,0.8452380952380952,0.9958613843342546,1.0,3/16,14.25%,ZC3H7A;NOTCH4;ZFP36
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.5089370591840606,-0.7755230913171253,0.8493150684931506,0.9955619796363228,1.0,5/8,37.46%,ACER2;PDE4B;REST;TFRC;MEF2C
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.414737620424563,-0.7754225714659698,0.7976190476190477,0.9951776190980427,1.0,6/24,19.24%,LGALS3;HIP1R;RUFY2;LRPAP1;PICALM;MTMR2
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.48778437152080917,-0.7753822515938479,0.7162162162162162,0.9946658236520218,1.0,1/6,4.49%,ABCA5
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.47469146915717153,0.7743318988962813,0.6875,1.0,1.0,1/6,1.48%,ACAT1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.43126541330083923,-0.7742774793909204,0.8,0.9956029071422857,1.0,8/17,23.13%,PECAM1;AFDN;PAK2;CLDN5;TBCD;DLG1;ECT2;CDH5
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.5250463934838037,-0.7740946617168581,0.7647058823529411,0.9952434932812234,1.0,4/5,40.21%,AHCYL1;ZFP36L1;DHX36;PAPOLA
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.5319343957823033,-0.7740302681901716,0.7794117647058824,0.9947629079537896,1.0,3/6,20.25%,PECAM1;MSN;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.4601192381900576,0.7733326512630151,0.6785714285714286,1.0,1.0,1/6,4.88%,HSPD1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.4040803546505377,-0.7730996864264655,0.7560975609756098,0.9954857433605487,1.0,6/28,16.36%,DMD;PRKN;ENSA;PRNP;ARPP19;WWTR1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.4824287390227451,-0.7722402411665867,0.76,0.9954725810238496,1.0,2/6,16.04%,JAK1;GRB2
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.4824287390227451,-0.7722402411665867,0.76,0.9954725810238496,1.0,2/6,16.04%,JAK1;GRB2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3232757431572823,0.7719995041086826,0.6666666666666666,1.0,1.0,4/23,10.18%,THOC1;TENT2;SCAF8;RPRD1A
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.4880224911619149,-0.771603051471569,0.7733333333333333,0.9957268088236804,1.0,3/8,29.93%,PARVB;RHOJ;RAC1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.44043138489855876,-0.7715359514273165,0.8,0.9952775967032123,1.0,2/20,9.99%,RFC3;KLF4
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.4078112649280474,-0.771450976788049,0.8205128205128205,0.9948652326767121,1.0,4/25,13.86%,CX3CL1;FES;PRKCE;NCK1
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.3348242540478401,0.771347057688382,0.8333333333333334,1.0,1.0,4/21,12.15%,THOC1;TENT2;RPRD1A;PNPT1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.41687778115063245,0.7701363922507578,0.6363636363636364,1.0,1.0,2/8,10.31%,ELAPOR2;PCM1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.27036363464168417,0.7695614377465283,0.8888888888888888,1.0,1.0,14/52,18.04%,RC3H1;EFNA5;CLASP1;CHN1;CDH2;ZMYM4;MARK2;SIPA1L1;PHLDB2;STAT2;ZRANB1;PDLIM5;EPHA4;ARHGAP35
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.46605525565816297,0.7692563080463264,0.72,1.0,1.0,3/5,27.70%,STX3;PPM1F;PDGFB
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.35714798973694273,0.7684782732951458,0.782608695652174,1.0,1.0,4/13,13.32%,HDAC9;ABL1;CDH2;CTNNA2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.35590520102979406,0.7680495353792075,0.7407407407407407,1.0,1.0,2/12,4.65%,MFF;RALA
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3385279268507785,0.7679702459116288,0.8461538461538461,1.0,1.0,5/28,10.41%,ANKRD6;TPD52L1;EIF2AK2;MFHAS1;KLHDC10
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.4998746858847674,-0.7676550183138964,0.7638888888888888,0.9992852072573949,1.0,2/7,31.62%,EMP2;ETS1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.4860968067756479,0.7675501807780193,0.7096774193548387,1.0,1.0,2/6,9.14%,EZH1;BAZ2A
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3772544629813323,0.7673718113154563,0.6857142857142857,1.0,1.0,2/11,8.18%,PPP1R13B;YWHAG
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3772544629813323,0.7673718113154563,0.6857142857142857,1.0,1.0,2/11,8.18%,PPP1R13B;YWHAG
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.4982773157153207,-0.7652073640908406,0.7692307692307693,1.0,1.0,3/6,23.49%,CD81;CBFB;PRKCH
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.46861478451621746,-0.7646026917868204,0.8356164383561644,1.0,1.0,2/10,19.21%,ZFPM2;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.3081738206167164,0.7645859129717945,0.9333333333333333,1.0,1.0,3/33,5.43%,ATG10;CPEB3;LARP4B
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.48534788608248536,-0.7645635726140986,0.75,1.0,1.0,4/5,23.94%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.48534788608248536,-0.7645635726140986,0.75,1.0,1.0,4/5,23.94%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.4210584291471328,-0.7645011124436619,0.84,1.0,1.0,3/14,13.63%,PLOD2;COL18A1;PLEC
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.46582154694931116,-0.7641374848148228,0.7638888888888888,1.0,1.0,2/8,12.07%,KLF6;DCLK1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.463999205927349,-0.7638913881167669,0.75,1.0,1.0,4/9,38.97%,LCP2;MAP3K2;FGR;MAP3K8
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.4676666725108539,-0.7635656782458335,0.7857142857142857,0.9999033639168091,1.0,3/8,11.76%,LGALS3;CD81;PRNP
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.4794544558577177,-0.7635611496781655,0.8028169014084507,0.9993581742212724,1.0,1/7,2.67%,RTN4
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.43211421936941047,-0.7632976460120966,0.7733333333333333,0.999156818125475,1.0,5/19,21.65%,RTN4;LRRC4C;PAK2;ROBO2;PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.4752760338657061,-0.7631958457259754,0.8513513513513513,0.998751061149145,1.0,1/11,4.83%,HIF1A
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.507508463725428,-0.7631825125183181,0.8823529411764706,0.998213420781108,1.0,1/6,5.22%,LRRC32
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.4047347891057601,-0.7628888260737106,0.7701149425287356,0.9979348746363338,1.0,6/24,18.12%,RAPGEF3;PRKN;CST3;PINK1;NOTCH4;CDK6
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.4043576373343101,0.7624595270911264,0.75,1.0,1.0,4/8,8.02%,MFF;RALA;HSPD1;FBXO7
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4846984744444014,-0.7622328486103386,0.8169014084507042,0.9983235657273616,1.0,1/8,11.94%,ACSL5
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.5080549049277996,-0.7620635453864787,0.8088235294117647,0.9979852142997377,1.0,3/5,27.08%,ERBIN;VIM;ARHGEF2
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.36564426408141865,0.7608260853950345,0.8333333333333334,1.0,1.0,3/20,3.76%,ATR;RHBDD1;INO80
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.43665394553536707,-0.760327899274969,0.7721518987341772,0.9996998460284429,1.0,8/14,27.57%,SLC6A6;SLC8A1;ATP1B3;SCN3A;SCN2A;NEDD4L;ATP1B1;SLC5A6
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.41341155852747286,-0.759554348750916,0.8,0.9999849540238148,1.0,4/23,12.59%,B3GNT2;GGT5;SLC26A2;CHST11
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.4493542273059117,-0.7586245461110183,0.7831325301204819,1.0,1.0,4/18,18.30%,PTPRD;IL1RAPL1;LIMS1;CLDN5
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.4401139094305143,-0.7584187869510693,0.8,1.0,1.0,6/12,32.14%,GAS7;SPIRE1;PREX1;RAC1;FAM107A;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.43363901669000793,-0.7574370089030966,0.8625,1.0,1.0,2/15,10.33%,PIK3R1;ARPC2
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.46386906778511355,-0.7572928717723282,0.8115942028985508,1.0,1.0,2/10,8.18%,HIF1A;MBP
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.4895632927791286,-0.7568992633068643,0.7761194029850746,1.0,1.0,2/6,21.60%,OGT;KMT2A
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.4942489742395537,-0.756730569314092,0.7419354838709677,0.9996235947703038,1.0,2/6,20.51%,NDUFA12;COX6C
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.4942489742395537,-0.756730569314092,0.7419354838709677,0.9996235947703038,1.0,2/6,20.51%,NDUFA12;COX6C
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.4160720750085578,0.7566397327184747,0.6666666666666666,1.0,1.0,2/6,2.75%,SLC4A4;SLC26A3
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.46447154941832913,-0.7565125610505147,0.7875,0.9988003120505007,1.0,3/10,8.28%,ATP2B1;GPM6B;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.46447154941832913,-0.7565125610505147,0.7875,0.9988003120505007,1.0,3/10,8.28%,ATP2B1;GPM6B;SLC8A1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.48910103355416457,-0.7564686981635078,0.8169014084507042,0.9983147728856966,1.0,1/6,4.70%,SPG7
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.39362414663798717,-0.7562397613239692,0.7407407407407407,0.9980026758968359,1.0,10/20,32.14%,CFL1;GAS7;SPIRE1;PREX1;ABI1;DSTN;ABI2;RAC1;FAM107A;MICALL2
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.4975139283844894,-0.7560791062288209,0.8032786885245902,0.997613449062397,1.0,2/7,11.58%,LGALS3;CD55
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.456483244592754,-0.755334683998752,0.8441558441558441,0.9980465741685861,1.0,5/10,21.37%,TMBIM6;CPEB4;LARS1;MTOR;SPAAR
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.4976716138207976,-0.7553113976800697,0.8461538461538461,0.9975446450941425,1.0,4/7,29.72%,GGT5;NPEPPS;ECE1;ERAP1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.42689506502787294,-0.7547375566221838,0.8783783783783784,0.9976977089655731,1.0,5/23,21.00%,SCARB2;SCP2;TMEM30A;ATP8B1;SCARB1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.4170802413363443,-0.7545350525126995,0.8125,0.9974046355444507,1.0,8/19,23.13%,PECAM1;AFDN;PAK2;CLDN5;TBCD;DLG1;ECT2;CDH5
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.44448520899614774,0.7545106037698601,0.75,1.0,1.0,1/5,3.50%,MFF
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.4024002642737943,-0.7541928655530182,0.8214285714285714,0.9973258304052791,1.0,6/37,12.54%,GRIN2B;ANKS1B;ARPC2;VAV3;EFNB2;SDCBP
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.39929919252123647,-0.7535031831152704,0.8,0.9975203423291907,1.0,8/32,16.15%,NFASC;GRIA2;GPM6B;TMEM132C;GJA1;S1PR1;CADM2;PLP1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.40342492452907536,-0.7530309522025945,0.8045977011494253,0.9975246721658335,1.0,6/23,28.06%,ADAMTS1;ANXA1;MECP2;EGFR;RAB11A;BRD4
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.4596292769568797,-0.7524598584969403,0.7808219178082192,0.9977663318552688,1.0,7/10,33.15%,DYNC1I2;KIF1B;CCDC88A;CCDC88C;TUBA1B;TUBB;HOOK3
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.4977294725983783,-0.7522378639206698,0.8153846153846154,0.9975036670208425,1.0,2/7,28.82%,AGO2;PRKRA
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.4263608777357127,-0.7517522515117653,0.8289473684210527,0.9975435604274832,1.0,3/15,13.06%,KLF6;JAG2;PLCG2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.4847955129178054,-0.751751620302844,0.7288135593220338,0.9970028864109913,1.0,1/7,6.33%,ARHGAP21
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.4949175091895911,-0.7516768172474295,0.821917808219178,0.9965516057808628,1.0,1/5,4.65%,SCP2
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.44918915407603366,-0.7515404375555711,0.8125,0.9961422349259107,1.0,2/12,12.85%,PIK3R1;GPM6A
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.45173041728048846,-0.7509659926606469,0.7714285714285715,0.9962537478850532,1.0,1/8,11.34%,EPAS1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.4377967668723277,-0.7507032614926582,0.7910447761194029,0.996063684266166,1.0,4/14,27.44%,SLC6A6;SLC38A2;SLC3A2;SLC7A11
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.45563914794978594,-0.7505396986170828,0.8648648648648649,0.9957556720002405,1.0,2/11,11.47%,SMAD7;AFDN
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3649841098378727,-0.7505028460606066,0.845360824742268,0.9952590480788414,1.0,12/79,14.72%,NPLOC4;RPS27A;NDFIP1;RNF19A;FEM1C;PRKN;ARIH2;UBC;CHFR;PINK1;HERPUD1;AMFR
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4497282396164759,0.7503036934032244,0.6470588235294118,1.0,1.0,1/7,0.39%,BMP6
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.49399963606922465,-0.7500318590111744,0.7540983606557377,0.9952822771782737,1.0,2/5,17.26%,LPGAT1;LPIN2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.4900956161324221,-0.749842498381105,0.746268656716418,0.9949987778474466,1.0,2/6,10.72%,SLC4A10;SLC4A7
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.3417491085609956,0.7488357362712558,0.875,1.0,1.0,2/17,4.78%,WDPCP;CLASP1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.3420270044339997,0.7486018687663427,0.75,1.0,1.0,3/14,10.49%,SLCO1A2;NCOA2;ABCG2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.46027614259810173,0.7481708097515424,0.8,1.0,1.0,3/6,14.12%,SPG11;RAB27A;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.45352693692735535,-0.74810227445111,0.8333333333333334,0.9965842867249032,1.0,3/10,23.70%,PLCG2;MTOR;VIM
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4985827976909997,-0.7480313434759268,0.8260869565217391,0.9961177459097174,1.0,2/9,5.87%,HIF1A;NFE2L2
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.41500402955849747,-0.7471829531888348,0.8214285714285714,0.9966586597788203,1.0,11/20,23.86%,TRAM1;ZDHHC6;SDCBP;RAB8B;PIKFYVE;CHM;CHMP4B;ZDHHC14;SEC62;ZDHHC21;VPS37A
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.37389252540136764,0.7470221992350257,0.8148148148148148,1.0,1.0,1/12,0.60%,HOMER1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.4351065595345404,-0.7469028001467461,0.8356164383561644,0.9964927386596145,1.0,3/11,19.21%,SULF2;HYAL2;ROBO2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.4914442998083025,-0.7466510808655689,0.7611940298507462,0.9962858202577114,1.0,4/6,37.02%,FGFR1;LRP6;ANKRD11;DYNC2I1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.38665111519934786,-0.7462401471256005,0.8723404255319149,0.9962143438836195,1.0,9/47,17.91%,FOXF1;ERBB4;CDKN1B;DLC1;ZFPM2;MEF2A;CACNA1C;CDKN1A;ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.4381257469435974,-0.7461519092410083,0.8194444444444444,0.9958021396022152,1.0,4/16,13.86%,PNP;CD81;ANXA1;NCK1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.5009179645857101,-0.7460638008292724,0.7741935483870968,0.9953668871659,1.0,3/6,24.27%,ENSA;ARPP19;PPP1R16B
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.4418271830949193,-0.7454910426963314,0.8529411764705882,0.9954838477203942,1.0,3/12,28.35%,RACK1;GLI3;GPC3
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.2684755467788711,0.7454415084912733,1.0,1.0,1.0,2/34,4.15%,HOMER1;TTN
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.4359804556929989,-0.7446773927782009,0.7971014492753623,0.9959644046055875,1.0,1/14,2.88%,PPARG
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.36269439812983706,0.7444899894443106,0.7428571428571429,1.0,1.0,2/12,6.93%,ATR;SLF2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.4086077650596008,-0.7440587019013121,0.7571428571428571,0.996233365816191,1.0,3/14,19.91%,GGT5;PELI1;ERBIN
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.3207631713746217,0.743835314046495,0.9230769230769231,1.0,1.0,2/15,6.36%,PLPPR4;MTMR3
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.3710461061271083,-0.742881105710353,0.9381443298969072,0.9971349392244214,1.0,19/88,25.60%,EHD4;RAB11FIP3;EMP1;RAP1A;S1PR1;NUDCD3;SDCBP;GOLPH3;FGD4;PARVB;RAB1A;RAB8B;EMP2;ITGB1;AHI1;RAB11A;VCL;SCLT1;CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.364994219364582,0.7426906773757548,0.7894736842105263,1.0,1.0,2/10,4.78%,OCLN;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.420515731728928,0.7425846659997354,0.8125,1.0,1.0,1/8,4.57%,HSPB1
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.46834042797640485,-0.7421574727673184,0.8243243243243243,0.9975611252264015,1.0,2/9,21.42%,ZC3H18;GIGYF2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.5193513695766172,-0.7415600808307803,0.8208955223880597,0.997571226834637,1.0,1/5,25.36%,AGO2
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.3671977078777502,-0.7406545406698878,0.8764044943820225,0.9980727831102538,1.0,12/50,21.39%,NES;MAP1B;NFASC;ANK2;GJA1;DCLK1;ADGRL3;PLP1;NAV2;PCDH7;GPRC5B;BOC
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4865109704572092,-0.7400255632897011,0.8717948717948718,0.9983048108153274,1.0,1/7,7.17%,TIMP3
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.4415502838047368,-0.7390352172308244,0.8311688311688312,0.9988112828982605,1.0,3/12,12.56%,HSPA5;PRKN;TMBIM6
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.490504767109888,-0.7388483044843696,0.9054054054054054,0.9984760522346267,1.0,1/6,13.16%,CTNND2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.42604626982063964,0.7386857295596758,0.7352941176470589,1.0,1.0,5/5,57.45%,NRP2;NF1;NRP1;SEMA3F;CTNNB1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.4681888844370538,-0.7376343209823024,0.8356164383561644,0.999478145360569,1.0,5/11,27.08%,YBX3;SERPINB6;SCN2A;STK39;ARHGEF2
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.3635264404208056,0.7371702529257209,0.7857142857142857,1.0,1.0,2/10,12.15%,XAF1;PNPT1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.44546363597602623,-0.7369074756327724,0.8024691358024691,0.9998898172031384,1.0,2/13,12.33%,PIK3R1;LIMS1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.47258464629864283,-0.7361163992665115,0.85,1.0,1.0,3/8,19.24%,LGALS3;PICALM;MTMR2
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.4530675290092777,-0.7359668399146108,0.8157894736842105,0.9997442400549974,1.0,3/12,20.33%,KDM1A;PTTG1IP;CLU
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.4533002299479488,-0.7353261026155604,0.7887323943661971,1.0,1.0,3/10,17.89%,EEF1A1;RACK1;MRPL33
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.45872015989965215,-0.7347053118144529,0.796875,1.0,1.0,2/9,17.16%,NPM1;MALT1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.4444089470576015,-0.7346735901801396,0.8285714285714286,0.9996370285908562,1.0,3/11,15.24%,PCK1;CD81;RIOK3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.511785649334945,-0.7340962801667981,0.8225806451612904,0.99979719062425,1.0,2/5,13.19%,PRKN;PINK1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.41542794097558405,0.7335432983979507,0.8387096774193549,1.0,1.0,1/7,1.01%,UGCG
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.3609505429294696,-0.7333777032153073,0.8977272727272727,1.0,1.0,6/57,11.60%,PSMC6;PSMB9;RPS27A;PSMA1;UBC;NPM1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.4164283857551338,0.7328326343730129,0.7,1.0,1.0,5/5,58.41%,UBN1;ATRX;RBBP4;CABIN1;NASP
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.43683657070054654,-0.7325784521780236,0.8307692307692308,0.9999107983578984,1.0,1/14,7.19%,ELL2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.43683657070054654,-0.7325784521780236,0.8307692307692308,0.9999107983578984,1.0,1/14,7.19%,ELL2
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.43241621817030823,-0.7324375287014284,0.8227848101265823,0.9994842533836419,1.0,3/16,10.83%,NR4A1;FLT1;ANXA1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.488612853323953,-0.7321392516051078,0.8387096774193549,0.99934821578762,1.0,2/5,17.32%,RB1CC1;PIK3C3
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.468488571685665,-0.7312359680183548,0.8108108108108109,0.9998906901555793,1.0,2/6,8.52%,SCP2;LSS
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.34280579922465265,0.7310388451182264,0.9523809523809523,1.0,1.0,3/17,10.80%,MLLT3;CDK12;RTF1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.34280579922465265,0.7310388451182264,0.9523809523809523,1.0,1.0,3/17,10.80%,MLLT3;CDK12;RTF1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.44869307508490275,-0.73082098529035,0.8076923076923077,0.9998473003526789,1.0,3/12,25.26%,RIOK3;TBK1;HSP90AA1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.454728554418798,-0.7302432048182683,0.8253968253968254,0.9999603369924678,1.0,2/10,13.06%,KLF6;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.38743622761791174,-0.7300746503723615,0.8333333333333334,0.9996101498132348,1.0,8/26,20.33%,HSPA5;LGALS3;RAPGEF3;TMEFF2;RIOK3;DNM2;MTMR2;CLU
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.38963018224333595,0.7294161283913888,0.8666666666666667,1.0,1.0,2/7,12.15%,ENTPD1;PNPT1
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.4285312255425888,-0.7292275029367584,0.7945205479452054,1.0,1.0,1/8,10.83%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.39982558983330163,-0.7287597922692438,0.8641975308641975,1.0,1.0,1/24,1.27%,BTG2
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.39843953185955794,0.7283132588389694,0.8076923076923077,1.0,1.0,7/7,60.23%,APP;AKAP9;ROCK2;NOS3;DLGAP4;DLGAP2;DLGAP1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.4292262273880806,-0.727806280303957,0.8450704225352113,1.0,1.0,2/11,14.67%,RAPGEF3;TPR
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.4049462047682879,-0.7271484153734883,0.8641975308641975,1.0,1.0,4/24,8.28%,SLC6A6;KCNMB4;NDFIP1;SLC8A1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.4769585535301595,-0.7269639704690176,0.8484848484848485,1.0,1.0,1/8,6.65%,MGAT4A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.4828695310829634,-0.7269609019677552,0.8225806451612904,1.0,1.0,2/5,13.06%,NPM1;PLCG2
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.4210995766299884,0.726710363196586,0.78125,1.0,1.0,2/7,7.63%,ARNT2;CHD7
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.34417016448813936,0.7265695401717989,0.8333333333333334,1.0,1.0,4/13,24.12%,OAS3;STAT2;ISG15;PTPN2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.4278839721823694,-0.726367035785717,0.8450704225352113,1.0,1.0,4/11,17.50%,CX3CL1;BCL2L14;TMBIM6;CYLD
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.3585086066673624,-0.7252579577416366,0.8444444444444444,1.0,1.0,15/56,23.42%,GRK5;FES;ERBB4;FLT1;SIK2;FGFR1;PINK1;PAK2;VRK2;TEC;PIKFYVE;MTOR;STK10;STK39;EGFR
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.4611999636120119,-0.7249480543848997,0.8311688311688312,1.0,1.0,2/11,23.42%,SDCBP;EGFR
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.44389395618339844,-0.7248770308477461,0.8289473684210527,1.0,1.0,2/10,9.61%,RAPGEF3;RAP1A
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.4799328204915735,-0.7246776279589657,0.847457627118644,0.9999837789633632,1.0,2/5,14.62%,NPM1;DDX18
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.38667004459837867,0.724178965471951,0.72,1.0,1.0,2/9,4.65%,MFF;RALA
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.368750172606251,-0.7239443190651028,0.8518518518518519,1.0,1.0,7/26,22.12%,SMAD7;SDCBP;SMAD3;WWTR1;MTOR;DAG1;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.46556773330997425,-0.7238807327662599,0.8260869565217391,0.9998688400916007,1.0,1/6,5.11%,RIMS1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.4437362372772584,-0.7237599703712135,0.8108108108108109,0.9994121009930012,1.0,4/8,29.93%,TPM1;LIMA1;AIF1L;RAC1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.4660474598197651,-0.723133857525319,0.8939393939393939,0.9997196837832696,1.0,2/9,13.94%,PIK3R1;ARPP19
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.41317011458804254,-0.723061842606661,0.8857142857142857,0.9992635027910278,1.0,6/19,24.90%,RAB11FIP3;RACK1;PIK3C3;CSPP1;RAB11A;PRPF40A
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3421135915819095,-0.7224421775655195,0.8775510204081632,0.9994905206708713,1.0,27/87,27.10%,PPP1R9A;RPS27A;ACTN1;PLOD2;COL18A1;TPM1;HIP1R;PRKN;UBC;CST3;PLEC;MYO1B;BCAR1;ARHGAP17;MYO1E;DLG1;EMP2;MTM1;VIM;B2M;SERPINH1;MPRIP;DSP;CCDC88A;RHOA;ARHGEF2;TPM4
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.330346322835269,0.7216916726294585,0.9411764705882353,1.0,1.0,7/20,11.99%,SLCO1A2;SLC23A2;SLC38A3;NCOA2;SLC25A29;ABCG2;PPARD
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.3732857529350486,-0.7215570682576722,0.898876404494382,0.9998262488509696,1.0,8/44,17.52%,SEC22B;NPLOC4;ARHGAP21;RAB2A;GOLPH3;TMED10;RAB1A;RAB30
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.441682810911729,-0.7212716325783839,0.8552631578947368,0.9995369322573036,1.0,6/9,39.12%,AHCYL1;NEDD4L;NEDD4;ANO6;YWHAE;AKAP6
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.4179863852682451,-0.7212308637938826,0.8125,0.9990818034010654,1.0,2/15,15.76%,NDFIP1;STXBP5L
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3567563124464501,-0.7201036250802985,0.9666666666666667,0.9997893509560037,1.0,17/68,21.78%,CX3CL1;RAPGEF3;RAP1A;TBC1D15;TGM2;AFDN;LIMS1;RSU1;RGS7;RACK1;LARS1;PICALM;ARHGAP29;TBC1D9;ITGB1;ECT2;CAV2
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.4128073941240057,-0.7194433139249872,0.8450704225352113,1.0,1.0,1/15,1.84%,NDRG1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.3876244727787047,0.7187990223502183,0.7241379310344828,1.0,1.0,3/8,19.89%,ATP6V1H;CLCN3;DMXL1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.4629801421356591,-0.7185617782081729,0.7971014492753623,0.9999640659623182,1.0,4/5,27.41%,ZDHHC6;ZDHHC14;ZDHHC21;ZDHHC20
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.4629801421356591,-0.7185617782081729,0.7971014492753623,0.9999640659623182,1.0,4/5,27.41%,ZDHHC6;ZDHHC14;ZDHHC21;ZDHHC20
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3967442657104363,0.7182596378091345,0.8055555555555556,1.0,1.0,1/8,2.65%,RHBDD1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.47838089592502675,-0.7176750138018348,0.8688524590163934,1.0,1.0,1/5,15.89%,UPP1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.4457239455779899,-0.7173632683438699,0.7966101694915254,1.0,1.0,4/5,44.26%,NEDD4L;YWHAE;AKAP6;CACNA2D1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.4234115797121377,-0.7171149330244231,0.8088235294117647,0.9998357528384378,1.0,5/15,24.64%,SRGN;CD34;ARFGEF2;CAV2;WASHC4
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.5165644874330872,-0.7169990783790762,0.8524590163934426,0.9994508188072645,1.0,3/5,33.54%,TNKS2;PARP12;TNKS
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.4155458990551197,-0.7164206432078133,0.8024691358024691,0.9995850982259806,1.0,5/16,17.32%,ATG12;RB1CC1;RAB1A;GABARAPL1;PIK3C3
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.3539554446076957,-0.7158765495403879,0.9120879120879121,0.9996337637750246,1.0,19/71,21.78%,CX3CL1;RAPGEF3;RAP1A;TBC1D15;TGM2;VAV3;ARHGAP15;AFDN;LIMS1;FGD4;RSU1;RGS7;RACK1;LARS1;PICALM;ITGB1;ECT2;PLXNA2;CAV2
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.4218460450990003,-0.7158626496454727,0.8375,0.9991185451676446,1.0,2/12,23.52%,SLC30A1;TF
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.4488655982672145,-0.7156356886478986,0.8412698412698413,0.9988543253678602,1.0,3/8,19.96%,KPNB1;NUP54;KPNA4
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3351952041776354,0.7142557136782356,0.8461538461538461,1.0,1.0,3/22,4.78%,INO80;OFD1;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.4466458247520295,-0.7134169297622727,0.8382352941176471,1.0,1.0,2/8,14.67%,RAPGEF3;TPR
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.39587417926332646,-0.7122863529761195,0.8641975308641975,1.0,1.0,3/24,12.33%,NEDD9;RREB1;LIMS1
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.417986556621414,0.7122242702738747,0.7666666666666667,1.0,1.0,3/8,24.27%,PCM1;DYNC2H1;TRIP11
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.43515341429555077,-0.7120181921781298,0.8194444444444444,1.0,1.0,3/13,14.77%,PPM1D;MTF2;PPHLN1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.4706708904771807,-0.7115036842666399,0.8028169014084507,1.0,1.0,1/6,14.20%,FGD4
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.48908859602850724,-0.7114310822019757,0.8405797101449275,1.0,1.0,2/5,13.24%,LAMA5;RPL8
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.47415957606459336,-0.7107229125550222,0.9014084507042254,1.0,1.0,3/8,20.33%,PRKN;PINK1;CLU
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.4754144992611632,-0.7105238832042533,0.8208955223880597,1.0,1.0,1/5,25.36%,AGO2
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.4408129496044143,-0.7099782165324784,0.8714285714285714,1.0,1.0,5/10,20.33%,PRKN;TMBIM6;HERPUD1;RACK1;CLU
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.3521605292670608,0.7086392742250444,0.8571428571428571,1.0,1.0,1/12,4.78%,CLASP1
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.42979475198095934,-0.708127215331824,0.8857142857142857,1.0,1.0,1/10,3.19%,BCAP31
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.4044979111233501,-0.7078147929649149,0.8142857142857143,1.0,1.0,2/14,11.76%,VSIR;PRNP
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.4273459838835456,0.7074297049814139,0.8275862068965517,1.0,1.0,5/5,57.32%,PHIP;PDGFB;EDN1;INSR;RGCC
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.31695135179980766,0.7061201672529788,0.95,1.0,1.0,7/17,18.02%,MGMT;SLF2;ERCC6;KMT5B;SHLD2;SPIDR;PARP9
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.35090623819277666,-0.7039192737478378,0.9010989010989011,1.0,1.0,6/59,15.21%,BTG2;GAPDH;NPM1;RPL10;RPL13A;RACK1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.41818943544989606,0.7027448673217165,0.75,1.0,1.0,1/5,14.51%,ST3GAL1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3642482575826435,-0.7025995288886124,0.9111111111111111,1.0,1.0,12/45,27.08%,CX3CL1;RPS27A;UBC;NPM1;NFKBIA;MALT1;IL18R1;CLU;PRKCH;MAP3K13;TERF2IP;ARHGEF2
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.4193285810162485,-0.7024014107044193,0.8571428571428571,1.0,1.0,8/11,33.62%,PLPP1;SAMD8;ACER2;ACER3;NSMAF;CERK;SPTLC2;ST6GALNAC3
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.43766099474548237,-0.7018401034647753,0.8636363636363636,1.0,1.0,3/9,14.04%,BCAP31;TGM2;HERPUD1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.29658373857344267,0.7013882647088594,0.9333333333333333,1.0,1.0,3/23,9.81%,EXOC5;VPS35L;STXBP6
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.3753505447589293,-0.7013014558039671,0.8372093023255814,1.0,1.0,2/28,4.41%,PPARG;SMAD7
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.4496914005104732,-0.6999778602605405,0.8769230769230769,1.0,1.0,1/6,5.61%,LGALS3
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.4400028139808936,0.6999387198988348,0.7674418604651163,1.0,1.0,2/5,18.04%,PIK3CA;ARHGAP35
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.4440271934177761,0.6998219584049186,0.8235294117647058,1.0,1.0,1/5,3.01%,EYS
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.4580534000930892,-0.6996626043673491,0.8805970149253731,1.0,1.0,1/6,17.50%,CYLD
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.43613003162299,-0.6988336985759498,0.8387096774193549,1.0,1.0,2/11,13.94%,PIK3R1;ARPP19
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.41395707423999495,-0.6986570675224877,0.8840579710144928,1.0,1.0,4/9,23.55%,ANXA1;GATA2;JCAD;RHOJ
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.3909145653648596,-0.6986435403021817,0.8928571428571429,1.0,1.0,4/19,15.71%,IPO7;PTTG1IP;TPR;KPNB1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.3913889997985927,-0.6981886770089559,0.8933333333333333,1.0,1.0,7/24,23.55%,HIF1A;TMSB4X;ANXA1;FGFR1;GATA2;JCAD;RHOJ
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4438488059903358,-0.6981399554705853,0.835820895522388,1.0,1.0,4/10,15.78%,GRM7;IL1RAPL1;ANXA1;SLC30A1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.37991157641282264,-0.6977741758544295,0.8705882352941177,1.0,1.0,7/27,16.93%,SYTL4;CNST;GOLPH3;TMED10;TPR;RACK1;MYH10
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.34643663788958157,-0.6967596002293042,0.9113924050632911,1.0,1.0,6/38,17.45%,BAZ1A;SMARCA1;PBRM1;NPM1;SMARCC1;MBD2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.38073662885624543,-0.6952524599819857,0.8804347826086957,1.0,1.0,4/28,8.46%,SEC24D;CANX;ARF1;AP1G1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.40791756076153324,-0.6938362178235672,0.8805970149253731,1.0,1.0,3/11,16.43%,PRKCE;NCK1;SPIRE1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.4025419775435503,0.6937413613051389,0.8,1.0,1.0,1/8,1.01%,UGCG
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.35875702871029763,0.6935200775075503,0.84,1.0,1.0,4/10,19.91%,ZSWIM5;ZSWIM6;STX3;PPM1F
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.3752611119181326,-0.6931763568778183,0.8735632183908046,1.0,1.0,4/24,14.67%,ATF3;NPM1;NCK1;TPR
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.3377381604011302,0.6931138499509533,0.8666666666666667,1.0,1.0,2/10,13.40%,ELAPOR2;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.4557196483366119,-0.6930224765576276,0.9122807017543859,1.0,1.0,2/6,14.77%,TPR;PPHLN1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.4230534453991045,-0.6925029015110915,0.8676470588235294,1.0,1.0,2/11,4.57%,ENPP2;CHPT1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.45174346863379394,-0.6924531500176319,0.855072463768116,1.0,1.0,3/6,38.99%,AGO2;DHX36;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.44211658920913793,-0.6919393334265543,0.8787878787878788,1.0,1.0,3/8,35.20%,STK39;RHOA;CXCL12
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.3884734985675584,0.6919092424762957,0.8,1.0,1.0,4/6,25.60%,RNF216;PARP9;TRIM44;DHX9
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.42485167939294277,-0.6916241896853522,0.8695652173913043,1.0,1.0,2/9,10.83%,JAG2;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.43804545849020843,-0.690981059743835,0.88,1.0,1.0,1/11,14.23%,NOTCH4
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.42867955616951003,0.6906829809291357,0.8125,1.0,1.0,1/5,5.22%,HDAC9
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.42030618215177307,-0.6902973517973647,0.873015873015873,1.0,1.0,1/10,4.83%,HIF1A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.36427083526671455,0.690243131388689,0.7666666666666667,1.0,1.0,3/8,16.69%,GBP1;PPP2R5A;NUMB
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.36427083526671455,0.690243131388689,0.7666666666666667,1.0,1.0,3/8,16.69%,GBP1;PPP2R5A;NUMB
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.36427083526671455,0.690243131388689,0.7666666666666667,1.0,1.0,3/8,16.69%,GBP1;PPP2R5A;NUMB
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.4305326564467926,-0.6899839651484692,0.8275862068965517,1.0,1.0,3/9,20.25%,GJA1;PAFAH1B1;ITGB1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.4573709932603368,-0.6890462230802112,0.835820895522388,1.0,1.0,1/5,6.67%,FOXF1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.29284779846389264,0.6880722355168644,0.9285714285714286,1.0,1.0,3/24,8.31%,ATR;INO80;ATM
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.37501617689575206,0.68717530497879,0.8918918918918919,1.0,1.0,5/8,26.38%,DISP1;CFLAR;BASP1;LARGE1;SVIL
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.47815236493797975,-0.6870239870340021,0.95,1.0,1.0,1/5,11.60%,NPM1
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.47040183020896,-0.6869773851031734,0.8571428571428571,1.0,1.0,2/8,10.25%,FLT1;CD81
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.3888876329426546,-0.6864975673533291,0.875,1.0,1.0,6/15,39.46%,RIOK3;PPM1A;OTUD7B;DAB2IP;CARD8;TANK
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.44265219295099906,-0.6862727213100375,0.8767123287671232,1.0,1.0,2/5,23.49%,CD81;PRKCH
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.3888647305598285,0.6861723070642759,0.8571428571428571,1.0,1.0,2/6,9.27%,PARD3;ADGRG6
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.40029817826799585,0.6860383716234311,0.7857142857142857,1.0,1.0,3/6,18.67%,TAPT1;ARHGAP35;SEPTIN9
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.4155074688852759,-0.6853179029702101,0.8026315789473685,1.0,1.0,2/9,10.85%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.3874931332549865,-0.6848602793824469,0.8518518518518519,1.0,1.0,5/20,16.93%,GLUD1;SYTL4;GOLPH3;TMED10;MYH10
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.3908495863707559,-0.6845922716900033,0.8795180722891566,1.0,1.0,2/15,13.11%,CFL1;PPFIA2
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.3769410477448884,-0.683577957732371,0.9135802469135802,1.0,1.0,10/30,23.49%,LGALS3;PIK3R1;PRKCE;DPP10;TMEM59;PICALM;DLG1;ITGB1;EGFR;PRKCH
prerank,GO_Biological_Process_2021__morphogenesis of an endothelium (GO:0003159),0.4103247676218654,0.6829487425496786,0.7777777777777778,1.0,1.0,1/5,6.02%,CCM2
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.40844909620136527,-0.6820269582814911,0.8860759493670886,1.0,1.0,4/9,37.15%,NCK1;TNS2;PTPN1;GRB10
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.34541048886634507,-0.6808986841376564,0.8977272727272727,1.0,1.0,14/34,28.27%,ATP2B1;SLC8A1;ANK2;HERPUD1;SLC30A1;ATP13A3;MICU2;CAV2;TMEM165;CDH5;VAPB;ATP1B1;CAMK2D;CALR
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.41772809981803993,0.6801360036602028,0.8461538461538461,1.0,1.0,5/5,58.28%,RALB;PIP4K2A;RAB3GAP1;SH3GLB1;RAB3GAP2
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.39640660135021355,-0.6794679362233694,0.8780487804878049,1.0,1.0,1/13,9.99%,KLF4
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.44574198902668705,-0.6790878631114886,0.875,1.0,1.0,1/6,15.24%,RIOK3
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.4845475029579203,-0.6775596614083595,0.8970588235294118,1.0,1.0,1/5,8.41%,WDR48
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.39311070434609446,-0.6773743934469939,0.8732394366197183,1.0,1.0,7/16,19.89%,PNP;ANXA1;PRNP;PLCG2;ZFP36;MALT1;CD34
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.36175143888732764,0.6773534639285926,0.8,1.0,1.0,1/7,9.35%,TMCC1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3763342244418864,-0.6765241685257767,0.8734177215189873,1.0,1.0,3/19,12.72%,PIK3R1;FLT1;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.43387959664705383,-0.6763109299688695,0.873015873015873,1.0,1.0,1/8,4.83%,HIF1A
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.43387959664705383,-0.6763109299688695,0.873015873015873,1.0,1.0,1/8,4.83%,HIF1A
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.36552303453556556,0.6762490954029079,0.9032258064516129,1.0,1.0,2/6,15.52%,SFSWAP;RBMX
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.36552303453556556,0.6762490954029079,0.9032258064516129,1.0,1.0,2/6,15.52%,SFSWAP;RBMX
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.38855656697009117,0.6759605946974683,0.8,1.0,1.0,7/7,61.21%,MAPKBP1;ITCH;IFI16;IRAK3;ILRUN;PCBP2;CARD8
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.3562186829780002,-0.675874496823458,0.8837209302325582,1.0,1.0,9/35,22.12%,PRKAG2;RAP1A;TRIB2;PAK2;CDKN1A;WWTR1;LCP2;ECT2;SPRED1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.380630342490314,0.6757807493331068,0.7804878048780488,1.0,1.0,2/6,13.47%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.3910866567177321,-0.6757651897331224,0.9058823529411765,1.0,1.0,5/19,17.32%,ATG12;RB1CC1;RAB1A;GABARAPL1;PIK3C3
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.43548543724730826,-0.6755857659710361,0.8695652173913043,1.0,1.0,2/6,9.99%,MBP;KLF4
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.411158480615987,-0.6750903857622188,0.8780487804878049,1.0,1.0,5/11,27.21%,ATP1A1;ANK3;DLG1;AHCYL1;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3625214323996084,-0.674600240912784,0.9375,1.0,1.0,5/26,16.36%,CDKN1B;PRKN;PRNP;CDKN1A;WWTR1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.44128018523674384,-0.6741517739633031,0.8873239436619719,1.0,1.0,1/7,4.65%,SCP2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.3627901654147133,0.6735853887542534,0.8260869565217391,1.0,1.0,1/10,1.56%,ARHGAP12
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.42196193197253,-0.6735814195281756,0.8666666666666667,1.0,1.0,1/7,4.70%,SPG7
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.4145426801513158,-0.6732199920420328,0.9104477611940298,1.0,1.0,3/10,14.49%,DUSP1;ITGB5;DUSP5
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.34976021768491183,-0.6723495426226587,0.9058823529411765,1.0,1.0,5/26,16.98%,LIMS1;PPFIA2;CTNND2;SMAD3;RAB8B
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.3488849140744209,0.6719639811166691,0.90625,1.0,1.0,4/14,12.23%,HDAC9;TBL1X;BAZ2A;TBL1XR1
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2882247553465505,0.6719260332722227,0.9375,1.0,1.0,8/26,17.83%,TNRC6C;ATF7IP;MED27;MED23;MED15;TNRC6A;PTEN;TCF7L2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3513513717014363,-0.6718440876062843,0.927710843373494,1.0,1.0,7/25,26.69%,RAPGEF3;PINK1;TBK1;SH2D3C;EGFR;HSP90AA1;TERF2IP
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.447657244578828,-0.6712299816488885,0.8529411764705882,1.0,1.0,4/7,32.32%,LARS1;MTOR;UBR1;SESN3
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.447657244578828,-0.6712299816488885,0.8529411764705882,1.0,1.0,4/7,32.32%,LARS1;MTOR;UBR1;SESN3
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.3580243492802503,-0.6712021912716625,0.9397590361445783,1.0,1.0,4/28,18.30%,HIP1R;PRKN;AMFR;CLDN5
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.4171675860979168,-0.6706178509227544,0.92,1.0,1.0,2/8,20.25%,MCL1;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.3829433301814671,-0.6703037278078279,0.9315068493150684,1.0,1.0,2/17,3.76%,CX3CL1;SPOCK1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.44440005481624634,-0.6701929145862329,0.921875,1.0,1.0,2/6,15.71%,CFL1;KPNB1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.336472658292889,0.6701771711473221,0.8888888888888888,1.0,1.0,2/8,13.40%,CCM2;RBPJ
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.40651609371297887,-0.6700289062086028,0.8552631578947368,1.0,1.0,3/11,19.34%,LCP2;IL18R1;CHSY1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.39924026262680723,-0.6694062882368421,0.8695652173913043,1.0,1.0,2/13,14.33%,HIP1R;PPP3CC
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.41888755497574554,-0.669202514733949,0.8695652173913043,1.0,1.0,4/9,26.40%,MEF2A;PTMA;THRB;POLR2B
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.3802401136397065,-0.6680507152966939,0.9154929577464789,1.0,1.0,1/12,4.44%,KDM1A
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.38418790261905544,0.6679310647410605,0.8518518518518519,1.0,1.0,2/7,12.46%,PRKD1;TEK
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.42219201547406515,-0.6676002699236552,0.8787878787878788,1.0,1.0,3/9,20.33%,PRKN;PINK1;CLU
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.38928327871188795,-0.6672856935910805,0.8939393939393939,1.0,1.0,1/13,4.62%,SLC6A6
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.3793616733501184,0.6672827398579807,0.8529411764705882,1.0,1.0,1/6,2.13%,TBC1D5
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.3485290422634811,-0.6672176129820206,0.8924731182795699,1.0,1.0,3/42,5.45%,NR4A1;PPARG;ESR2
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.4301458522559334,-0.6663597500206562,0.8571428571428571,1.0,1.0,3/6,33.98%,ELP4;SRP14;STXBP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),-0.44268674388397256,-0.6659562740927992,0.9,1.0,1.0,2/5,45.77%,DIP2A;SIRT1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.4392036672372206,-0.6656403443970008,0.8448275862068966,1.0,1.0,2/5,29.72%,B2M;ERAP1
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.3793388169096269,-0.6654201540633179,0.8875,1.0,1.0,5/19,20.59%,FOXK1;PINK1;MCL1;MTOR;TLK2
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.3818031167768279,-0.664234053981904,0.8985507246376812,1.0,1.0,1/10,4.44%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.3791217966424965,-0.6635831144085772,0.9041095890410958,1.0,1.0,4/12,26.69%,CDKN1A;ACVRL1;KMT2A;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.44375256099388694,-0.663552887300241,0.9253731343283582,1.0,1.0,2/6,10.23%,RAB11FIP3;PRKN
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.4026033876422722,-0.6633727830486065,0.8888888888888888,1.0,1.0,2/11,8.20%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.32809763104886375,0.6624842808837736,0.9655172413793104,1.0,1.0,3/12,16.10%,SLC25A29;TRPM7;PKD2
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.39910615498283164,-0.6621866272140333,0.9459459459459459,1.0,1.0,2/9,20.25%,MCL1;ITGB1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.36606550860488885,0.6617786453570819,1.0,1.0,1.0,2/8,4.88%,MFF;HSPD1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.40745840805430705,-0.6610858534989603,0.8666666666666667,1.0,1.0,3/7,32.24%,MAP3K13;FZD4;MFSD2A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.3641530381038716,-0.660623684760636,0.9146341463414634,1.0,1.0,14/36,29.93%,HIF1A;TMSB4X;FGFR1;BCAR1;SPARC;GATA2;SCARB1;PIK3CB;ANXA3;SASH1;ATOH8;CALR;RHOB;RAC1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.41151186830189024,-0.6605808404814953,0.8923076923076924,1.0,1.0,2/7,19.65%,SAMD8;AGPAT4
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.42412087424277206,-0.6566401244817462,0.9428571428571428,1.0,1.0,3/7,21.50%,SLC8A1;CACNA1C;MICU2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.38798948317256654,0.6562573686526489,0.8181818181818182,1.0,1.0,1/5,12.69%,ACVR1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.3268595474598795,-0.6560163162419635,0.9647058823529412,1.0,1.0,11/54,21.13%,TIMP3;GGT5;REL;IL1RAPL1;CALCOCO2;ANXA1;SMAD3;TBK1;MCL1;IL18R1;IFITM3
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.340491599404923,-0.6559711287905893,0.891566265060241,1.0,1.0,10/34,22.82%,SLC6A6;SLC8A1;ATP1B3;CACNA1C;SLC30A1;SCN3A;ATP1A1;SCN2A;RYR3;TMEM165
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.42300328405887266,-0.6557926534137438,0.8870967741935484,1.0,1.0,1/8,10.88%,DLC1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.41240877564065775,-0.6552094974717427,0.918918918918919,1.0,1.0,3/10,28.66%,HSP90AA1;TERF2IP;RFC1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.41240877564065775,-0.6552094974717427,0.918918918918919,1.0,1.0,3/10,28.66%,HSP90AA1;TERF2IP;RFC1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.41240877564065775,-0.6552094974717427,0.918918918918919,1.0,1.0,3/10,28.66%,HSP90AA1;TERF2IP;RFC1
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.44001909023137775,-0.6542873721788497,0.9,1.0,1.0,1/5,4.08%,ENPP2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.4228916587593823,-0.6531374982450652,0.8387096774193549,1.0,1.0,1/5,16.98%,RAB8B
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.43965020937162946,0.6525165082662892,0.8888888888888888,1.0,1.0,2/5,11.01%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.3837018478205374,-0.6522320924803382,0.8648648648648649,1.0,1.0,2/12,9.61%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.414619527054438,-0.6521448520385118,0.8636363636363636,1.0,1.0,3/5,32.04%,ATP1A1;TFPI;ABHD2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.36671154686792073,-0.6516798966819025,0.918918918918919,1.0,1.0,4/15,14.82%,ANK2;FGFR1;CTNND2;BCAR1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.33097671511889076,0.651417028949855,0.9117647058823529,1.0,1.0,3/10,15.34%,NDUFS4;NDUFAF2;IMMP2L
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.41018556613966467,-0.650985243578087,0.9066666666666666,1.0,1.0,3/10,24.84%,DNM2;TF;ATP6V1E1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.4299454120093581,0.6492145202506124,0.8125,1.0,1.0,5/5,57.06%,BCOR;UBR2;RNF168;UBE2B;RYBP
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.29552509727064236,0.6489765341334994,0.9166666666666666,1.0,1.0,4/26,12.36%,THOC1;XPO4;XPO7;NUP214
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.38501623045411004,-0.6489269904214457,0.8846153846153846,1.0,1.0,1/11,17.06%,NAA16
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.32861017069648435,-0.6480938952817379,0.946236559139785,1.0,1.0,13/44,25.16%,ARF1;AP1G1;COMMD1;MYO1B;KIF16B;RAB14;ACBD3;DNM2;CLTA;ARFGEF2;FTL;SCAMP1;KLHL20
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.43338390703161556,-0.6473307397937044,0.9552238805970149,1.0,1.0,1/5,10.23%,PRKN
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.30784582551966333,0.6472261810001448,0.96875,1.0,1.0,4/17,12.23%,HDAC9;TBL1X;BAZ2A;TBL1XR1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.29485673200649754,-0.64714520973297,1.0,1.0,1.0,19/174,16.12%,PSMC6;PSMB9;HIF1A;NFE2L2;RPS27A;RNF19A;COMMD1;KLHL7;PRKN;ARIH2;PSMA1;UBC;EPAS1;CHFR;PINK1;PELI1;AMFR;RACK1;SH3RF3
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.39992649938121955,-0.6469360917311295,0.9295774647887324,1.0,1.0,2/13,6.26%,HIF1A;FES
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.4350683108119975,-0.6456897517085664,0.8412698412698413,1.0,1.0,3/5,36.50%,TNKS2;TNKS;PARP14
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.3131526098904675,-0.6455339363482778,0.9333333333333333,1.0,1.0,20/78,23.42%,PSMC6;ZEB2;PSMB9;GPC5;PRKN;PSMA1;CDK14;CTNND2;AMFR;XIAP;WWTR1;PSMA7;CYLD;USP34;GPRC5B;PPM1A;CSNK1D;TNKS2;CCNY;EGFR
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.43215866397594677,0.6452217430521513,0.9090909090909091,1.0,1.0,1/5,2.21%,CTBP2
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.34594668772151577,-0.645085555589598,0.9518072289156626,1.0,1.0,9/24,24.82%,AFDN;LIMS1;CTNND2;SMAD3;CADM2;CTNNA1;CLDN5;CDH5;DSP
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.34615874771299576,-0.6450452463509847,0.9534883720930233,1.0,1.0,8/30,31.07%,CSTF3;ZFP36;DCP2;USP39;PTBP1;SRSF7;SFPQ;HIPK3
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.358752289615364,0.6444498688806133,0.90625,1.0,1.0,2/8,12.80%,OCLN;ROCK1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3271921327821123,-0.6441808698372877,0.9560439560439561,1.0,1.0,13/54,20.25%,JUN;FOS;SMAD7;LRRC32;RPS27A;UBC;ITGB5;SMAD3;ACVRL1;CLDN5;DUSP22;SMAD5;ITGB1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.3348309868573708,0.6440148254072421,0.9333333333333333,1.0,1.0,2/14,7.48%,PLCB4;PPIP5K2
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.3348309868573708,0.6440148254072421,0.9333333333333333,1.0,1.0,2/14,7.48%,PLCB4;PPIP5K2
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.3774487731561105,-0.6431497134459477,0.9117647058823529,1.0,1.0,5/14,31.54%,LRRC8B;SLC3A2;SLC5A6;SLC1A2;SLC7A5
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.34127468988101956,-0.6429339376687028,0.9523809523809523,1.0,1.0,6/28,16.54%,SCARB2;TBC1D15;VAV3;ARHGAP15;FGD4;PAFAH1B1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.39804660030852085,-0.642834053581593,0.9166666666666666,1.0,1.0,3/12,11.63%,GRM7;SLC52A3;SERPINB6
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.39804660030852085,-0.642834053581593,0.9166666666666666,1.0,1.0,3/12,11.63%,GRM7;SLC52A3;SERPINB6
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.38350124758189214,-0.6426318446750356,0.8961038961038961,1.0,1.0,4/10,37.15%,NCK1;TNS2;PTPN1;GRB10
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.3916292628181969,-0.6421421584307486,0.9375,1.0,1.0,4/12,29.98%,TIE1;ROBO2;DLL4;EFNA1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.390058394790602,-0.6409669400059921,0.8441558441558441,1.0,1.0,1/12,11.99%,MEF2A
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.3363416984478423,-0.6404921350317665,0.9444444444444444,1.0,1.0,11/44,25.91%,FES;DUSP1;TPM1;TGM2;RSU1;ACVRL1;PODXL;PLXNA2;ADGRG1;ATXN3;RASA1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.355063331783924,0.6403258422573447,0.8620689655172413,1.0,1.0,2/7,13.47%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.3721739017798271,-0.6392613967795218,0.9487179487179487,1.0,1.0,3/16,13.21%,WDR48;PINK1;OGT
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.40368735413752493,-0.6387321570766635,0.8656716417910447,1.0,1.0,2/6,27.21%,TPR;NEDD4
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.4124432783465134,-0.6384255253524461,0.9605263157894737,1.0,1.0,2/8,10.83%,PCK1;ANXA1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.41842140407636985,-0.6362726523551898,0.9154929577464789,1.0,1.0,2/10,24.66%,ACVRL1;DLL4
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.41138762893572256,-0.6362682069602354,0.8833333333333333,1.0,1.0,1/6,4.83%,HIF1A
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.31663642756249033,-0.6353873282279842,0.9411764705882353,1.0,1.0,11/35,28.48%,KIAA1217;TIMP3;GJA1;EPAS1;PLSCR4;CALD1;CDH5;EGFR;SASH1;SPARCL1;TNS2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.37395567783416067,-0.635305242444002,0.8955223880597015,1.0,1.0,4/12,29.05%,PINK1;PPA2;SLC25A36;BCL2L1
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.3707404033639424,0.6349825896082566,0.9655172413793104,1.0,1.0,1/7,4.65%,RALA
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.2949649536552878,-0.6347843105384348,0.9693877551020408,1.0,1.0,11/119,14.72%,PSMC6;PSMB9;RPS27A;RNF19A;PRKN;ARIH2;PSMA1;UBC;CHFR;PELI1;AMFR
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.3167119894581054,0.6346654040971879,1.0,1.0,1.0,1/17,1.84%,ATR
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.40932005639957153,-0.6343595778215818,0.8870967741935484,1.0,1.0,3/6,28.56%,EMP2;CAMK2D;CCDC88C
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.42222213999306796,-0.6338056807935126,0.9104477611940298,1.0,1.0,2/6,24.79%,ZDHHC21;VCL
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.3251959156069528,-0.6330642486335248,0.9340659340659341,1.0,1.0,4/47,9.61%,CX3CL1;ERBB4;TIMP3;RAP1A
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.3554324444344684,-0.632937948902931,0.9382716049382716,1.0,1.0,6/20,27.05%,ARID5A;ATP1A1;ROBO2;THRB;TFPI;STAT5B
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.30440216776836176,-0.6328445779260429,0.9591836734693877,1.0,1.0,27/109,23.81%,PPARG;CANX;ARF1;LAMP2;TBC1D15;SNX6;RAB21;NPM1;GOLPH3;TMED10;COPA;LRP1B;RAB14;RAB1A;ARL4A;RAB8B;MIA2;DNM2;ANK3;TBC1D9;USO1;CLU;PREPL;ARRDC3;TF;ARL5B;SCAMP1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.41394297952850845,-0.632096335416755,0.921875,1.0,1.0,2/6,19.63%,PINK1;PIKFYVE
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.3286365149854209,-0.6311504009506301,0.9878048780487805,1.0,1.0,6/25,18.28%,MGLL;SLC8A1;GAS7;CPEB4;SOD2;CHL1
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.33100740805543255,-0.630117570828708,0.9390243902439024,1.0,1.0,4/25,19.31%,PLOD2;PIAS2;TPR;NUP54
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.387448714538708,-0.6299443427797173,0.948051948051948,1.0,1.0,3/13,24.84%,DNM2;TF;ATP6V1E1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.3555487136079271,-0.6266802147565987,0.9722222222222222,1.0,1.0,5/13,27.28%,CD55;MALT1;B2M;ZBTB1;HLA-B
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.43590786485183736,-0.6261719336803987,0.8805970149253731,1.0,1.0,1/5,17.81%,MYEF2
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.435562338525201,-0.6257191407895173,0.9253731343283582,1.0,1.0,1/5,19.21%,ROBO2
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.3719575460569029,-0.6256070149856052,0.8769230769230769,1.0,1.0,3/9,25.16%,TPR;IFITM3;KLHL20
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3566324675767352,0.6250737312774943,0.896551724137931,1.0,1.0,1/7,8.31%,ATM
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.3525570888686883,-0.6248226332526059,0.9390243902439024,1.0,1.0,1/15,4.44%,KDM1A
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.338582214681198,-0.6242719107208813,0.9642857142857143,1.0,1.0,2/19,9.09%,TPM1;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.3515413409079121,-0.6240848621451631,0.9736842105263158,1.0,1.0,2/18,12.85%,PIK3R1;GPM6A
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.3416418487790542,-0.6240424588371528,0.9305555555555556,1.0,1.0,4/21,13.86%,FES;PRKCE;PINK1;NCK1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.41931550989123223,-0.6232868868477496,0.8955223880597015,1.0,1.0,1/6,25.36%,AGO2
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.4242776240978487,-0.6224804186830337,0.9178082191780822,1.0,1.0,1/6,6.67%,FOXF1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.32824229659118487,0.6221463424950276,0.9166666666666666,1.0,1.0,3/7,18.02%,KMT5B;SHLD2;PARP9
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.3842253279380051,-0.6218790596635053,0.9333333333333333,1.0,1.0,3/12,23.42%,PRNP;CLU;EGFR
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4281501800967435,-0.6217532335839611,0.9180327868852459,1.0,1.0,1/5,21.65%,PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.35035024204862575,-0.6211571830832536,0.9390243902439024,1.0,1.0,4/17,20.90%,IFNGR1;PLCG2;CLU;ARFGEF2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.35035024204862575,-0.6211571830832536,0.9390243902439024,1.0,1.0,4/17,20.90%,IFNGR1;PLCG2;CLU;ARFGEF2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.39699568408471536,-0.6209219977696655,0.8939393939393939,1.0,1.0,2/8,23.42%,CCNY;EGFR
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.36381550503949,-0.6200124177081753,0.9240506329113924,1.0,1.0,4/18,14.51%,SLC20A2;SLC8A1;SLC26A2;SLC20A1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.4029352609316976,-0.619788044110452,0.8648648648648649,1.0,1.0,1/9,11.99%,MEF2A
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.40938622113827217,-0.6189326921676609,0.9090909090909091,1.0,1.0,1/5,22.48%,UNC5C
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.39876461410173536,-0.6189048603600948,0.9354838709677419,1.0,1.0,2/6,33.62%,B4GALT1;ST6GALNAC3
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.42563849881093474,-0.618572731842259,0.9333333333333333,1.0,1.0,1/5,6.67%,FOXF1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.40159975790837904,-0.6183081485890327,0.918918918918919,1.0,1.0,2/6,29.41%,MTOR;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3782427997904477,-0.6178792708734344,0.927536231884058,1.0,1.0,4/7,42.81%,HLA-B;HLA-E;HLA-F;CYRIB
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.41817740317384633,-0.6176692589403686,0.9104477611940298,1.0,1.0,4/6,40.42%,MYEF2;ADGRB3;MEF2C;SORT1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.27372751797075784,0.6175150441705468,0.9230769230769231,1.0,1.0,4/16,13.16%,EIF2AK2;NFAT5;NOD1;PDCD4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.36598631545047683,0.6174073477279765,0.92,1.0,1.0,1/7,3.17%,TNRC6C
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.36598631545047683,0.6174073477279765,0.92,1.0,1.0,1/7,3.17%,TNRC6C
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.38220948161705054,-0.6173644383617052,0.9508196721311475,1.0,1.0,3/10,25.16%,KIF16B;RAB14;KLHL20
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.25259931129213486,0.6153382300440002,1.0,1.0,1.0,3/36,7.11%,CPEB3;LARP4B;SLC25A37
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.29846576464662794,0.6152749941407131,1.0,1.0,1.0,3/15,10.88%,USP25;OPHN1;PSMF1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.33808759910775354,0.6146728725994581,0.8292682926829268,1.0,1.0,1/5,7.58%,ABL1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.30334624720297076,-0.6140516337753711,0.9894736842105263,1.0,1.0,10/93,14.28%,NR4A1;PPARG;ESR2;ELL2;RREB1;AFF4;CCNH;CSTF3;NOTCH4;ELP4
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3504748992081519,-0.6140135843036025,0.9166666666666666,1.0,1.0,2/15,14.02%,ZC3H7A;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.4046988079705573,-0.6135617577279064,0.9285714285714286,1.0,1.0,3/7,26.17%,GADD45B;RELL1;SASH1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.3470017215180001,0.6134740336873427,0.8611111111111112,1.0,1.0,1/5,8.54%,PLAAT3
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.33431250919287475,-0.6132647977136547,0.948051948051948,1.0,1.0,11/27,29.98%,IFNGR1;NPM1;RACK1;PICALM;SLC2A13;MTOR;CLU;VIM;NSMAF;LARP4;EFNA1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.2847835143662828,0.6131099329380421,1.0,1.0,1.0,2/14,10.25%,CPEB3;SESN1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.37082476914356044,-0.6119447148255801,0.9154929577464789,1.0,1.0,3/13,13.06%,MBP;HYAL2;PLCG2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.3153871131610727,0.611660570929553,0.9583333333333334,1.0,1.0,1/10,5.74%,RCSD1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.3745775929295555,0.610783771211229,0.8333333333333334,1.0,1.0,5/5,62.59%,PKD2;STAT1;COL4A1;MTSS1;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4050907961159754,-0.609265656159963,0.9,1.0,1.0,2/7,23.42%,CCNY;EGFR
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.3203287223317514,0.6089648396049405,0.9166666666666666,1.0,1.0,1/8,8.31%,ATM
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.3788336510027849,-0.6088507715434375,0.8769230769230769,1.0,1.0,3/7,35.12%,B2M;ERAP1;HLA-E
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4066689525730742,-0.6074467092563672,0.9305555555555556,1.0,1.0,4/6,29.05%,FGFR1;MCL1;MAP2K5;BCL2L1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.3978463538125038,-0.6073811875192999,0.9452054794520548,1.0,1.0,2/5,30.32%,RAC1;CD74
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.3978463538125038,-0.6073811875192999,0.9452054794520548,1.0,1.0,2/5,30.32%,RAC1;CD74
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.3978463538125038,-0.6073811875192999,0.9452054794520548,1.0,1.0,2/5,30.32%,RAC1;CD74
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.3922413504067588,-0.6072604521978038,0.9264705882352942,1.0,1.0,4/7,27.21%,SLC2A1;NEDD4L;CTTNBP2NL;NEDD4
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3321889059871587,0.6071408799243604,0.8857142857142857,1.0,1.0,1/8,7.97%,TMEM106B
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.39546585257450595,-0.6069758773131417,0.84375,1.0,1.0,2/6,16.23%,NFE2L2;SOD2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.3642745709828392,0.6068863458379881,0.9166666666666666,1.0,1.0,6/6,63.63%,PARN;XRN1;DIS3L2;TUT4;MTREX;SND1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.4099992956807398,-0.6067652829095072,0.9428571428571428,1.0,1.0,1/5,17.86%,CHD1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.3742280493662346,0.6058097463177049,0.9142857142857143,1.0,1.0,1/5,10.98%,NCOA3
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.3104567396008691,-0.6056247178488477,0.9880952380952381,1.0,1.0,7/42,20.04%,GPM6B;HIP1R;DLC1;PAK2;ARHGAP17;CYLD;MTOR
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.37443463936098287,0.6053464189799508,0.8947368421052632,1.0,1.0,1/5,13.16%,PDCD4
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.4163998274034198,-0.6050911308596574,0.9,1.0,1.0,2/6,21.78%,MYL6;CAV2
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.38855140877106586,-0.6048863346133508,0.9016393442622951,1.0,1.0,1/5,20.04%,MTOR
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.3256641592378298,0.603819128534489,0.9333333333333333,1.0,1.0,2/8,10.64%,IL6R;TNFRSF1B
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4002618463109907,-0.6036046484102772,0.9545454545454546,1.0,1.0,1/6,11.01%,NDUFA12
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.4002618463109907,-0.6036046484102772,0.9545454545454546,1.0,1.0,1/6,11.01%,NDUFA12
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.32444207142273107,-0.6022192767621337,0.9625,1.0,1.0,9/29,29.08%,PIK3R1;FLT1;FGFR1;PIP5K1C;EGFR;PIK3CB;PPP1R16B;NEDD4;DIPK2A
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.36107604810464655,-0.6022028276924906,0.96,1.0,1.0,1/20,1.27%,BTG2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.32810461797112933,-0.6021833231454221,0.9375,1.0,1.0,4/21,19.08%,GAS7;DCLK1;GPM6A;DNM2
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.37684698958715046,-0.601743307799232,0.9166666666666666,1.0,1.0,1/8,11.60%,NPM1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.37684698958715046,-0.601743307799232,0.9166666666666666,1.0,1.0,1/8,11.60%,NPM1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.37684698958715046,-0.601743307799232,0.9166666666666666,1.0,1.0,1/8,11.60%,NPM1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.37684698958715046,-0.601743307799232,0.9166666666666666,1.0,1.0,1/8,11.60%,NPM1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.34407974046749823,-0.60172075617354,0.9390243902439024,1.0,1.0,2/18,10.28%,PLCL1;LAMA4
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.3292898436487311,-0.6016608040269859,1.0,1.0,1.0,3/26,9.42%,JAK1;IFNGR2;IFNGR1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.38199001683120914,-0.6016058781593779,0.8783783783783784,1.0,1.0,1/10,11.99%,MEF2A
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.3433027464859707,-0.6013358024557955,0.9615384615384616,1.0,1.0,3/16,28.25%,VAPB;POLR2B;PABPC1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.3528590792972055,-0.6005746580026347,0.875,1.0,1.0,1/11,11.60%,NPM1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.37591845336598345,-0.5999086604269844,0.9230769230769231,1.0,1.0,3/7,32.04%,ATP1A1;TFPI;ABHD2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.4019056293971325,-0.5995381924051246,0.9344262295081968,0.9997450483268562,1.0,2/5,31.02%,MTOR;SMARCA4
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.39567700472119116,-0.5992650743121357,0.9206349206349206,0.999432400216295,1.0,1/5,16.54%,PAFAH1B1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.27124994185796386,0.5992242754922055,1.0,1.0,1.0,1/16,3.76%,INO80
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.34210151738926176,0.599168992947532,0.9714285714285714,1.0,1.0,3/6,18.90%,WWC3;PTEN;LATS1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.3558398006747855,-0.5986675824879503,0.9726027397260274,0.9993629201143525,1.0,2/14,13.29%,KDM1A;PTTG1IP
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3845117996565689,-0.5985174217097234,0.9420289855072463,0.9989990975530845,1.0,1/9,5.76%,HMGN1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.35445177754189183,-0.5984249661544114,0.961038961038961,0.9985685047104534,1.0,3/12,15.84%,CDKN1B;PLCG2;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.3335216462954606,0.5963394665186411,0.8823529411764706,1.0,1.0,3/10,12.80%,ABL1;TEK;ROCK1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.337082076780597,-0.5960355748273314,0.9506172839506173,0.9993716009238064,1.0,4/14,20.25%,PECAM1;HMCN1;ROBO2;ITGB1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.34286456979464514,0.5950005443532255,0.8125,1.0,1.0,5/5,65.76%,EPC1;TRRAP;MORF4L2;MORF4L1;EP400
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.3612039287278309,-0.5939972686649124,0.9,1.0,1.0,2/7,31.65%,GLI3;KIAA0586
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.3611004918578361,-0.5937083615655566,0.9487179487179487,0.9997846439342549,1.0,2/13,19.34%,S1PR1;CHSY1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.33922400161944066,0.5936291529413273,0.9375,1.0,1.0,1/6,6.36%,MTMR3
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.38591652543022004,-0.5931901262261484,0.9571428571428572,0.9996121367284159,1.0,2/7,34.24%,MAP3K13;CDKL5
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.32472160950949147,-0.592306104598111,0.9523809523809523,0.9996458101365864,1.0,4/21,14.04%,HSPA5;PRKN;TMBIM6;HERPUD1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.3372334893395734,0.5919791814797956,1.0,1.0,1.0,6/6,66.33%,SKI;CDC73;NF1;MORC3;FTH1;DAB2IP
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.3720018777252056,-0.5913348079239891,0.9285714285714286,0.9997412281174083,1.0,1/9,11.60%,NPM1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.299621975954947,0.5907659595111079,1.0,1.0,1.0,3/11,12.15%,TENT2;SCAF8;PNPT1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.299621975954947,0.5907659595111079,1.0,1.0,1.0,3/11,12.15%,TENT2;SCAF8;PNPT1
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.4074478860497414,-0.5893802320825622,0.9333333333333333,1.0,1.0,1/5,8.28%,SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.34677845584335987,0.5887933078762488,0.972972972972973,1.0,1.0,1/6,13.16%,PDCD4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.39539102911699414,-0.5887597402747662,0.9310344827586207,1.0,1.0,3/5,23.94%,JCAD;CD63;PIK3CB
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.37186901948779166,-0.5880735542816479,0.972972972972973,1.0,1.0,6/14,34.01%,DLG1;RHOA;PPP2R3C;RHOB;RAC1;FMNL3
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.3401591596030795,-0.5864189648453948,0.9545454545454546,1.0,1.0,4/11,31.54%,SLC38A2;SLC3A2;SLC1A2;SLC7A5
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.3731101923914322,-0.5862172939704577,0.8805970149253731,1.0,1.0,2/5,23.13%,AFDN;CDH5
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.30125425701483505,-0.5857909400256979,0.9647058823529412,0.9998960388165992,1.0,5/36,15.21%,SULF2;PRKN;CDK14;CTNND2;RACK1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.34277174731342536,-0.5845287082737192,0.961038961038961,1.0,1.0,4/15,19.91%,LRRC7;MSN;DLG1;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.36113513170284295,0.5835286649480108,0.9705882352941176,1.0,1.0,1/5,5.87%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.36113513170284295,0.5835286649480108,0.9705882352941176,1.0,1.0,1/5,5.87%,HSPA1A
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.29030191821256757,-0.5831468484186408,1.0,1.0,1.0,2/58,3.74%,EHD4;RAB11FIP3
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.33482088706827673,0.5826766036038077,0.875,1.0,1.0,1/7,8.23%,INVS
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.37375348320521334,-0.5826057409554107,0.9493670886075949,1.0,1.0,3/9,23.49%,ZFP36;CBFB;PRKCH
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.38241954254459665,-0.5805725835073089,0.972972972972973,1.0,1.0,2/7,26.38%,MSN;RHOA
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.35583342403535523,-0.5804046469363368,0.9722222222222222,1.0,1.0,3/10,22.98%,NPAS2;MCL1;BCLAF1
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.3945335361521086,-0.5802053103937516,0.9264705882352942,1.0,1.0,2/7,19.94%,SLC30A1;MT1M
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.3940331190505892,0.5794141063308137,0.9302325581395349,1.0,1.0,1/5,6.15%,ATF7IP
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3940331190505892,0.5794141063308137,0.9302325581395349,1.0,1.0,1/5,6.15%,ATF7IP
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.315308493079642,-0.5793745728568628,0.9764705882352941,1.0,1.0,8/27,23.73%,NDFIP1;ARF1;PRNP;SLC30A1;MT1M;FTL;TF;CUL1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.341274113080131,0.5792128369381303,0.90625,1.0,1.0,1/6,12.15%,PNPT1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.3035048428828258,0.5789238320335252,0.96875,1.0,1.0,2/6,18.04%,PTEN;ARHGAP35
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.29028871522831723,0.5788314597677617,0.9565217391304348,1.0,1.0,4/12,16.69%,NKD1;PPARD;RBPJ;NUMB
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.34645231274989363,0.578618026779327,0.9375,1.0,1.0,1/7,5.50%,RAB11FIP2
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.29414301012511007,-0.5782237219576309,1.0,1.0,1.0,1/30,2.15%,EHD4
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.2986693420831833,-0.5778489169253301,0.9782608695652174,0.9998838100988535,1.0,6/52,13.06%,CX3CL1;ERBB4;FLT1;RAP1A;FGFR1;PLCG2
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.3724216095348012,-0.5777316461790113,0.9375,0.999431684787278,1.0,2/7,24.33%,CDK6;B2M
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.28999158656314267,0.5774295442858288,0.9629629629629629,1.0,1.0,1/12,3.76%,INO80
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.3409962577645291,-0.5773302622106824,0.9404761904761905,0.9991536244111522,1.0,4/15,23.49%,RAP1A;CLDN5;CBFB;PRKCH
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.27534784937926404,0.5768396611927246,0.9565217391304348,1.0,1.0,2/16,9.76%,EFNA5;ZMYM4
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.2923276983094929,0.5756569450419272,0.9032258064516129,1.0,1.0,7/7,70.82%,ROCK1;ACTG1;ROCK2;AKAP13;CDC42;RAC1;ALMS1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.3158548335455603,-0.5740958064740102,0.9891304347826086,1.0,1.0,8/36,19.83%,MAP3K5;PRKN;SDCBP;PINK1;SH3RF3;CYLD;GADD45B;DUSP22
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.3244495587172187,0.5726289292968405,0.9259259259259259,1.0,1.0,1/7,9.24%,SEMA6A
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.3622544660436867,-0.5723397455725411,0.9692307692307692,1.0,1.0,3/5,42.06%,HLA-B;HLA-E;HLA-F
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.35767991093038504,-0.5709895455719949,0.9696969696969697,1.0,1.0,2/8,30.19%,RBM17;SFPQ
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.36622383892290733,-0.5707068232673852,0.9538461538461539,1.0,1.0,2/7,20.04%,RREB1;MTOR
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.37492145866775195,0.5705961015659446,0.9459459459459459,1.0,1.0,1/5,3.12%,ALS2
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.33696245317515927,-0.5691352981216783,0.9629629629629629,1.0,1.0,2/13,17.91%,CDKN1A;ACVRL1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.37982297845594987,-0.5671830253437741,1.0,1.0,1.0,1/6,14.33%,PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.37982297845594987,-0.5671830253437741,1.0,1.0,1.0,1/6,14.33%,PPP3CC
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3757951425310622,-0.5670946853938436,0.9142857142857143,1.0,1.0,2/5,31.75%,RIF1;SMCHD1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.34165430813609177,0.5654187640032043,0.9,1.0,1.0,2/5,15.01%,KMT5B;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.34165430813609177,0.5654187640032043,0.9,1.0,1.0,2/5,15.01%,KMT5B;SHLD2
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.3084324369210205,-0.5634781354247279,0.9625,1.0,1.0,5/23,24.25%,RAD21;KPNB1;CHMP4B;EML4;RAB11A
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.3494775161748808,-0.5617923169799701,0.9852941176470589,1.0,1.0,5/15,24.48%,ADSS2;SULT1C4;GNAI3;MFN1;ACOT9
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.3218621652197516,-0.5616887777035771,0.9871794871794872,1.0,1.0,5/21,18.90%,TNS1;MSRB3;LAMA4;CALD1;SPARC
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.29227706889762756,-0.5608260204905687,1.0,1.0,1.0,6/24,32.27%,DDX24;PTBP1;POLR2B;WTAP;HNRNPA3;MMS19
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.3131900730061076,-0.55794969059301,0.9876543209876543,1.0,1.0,8/19,33.72%,CDK6;SPARC;CAV2;B2M;NFIB;ATOH8;CASK;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3057874792418558,0.5575465258348772,0.925,1.0,1.0,3/6,22.35%,KMT5B;SHLD2;NECTIN2
prerank,PanglaoDB_Augmented_2021__B Cells,0.265051089713262,0.5572381602803449,0.9,1.0,1.0,3/15,11.60%,RCSD1;RASGRP3;EBF1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.3354906154987012,-0.5567534976860767,0.9859154929577465,1.0,1.0,3/12,14.12%,JAG2;NCK1;MSN
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3854251581802576,-0.5559688913363237,1.0,1.0,1.0,2/6,26.38%,MSN;RHOA
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.3365439734205617,-0.5553539788846993,0.987012987012987,1.0,1.0,2/10,21.81%,CYREN;RIF1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3422033723437748,-0.5549374350176308,0.9466666666666667,1.0,1.0,3/10,28.79%,TPR;NUP54;NUP98
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.3422033723437748,-0.5549374350176308,0.9466666666666667,1.0,1.0,3/10,28.79%,TPR;NUP54;NUP98
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.3422033723437748,-0.5549374350176308,0.9466666666666667,1.0,1.0,3/10,28.79%,TPR;NUP54;NUP98
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.317702563090162,0.5541484119714751,0.9655172413793104,1.0,1.0,1/5,8.31%,ATM
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3738911769877173,-0.5495309404715818,0.9710144927536232,1.0,1.0,3/7,26.82%,GOLPH3;ITGB1;GCNT1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.26763863577193425,0.547375357955655,0.9666666666666667,1.0,1.0,11/11,73.31%,KAT6B;TRRAP;MORF4L2;EP300;NAA50;MORF4L1;PHF20;CREBBP;KAT6A;KAT2B;PHF20L1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.28907228273163493,0.5467904424353313,0.9259259259259259,1.0,1.0,2/8,10.25%,ATM;SESN1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.2620935813488996,-0.5464337057876276,1.0,1.0,1.0,19/77,30.69%,YTHDC1;CSTF3;HNRNPH3;SRRM1;RNPC3;STRAP;RBM17;TRA2B;USP39;PRPF40A;SPEN;PTBP1;POLR2B;PABPC1;CWF19L2;SRSF7;SFPQ;HNRNPA3;CWC22
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.3751679948633047,-0.5460725638050555,0.967741935483871,1.0,1.0,3/5,29.98%,SMAD5;DSP;EFNA1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.2605158611564901,-0.5458858861819057,1.0,1.0,1.0,18/71,30.69%,YTHDC1;CSTF3;HNRNPH3;SRRM1;RNPC3;RBM17;TRA2B;USP39;PRPF40A;SPEN;PTBP1;POLR2B;PABPC1;CWF19L2;SRSF7;SFPQ;HNRNPA3;CWC22
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.328653146125845,0.5451373957693942,0.9333333333333333,1.0,1.0,6/6,67.19%,URI1;PPP6R3;PPP6R2;HTT;HSP90B1;MTMR9
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.3489300501756798,-0.5446333488183195,0.9594594594594594,1.0,1.0,2/6,30.32%,RAC1;CD74
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.36420213127491163,-0.5437836225121988,0.9841269841269841,1.0,1.0,4/5,28.19%,KPNB1;DLG1;RAB11A;LIMK2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.3745954858392073,-0.5429115690013426,0.9571428571428572,1.0,1.0,3/6,26.82%,GOLPH3;ITGB1;GCNT1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3267178103912789,-0.5420152987599156,0.974025974025974,1.0,1.0,3/11,19.91%,LRRC7;DLG1;ERBIN
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.3454333658394152,-0.5415854911239107,0.971830985915493,1.0,1.0,2/9,10.54%,CD81;VAV3
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.31715311144820657,-0.540568759155832,0.9879518072289156,1.0,1.0,3/11,21.39%,MEF2A;CTNNA1;BOC
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.3510715093054344,-0.5405238187430211,0.9384615384615385,1.0,1.0,2/5,21.11%,TPR;CHMP4B
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.3526140074244915,-0.540065438485261,0.9594594594594594,1.0,1.0,1/6,14.82%,BCAR1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.31440235970862773,-0.5399765968714897,0.9722222222222222,0.9997779797536374,1.0,2/11,15.19%,CBX5;MAX
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.31440235970862773,-0.5399765968714897,0.9722222222222222,0.9997779797536374,1.0,2/11,15.19%,CBX5;MAX
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.32711787728066644,0.5383634200536058,0.9487179487179487,1.0,1.0,3/6,21.65%,PARP9;PARP4;PARP11
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.31701736620723414,-0.5375667052027071,0.9594594594594594,0.9997279592319492,1.0,4/9,34.09%,UGGT2;UBE2J1;MCFD2;MGAT1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.31701736620723414,-0.5375667052027071,0.9594594594594594,0.9997279592319492,1.0,4/9,34.09%,UGGT2;UBE2J1;MCFD2;MGAT1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.36047205023220447,-0.5368068814835761,0.953125,0.9994895214167545,1.0,2/5,20.38%,MSN;STK10
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.33055655912350596,-0.5359595861820121,0.9565217391304348,0.9993466889041214,1.0,3/7,28.82%,AGO2;TUT7;PRKRA
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.30273747774796483,-0.5350657354109754,0.972972972972973,0.9991989695268472,1.0,3/16,19.31%,PIAS2;TPR;NUP54
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.2825182101977108,0.534488864311217,1.0,1.0,1.0,8/8,71.81%,CIRBP;LARP1;THRAP3;NBAS;TAF15;FUS;HNRNPU;PABPC1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.3402548852439036,-0.5330939315465251,0.9428571428571428,0.9994275648144303,1.0,3/6,23.16%,CENATAC;ITGB1;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.30341343275478017,-0.5322648210175789,0.9861111111111112,0.9992298096576677,1.0,4/15,22.12%,TIMP3;DLG1;DUSP6;SPRED1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.33584611385495206,0.5307914617777517,0.9777777777777777,1.0,1.0,5/5,66.46%,HDAC4;LYPLAL1;SIRT1;LYPLA1;HDAC7
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.30671035308148975,-0.5296021940129894,0.9866666666666667,0.999748826233487,1.0,4/13,31.75%,RIF1;POLR2B;TERF2IP;SMCHD1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.32640418006721506,-0.5291149007350544,0.974025974025974,0.9994359021289688,1.0,1/11,8.41%,WDR48
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.3193580066485765,0.5284317787418852,0.9354838709677419,1.0,1.0,1/6,12.05%,ATP6V1H
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.32242875894897116,-0.5280923057727628,0.963855421686747,0.999343552060904,1.0,3/8,24.82%,CTNNA3;ITGB1;DSP
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.2759281804198494,-0.5271729540762727,1.0,0.9991612102750294,1.0,5/33,19.83%,GPM6B;DLC1;LIMS1;ACVRL1;DUSP22
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.3298816261485531,-0.5245119636555321,0.972972972972973,0.9996342905703742,1.0,2/7,30.45%,CDH5;CDH18
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.3215157595555296,-0.5238635831511922,0.9863013698630136,0.9993519894161572,1.0,4/11,33.20%,RACK1;CDH5;RAP1B;ARFGEF1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.2626189099961272,0.5233589618614924,0.9545454545454546,1.0,1.0,2/14,9.94%,MGA;PHC3
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.3066116511116701,-0.5183182320629469,0.9558823529411765,1.0,1.0,4/11,33.72%,DLC1;MAPKAP1;RASIP1;DAB2IP
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.32608178604261706,-0.5159469230737612,0.9863013698630136,1.0,1.0,2/9,18.82%,BCAR1;PLAT
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.35134478717383244,-0.5156465606209193,0.9682539682539683,1.0,1.0,1/5,10.18%,TGM2
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.28147762747138383,0.5124800115366438,0.96875,1.0,1.0,8/8,71.91%,USP6NL;AKAP9;STX18;ARMH3;PDCD10;CAMSAP2;MAPK1;MAP2K1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.3010580843145768,0.510861329399172,1.0,1.0,1.0,2/9,11.01%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),-0.3520584227251692,-0.5104512035765766,0.9733333333333334,1.0,1.0,1/5,17.91%,ACVRL1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.24026579216498029,-0.5084880742858962,1.0,1.0,1.0,21/85,31.26%,YTHDC1;CCNH;CSTF3;HNRNPH3;SRRM1;RNPC3;RBM17;TRA2B;USP39;PRPF40A;SPEN;PTBP1;POLR2B;RPRD1B;PABPC1;CWF19L2;SRSF7;SFPQ;HNRNPA3;CWC22;THOC2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.31037171822199133,0.5081699347433934,0.9333333333333333,1.0,1.0,5/5,69.00%,EIF4A2;EIF5;DHX29;EIF2S2;EIF3A
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.31141532297278296,-0.5059673270973944,0.9705882352941176,1.0,1.0,2/11,14.67%,DUSP16;TPR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.32129219038709045,-0.5058372342074434,1.0,1.0,1.0,4/8,30.71%,PLCG2;CD34;CD46;STAT3
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.33402651416688334,0.5049299548841435,0.9333333333333333,1.0,1.0,5/5,66.64%,ISG15;SP100;SETD2;TRIM56;MX1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.28839581927329117,-0.5035662347621725,1.0,1.0,1.0,1/16,9.99%,KLF4
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.28267145781196024,-0.5031384655464367,1.0,1.0,1.0,1/11,11.60%,NPM1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.3155811567608828,-0.5012568244457457,1.0,1.0,1.0,1/9,14.33%,PPP3CC
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.3011460651269437,-0.5005837614275835,0.9876543209876543,1.0,1.0,2/12,18.69%,ZFP36;DCP2
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.305692747595529,0.4999335409401647,0.9375,1.0,1.0,5/5,69.47%,ST3GAL6;SPTLC1;MGST2;SERINC1;CERK
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.3331587629688324,-0.4992625462778554,1.0,1.0,1.0,1/6,19.21%,ROBO2
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.27176874185020183,0.49783825524631226,1.0,1.0,1.0,3/8,18.90%,ARHGAP35;FCHSD2;LATS1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.2868541715920079,-0.4975007474631807,0.9868421052631579,1.0,1.0,7/21,34.71%,KPNB1;PTBP1;POLR2B;NUP98;EIF3A;TFRC;ILF3
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.30309331946971674,0.49633535215399543,1.0,1.0,1.0,5/5,69.73%,TRIM44;DHX9;IFIH1;GAS6;CD74
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.2922486301936913,-0.49448303803670596,0.9722222222222222,1.0,1.0,2/11,21.81%,CYREN;RIF1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.34385429673438817,-0.4940553607761562,1.0,1.0,1.0,2/6,41.77%,ANXA2;RAB3GAP2
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.27589055229745674,-0.49347028802908616,1.0,1.0,1.0,7/19,29.93%,GRB2;ERBIN;SHOC2;ADGRG1;PIK3CB;ARHGEF3;RAC1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.31753516519469305,-0.49200354915414357,0.9078947368421053,0.9999748521567994,1.0,2/7,34.01%,DLG1;FMNL3
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.3141762153030493,-0.48934215197780206,0.972972972972973,0.9999872728609092,1.0,1/10,9.84%,IL1RAPL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.30367799230856524,-0.4887537267983448,0.9848484848484849,0.9996626349419409,1.0,2/10,17.16%,TMED10;MALT1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.31810309456177766,-0.4877622054099478,1.0,0.9995216016266517,1.0,2/8,26.38%,MSN;RHOA
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.2652000040733432,-0.4875873425005888,0.9866666666666667,0.9991330917621938,1.0,9/18,33.15%,KPNB1;DLG1;RAB11A;CCDC88A;RHOA;LIMK2;CCDC88C;DYNC1H1;HOOK3
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.29971406290616054,0.4874557682779156,1.0,1.0,1.0,5/5,70.07%,RIC1;EPHA4;DAB2IP;ANXA2;EFNA1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.29152039281939973,-0.4826539979129979,1.0,0.9995567082739352,1.0,4/16,20.33%,KLF4;CDK6;CD34;CLU
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.24709018806772706,0.4792536899649829,1.0,1.0,1.0,1/9,7.97%,TMEM106B
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.281935524108363,-0.478257687578773,0.9873417721518988,0.9998463559532763,1.0,3/12,30.06%,TPR;NEDD4;DYNC1H1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.2817780088380557,0.4749529884000321,0.9354838709677419,1.0,1.0,5/5,71.86%,MAP4;ODF2L;YAP1;TCHP;LIMK2
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.25202213649699307,0.4747762001457537,0.96875,1.0,1.0,1/8,10.31%,PCM1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.2784711388455536,0.4740885105397649,0.9666666666666667,1.0,1.0,6/6,72.20%,SPIDR;GAPVD1;CEP290;SCFD1;KIAA0586;DNAJA1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.30798456304860117,-0.473384803542932,0.9833333333333333,1.0,1.0,2/6,30.06%,PAFAH1B1;DYNC1H1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.29213850672306185,0.4729115323363404,0.9722222222222222,0.9999113995354342,1.0,2/6,15.01%,KMT5B;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.23457432960166602,0.4726472099965215,0.9565217391304348,0.9980584162309228,1.0,11/11,76.61%,TOP2B;LARP1;ADARB1;STAU1;ADAR;SRPK1;SRPK2;PKN2;DDX3X;PABPC1;VAPB
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.23451156872231343,0.4675075957908869,1.0,0.9972959151836712,1.0,1/8,8.67%,MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.29563182527301085,0.46726324302427547,1.0,0.9954267790891307,1.0,6/6,70.48%,FCHSD2;WASF2;CYFIP1;NCKAP1;GSN;ABI2
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.2734331756607775,0.4646796593372996,1.0,0.9939908430872656,1.0,1/5,10.64%,TNFRSF1B
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.2783110694649943,-0.4645604156261746,1.0,1.0,1.0,3/10,31.54%,SLC3A2;SLC1A2;SLC7A5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.3234631986991219,-0.4622467039979488,1.0,1.0,1.0,2/5,23.42%,TEC;EGFR
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.28859465035034076,-0.46172600679520165,1.0,1.0,1.0,2/7,21.11%,TPR;CHMP4B
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.25643927674484546,-0.46013459905122767,1.0,1.0,1.0,3/19,17.19%,TNFRSF10B;SMAD3;MCL1
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.28616187207774646,-0.45926856811904565,1.0,1.0,1.0,4/11,36.50%,TNKS2;PARP12;TNKS;PARP14
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.27395460962121837,-0.4580123445808411,1.0,1.0,1.0,4/9,36.42%,AGO2;TUT7;PRKRA;SND1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.2891801840730813,-0.45329486142951414,1.0,1.0,1.0,2/7,21.11%,TPR;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.30085959191869627,0.45085078914018656,1.0,0.9948419277586475,1.0,2/5,21.94%,FCHSD2;WASF2
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.2985227084087488,-0.44163520132345757,1.0,1.0,1.0,4/9,39.72%,LRCH1;ARFGEF1;DAB2IP;RDX
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.25086402401737706,-0.4387101415382261,1.0,1.0,1.0,1/14,14.67%,TPR
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.25160839193290907,-0.4370314168944533,1.0,1.0,1.0,5/17,28.79%,TPR;NUP54;AGO2;POLR2B;NUP98
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.25160839193290907,-0.4370314168944533,1.0,1.0,1.0,5/17,28.79%,TPR;NUP54;AGO2;POLR2B;NUP98
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.29017889491154425,-0.4341954627373335,1.0,1.0,1.0,2/5,22.22%,LCP2;FTL
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.28593360326654144,-0.43356069017166665,0.9848484848484849,0.9997688301440099,1.0,3/7,33.62%,SAMD8;SPTLC2;ST6GALNAC3
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.2808600526990429,-0.42768922974178997,0.9714285714285714,0.9998500310616588,1.0,1/6,24.48%,ACOT9
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.26096907137502257,-0.4247635468880557,1.0,0.9996609976001861,1.0,3/9,25.26%,TPR;ATXN3;HSP90AA1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.2807732544620218,-0.4117283312831084,1.0,0.9997005871563011,1.0,2/5,31.85%,TUBB4B;TUBB
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.2807732544620218,-0.4117283312831084,1.0,0.9997005871563011,1.0,2/5,31.85%,TUBB4B;TUBB
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.26997455328138115,-0.40538361101183434,1.0,0.9996786592852813,1.0,2/6,24.20%,CHMP4B;TMEM50B
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.24749109950178583,-0.39883401500600524,1.0,0.9995194611952305,1.0,4/11,33.20%,RACK1;CDH5;RAP1B;ARFGEF1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.22835572370435894,-0.3758020814308137,1.0,0.9999583293178061,1.0,3/10,35.10%,IFITM3;CD74;LY6E
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.23941470234229692,-0.3658720658781065,1.0,0.9996521841366574,1.0,3/6,38.60%,TNKS2;TNKS;MAPK1
